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A B S T R A C T
Background
Mechanical methods were the first methods developed to ripen the cervix and induce labour. During recent decades they have been substi-
tuted by pharmacological methods. Potential advantages of mechanical methods, compared with pharmacological methods may include
reduction in side effects that could improve neonatal outcomes. This is an update of a review first published in 2001, last updated in 2012.
Objectives
To determine the effectiveness and safety of mechanical methods for third trimester (> 24 weeks' gestation) induction of labour in com-
parison with prostaglandin E2 (PGE2) (vaginal and intracervical), low-dose misoprostol (oral and vaginal), amniotomy or oxytocin.
Search methods
For this update, we searched Cochrane Pregnancy and Childbirth’s Trials Register, ClinicalTrials.gov, the WHO International Clinical Trials
Registry Platform (ICTRP), and reference lists of retrieved studies (9 January 2018). We updated the search in March 2019 and added the
search results to the awaiting classification section of the review.
Selection criteria
Clinical trials comparing mechanical methods used for third trimester cervical ripening or labour induction with pharmacological methods.
Mechanical methods include: (1) the introduction of a catheter through the cervix into the extra-amniotic space with balloon insufflation;
(2) introduction of laminaria tents, or their synthetic equivalent (Dilapan), into the cervical canal; (3) use of a catheter to inject fluid into
the extra-amniotic space (EASI).
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This review includes the following comparisons: (1) specific mechanical methods (balloon catheter, laminaria tents or EASI) compared
with prostaglandins (different types, different routes) or with oxytocin; (2) single balloon compared to a double balloon; (3) addition of
prostaglandins or oxytocin to mechanical methods compared with prostaglandins or oxytocin alone.
Data collection and analysis
Two review authors independently assessed trials for inclusion and assessed risk of bias. Two review authors independently extracted
data and assessed the quality of the evidence using the GRADE approach.
Main results
This review update includes a total of 113 trials (22,373 women) contributing data to 21 comparisons. Risk of bias of trials varied. Overall,
the evidence was graded from very-low to moderate quality. All evidence was downgraded for lack of blinding and, for many comparisons,
the effect estimates were too imprecise to make a valid judgement.
Balloon versus vaginal PGE2: there may be little or no difference in vaginal deliveries not achieved within 24 hours (average risk ratio
(RR) 1.01, 95% confidence interval (CI) 0.82 to 1.26; 7 studies; 1685 women; I2 = 79%; low-quality evidence) and there probably is little or no
difference in caesarean sections (RR 1.00, 95% CI 0.92 to 1.09; 28 studies; 6619 women; moderate-quality evidence) between induction
of labour with a balloon catheter and vaginal PGE2. A balloon catheter probably reduces the risk of uterine hyperstimulation with fetal
heart rate (FHR) changes (RR 0.35, 95% CI 0.18 to 0.67; 6 studies; 1966 women; moderate-quality evidence), serious neonatal morbidity
or perinatal death (RR 0.48, 95% CI 0.25 to 0.93; 8 studies; 2757 women; moderate-quality evidence) and may slightly reduce the risk
of aneonatal intensive care unit (NICU) admission (RR 0.82, 95% CI 0.65 to 1.04; 3647 women; 12 studies; low-quality evidence). It is
uncertain whether there is a difference in serious maternal morbidity or death (RR 0.20, 95% CI 0.01 to 4.12; 4 studies; 1481 women) or
five-minute Apgar score < 7 (RR 0.74, 95% CI 0.49 to 1.14; 4271 women; 14 studies) because the quality of the evidence was found to be
very low and low, respectively.
Balloon versus low-dose vaginal misoprostol: it is uncertain whether there is a difference in vaginal deliveries not achieved within 24
hours between induction of labour with a balloon catheter and vaginal misoprostol (RR 1.09, 95% CI 0.85 to 1.39; 340 women; 2 studies;
low-quality evidence). A balloon catheter probably reduces the risk of uterine hyperstimulation with FHR changes (RR 0.39, 95% CI 0.18
to 0.85; 1322 women; 8 studies; moderate-quality evidence) but may increase the risk of a caesarean section (average RR 1.28, 95% CI
1.02 to 1.60; 1756 women; 12 studies; I2 = 45%; low-quality evidence). It is uncertain whether there is a difference in serious neonatal
morbidity or perinatal death (RR 0.58, 95% CI 0.12 to 2.66; 381 women; 3 studies), serious maternal morbidity or death (no events; 4
studies, 464 women), both very low-quality evidence, and five-minute Apgar score < 7 (RR 1.00, 95% CI 0.50 to 1.97; 941 women; 7 studies)
and NICU admissions (RR 1.00, 95% CI 0.61 to 1.63; 1302 women; 9 studies) both low-quality evidence.
Balloon versus low-dose oral misoprostol: a balloon catheter probably increases the risk of a vaginal delivery not achieved within 24
hours (RR 1.28, 95% CI 1.13 to 1.46; 782 women, 2 studies, and probably slightly increases the risk of a caesarean section (RR 1.17, 95% CI
1.04 to 1.32; 3178 women; 7 studies; both moderate-quality evidence) when compared to oral misoprostol. It is uncertain whether there is
a difference in uterine hyperstimulation with FHR changes (RR 0.81, 95% CI 0.48 to 1.38; 2033 women; 2 studies), serious neonatal mor-
bidity or perinatal death (RR 1.11, 95% CI 0.60 to 2.06; 2627 women; 3 studies), both low-quality evidence, serious maternal morbidity
or death (RR 0.50, 95% CI 0.05 to 5.52; 2627 women; 3 studies), very low-quality evidence, five-minute Apgar scores < 7 (RR 0.71, 95% CI
0.38 to 1.32; 2693 women; 4 studies) and NICU admissions (RR 0.82, 95% CI 0.58 to 1.17; 2873 women; 5 studies) both low-quality evidence.
Authors' conclusions
Low- to moderate-quality evidence shows mechanical induction with a balloon is probably as effective as induction of labour with vaginal
PGE2. However, a balloon seems to have a more favourable safety profile. More research on this comparison does not seem warranted.
Moderate-quality evidence shows a balloon catheter may be slightly less effective as oral misoprostol, but it remains unclear if there is a
difference in safety outcomes for the neonate. When compared to low-dose vaginal misoprostol, low-quality evidence shows a balloon
may be less effective, but probably has a better safety profile.
Future research could be focused more on safety aspects for the neonate and maternal satisfaction.
P L A I N   L A N G U A G E   S U M M A R Y
Mechanical methods for induction of labour
We set out to determine from randomised controlled trials the effectiveness and safety of mechanical methods to bring on labour in the
third trimester of pregnancy (> 24 weeks' gestation). Use of a balloon to stretch the cervix (the lower end of the uterus) was compared with
prostaglandin E2 (PGE2), low-dose misoprostol or oxytocin.
What is the issue?
Induction is carried out generally when the risk of continuing pregnancy outweighs the benefits, or at the request of pregnant women.
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Mechanical methods for induction promote cervical ripening and onset of labour by stretching the cervix. They are amongst the oldest
methods used to initiate labour. During the last decades, medication such as PGE2, misoprostol and oxytocin have partly replaced me-
chanical methods.
Why is this important?
More and more women have labour induced and indications are often not urgent. This means that the safety aspects of induction meth-
ods become more important, although this could be at the expense of effectiveness. Mechanical methods could have advantages over
pharmacological methods as they are widely available, low in cost and may have fewer side effects, such as excessive contractions of the
uterus (uterine hyperstimulation). This could potentially be safer for the baby because if contractions are too long or very close together,
the baby may not receive sufficient oxygen.
What evidence did we find?
For this review we included a total of 113 randomised controlled trials involving 22,373 women who were scheduled for induction of labour
for different indications. The data contributed to 21 different comparisons and 20 subgroup comparisons. Overall, the evidence was graded
from very low to moderate quality. For many comparisons there were too few women in the trials to determine any clear differences in
serious illness for mothers and babies.
Twenty-eight trials (6619 women) showed mechanical induction with a balloon is as effective as vaginal PGE2 as there may be little or no
difference in vaginal deliveries within 24 hours and there probably is little or no difference in caesarean sections between groups. However,
a balloon appears to be safer for the neonate as it probably reduces the risk of uterine hyperstimulation with an abnormal heart rate of
the baby, serious illness or death of the baby and may slightly reduce the risk for a neonatal intensive care unit admission. It was unclear
if there was a difference in serious illness or death of the mother or in the five-minute Apgar score less than seven.
Thirteen trials (1818 women) compared induction of labour with a balloon with vaginal misoprostol and showed a balloon probably re-
duces the risk of uterine hyperstimulation with an abnormal heart rate of the baby, but may increase the risk of a caesarean section. It was
unclear if there was a difference in vaginal deliveries within 24 hours, serious illness or death of the baby, serious illness or death of the
mother, five-minute Apgar score less than seven or neonatal intensive care unit admissions.
Seven trials (3178 women) showed a balloon may be less effective than oral misoprostol as a balloon probably increases the risk of a
vaginal delivery not achieved within 24 hours and probably slightly increases the risk of a caesarean section. Data on safety are still unclear
as it is uncertain whether there is a difference in uterine hyperstimulation with an abnormal heart rate of the baby, serious illness or death
of the baby, serious illness or death of the mother, five-minute Apgar score less than seven or neonatal intensive care unit admissions.
What does this mean?
Mechanical induction with a balloon is probably as effective as induction of labour with vaginal PGE2. However, a balloon seems to have
a more favourable safety profile for the baby. More research on this comparison does not seem warranted.
A balloon catheter may be slightly less effective as oral misoprostol, but It remains unclear if there is a difference in safety outcomes for the
baby. When compared to low-dose vaginal misoprostol, a balloon catheter may be less effective, but probably has a better safety profile
for the baby.
Future research could focus more on safety aspects for the baby and maternal satisfaction.
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Summary of findings for the main comparison.   Balloon (Foley or ATAD) compared to vaginal prostaglandin E2 for third trimester labour induction in
women with a viable fetus
Balloon (Foley or ATAD) compared to vaginal prostaglandin E2 for third trimester labour induction in women with a viable fetus
Patient or population: third trimester labour induction in women with a viable fetus
Setting: Australia, China, Denmark, Iran, Jordan, India, Italy, Israel, Nigeria, Pakistan, Singapore, Sweden, the Netherlands, USA, UK
Intervention: balloon (Foley or ATAD)
Comparison: vaginal prostaglandin E2
Anticipated absolute effects* (95% CI)Outcomes
Risk with vaginal
prostaglandin E2
Risk with balloon
(Foley or ATAD)
Relative effect
(95% CI)
№ of partici-
pants
(studies)
Certainty of the
evidence
(GRADE)
Comments
Study populationVaginal delivery not achieved in 24
hours
528 per 1000 533 per 1000
(433 to 665)
RR 1.01
(0.82 to 1.26)
1685
(7 RCTs)
⊕⊕⊝⊝
LOW 1 2
 
Study populationUterine hyperstimulation with FHR
changes
31 per 1000 11 per 1000
(6 to 21)
RR 0.35
(0.18 to 0.67)
1966
(6 RCTs)
⊕⊕⊕⊝
MODERATE 1
 
Study populationCaesarean section
238 per 1000 238 per 1000
(219 to 260)
RR 1.00
(0.92 to 1.09)
6619
(28 RCTs)
⊕⊕⊕⊝
MODERATE 1
 
Study populationSerious neonatal morbidity or peri-
natal death
20 per 1000 9 per 1000
(5 to 18)
RR 0.48
(0.25 to 0.93)
2757
(8 RCTs)
⊕⊕⊕⊝
MODERATE 1
 
Study populationSerious maternal morbidity or
death
3 per 1000 1 per 1000
(0 to 11)
RR 0.20
(0.01 to 4.12)
1481
(4 RCTs)
⊕⊝⊝⊝
VERY LOW 1 3
 
Apgar score < 7 at 5 minutes Study population RR 0.74
(0.49 to 1.14)
4271
(14 RCTs)
⊕⊕⊝⊝
LOW 1 4
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22 per 1000 16 per 1000
(11 to 25)
Study populationNeonatal intensive care unit ad-
mission
74 per 1000 60 per 1000
(48 to 77)
RR 0.82
(0.65 to 1.04)
3647
(12 RCTs)
⊕⊕⊝⊝
LOW 1 4
 
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio
GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect
1We downgraded (1) level for serious limitation in study design due to lack of blinding (although not feasible due to nature of event)
2We downgraded (1) level for serious inconsistency due to evidence of statistical heterogeneity (I2 = >30%)
3We downgraded (2) levels for very serious imprecision due to wide CI crossing the line of no effect and small number of events
4We downgraded (1) level for serious imprecision due to wide CI crossing the line of no effect
 
 
Summary of findings 2.   Balloon (Foley or ATAD) compared to low-dose vaginal misoprostol for third trimester induction of labour in women with a
viable fetus
Balloon (Foley or ATAD) compared to low-dose vaginal misoprostol for third trimester induction of labour in women with a viable fetus
Patient or population: third trimester induction of labour in women with a viable fetus
Setting: Brazil, Egypt, India, Iran, Nigeria, the Netherlands, Sweden
Intervention: balloon (Foley or ATAD)
Comparison: low-dose vaginal misoprostol
Anticipated absolute effects* (95% CI)Outcomes
Risk with low-dose
vaginal misoprostol
Risk with balloon (Fo-
ley or ATAD)
Relative effect
(95% CI)
№ of partici-
pants
(studies)
Certainty of
the evidence
(GRADE)
Comments
Vaginal delivery not achieved in 24
hours
Study population RR 1.09
(0.85 to 1.39)
340
(2 RCTs)
⊕⊕⊝⊝
LOW 1 2
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412 per 1000 449 per 1000
(350 to 573)
Study populationUterine hyperstimulation with FHR
changes
33 per 1000 13 per 1000
(6 to 28)
RR 0.39
(0.18 to 0.85)
1322
(8 RCTs)
⊕⊕⊕⊝
MODERATE 1
 
Study populationCaesarean section
243 per 1000 311 per 1000
(247 to 388)
RR 1.28
(1.02 to 1.60)
1756
(12 RCTs)
⊕⊕⊝⊝
LOW 1 3
 
Study populationSerious neonatal morbidity or peri-
natal death
21 per 1000 12 per 1000
(2 to 55)
RR 0.58
(0.12 to 2.66)
381
(3 RCTs)
⊕⊝⊝⊝
VERY LOW 1 4
 
Study populationSerious maternal morbidity or
death
0 per 1000 0 per 1000
(0 to 0)
not estimable 464
(4 RCTs)
⊕⊝⊝⊝
VERY LOW 1 5
no events oc-
curred in in-
cluded stud-
ies
Study populationApgar score < 7 at 5 minutes
30 per 1000 30 per 1000
(15 to 59)
RR 1.00
(0.50 to 1.97)
941
(7 RCTs)
⊕⊕⊝⊝
LOW 1 2
 
Study populationNeonatal intensive care unit ad-
mission
47 per 1000 47 per 1000
(29 to 77)
RR 1.00
(0.61 to 1.63)
1302
(9 RCTs)
⊕⊕⊝⊝
LOW 1 2 6
 
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio
GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect
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1We downgraded (1) level for serious limitation in study design due to lack of blinding (although not feasible due to nature of event)
2We downgraded (1) level for serious imprecision due to wide CI crossing the line of no effect
3We downgraded (1) level for serious inconsistency due to evidence of statistical heterogeneity (I2 = >30%)
4We downgraded (2) levels for very serious imprecision due to wide CI crossing the line of no effect and small number of events
5 We downgraded (2) levels for very serious imprecision due to wide CI crossing the line of no effect and no events reported in included studies
6 Although there was some evidence suggesting small-study effect we did not downgrade for publication bias because individual studies did not reach statistical significance and
there was low heterogeneity across all studies for this outcome. Also, no difference was found between fixed-effect or random-effect analyses
 
 
Summary of findings 3.   Balloon (Foley or ATAD) compared to low-dose oral misoprostol for third trimester induction of labour in women with a
viable fetus
Balloon (Foley or ATAD) compared to low-dose oral misoprostol for third trimester induction of labour in women with a viable fetus
Patient or population: third trimester induction of labour in women with a viable fetus
Setting: Finland, India, Pakistan, Sri Lanka, the Netherlands
Intervention: balloon (Foley or ATAD)
Comparison: low-dose oral misoprostol
Anticipated absolute effects* (95% CI)Outcomes
Risk with low-dose oral
misoprostol
Risk with balloon (Foley or
ATAD)
Relative effect
(95% CI)
№ of partici-
pants
(studies)
Certainty of the
evidence
(GRADE)
Comments
Study populationVaginal delivery not
achieved within 24 hours
476 per 1000 609 per 1000
(538 to 695)
RR 1.28
(1.13 to 1.46)
782
(2 RCTs)
⊕⊕⊕⊝
MODERATE 1
 
Study populationUterine hyperstimulation
with FHR changes
29 per 1000 24 per 1000
(14 to 40)
RR 0.81
(0.48 to 1.38)
2033
(2 RCTs)
⊕⊕⊝⊝
LOW 1 2
 
Study populationCaesarean section
222 per 1000 259 per 1000
(230 to 293)
RR 1.17
(1.04 to 1.32)
3178
(7 RCTs)
⊕⊕⊕⊝
MODERATE 1 3
 
Study populationSerious neonatal morbidity
or perinatal death
14 per 1000 16 per 1000
(9 to 30)
RR 1.11
(0.60 to 2.06)
2627
(3 RCTs)
⊕⊕⊝⊝
LOW 1 2 4
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Study populationSerious maternal morbidity
or death
2 per 1000 1 per 1000
(0 to 8)
RR 0.50
(0.05 to 5.52)
2627
(3 RCTs)
⊕⊝⊝⊝
VERY LOW 1 5
 
Study populationApgar score < 7 after 5 min-
utes
18 per 1000 13 per 1000
(6 to 28)
RR 0.71
(0.38 to 1.32)
2693
(4 RCTs)
⊕⊕⊝⊝
LOW 1 2 4
 
Study populationNeonatal intensive care unit
admission
46 per 1000 37 per 1000
(26 to 53)
RR 0.82
(0.58 to 1.17)
2873
(5 RCTs)
⊕⊕⊝⊝
LOW 1 2 4
 
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).
CI: Confidence interval; RR: Risk ratio
GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect
1We downgraded (1) level for serious limitation in study design due to lack of blinding (although not feasible due to nature of event)
2We downgraded (1) level for serious imprecision due to wide CI crossing the line of no effect
3 Trial of Mundle 2017 did not meet the pre-specified population as pregnancies with a non viable fetus were included. Sensitivity analyses did not alter the estimated effect
size. Therefore we did not downgrade
4 Trial of Mundle 2017 did not meet the pre-specified population as pregnancies with a non viable fetus were included. Sensitivity analysis did not change the direction of the
effect size and numbers of events were not higher compared to other trials. Therefore we did not downgrade.
5 We downgraded (2) levels for very serious imprecision due to wide CI crossing the line of no effect and small number of events
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B A C K G R O U N D
The previous version of this review formed one of a series of reviews
of methods for induction of labour that followed a standardised
published ’generic’ protocol (Hofmeyr 2009). These reviews were
initially developed to help inform the recommendations of the Na-
tional Institute for Health and Care Excellence (NICE) clinical prac-
tice guidelines on induction of labour (NICE 2008). This review no
longer strictly follows the original protocol and has been updated
with the intention of being a stand-alone review. This is an update
of a review first published in 2001 (Boulvain 2001), and last updated
in 2012 (Jozwiak 2012).
Description of the condition
Labour induction is a common obstetric procedure, which is gen-
erally carried out when the risk of continuing pregnancy outweighs
the benefits. Also, induction of labour is being used more and more
at the request of pregnant women to shorten the duration of preg-
nancy or to time the birth of the baby according to the conve-
nience of the mother and/or healthcare workers (WHO 2011). In the
USA, approximately one in four women are induced and in the last
decade, the induction rate in the UK has risen up to almost 30%
(NICE 2008; NHS 2017). Although rates are generally lower in devel-
oping countries, in some settings they can be as high as those ob-
served in developed countries (WHO 2011). To maximise the suc-
cess of induction of labour in women with an unfavourable cervix,
various ripening methods are available.
Description of the intervention
Mechanical methods were the first methods developed to ripen
the cervix and induce labour (Thiery 1989). Devices that were
used in this context include various type of catheters and laminar-
ia tents, introduced into the cervical canal or through the cervix
into the extra-amniotic space. During recent decades they were
partly substituted by pharmacological methods, including various
prostaglandin E2 (PGE2) preparations (vaginal gel, tablets, inserts,
intracervical gel), prostaglandin E1 (PGE1; misoprostol tablets, ap-
plied either orally or vaginally) and oxytocin. Pharmacological
methods however, have a variety of effects at different sites and re-
ceptors in the body that can lead to unwanted side effects when
used, such as uterine hyperstimulation (excessive contractions of
the uterus) and as result, fetal distress. Therefore, mechanical in-
duction methods are gaining in popularity as it has the potential
to have a better safety profile compared to pharmacological meth-
ods, however possibly at the cost of a longer duration of labour.
These factors need to be considered to determine the most appro-
priate methods depending on the clinical situation, with impact on
labour duration possibly being of secondary importance as more
women have labour induced for less urgent indications.
How the intervention might work
The goal of mechanical induction methods is to ripen the cervix,
which can be achieved directly through dilatation of the canal, in-
directly by increasing prostaglandin or oxytocin secretion, or both
(Keirse 1983). In addition to the local effect, mechanisms which
involve neuro-endocrine reflexes (the Ferguson reflex) may pro-
mote the onset of contractions, leading to labour onset (Krammer
1995b).
The standard Foley urinary catheter can be used, as well as a spe-
cially developed 'Atad' double-balloon catheter (Atad 1996) or Cook
balloon. The catheter is introduced through the cervical canal to
reach the extra-amniotic space. The balloon is then inflated to
keep the catheter in place. Traction is applied to the catheter in
some cases. Another method involving catheters consists of infus-
ing saline solution or prostaglandins through a catheter inserted,
via the cervical canal, in the extra-amniotic space (EASI).
Laminaria tents, made from sterile sea-weed or synthetic hy-
drophilic materials (e.g. Lamicel), are introduced into the cervi-
cal canal. These devices increase in diameter because of their
hydrophilic properties. This achieves a gradual stretching of the
cervix.
Digital stripping or sweeping of the membranes is evaluated in a
different review (Boulvain 2005).
Why it is important to do this review
Mechanical methods were never completely abandoned, but were
substituted by pharmacological methods in recent decades. How-
ever, as induction rates rise and indications are often less urgent,
the safety aspects of induction methods become more important,
although this could be at the expense of effectiveness. Apart for be-
ing widely available and low in cost, potential advantages of me-
chanical methods over pharmacological ones may include a reduc-
tion in side effects, such as uterine hyperstimulation, thereby hav-
ing the potential to improve neonatal outcomes.
O B J E C T I V E S
To determine the effectiveness and safety of mechanical methods
for third trimester (> 24 weeks' gestation) induction of labour in
comparison with prostaglandin E2 (PGE2) (vaginal and intracervi-
cal), low-dose misoprostol (oral and vaginal), amniotomy or oxy-
tocin.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Clinical trials, comparing mechanical methods for cervical ripen-
ing or labour induction with other induction methods. Quasi-ran-
domised controlled trials and trials only reported as abstract were
eligible for inclusion. Cluster-randomised trials are unlikely to be
conducted in this area, however, if identified by a future search,
they will be handled with appropriate methods.
Types of participants
Pregnant women due for third trimester induction of labour, carry-
ing a viable fetus.
Predefined subgroup comparisons were: previous caesarean sec-
tion or not, nulliparity or multiparity. Only those outcomes with da-
ta appear in the analyses tables.
Types of interventions
Different types of intervention have been considered as mechanical
methods: (1) the introduction of a catheter (Foley single balloon,
Atad/Cook double balloon or other type), through the cervix into
the extra-amniotic space, either with or without traction; (2) intro-
duction of laminaria tents, or their synthetic equivalent (Dilapan),
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into the cervical canal; (3) use of a catheter to inject fluids, usually
saline water, in the extra-amniotic space (EASI).
Mechanical methods were compared with other induction meth-
ods (i.e. vaginal PGE2, intracervical PGE2, intravenous oxytocin,
amniotomy, vaginal and oral misoprostol). For this update, the
comparison with placebo/no treatment was leH out. When the pro-
tocol for reviews of induction methods was designed, it was rele-
vant to know if cervical ripening before actual induction of labour
(rupturing the membranes, and if needed, administer of oxytocin)
was beneficial. Since we already know the advantages of cervi-
cal ripening in case of an unfavourable cervix, no future trials will
be done to study the effect of cervical ripening with a mechani-
cal method versus no ripening. Also, in the case of pharmacologi-
cal methods, it is possible to perform a placebo-controlled study,
but with mechanical methods of labour, this is not possible. Stud-
ies which do make this comparison between mechanical induction
and no treatment, explore other objectives rather than the ones rel-
evant for his review (induction of labour versus expectant manage-
ment to improve birth outcome). Therefore, the choice was made
to depart from the original research protocol and leave out this pre-
specified comparison. For this update, we also chose only to in-
clude low-dose misoprostol (defined as ≤ 50 mcg every ≥ 4 hours)
as evidence suggests low-dose misoprostol is superior to high-dose
misoprostol regarding safety outcomes and being equally effective
(Alfirevic 2014; Hofmeyr 2010).
In addition, other comparisons were made: (1) a single balloon
compared to a double balloon; (2) laminaria tent compared to oth-
er hygroscopic dilatators; (3) addition of prostaglandins or oxytocin
to mechanical methods compared with prostaglandins or oxytocin
alone. These comparisons were not pre-specified in the generic
protocol of induction of labour reviews (Hofmeyr 2009).
Types of outcome measures
We included all clinically relevant outcomes for trials of methods
of cervical ripening/labour induction as had been pre-specified by
two authors of the generic protocol for labour induction reviews
(Justus Hofmeyr and Zarko Alfirevic). We added six more outcomes
to the list of the original protocol. Differences were settled by dis-
cussion.
Primary outcomes
Five primary outcomes were chosen as being most representative
of the clinically important measures of effectiveness and compli-
cations. Subgroup comparisons were limited to the primary out-
comes:
1. vaginal delivery not achieved within 24 hours (from start cervical
ripening);
2. uterine hyperstimulation with fetal heart rate (FHR) changes;
3. caesarean section;
4. serious neonatal morbidity or perinatal death (e.g. seizures,
birth asphyxia defined by trialists, neonatal encephalopathy,
disability in childhood);
5. serious maternal morbidity or death (e.g. uterine rupture, ad-
mission to intensive care unit, septicaemia).
Perinatal and maternal morbidity and mortality are composite out-
comes. This is not an ideal solution because some components are
clearly less severe than others. It is possible for one intervention to
cause more deaths but less severe morbidity. However, in the con-
text of labour induction in mainly term pregnancies, this is unlikely.
All these events are rare, and a modest change in their incidence will
be easier to detect if composite outcomes are presented. The inci-
dence of individual components were explored as secondary out-
comes (see below).
Secondary outcomes relate to measures of effectiveness, compli-
cations and satisfaction.
Measures of e>ectiveness:
1. cervix unfavourable/unchanged after 12 to 24 hours;
2. oxytocin augmentation.
Complications:
1. uterine hyperstimulation without FHR changes;
2. uterine rupture;
3. epidural analgesia;
4. instrumental vaginal delivery;
5. meconium-stained liquor;
6. Apgar score less than seven at five minutes;
7. neonatal intensive care unit (NICU) admission;
8. neonatal encephalopathy;
9. perinatal death;
10.disability in childhood;
11.maternal side effects (all);
12.maternal nausea;
13.maternal vomiting;
14.maternal diarrhoea;
15.other maternal side effects;
16.postpartum haemorrhage (as defined by the trial authors);
17.serious maternal complications (e.g. intensive care unit admis-
sion, septicaemia but excluding uterine rupture);
18.maternal death.
Measures of satisfaction:
1. woman not satisfied;
2. caregiver not satisfied.
The terminology of uterine hyperstimulation is problematic (Cur-
tis 1987). In the review, we use the term 'uterine hyperstimulation
without FHR changes' to include uterine tachysystole (more than
five contractions per 10 minutes for at least 20 minutes) and uterine
hypersystole/hypertonus (a contraction lasting at least two min-
utes) and 'uterine hyperstimulation with FHR changes' to denote
uterine hyperstimulation syndrome (tachysystole or hypersystole
with FHR changes such as persistent decelerations, tachycardia or
decreased short-term variability).
Search methods for identification of studies
The following methods section of this review is based on a standard
template used by Cochrane Pregnancy and Childbirth.
Electronic searches
For this update, we searched Cochrane Pregnancy and Childbirth’s
Trials Register by contacting their Information Specialist (9 January
2018). We updated this search on 19 March 2019 and added the re-
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sults to Studies awaiting classification for consideration in the next
update.
The Register is a database containing over 25,000 reports of con-
trolled trials in the field of pregnancy and childbirth. It represents
over 30 years of searching. For full current search methods used to
populate Pregnancy and Childbirth’s Trials Register including the
detailed search strategies for CENTRAL, MEDLINE, Embase and CI-
NAHL; the list of handsearched journals and conference proceed-
ings, and the list of journals reviewed via the current awareness ser-
vice, please follow this link.
Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is
maintained by their Information Specialist and contains trials iden-
tified from:
1. monthly searches of the Cochrane Central Register of Controlled
Trials (CENTRAL);
2. weekly searches of MEDLINE (Ovid);
3. weekly searches of Embase (Ovid);
4. monthly searches of CINAHL (EBSCO);
5. handsearches of 30 journals and the proceedings of major con-
ferences;
6. weekly current awareness alerts for a further 44 journals plus
monthly BioMed Central email alerts.
Search results are screened by two people and the full text of all
relevant trial reports identified through the searching activities de-
scribed above is reviewed. Based on the intervention described,
each trial report is assigned a number that corresponds to a specific
Pregnancy and Childbirth review topic (or topics) and is then added
to the Register. The Information Specialist searches the Register for
each review using this topic number rather than keywords. This re-
sults in a more specific search set that has been fully accounted for
in the relevant review sections (Included, Excluded, Awaiting Clas-
sification or Ongoing).
In addition, we searched ClinicalTrials.gov and the WHO Interna-
tional Clinical Trials Registry Platform (ICTRP) for unpublished,
planned and ongoing trial reports (19 March 2019) using the search
methods detailed in Appendix 1.
Searching other resources
We searched the reference lists of retrieved studies.
We did not apply any language or date restrictions.
Data collection and analysis
For methods used in the previous version of this review, see
Jozwiak 2012.
For this update, the following methods were used for assessing the
247 reports that were identified as a result of the updated search.
The following methods section of this review is based on a standard
template used by Cochrane Pregnancy and Childbirth.
Selection of studies
Two review authors (Marieke de Vaan and Mieke ten Eikelder) in-
dependently assessed all potential studies identified as a result of
the search strategy for inclusion. Any disagreement was resolved
through discussion, or if required, by involving a third review author
(Marta Jozwiak).
Data extraction and management
We designed a form to extract data. For eligible studies, two groups
of two review authors (Marieke de Vaan, Marta Jozwiak, Ben Willem
Mol and Kirsten Palmer) extracted the data using the agreed form.
We resolved discrepancies through discussion or, if required, we
consulted a third review author. Data were entered into Review
Manager software (RevMan 2014) and checked by a second review
author for accuracy.
When information regarding any of the above was unclear, we con-
tacted authors of the original reports to provide further details.
Assessment of risk of bias in included studies
Two review authors (Marieke de Vaan and Mieke ten Eikelder) inde-
pendently assessed risk of bias for each study using the criteria out-
lined in the Cochrane Handbook for Systematic Reviews of Interven-
tions (Higgins 2011). Any disagreement was resolved by discussion
or by involving a third assessor (Marta Jozwiak).
(1) Random sequence generation (checking for possible
selection bias)
We described for each included study the method used to generate
the allocation sequence in sufficient detail to allow an assessment
of whether it should produce comparable groups.
We assessed the method as:
• low risk of bias (any truly random process, e.g. random number
table; computer random number generator);• high risk of bias (any non-random process, e.g. odd or even date
of birth; hospital or clinic record number);• unclear risk of bias.
(2) Allocation concealment (checking for possible selection bias)
We described for each included study the method used to con-
ceal allocation to interventions prior to assignment and assessed
whether intervention allocation could have been foreseen in ad-
vance of, or during recruitment, or changed after assignment.
We assessed the methods as:
• low risk of bias (e.g. telephone or central randomisation; con-
secutively numbered sealed opaque envelopes);• high risk of bias (open random allocation; unsealed or non-
opaque envelopes, alternation; date of birth);• unclear risk of bias.
(3.1) Blinding of participants and personnel (checking for
possible performance bias)
We described for each included study the methods used, if any, to
blind study participants and personnel from knowledge of which
intervention a participant received. We considered that studies
were at low risk of bias if they were blinded, or if we judged that
the lack of blinding unlikely to affect results. We assessed blinding
separately for different outcomes or classes of outcomes.
We assessed the methods as:
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• low, high or unclear risk of bias for participants;• low, high or unclear risk of bias for personnel.
(3.2) Blinding of outcome assessment (checking for possible
detection bias)
We described for each included study the methods used, if any, to
blind outcome assessors from knowledge of which intervention a
participant received. We assessed blinding separately for different
outcomes or classes of outcomes.
We assessed methods used to blind outcome assessment as:
• low, high or unclear risk of bias.
(4) Incomplete outcome data (checking for possible attrition
bias due to the amount, nature and handling of incomplete
outcome data)
We described for each included study, and for each outcome or
class of outcomes, the completeness of data including attrition and
exclusions from the analysis. We stated whether attrition and ex-
clusions were reported and the numbers included in the analysis at
each stage (compared with the total randomised participants), rea-
sons for attrition or exclusion where reported, and whether miss-
ing data were balanced across groups or were related to outcomes.
Where sufficient information was reported, or could be supplied
by the trial authors, we planned to re-include missing data in the
analyses which we undertook.
We assessed methods as:
• low risk of bias (e.g. no missing outcome data; missing outcome
data balanced across groups);• high risk of bias (e.g. numbers or reasons for missing data im-
balanced across groups; ‘as treated’ analysis done with substan-
tial departure of intervention received from that assigned at ran-
domisation);• unclear risk of bias.
(5) Selective reporting (checking for reporting bias)
We described for each included study how we investigated the pos-
sibility of selective outcome reporting bias and what we found.
We assessed the methods as:
• low risk of bias (where it is clear that all of the study’s pre-spec-
ified outcomes and all expected outcomes of interest to the re-
view have been reported);• high risk of bias (where not all the study’s pre-specified out-
comes have been reported; one or more reported primary out-
comes were not pre-specified; outcomes of interest are report-
ed incompletely and so cannot be used; study fails to include re-
sults of a key outcome that would have been expected to have
been reported);• unclear risk of bias.
(6) Other bias (checking for bias due to problems not covered by
(1) to (5) above)
We described for each included study any important concerns we
had about other possible sources of bias.
Assessment of the quality of the evidence using the GRADE
approach
For this update, the quality of the evidence was assessed for the
comparisons relating to the most frequently used methods of cervi-
cal ripening (i.e. vaginal prostaglandin E2 (PGE2), vaginal misopros-
tol, and oral misoprostol) using the GRADE approach as outlined in
the GRADE handbook in order to assess the quality of the body of
evidence relating to the following outcomes.
1. Vaginal delivery not achieved within 24 hours
2. Uterine hyperstimulation with FHR changes
3. Caesarean section
4. Serious neonatal morbidity or perinatal death (e.g. seizures,
birth asphyxia defined by trialists, neonatal encephalopathy,
disability in childhood)
5. Serious maternal morbidity or death (e.g. uterine rupture, ad-
mission to intensive care unit, septicaemia)
6. Neonatal intensive care unit admission
7. Apgar score less than seven at five minutes
For the main comparisons we used GRADEpro Guideline Develop-
ment Tool to import data from Review Manager 5.3 (RevMan 2014)
in order to create ’Summary of findings’ tables. A summary of the in-
tervention effect and a measure of quality for each of the above out-
comes was produced using the GRADE approach. The GRADE ap-
proach uses five considerations (study limitations, consistency of
effect, imprecision, indirectness and publication bias) to assess the
quality of the body of evidence for each outcome. The evidence can
be downgraded from 'high quality' by one level for serious (or by
two levels for very serious) limitations, depending on assessments
for risk of bias, indirectness of evidence, serious inconsistency, im-
precision of effect estimates or potential publication bias.
Measures of treatment e>ect
Dichotomous data
For dichotomous data, we presented results as summary risk ratio
with 95% confidence intervals.
Continuous data
No continuous data were analysed in this update. If outcomes using
continuous data are included in future versions of this review, we
will use the mean difference if outcomes are measured in the same
way between trials. We will use the standardised mean difference
to combine trials that measure the same outcome but use different
methods.
Unit of analysis issues
Cluster-randomised trials
Cluster-randomised trials are eligible for inclusion in the analy-
ses along with individually-randomised trials. None have currently
been identified. If in the future such trials are identified, we will ad-
just their standard errors using the methods described in the Hand-
book (Higgins 2011) using an estimate of the intracluster correla-
tion co-efficient (ICC) derived from the trial (if possible), from a sim-
ilar trial or from a study of a similar population. If we use ICCs from
other sources, we will report this and conduct sensitivity analy-
ses to investigate the effect of variation in the ICC. If we identify
both cluster-randomised trials and individually-randomised trials,
we plan to synthesise the relevant information. We will consider it
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reasonable to combine the results from both if there is little hetero-
geneity between the study designs and the interaction between the
effect of intervention and the choice of randomisation unit is con-
sidered to be unlikely.
We will also acknowledge heterogeneity in the randomisation unit
and perform a sensitivity analysis to investigate the effects of the
randomisation unit.
Cross-over trials
Cross-over trials were not eligible for inclusion.
Other unit of analysis issues
Trials in pregnancy and childbirth may include outcomes for mul-
tiple pregnancies, but the trials identified to date have included
singleton pregnancies only. Trials with multiple pregnancy will be
included, but the outcomes relating to the babies will have to
take account of clustering of events, as outlined in the Pregnancy
and Childbirth Group Methodological Guidelines and the Handbook
(Higgins 2011).
Some trials are multi-arm studies, where this occurs only the inter-
vention arms relevant to this review were included and this is noted
in the Characteristics of included studies table.
Dealing with missing data
For included studies, levels of attrition were noted. In future up-
dates, if more eligible studies are included, we will explore the im-
pact of including studies with high levels of missing data in the over-
all assessment of treatment effect by using sensitivity analysis.
For all outcomes, analyses were carried out, as far as possible, on
an intention-to-treat basis, i.e. we attempted to include all partici-
pants randomised to each group in the analyses. The denominator
for each outcome in each trial was the number randomised minus
any participants whose outcomes were known to be missing.
Assessment of heterogeneity
We assessed statistical heterogeneity in each meta-analysis using
the Tau2, I2 and Chi2 statistics. We regarded heterogeneity as sub-
stantial if an I2 was greater than 30% and either a Tau2 was greater
than zero, or there was a low P value (less than 0.10) in the Chi2 test
for heterogeneity. In the case of substantial heterogeneity (above
30%), if possible, we explored it by subgroup analyses.
Assessment of reporting biases
When there were 10 or more studies in the meta-analysis, we in-
vestigated reporting biases (such as publication bias) using funnel
plots. We assessed funnel plot asymmetry visually. If asymmetry
was suggested by a visual assessment, we performed exploratory
analyses to investigate it.
Data synthesis
We carried out statistical analysis using the Review Manager soft-
ware (RevMan 2014). We used fixed-effect meta-analysis for com-
bining data where it was reasonable to assume that studies were
estimating the same underlying treatment effect: i.e. where trials
were examining the same intervention, and the trials’ populations
and methods were judged sufficiently similar.
If there was clinical heterogeneity sufficient to expect that the un-
derlying treatment effects differed between trials, or if substan-
tial statistical heterogeneity was detected, we used random-effects
meta-analysis to produce an overall summary, if an average treat-
ment effect across trials was considered clinically meaningful. The
random-effects summary was treated as the average range of pos-
sible treatment effects and the clinical implications of treatment
effects differing between trials is discussed. If the average treat-
ment effect was not clinically meaningful, we did not combine tri-
als. When random-effects analyses were used, the results were pre-
sented as the average treatment effect with 95% confidence inter-
vals, and the estimates of Tau2 and I2.
Subgroup analysis and investigation of heterogeneity
We did not carry out formal subgroup analysis to investigate het-
erogeneity, but carried out additional analyses of subgroups of tri-
als based on the following.
1. Previous caesarean section or not
2. Nulliparity or multiparity
The following outcomes were used in the subgroups.
1. Vaginal delivery not achieved within 24 hours
2. Uterine hyperstimulation with FHR changes
3. Caesarean section
4. Serious neonatal morbidity or perinatal death (e.g. seizures,
birth asphyxia defined by trialists, neonatal encephalopathy,
disability in childhood)
5. Serious maternal morbidity or death (e.g. uterine rupture, ad-
mission to intensive care unit, septicaemia)
Sensitivity analysis
We carried out sensitivity analyses to explore the effect of trial qual-
ity assessed by concealment of allocation, high attrition rates, or
both, with poor quality studies being excluded from the analyses
in order to assess whether this made any difference to the overall
result.
R E S U L T S
Description of studies
Results of the search
See: Figure 1.
 
Mechanical methods for induction of labour (Review)
Copyright © 2019 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane
Collaboration.
13
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Figure 1.   Study flow diagram.
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For this update, we identified 418 trial reports to assess in the
search of 9 January 2018. One study (Pineda Rivas 2016) was re-
trieved through other sources. When exploring the included trial
registration of this study, we found out that an abstract of this study
was published.
We also reassessed the 17 reports awaiting classification and the
four ongoing studies in the previous version of the review (Jozwiak
2012). One hundred and seventy-one reports were screened out
because they did not meet the scope for this review or were not
randomised controlled trials. We then assessed trial reports which
related to 166 new trials (247 reports). We included 60 new trials
(120 reports), added two trial reports to already included studies
and excluded 74 trials (102 reports). Two trials from the January
2018 search are awaiting classification (Agboghoroma 2015; Mallah
2011), and 21 are ongoing (Argilagos 2016; Beckmann 2013; Bekele
2017; Berndl 2016; Bhide 2017; Eser 2016; Goli 2017; Goonewardene
2016; Gupta 2016; Hassanzadeh 2017; Igwe 2017; Lacarin 2017;
Lauterbach 2017; Levy 2016; Osoti 2016; Park 2012; Perrotin 2016;
Tagore 2015; Viteri 2015; Wise 2016; Yildirim 2017).
Of the 71 previous included studies, we excluded 18 trials because
they were no longer within the scope of this review. Four stud-
ies were excluded because they compared a mechanical method
with a placebo or no cervical ripening (De Oliveira 2003; Gilson
1996; Gower 1982; Lackritz 1979), 11 studies because of the use of
high-dose misoprostol (Adeniji 2005b; Barrilleaux 2002a; Buccella-
to 2000; Chung 2003; Greybush 2001; Hill 2009; Kashanian 2006;
Owolabi 2005; Rust 2001; Sciscione 2001; Vengalil 1998), two stud-
ies compared extra-amniotic space infusion (EASI) versus induc-
tion with a balloon or laminaria (El-Torkey 1995; Lin 1995), and one
study compared a balloon versus prostaglandin F2alpha (Mawire
1999).
In the updated search of 19 March 2019, we identified an additional
38 trial reports which were added to Studies awaiting classification
for consideration in the next update. The references have been as-
sessed but not incorporated into the review. Only seven of these tri-
als are likely to contribute data for this review and are mainly small
trials (Khatib 2019; Lim 2018; Osoti 2018; Souizi 2018; ten Eikelder
2017; Tulek 2018; Viteri 2019). We imputed the data for these trials
and this resulted in no changes in terms of the direction or strength
of the evidence. We will incorporate these studies fully at the next
update.
Included studies
Altogether, this review now comprises 113 included studies, 105 of
which contributed data. The studies that contributed data involved
22,373 women (see Characteristics of included studies). Trials with
more than two arms may be included in more than one comparison.
No cluster-randomised trials were identified by the search.
Eight studies did not contribute any data to this review because
the outcomes of interest were not reported, or reported in a for-
mat that could not be included in this review (Biron-Shental 2004;
Deo 2013; Hughes 2002; Jalilian 2011; Peedicayil 1998; Qamar 2012;
Thiery 1981; Zahoor 2014). These studies are therefore not includ-
ed in the descriptions of study details and 'Risk of bias' assessment
below.
Design
All included studies were randomised controlled trials although the
randomisation method was not always well described and in three
studies the allocation process was not truly random (Jagani 1982;
Kandil 2012; Roztocil 1998). All studies involved two trial arms ex-
cept for Aduloju 2016, Allouche 1993, Atad 1996, Browne 2011, Cro-
mi 2011, Deo 2012, Dionne 2011, El Khouly 2017, Guinn 2000, Ma-
tonhodze 2003, Lewis 1983, Orhue 1995, Pennell 2009, Prager 2008,
Saleem 2006, Sheikher 2009 and Yuen 1996, which had three arms.
Gelisen 2005, Lyndrup 1989 and Roberts 1986 had four arms, and
Jagani 1982 had five arms. Not all comparisons in these studies
were relevant for this review and therefore one or more arms in the
studies of Gelisen 2005, Jagani 1982, Lewis 1983 and Roberts 1986
were excluded.
Setting
Nine studies were multicentre studies (Edwards 2014c; Guinn 2000;
Jozwiak 2012; Jozwiak 2013; Jozwiak 2014; Lokkegaard 2015; Mun-
dle 2017; Sarreau 2016; ten Eikelder 2016), the remaining studies
were single-centre studies.
All studies took place in a hospital setting, except for Henry 2013,
in which the period of cervical ripening took place in an outpatient
setting.
The included studies were conducted in the following countries:
Australia (Henry 2013; Pennell 2009), Brazil (Filho 2002; Oliveira
2010, Canada (Lemyre 2006; Pineda Rivas 2016; St Onge 1995),
Czech Republic (Roztocil 1998), China (Wang 2012; Wang 2014;
Wu 2017; Yuen 1996), Denmark (Lokkegaard 2015; Lyndrup 1989;
Lyndrup 1994), Egypt (Ahmed 2016; El Khouly 2017; Kandil 2012),
Finland (Kruit 2016), France (Allouche 1993; Sarreau 2016;), In-
dia (Chavakula 2015; Dalui 2005; Deo 2012; Deshmukh 2011;
Goonewardene 2014; Gunawardena 2012; Joshi 2016; Kuppulak-
shmi 2016; Laddad 2013; Lanka 2014; Meetei 2015; Mundle 2017;
Sheikher 2009), Iran (Moini 2003; Niromanesh 2003; Roudsari 2011;
Sharami 2005) Italy (Cromi 2011; Cromi 2012), Israel (Atad 1996;
Barda 2018; Ophir 1992; Shechter-Maor 2015; Salim 2011; Solt
2009), Jordan (Al-Taani 2004; Khamaiseh 2012), the Netherlands
(Jozwiak 2012; Jozwiak 2013; Jozwiak 2014; ten Eikelder 2016),
Nigeria (Aduloju 2016; Garba 2016; Orhue 1995; Tabowei 2003), Nor-
way (Haugland 2012), Pakistan (Husain 2017; Matonhodze 2003;
Mazhar 2003; Saleem 2006), Russia (Glagoleva 1999), Rwanda
(Gilson 2017), South Africa (Bagratee 1990; Jeeva 1982; Ntsalu-
ba 1997), Singapore (Chua 1997), Sri Lanka (Rudra 2012; Somi-
rathne 2017; Tan 2015), Sweden (Hemlin 1998; Prager 2008), Tu-
nis (Benzineb 1996), Turkey (Gelisen 2005), the UK (Dionne 2011;
Guinn 2000; Hay 1995; Johnson 1985; Lewis 1983), the USA (Al-Ibra-
heemi 2018; Amorosa 2017; Blumenthal 1990; Browne 2011; Car-
bone 2013; Casey 1995; Culver 2004; Edwards 2014c; Hibbard 1998;
Hoppe 2016; Hudon 1999; Jagani 1982; Krammer 1995a; Mackeen
2018; Mullin 2002; Perry 1998; Ridgway 1991; Roberts 1986; Rouben
1993; Sanchez-Ramos 1992; Sciscione 1999; Suffecool 2014; Sulli-
van 1996; Tita 2006; Turnquest 1997).
Dates
The study of Blumenthal 1990 and Sanchez-Ramos 1992 took place
between 1980 and 1989; the studies of Allouche 1993, Guinn 2000,
Hemlin 1998, Hibbard 1998, Khamaiseh 2012, Lyndrup 1994, Orhue
1995, Perry 1998, Roudsari 2011, Roztocil 1998, Sciscione 1999,
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St Onge 1995, Sullivan 1996 and Turnquest 1997 between 1990
and 1999; the studies of Tabowei 2003, Culver 2004 and Mullin
2002 between 1998 and 2001; the studies of Al-Taani 2004, Cro-
mi 2011, Deshmukh 2011, Dionne 2011, Filho 2002, Joshi 2016,
Jozwiak 2012, Jozwiak 2013, Krammer 1995a, Lokkegaard 2015,
Matonhodze 2003, Mazhar 2003, Moini 2003, Niromanesh 2003,
Oliveira 2010, Pennell 2009, Prager 2008, Roudsari 2011, Rudra
2012, Saleem 2006, Sharami 2005 and Tita 2006 between 2000 and
2009; the studies of Jozwiak 2014 and Salim 2011 between 2008
and 2011; and the studies of Aduloju 2016, Ahmed 2016, Al-Ibrahee-
mi 2018, Amorosa 2017, Barda 2018, Browne 2011, Carbone 2013,
Chavakula 2015, Cromi 2012, Edwards 2014c, El Khouly 2017, Gar-
ba 2016, Goonewardene 2014, Haugland 2012, Henry 2013, Hoppe
2016, Husain 2017, Kandil 2012, Kruit 2016, Kuppulakshmi 2016,
Laddad 2013, Mundle 2017, Noor 2015, Sarreau 2016, Somirathne
2017, Suffecool 2014, ten Eikelder 2016, Wang 2014 and Wu 2017
between 2010 and the present day.
For the remaining studies, no study period was reported (Atad 1996;
Bagratee 1990; Benzineb 1996; Casey 1995; Chua 1997; Dalui 2005;
Deo 2012; Gelisen 2005; Gilson 2017; Glagoleva 1999; Gunawarde-
na 2012; Hay 1995; Hudon 1999; Jagani 1982; Jeeva 1982; Johnson
1985; Lanka 2014; Lanka 2014; Lewis 1983; Lyndrup 1989; Ntsaluba
1997; Ophir 1992; Pineda Rivas 2016; Ridgway 1991; Roberts 1986;
Rouben 1993; Solt 2009; Shechter-Maor 2015; Sheikher 2009; Tan
2015; Wang 2012; Yuen 1996).
Participants
Most studies included both nulliparous and multiparous women.
Nine studies included only nulliparous women (Culver 2004; Desh-
mukh 2011; Gunawardena 2012; Johnson 1985; Kandil 2012; Pen-
nell 2009; Sharami 2005; Suffecool 2014; Wang 2012) and two stud-
ies included only multiparous women (Al-Taani 2004; Garba 2016).
Thirteen studies included women with a specific indication for
labour induction or specific patient groups, i.e. women with a hy-
pertensive disease (Mundle 2017), women with a body mass index
(BMI) greater than 30 (Pineda Rivas 2016), post-date pregnancies
(Gelisen 2005; Goonewardene 2014; Gunawardena 2012; Kandil
2012; Somirathne 2017), oligohydramnios (Shechter-Maor 2015;
Wang 2014) or pre labour rupture of membranes (PROM; Amorosa
2017; Kruit 2016; Mackeen 2018; Tita 2006). Most authors specified
that only women with intact membranes were included, except for
Prager 2008, in which this was not an exclusion criteria. Orhue 1995,
Roudsari 2011 and Roztocil 1998 reported nothing on membrane
status, so it was not clear if women with ruptured membranes could
be included.
Most studies excluded women with a past history of caesarean sec-
tion, although four studies only included women with a past his-
tory of caesarean section (Joshi 2016; Meetei 2015; Sarreau 2016;
Tabowei 2003). Three studies did not exclude women with a past
history of caesarean section, but did not specify the outcomes for
this subgroup of women separately (Mackeen 2018; Tabowei 2003;
Tita 2006). Benzineb 1996, Cromi 2011, Deo 2012, Guinn 2000, Haug-
land 2012, Lyndrup 1994, Pineda Rivas 2016, Rouben 1993, and Wu
2017 reported nothing on previous caesarean section in their inclu-
sion and exclusion criteria.
The majority of studies included women with a gestational age be-
yond 37 weeks, except for Edwards 2014c and Hemlin 1998 who
reported a minimal gestational age of 36 weeks, Amorosa 2017,
Chavakula 2015, Cromi 2011, Cromi 2012, Mackeen 2018 Maton-
hodze 2003, Pennell 2009; Roudsari 2011 and Sharami 2005 of 34
weeks, Dalui 2005 of 33 weeks, Lokkegaard 2015 of 32 weeks, Culver
2004, Lanka 2014 and El Khouly 2017 of 28 weeks, Browne 2011 of
26 weeks, Carbone 2013 of 24 weeks and Mundle 2017 of 20 weeks,
although in this last study, no women with a gestational age below
28 weeks were included.
Twenty-four studies were not clear on their inclusion and exclusion
criteria: Gilson 2017, Jeeva 1982 and Kuppulakshmi 2016 report-
ed no inclusion or exclusion criteria. Jagani 1982, Rudra 2012 and
Turnquest 1997 only reported that women with intact membranes
were included. Glagoleva 1999 only reported that women with a
previous caesarean section were excluded. Bagratee 1990, Dionne
2011, Johnson 1985, Lyndrup 1989, Ridgway 1991, Solt 2009; Sulli-
van 1996 reported that only women with an indication for labour
induction with an unfavourable cervix were included. Hemlin 1998
reported nothing on membrane status or previous caesarean sec-
tion. Casey 1995, Garba 2016, Hudon 1999, Krammer 1995a, Lemyre
2006, Lewis 1983 and Saleem 2006 reported nothing on fetal pre-
sentation, membrane status or previous caesarean section. Chua
1997 and Ophir 1992 reported nothing on gestational age, fetal pre-
sentation, membrane status or previous caesarean section.
Interventions and comparisons
The protocol of administration in the intervention and in the con-
trol groups varied between studies. Different mechanical devices
were evaluated (i.e. balloon catheter, laminaria tents, and ex-
tra-amniotic infusion). Prostaglandins (intracervical or intravaginal
PGE2, and oral or vaginal misoprostol) were used with different pro-
tocols of administration. We regrouped these protocols as follows:
(1) balloon catheter versus other interventions; (2) laminaria tent
versus other interventions: (3) extra-amniotic infusion versus oth-
er interventions; (4) any mechanical method combined with other
(non-mechanical) intervention versus other interventions. For this
last group of comparisons, we considered both PGE2 (intracervical
or intravaginal PGE2) and misoprostol (oral or vaginal misoprostol)
as a single intervention. The information on comparisons made in
each trial, used device and balloon size is summarised below.
Studies evaluating laminaria or Dilapan were considered togeth-
er, irrespective of the number of devices inserted. Similarly, eval-
uations of a Foley catheter (regardless of sizes and amount of liq-
uid used to inflate the balloon and traction applied on the catheter)
and a specially designed double-balloon catheter (ATAD or Cook
catheter), we considered as similar interventions. However, when a
catheter was used to perform extra-amniotic saline infusion (EASI),
we considered these studies separately. Despite having regrouped
similar interventions, this review still includes a large number of
comparisons.
Most of the studies included in the review examined a balloon and
compared it with either vaginal PGE2 or with vaginal or oral miso-
prostol. A smaller number of studies examined a balloon versus ei-
ther intracervical PGE2 or oxytocin. Since the last update, no more
studies have been published about induction of labour with a Lam-
inaria tent or with EASI. None of the included studies examined the
combination of a mechanical method with amniotomy.
The following comparisons were made in this review.
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1. Balloon comparisons
Balloon (Foley or ATAD) versus vaginal prostaglandin E2
PGE2 tablets: Al-Taani 2004 (50 cc); Atad 1996 (double balloon); Bar-
da 2018 (80 cc); Khamaiseh 2012 (50 cc to 60 cc); Lokkegaard 2015
(double balloon); Niromanesh 2003 (30 cc); Ophir 1992 (40 cc); Pen-
nell 2009 (30 cc and double balloon); Tan 2015 (double balloon).
PGE2 gel: Browne 2011 (40 cc); Deo 2012 (30 cc); Deshmukh 2011
(balloon size unknown); Henry 2013 (30 cc); Jozwiak 2012 (30 cc);
Orhue 1995 (30 cc); Prager 2008 (30 cc); Rouben 1993 (30 cc); Rudra
2012 (40 cc).
PGE2 vaginal insert: Cromi 2011 (50 cc; for this comparison the two
groups of Foley catheter (12 hours and 24 hours) were combined);
Cromi 2012 (double balloon); Edwards 2014c (30 cc); Jozwiak 2013
(30 cc); Lewis 1983 (30 cc); Lyndrup 1994 (30 cc); Pineda Rivas 2016
(balloon size unknown); Saleem 2006 (40 cc to 50cc); Shechter-Maor
2015 (double balloon); Suffecool 2014 (double balloon); Wang 2012
(80 cc); Wang 2014 (double balloon); Yuen 1996 (double balloon).
Balloon (Foley or ATAD) versus intracervical prostaglandin E2
PGE2 intracervical gel: Allouche 1993 (50 cc); gel: Benzineb 1996 (40
cc); Dalui 2005 (30 cc); Gunawardena 2012 (balloon size unknown);
Hudon 1999 (40 cc); Kuppulakshmi 2016 (30 cc); Laddad 2013: (bal-
loon size unknown); Moini 2003 (30 cc); Ntsaluba 1997 (30 cc); Scis-
cione 1999 (30 cc); St Onge 1995 (30 cc); Yuen 1996 (double balloon).
Balloon (Foley or ATAD) versus low-dose vaginal misoprostol
Misoprostol tablets: Aduloju 2016 (30 cc); Chavakula 2015 (30 cc);
Filho 2002 (30 cc); Jozwiak 2014 (30 cc); Kandil 2012 (30 cc); Lemyre
2006 (balloon size unknown); Noor 2015 (50 cc); Oliveira 2010 (30
cc); Prager 2008 (30 cc); Roudsari 2011 (50 cc); Sheikher 2009 (30 cc);
Tabowei 2003 (50 cc).
Balloon (Foley or ATAD) versus low-dose oral misoprostol
Misoprostol tablets: Goonewardene 2014 (balloon size unknown);
Kruit 2016 (50 cc to 60 cc); Mundle 2017 (30 cc); Saleem 2006 (40 cc to
50 cc); Sheikher 2009 (30 cc); Somirathne 2017 (60 cc);ten Eikelder
2016 (30 cc). misoprostol solution: Matonhodze 2003 (50 cc).
Balloon (Foley or ATAD) versus oxytocin
Amorosa 2017 (60 cc); Atad 1996 (double balloon); El Khouly 2017
(30 cc); Gelisen 2005 (50 cc); Jagani 1982 (70 to 80 cc); Joshi 2016;
(30 cc); Meetei 2015 (30 cc); Orhue 1995 (30 cc); Sarreau 2016 (50 cc).
Balloon (Foley or ATAD) versus amniotomy
Jagani 1982 (70 cc to 80 cc).
Single balloon (Foley versus double balloon (ATAD)
Ahmed 2016 (50 cc); Haugland 2012 (size unknown); Hoppe 2016
(30 cc); Pennell 2009 (30 cc); Salim 2011 (60 cc); Solt 2009 (balloon
size unknown).
No studies were found for the comparison of a balloon versus oxy-
tocin with amniotomy.
2. Laminaria comparisons
Laminaria tent versus vaginal prostaglandin E2
PGE2 tablets: Bagratee 1990 (Lamicel); Hay 1995 (Dilapan); Jeeva
1982; (laminaria).
PGE2 gel: Johnson 1985 (Lamicel); Roudsari 2011 (Dilapan);
Sanchez-Ramos 1992 (Dilapan).
Laminaria tent versus intracervical prostaglandin E2
PGE2 intracervical gel: Chua 1997 (Dilapan); Glagoleva 1999 (Dila-
pan); Krammer 1995a; (Dilapan); Roztocil 1998 (Dilapan).
Laminaria tent versus oxytocin
Jagani 1982 (70 to 80 cc); Roberts 1986 (Lamicel).
Laminaria tent versus amniotomy
Jagani 1982 (70 to 80 cc).
Laminaria tent versus other hygroscopic dilator
Blumenthal 1990 (Dilapan versus laminaria tent).
No studies were found for the comparison of laminaria tent versus
oxytocin with amniotomy or laminaria tent versus vaginal or oral
misoprostol.
3. EASI comparisons
The only studies which were found compared EASI with PGE2.
EASI versus vaginal prostaglandin E2
Vaginal insert: Mazhar 2003.
EASI versus intracervical prostaglandin E2
Intracervical gel: Hemlin 1998.
4. Any mechanical combined with prostaglandin E2 compar-
isons
Any mechanical method combined with prostaglandin E2 ver-
sus prostaglandin E2 alone
PGE2 intracervical gel: Allouche 1993 (50 cc); Casey 1995 (50 cc);
Ridgway 1991 (Lamicel); Sullivan 1996 (50 cc).
PGE2 vaginal gel: Browne 2011 (40 cc); Hibbard 1998 (Dilapan); Lyn-
drup 1989; (Lamicel); Turnquest 1997 (Laminaria)
Any mechanical method combined with prostaglandin E2 ver-
sus low-dose misoprostol alone
Vaginal misoprostol: Perry 1998.
Any mechanical method combined with prostaglandin E2 ver-
sus oxytocin alone
Lyndrup 1989 (Lamicel).
No studies were found which compared a mechanical method com-
bined with PGE2 with amniotomy or oxytocin with amniotomy
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5. Any mechanical combined with low-dose misoprostol com-
parisons
Any mechanical method combined with low-dose misoprostol
versus prostaglandin E2 alone
Oral misoprostol: Matonhodze 2003.
Any mechanical method combined with low-dose misoprostol
versus low-dose misoprostol alone
Vaginal misoprostol: Aduloju 2016 (30 cc); Al-Ibraheemi 2018 (60
cc); Carbone 2013 (60 cc); Dionne 2011 (balloon size and dosage of
misoprostol unknown); Lanka 2014 (30 cc).
Oral misoprostol: Husain 2017 (30 cc); Matonhodze 2003 (50 cc).
No studies were found which compared a mechanical method com-
bined with low-dose misoprostol with amniotomy, oxytocin or oxy-
tocin with amniotomy.
6. Any mechanical method combined with oxytocin compar-
isons
Any mechanical method combined with oxytocin versus
prostaglandin E2 alone
PGE2 intracervical gel: Guinn 2000 (laminaria + oxytocin and EASI +
oxytocin); Lyndrup 1989 (Lamicel); Sharami 2005 (EASI).
Any mechanical method combined with oxytocin versus low-
dose misoprostol alone
Vaginal misoprostol: Culver 2004 (30 cc); Dionne 2011 (balloon size
unknown); Gilson 2017 (30 cc); Garba 2016 (balloon size and dosage
of misoprostol unknown); Mullin 2002.
Any mechanical method combined with oxytocin versus oxy-
tocin alone
El Khouly 2017 (30 cc); Lyndrup 1989 (Lamicel); Mackeen 2018 (30
cc); Tita 2006 (balloon size unknown); Wu 2017 (double balloon).
No studies were found which compared a mechanical method com-
bined with oxytocin to amniotomy or oxytocin with amniotomy.
Outcomes
The study authors frequently reported on continuous outcome
measures such as change in the cervical status or time to onset of
labour, but also mean Apgar score after five minutes and mean pH
in the umbilical artery. As these were not pre-specified in our pro-
tocol, we have not included these results in the review. In several
studies, the only pre-specified result available was the number of
women delivered by caesarean section. Maternal or neonatal death
were infrequently pre-specified by the authors and therefore not
specifically reported. Therefore, these outcomes could not be in-
cluded in this review.
Maternal satisfaction was reported in seven studies (Ahmed 2016;
Chavakula 2015; Gilson 2017; Henry 2013; Lyndrup 1994; Mundle
2017; Shechter-Maor 2015). Of these seven studies, only three stud-
ies contributed data for the meta-analysis (Gilson 2017; Lyndrup
1994; Mundle 2017). The other four studies reported on maternal
satisfaction with continuous data. Because of the importance of
this outcome, we decided to report these results in narrative form.
Source of trial funding
Only 14 trials provided details for their funding sources: Filho
2002 received financial support from CAPES. Guinn 2000 reported
that UpJohn Pharmaceuticals provided funds to purchase study
drugs. Kruit 2016 received a grand from the Finnish medical soci-
ety Duodecim and Helsinky university central hospital. Lokkegaard
2015 reported the randomisation procedure was funded by Sned-
kermester Sophus Jacobsen & Astrid Jacobsens fond and the Dan-
ish Toyota Foundation. Mackeen 2018 received a small internal
grant to assist with the conduct and statistical analyses for the en-
tire study. Mundle 2017 received funding from the Department for
International Development, Medical Research Council, and Well-
come Trust Joint Global Health Trials Scheme. The study of Pen-
nell 2009 was supported by a grant from the Women and Infants Re-
search Foundation and Adeza Biomedical Corporation contributed
support for the fetal fibronectin test kits. Roberts 1986 and Sullivan
1996 stated they were supported by the Vicksburg hospital medical
foundation. Salim 2011 received funding from the Emek medical
centre. Tan 2015 reported that the double balloons were provided
by Cook medical. ten Eikelder 2016 received funding from Fonds
Nuts Ohra. Wang 2014 received financial support of The People’s
Liberation Army. Wu 2017 received a grant from the Nature Science
Foundation of China.
Thirteen studies reported they received no funding (Aduloju 2016;
El Khouly 2017; Garba 2016; Hoppe 2016; Husain 2017; Jozwiak
2012; Jozwiak 2013; Jozwiak 2014; Laddad 2013; Lanka 2014;
Meetei 2015; Shechter-Maor 2015; Somirathne 2017). All other stud-
ies did not provide information on received funding.
Declarations of interest
Thirty-five studies declared no conflict of interest (Aduloju 2016;
Ahmed 2016; Al-Ibraheemi 2018; Amorosa 2017; Barda 2018;
Chavakula 2015; Cromi 2012; Edwards 2014c; El Khouly 2017; Filho
2002; Garba 2016; Goonewardene 2014; Henry 2013; Hoppe 2016;
Husain 2017; Jozwiak 2012; Jozwiak 2013; Jozwiak 2014; Kandil
2012; Kruit 2016; Laddad 2013; Lanka 2014; Lewis 1983; Lokkegaard
2015; Mackeen 2018; Meetei 2015; Noor 2015; Pennell 2009; Salim
2011; Shechter-Maor 2015; Somirathne 2017;Tan 2015; ten Eikelder
2016; Wang 2014; Wu 2017).
Two studies reported they had conflicts of interest. Atad 1996 stat-
ed that the first author has a patent licensing arrangement for Atad
ripening device and thus has the potential gain from its sales. Mun-
dle 2017 reported that one of the authors was a scientific adviser to
Azanta, a Danish pharmaceutical company.
The remaining studies did not report whether any conflicts of inter-
est were present.
Excluded studies
In total, 138 studies were excluded (see Characteristics of ex-
cluded studies), 74 studies (102 reports) in this update. In this
update, most of the excluded trials (54 studies) made compar-
isons not within the scope of this review (Ahmad 2015; Arseni-
jevic 2012; Arshad 2016; Caughey 2007; Connolly 2016; Connol-
ly 2017; Demirel 2015; Edwards 2017; El-Khayat 2016; El Sharkwy
2017; Forgie 2016; Forooshani 2011; Fruhman 2017; Gadel 2015;
Ghanaei 2009; Ghanaie 2013; Gibson 2013; Gu 2015; Haghighi 2015;
Hallak 2008; He 2000; Hill 2013; Hussein 2012; Ifnan 2006; Jonsson
2011; Kehl 2012; Kehl 2015; Lam 2006; Leong 2017; Levine 2016;
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Lutgendorf 2012; Manish 2016; Mattingly 2015; McGee 2016; Mei-
Dan 2012a; Mei-Dan 2014; Movahed 2016; Mullin 2014; Neethurani
2013; Rameez 2007; Rezk 2014; Saad 2016; Salmeen 2012; Sandberg
2017; Schoen 2017; Sharma 2015a; Sharma 2017; Siddiqui 2013;
Torbenson 2015;Walfisch 2015; Wickramasinghe 2014; Wilkinson
2015; Yaddehige 2015; Zakaria 2017). Four studies were not ran-
domised trials (Du 2015; Miller 2015; Naseem 2007; Nasir 2012) and
one study did a cross-over after 24 hours (Ugwu 2013). Thirteen
trial registration were excluded because they exceeded the par-
ticipated end date by more than two years and it was presumed
the trial was terminated before enrolment (Anabosy 2014; Baacke
2006; Behrashi 2013; Cullimore 2009; Dias 2008 EUCTR 2012; Kam-
ilya 2011; Mei-Dan 2012; Park 2011 Pathiraja 2014; Reif 2012; Yaz-
dani 2011; Zhang 2014). For more information, see Characteristics
of excluded studies.
Risk of bias in included studies
The quality assessments are graphically summarised in Figure 2
and Figure 3.
 
Figure 2.   'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages
across all included studies.
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Figure 3.   'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.
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Figure 3.   (Continued)
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Figure 3.   (Continued)
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Figure 3.   (Continued)
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Figure 3.   (Continued)
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Figure 3.   (Continued)
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Figure 3.   (Continued)
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This review update includes nine comparisons with more than 10
studies, of which we constructed funnel plots (Figure 4; Figure 5;
Figure 6; Figure 7; Figure 8; Figure 9; Figure 10; Figure 11; Figure
12). Visual inspection of one funnel plot (Figure 5) was somewhat
asymmetrical suggesting some form of publication bias for this out-
come (oxytocin augmentation) for the comparison of a balloon ver-
sus vaginal PGE2. Visual assessment of the other funnel plots did
not show asymmetry, suggesting there is no publication bias for
these comparisons.
 
Figure 4.   Funnel plot of comparison: 1 Balloon (Foley or ATAD) versus vaginal Prostaglandin E2: all women,
outcome: 1.3 Caesarean section.
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Figure 5.   Funnel plot of comparison: 1 Balloon (Foley or ATAD) versus vaginal Prostaglandin E2: all women,
outcome: 1.6 Oxytocin augmentation.
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Figure 6.   Funnel plot of comparison: 1 Balloon (Foley or ATAD) versus vaginal Prostaglandin E2: all women,
outcome: 1.7 Uterine hyperstimulation without fetal heart rate changes.
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Figure 7.   Funnel plot of comparison: 1 Balloon (Foley or ATAD) versus vaginal Prostaglandin E2: all women,
outcome: 1.10 Instrumental vaginal delivery.
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Figure 8.   Funnel plot of comparison: 1 Balloon (Foley or ATAD) versus vaginal Prostaglandin E2: all women,
outcome: 1.12 Apgar score < 7 at 5 minutes.
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Figure 9.   Funnel plot of comparison: 1 Balloon (Foley or ATAD) versus vaginal Prostaglandin E2: all women,
outcome: 1.13 Neonatal intensive care unit admission.
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Figure 10.   Funnel plot of comparison: 1 Balloon (Foley or ATAD) versus vaginal Prostaglandin E2: all women,
outcome: 1.21 Fetal distress.
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Figure 11.   Funnel plot of comparison: 4 Balloon (Foley or ATAD) versus intracervical Prostaglandin E2: all women,
outcome: 4.3 Caesarean section.
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Figure 12.   Funnel plot of comparison: 7 Balloon (Foley or ATAD) versus low dose vaginal misoprostol: all women,
outcome: 7.3 Caesarean section.
 
Allocation
Sequence generation
We judged 62 trials to be at low risk of selection bias, reporting
some form of adequate random sequencing such as a comput-
er-generated sequence or a list of random numbers (Aduloju 2016;
Ahmed 2016; Al-Ibraheemi 2018; Al-Taani 2004; Amorosa 2017; Atad
1996; Bagratee 1990; Blumenthal 1990; Browne 2011; Carbone
2013; Chavakula 2015; Chua 1997; Cromi 2011; Cromi 2012; Culver
2004; Deo 2012; Edwards 2014c; El Khouly 2017; Filho 2002; Garba
2016; Gelisen 2005; Goonewardene 2014; Guinn 2000; Henry 2013;
Hibbard 1998; Husain 2017; Johnson 1985; Jozwiak 2012; Jozwiak
2013; Jozwiak 2014; Khamaiseh 2012; Krammer 1995a; Lanka 2014;
Lokkegaard 2015; Mackeen 2018; Matonhodze 2003; Mazhar 2003;
Meetei 2015; Mullin 2002; Mundle 2017; Niromanesh 2003; Oliveira
2010; Ophir 1992; Orhue 1995; Perry 1998; Prager 2008; Rouben
1993; Salim 2011; Sanchez-Ramos 1992; Sciscione 1999; Sharami
2005; Shechter-Maor 2015; Solt 2009; Somirathne 2017; St Onge
1995; Suffecool 2014; Tabowei 2003; Tan 2015; ten Eikelder 2016;
Turnquest 1997; Wang 2012; Yuen 1996).
Three trials were classified as high risk because they were qua-
si-randomised trials. Jagani 1982 randomised by last digit of the
chart number, Kandil 2012 randomised by odd or even admission
date and Roztocil 1998 randomised by week of admission.
We judged the remaining 40 trials to be at unclear risk of selec-
tion bias, as they did not report on how a random sequence was
generated (Allouche 1993; Barda 2018; Benzineb 1996; Casey 1995;
Dalui 2005; Deshmukh 2011; Dionne 2011; Gilson 2017; Glagoleva
1999; Gunawardena 2012; Haugland 2012; Hay 1995; Hemlin 1998;
Hoppe 2016; Hudon 1999; Jeeva 1982; Joshi 2016; Kruit 2016; Kup-
pulakshmi 2016; Laddad 2013; Lemyre 2006; Lewis 1983; Lyndrup
1989; Lyndrup 1994; Moini 2003; Noor 2015; Ntsaluba 1997; Pen-
nell 2009; Pineda Rivas 2016; Ridgway 1991; Roberts 1986; Roudsari
2011; Rudra 2012; Saleem 2006; Sarreau 2016; Sheikher 2009; Sulli-
van 1996;Tita 2006; Wang 2014; Wu 2017).
Allocation concealment
FiHy-five studies reported a method of allocation concealment like-
ly to have a low risk of bias, either by central randomisation or
sequentially numbered, sealed, opaque envelopes (Aduloju 2016;
Ahmed 2016; Al-Ibraheemi 2018; Amorosa 2017; Blumenthal 1990;
Browne 2011; Carbone 2013; Chavakula 2015; Cromi 2012; Culver
2004; Deo 2012; Edwards 2014c; El Khouly 2017; Filho 2002; Gelisen
2005; Goonewardene 2014; Guinn 2000; Hemlin 1998; Henry 2013;
Hibbard 1998; Hoppe 2016; Husain 2017; Jozwiak 2012; Jozwiak
2013; Jozwiak 2014; Kruit 2016; Lanka 2014; Lokkegaard 2015; Lyn-
drup 1989; Lyndrup 1994; Matonhodze 2003; Mullin 2002; Mundle
2017; Niromanesh 2003; Ntsaluba 1997; Oliveira 2010; Orhue 1995;
Pennell 2009; Perry 1998; Prager 2008; Roberts 1986; Rouben 1993;
Salim 2011; Sciscione 1999; Sharami 2005; Somirathne 2017; St
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Onge 1995; Suffecool 2014; Sullivan 1996; Tabowei 2003; Tan 2015;
ten Eikelder 2016; Turnquest 1997; Wang 2014; Yuen 1996).
Five studies were judged to be high risk. In the quasi-randomised
trials of Jagani 1982, Kandil 2012 and Roztocil 1998 no measures
were taken to conceal the allocation; Mackeen 2018 stated that the
allocation was not concealed and Ophir 1992 allocated women by
odd or even randomisation number.
The remaining 45 studies did not report a method for concealing
allocation and were judged as being at unclear risk of bias (Al-
louche 1993; Al-Taani 2004; Atad 1996; Bagratee 1990; Barda 2018;
Benzineb 1996; Casey 1995; Chua 1997; Cromi 2011; Dalui 2005;
Deshmukh 2011; Dionne 2011; Garba 2016; Gilson 2017; Glagoleva
1999; Gunawardena 2012; Haugland 2012; Hay 1995; Hudon 1999;
Jeeva 1982; Johnson 1985; Joshi 2016; Khamaiseh 2012; Kram-
mer 1995a; Kuppulakshmi 2016; Laddad 2013; Lemyre 2006; Lewis
1983; Mazhar 2003; Meetei 2015; Moini 2003; Noor 2015; Pineda Ri-
vas 2016; Ridgway 1991; Roudsari 2011; Rudra 2012; Saleem 2006;
Sanchez-Ramos 1992; Sarreau 2016; Shechter-Maor 2015; Sheikher
2009; Solt 2009; Tita 2006; Wang 2012; Wu 2017).
Blinding
Performance bias
Given the nature of the intervention (mechanical methods for in-
duction of labour) and comparison (pharmacological methods for
induction of labour), it was not possible for women or clinicians to
be blinded to the treatment group in any of the trials. For the more
objective outcomes such as perinatal death, the lack of blinding is
unlikely to be a major source of bias. Therefore, risk of performance
bias was judged as unclear in all studies, but was a reason to down-
grade the quality of evidence from high to moderate.
Detection bias
It would have been possible for outcome assessment to have been
undertaken by someone blinded to allocation groups. However,
only four trials reported blinded outcome assessment (rated as low
risk of bias). Gelisen 2005 blinded only for the outcome of hyper-
stimulation. In the studies of Pennell 2009 and Gelisen 2005, data
were collected by research midwives who were blinded to the in-
tervention. Rudra 2012 and Haugland 2012 both stated they per-
formed a double blind-trial but provided too little information to
assess how this was done. The remaining 101 trials did not detail
whether outcome assessment was blinded, and thus we judged risk
of detection bias to be unclear. Measurement of outcomes such as
perinatal death are unlikely to be biased by lack of blinding.
Incomplete outcome data
We considered 38 studies to be at low risk of attrition bias with da-
ta analyses according to intention- to-treat and minimal/no loss to
follow-up or exclusion of women (Aduloju 2016; Al-Ibraheemi 2018;
Al-Taani 2004; Amorosa 2017; Atad 1996; Carbone 2013; Chavakula
2015; Chua 1997; Cromi 2011; Culver 2004; Dalui 2005; Deshmukh
2011; Edwards 2014c; El Khouly 2017; Filho 2002; Guinn 2000; Hen-
ry 2013; Jeeva 1982; Jozwiak 2012; Jozwiak 2013; Jozwiak 2014;
Lanka 2014; Lokkegaard 2015; Mackeen 2018; Mullin 2002; Mundle
2017; Noor 2015; Ntsaluba 1997; Oliveira 2010; Pennell 2009; Perry
1998; Prager 2008; Roberts 1986; Roztocil 1998; Suffecool 2014; Sul-
livan 1996; ten Eikelder 2016; Wu 2017).
Forty-three studies were judged to be at unclear risk of attrition
bias, mainly because it was not clear if intention-to-treat analyses
was used (Allouche 1993; Benzineb 1996; Garba 2016; Gelisen 2005;
Hemlin 1998; Hibbard 1998; Hoppe 2016; Jagani 1982; Johnson
1985; Joshi 2016; Khamaiseh 2012; Laddad 2013; Lewis 1983; Ma-
tonhodze 2003; Meetei 2015; Niromanesh 2003; Roudsari 2011; Sal-
im 2011; Sanchez-Ramos 1992; Sharami 2005; Shechter-Maor 2015;
Somirathne 2017; St Onge 1995), or there was too little informa-
tion to judge attrition bias (Barda 2018; Casey 1995; Dionne 2011;
Gilson 2017; Glagoleva 1999; Gunawardena 2012; Haugland 2012;
Hay 1995; Hudon 1999; Kuppulakshmi 2016; Lemyre 2006; Mazhar
2003; Moini 2003; Pineda Rivas 2016; Ridgway 1991; Rudra 2012;
Saleem 2006; Sarreau 2016; Solt 2009; Tabowei 2003).
Twenty-four studies were classified as high risk for attrition bias.
In the studies of Ahmed 2016, Cromi 2012 and Wang 2014, women
were excluded because of failed placement of the balloon. Kandil
2012 also excluded nine patients because of failed placement of
the Foley catheter, but replaced them with women who did re-
ceive a Foley catheter. Deo 2012 analysed data as treated and al-
so four cases went missing without a given explanation. Husain
2017, Kruit 2016, Lyndrup 1989, Sciscione 1999, Tan 2015, Turn-
quest 1997, Wang 2012 and Yuen 1996 excluded cases because of
protocol violation and Krammer 1995a reported they analysed in-
tention-to-treat, but eventually excluded women because of proto-
col violation or if they delivered within six hours after induction had
started. Goonewardene 2014 also excluded women if they went in-
to spontaneous labour after the intervention. Lyndrup 1994 exclud-
ed women if they delivered after 48 hours of induction had started.
Orhue 1995 excluded women if they had an unfavourable cervix af-
ter 12 hours of induction. Rouben 1993 excluded women after failed
induction. The studies of Bagratee 1990, Blumenthal 1990, Browne
2011, Ophir 1992, Sheikher 2009, Tita 2006 were judged to be of high
risk for attrition bias because cases were missing without a given
explanation.
Selective reporting
Seventy-two studies were judged to be at low risk of reporting
bias as all pre-specified outcomes were reported (Aduloju 2016; Al-
Ibraheemi 2018; Al-Taani 2004; Amorosa 2017; Atad 1996; Bagra-
tee 1990; Barda 2018; Blumenthal 1990; Carbone 2013; Chavakula
2015; Chua 1997; Cromi 2011; Cromi 2012; Culver 2004; Dalui 2005;
Deo 2012; Deshmukh 2011; Edwards 2014c; El Khouly 2017; Filho
2002; Garba 2016; Gelisen 2005; Goonewardene 2014; Guinn 2000;
Hemlin 1998; Henry 2013; Hibbard 1998; Hoppe 2016; Husain 2017;
Jagani 1982; Johnson 1985; Joshi 2016; Jozwiak 2012; Jozwiak
2013; Jozwiak 2014; Kandil 2012; Khamaiseh 2012; Krammer 1995a;
Kruit 2016; Kuppulakshmi 2016; Lanka 2014; Lokkegaard 2015; Lyn-
drup 1994; Mackeen 2018; Matonhodze 2003; Mazhar 2003; Meetei
2015; Mullin 2002; Mundle 2017; Noor 2015; Ntsaluba 1997;Oliveira
2010; Ophir 1992; Orhue 1995; Pennell 2009; Perry 1998; Prager
2008; Rouben 1993; Roztocil 1998; Salim 2011; Sciscione 1999;
Sharami 2005; Solt 2009; Somirathne 2017; St Onge 1995; Suffecool
2014; Sullivan 1996; Tabowei 2003; ten Eikelder 2016; Turnquest
1997; Wang 2012;Wu 2017; Yuen 1996). It is important to note that
not all studies had a trial protocol available and therefore it was not
possible to check if there were other pre-specified outcomes not
reported in the method section of the article.
Twenty-eight studies were judged to be of unclear risk of reporting
bias. In 10 studies no outcomes were pre-specified in the methods
section (Allouche 1993; Benzineb 1996; Jeeva 1982; Laddad 2013;
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Lewis 1983; Lyndrup 1989; Roberts 1986; Sanchez-Ramos 1992;
Tan 2015; Wang 2014 and in 18 studies there was too little infor-
mation to judge reporting bias (Casey 1995; Dionne 2011; Gilson
2017; Glagoleva 1999; Guinn 2000; Gunawardena 2012; Haugland
2012; Hay 1995; Hudon 1999; Lemyre 2006; Moini 2003; Niromanesh
2003; Pineda Rivas 2016; Ridgway 1991; Roudsari 2011; Rudra 2012;
Saleem 2006; Sarreau 2016).
The studies of Ahmed 2016, Browne 2011, Shechter-Maor 2015,
Sheikher 2009 and Tita 2006 were judged as high risk as not all pre-
specified outcomes were reported in the results section.
Other potential sources of bias
For 24 studies it was not clear if there was another source of bias
and these were therefore judged as unclear. For one study (Bar-
da 2018), only a manuscript with no tables was available. Two tri-
als (Browne 2011; Tita 2006) were not published, but the results of
the primary outcome and adverse events were reported in the tri-
al registration. Guinn 2000 stopped recruiting women for one arm
of the study without an explanation. Mullin 2002 calculated a sam-
ple size of 140 women but included 200 women without explana-
tion. Prager 2008 included patients who did not meet inclusion cri-
teria. Eighteen studies were only published as abstracts, or there
was too little information provided and so it was not possible to
judge the risk of bias (Casey 1995; Dionne 2011; Garba 2016; Gilson
2017; Glagoleva 1999; Haugland 2012; Hay 1995; Hudon 1999; Le-
myre 2006; Oliveira 2010; Pineda Rivas 2016; Ridgway 1991; Rudra
2012; Sarreau 2016; Shechter-Maor 2015; Solt 2009; Tabowei 2003;
Wang 2012).
The studies of Culver 2004, Hibbard 1998, and Kruit 2016 were
judged as high risk for other potential sources of bias as they were
terminated early before the required sample size was recruited.
E>ects of interventions
See: Summary of findings for the main comparison Balloon
(Foley or ATAD) compared to vaginal prostaglandin E2 for third
trimester labour induction in women with a viable fetus; Summary
of findings 2 Balloon (Foley or ATAD) compared to low-dose vaginal
misoprostol for third trimester induction of labour in women with a
viable fetus; Summary of findings 3 Balloon (Foley or ATAD) com-
pared to low-dose oral misoprostol for third trimester induction of
labour in women with a viable fetus
Balloon (single or double) versus vaginal prostaglandin E2 (28
trials involving 6619 women)
Primary outcomes
Vaginal delivery not achieved within 24 hours
There may be little or no difference in vaginal deliveries not
achieved within 24 hours between induction of labour with a bal-
loon catheter and vaginal PGE2 (average risk ratio (RR) 1.01, 95%
confidence interval (CI) 0.82 to 1.26; 7 studies; 1685 women; low-
quality evidence; Analysis 1.1), although there was substantial het-
erogeneity for this outcome (Tau2 = 0.06; Chi2 = 29.06, df = 6 (P =<
0.0001); I2 = 79%).
A sensitivity analysis, after eliminating the two trials assessed as
having a potentially higher risk of concealment or attrition bias
(Cromi 2012; Wang 2014), did not change the effect observed, de-
spite the result becoming less precise (average RR 1.10, 95% CI 0.86
to 1.41; 1351 women; 5 studies; I2 = 82%).
The same result was seen on a subgroup comparison for primi-
parous women (RR 1.01, 95% CI 0.83 to 1.23; 330 women; 1 study;
Analysis 2.1). While for multiparous women, a balloon catheter may
increase the risk of a vaginal delivery not being achieved within 24
hours (RR 4.38, 95% CI 1.74 to 10.98; 147 women; 1 study; Analysis
3.1).
Uterine hyperstimulation with fetal heart rate (FHR) changes
A balloon catheter probably reduces the risk of uterine hyperstimu-
lation with FHR changes when compared to vaginal PGE2 (RR 0.35,
95% CI 0.18 to 0.67; 6 studies; 1966 women; moderate-quality evi-
dence; Analysis 1.2), the absolute effect being 21 less per 1000 de-
liveries.
The same result was seen on a subgroup comparison for primi-
parous women (RR 0.05, 95% CI 0.00 to 0.85; 330 women; 1 study;
Analysis 2.2). For multiparous women, no outcomes were reported.
Caesarean section
There probably is little or no difference in caesarean sections be-
tween both induction methods (RR 1.00, 95% CI 0.92 to 1.09; 28
studies; 6619 women; moderate-quality evidence; Analysis 1.3). Vi-
sual inspection of the funnel plot associated with this outcome
does not suggest any evidence of publication bias (Figure 4).
It is uncertain whether there is a difference in caesarean sections
between both induction methods on subgroups for both primi-
parous women (average RR 0.89, 95% CI 0.59 to 1.33; 828 women; 5
studies; Analysis 2.3) and multiparous women (RR 1.31, 95% CI 0.65
to 2.63; 180 women; 2 studies; Analysis 3.2) as the results of these
outcomes were imprecise. Furthermore, for the primiparous group,
there was also substantial heterogeneity (Tau2 = 0.11; Chi2 = 10.01,
df = 4 (P = 0.04); I2 = 60%).
Serious neonatal morbidity or perinatal death
A balloon catheter probably reduces the risk of serious neonatal
morbidity or perinatal death when compared to vaginal PGE2 (RR
0.48, 95% CI 0.25 to 0.93; 8 studies; 2757 women; moderate-quality
evidence; Analysis 1.4). However, numbers are low (12/1483 versus
25/1274, respectively) and almost all of these numbers were cases
of birth asphyxia. Only two perinatal deaths were reported, both
in the PGE2 group (Edwards 2014c). No heterogeneity was seen for
this outcome.
For primiparous women, it is uncertain whether there is a differ-
ence in effect as the result for this outcome was imprecise (RR 0.17,
95% CI 0.01 to 4.24; 330 women; 1 study; Analysis 2.4). For multi-
parous women, no outcomes were reported.
Serious maternal morbidity or death
It is uncertain whether there is a difference in serious maternal
morbidity or death between both induction methods (RR 0.20, 95%
CI 0.01 to 4.12; 4 studies; 1481 women; very low-quality evidence;
Analysis 1.5). Of all the 28 studies included for this comparison, only
four studies reported on this composite outcome. No events were
reported in the balloon group. One author (Jozwiak 2012) reported
two events in the PGE2 group, both events being uterine rupture.
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Only one study (60 women) reported on this outcome in primi-
parous women, in which no events were seen (Analysis 2.5). For
multiparous women, no outcomes were reported.
Secondary outcomes
Cervix unfavourable/unchanged aLer 24 hours
Not reported.
Oxytocin augmentation
Induction of labour with a balloon catheter may increase the risk
of oxytocin augmentation when compared to vaginal PGE2 (aver-
age RR 1.54, 95% CI 1.35 to 1.76; 4828 women; 16 studies; Analysis
1.6), although there was substantial heterogeneity for this outcome
(Tau2 = 0.05; Chi2 = 141.47, df = 15 (P = < 0.0001); I2 = 89%). Visual in-
spection of the funnel plot was somewhat asymmetrical, suggest-
ing some form of publication bias (Figure 5).
A sensitivity analysis, after eliminating the five trials assessed as
having a potentially higher risk of allocation or attrition bias (Cromi
2012; Deo 2012; Tan 2015; Wang 2012; Wang 2014), did not alter the
result, nor did it lower heterogeneity (average RR 1.37, 95% CI 1.21
to 1.54; 4005 women; 11 studies; I2 = 87%).
Uterine hyperstimulation without FHR changes
A balloon catheter may reduce the risk of uterine hyperstimulation
without FHR changes when compared to vaginal PGE2 (average RR
0.27, 95% CI 0.11 to 0.66; 2444 women; 15 studies; Analysis 1.7), al-
though there was moderate heterogeneity for this outcome (Tau2 =
1.13; Chi2 = 22.28, df = 12 (P = 0.03); I2 = 46%). Visual inspection of
the funnel plot associated with this outcome does not suggest any
evidence of publication bias (Figure 6).
A sensitivity analysis, after eliminating the seven trials assessed as
having a potentially higher risk of allocation or attrition bias (Deo
2012; Orhue 1995; Shechter-Maor 2015; Tan 2015; Wang 2012; Wang
2014; Zahoor 2014), made this result less precise and therefore rais-
es uncertainty as to whether there is a difference in uterine hyper-
stimulation without FHR changes (average RR 0.26, 95% CI 0.06 to
1.05; 1694 women; 8 studies; I2 = 62%).
Uterine rupture
It is uncertain whether there is a difference in uterine rupture be-
tween both induction methods (RR 0.20, 95% CI 0.01 to 4.12; 1045
women; 2 studies; Analysis 1.8). Only two cases of uterine rupture
were reported, both in the PGE2 group in the study of Jozwiak 2012.
Uterine rupture was defined by the authors as a separation of the
uterine wall, and in one case this was caused by inserting an in-
trauterine pressure catheter.
Epidural analgesia
A balloon catheter may slightly increase the use of epidural analge-
sia during labour when compared to vaginal PGE2 (average RR 1.14,
95% CI 1.00 to 1.29; 2828 women; 8 studies; Analysis 1.9). However,
there was substantial heterogeneity for this outcome (Tau2 = 0.02;
Chi2 = 32.09, df = 7 (P = < 0.0001); I2 = 78%).
A sensitivity analysis, after eliminating the two trials assessed as
having a potentially higher risk of allocation or attrition bias (Cro-
mi 2012; Tan 2015), did not alter the result, nor did it lower hetero-
geneity (average RR 1.11, 95% CI 0.97 to 1.28; 2537 women; 6 stud-
ies; I2 = 80%).
Instrumental vaginal delivery
There probably is little or no difference in instrumental vaginal de-
liveries between both induction methods (RR 0.93, 95% CI 0.79 to
1.09; 4514 women; 16 studies; Analysis 1.10). Visual inspection of
the funnel plot associated with this outcome does not suggest any
evidence of publication bias (Figure 7).
Meconium-stained liquor
It is uncertain whether there is a difference in meconium-stained
liquor between both induction methods (RR 0.89, 95% CI 0.67 to
1.19; 964 women; 4 studies; Analysis 1.11).
Apgar score less than seven at five minutes
It is uncertain whether there is a difference in Apgar score less than
seven at five minutes between both induction methods (RR 0.74,
95% CI 0.49 to 1.14; 4271 women; 14 studies; low-quality evidence;
Analysis 1.12). Visual inspection of the funnel plot associated with
this outcome does not suggest any evidence of publication bias
(Figure 8).
Neonatal intensive care unit (NICU) admission
A balloon catheter may reduce the risk of a NICU admission when
compared to vaginal PGE2 (RR 0.82, 95% CI 0.65 to 1.04; 3647
women; 12 studies; low-quality evidence; Analysis 1.13), the ab-
solute effect being 15 fewer NICU admission per 1000 deliveries. Al-
though it should be noted that there is a wide range of treatment
effects that are compatible with the data, from a very small increase
in risk to very large decrease. Visual inspection of the funnel plot as-
sociated with this outcome does not suggest any evidence of pub-
lication bias (Figure 9).
Neonatal encephalopathy
Not reported.
Perinatal death
It is uncertain whether there is a difference in perinatal death be-
tween both induction methods (RR 0.21, 95% CI 0.01 to 4.27; 1036
women; 5 studies; Analysis 1.14). Only two cases of perinatal death
were reported by Edwards 2014c, both being cases of neonatal
death and born to women randomised to vaginal PGE2. The authors
describe that in both cases the neonates died as a result of compli-
cations related to a congenital diaphragmatic hernia and were un-
related to the induction method.
Disability in childhood
Not reported.
Maternal side e>ects (all)
Not reported.
Maternal nausea
Not reported.
Maternal vomiting
Not reported.
Maternal diarrhoea
Not reported.
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Other maternal side e>ects
Not reported.
Postpartum haemorrhage
It is uncertain whether there is a difference in postpartum haem-
orrhage between both induction methods (RR 0.82, 95% CI 0.63 to
1.06; 2215 women; 8 studies; Analysis 1.15).
Serious maternal complications
Not reported.
Maternal death
Not reported.
Woman not satisfied
A balloon catheter may reduce the amount of women not being sat-
isfied with the induction method when compared to prostaglandin
E2 (RR 0.61, 95% CI 0.39 to 0.97; 93 women; 1 study; Analysis 1.16),
the absolute effect being 224 fewer women not satisfied per 1000
deliveries. This outcome was reported by Henry 2013 by asking the
women if they would choose the randomised induction method
again. Patient satisfaction was also reported by Shechter-Maor
2015, but could not be included in the meta-analysis. In this study
women were asked to score their satisfaction with the induction
process on a five-point Likert scale. No difference in satisfaction
was seen between both induction methods (3.41 (± 1.3) versus 3.33
(± 1.2), respectively; P = 0.860).
Caregiver not satisfied
Not reported.
Other outcomes (not pre-specified)
Maternal fever during labour
It is uncertain whether there is a difference in maternal fever during
labour between both methods (RR 0.87, 95% CI 0.65 to 1.17; 2362
women; 7 studies; Analysis 1.17).
Antibiotics during labour
It is uncertain whether there is a difference in antibiotics during
labour between both methods (RR 1.43, 95% CI 0.89 to 2.29; 330
women; 1 study; Analysis 1.18).
Chorioamnionitis
It is uncertain whether there is a difference in chorioamnionitis be-
tween both induction methods (RR 0.69, 95% CI 0.32 to 1.49; 376
women; 1 study; Analysis 1.19).
Endometritis
It is uncertain whether there is a difference in endometritis between
both induction methods (RR 0.49, 95% CI 0.19 to 1.27; 706 women;
2 studies; Analysis 1.20).
Fetal distress
A balloon catheter probably reduces the risk of fetal distress for
which a caesarean section is indicated when compared to vaginal
PGE2 (RR 0.71, 95% CI 0.60 to 0.83; 4753 women; 20 studies; Analysis
1.21). Visual inspection of the funnel plot associated with this out-
come does not suggest any evidence of publication bias (Figure 10).
Umbilical artery pH < 7.10
A balloon catheter probably reduces the risk of an umbilical artery
pH less than 7.10 directly postpartum when compared to vaginal
PGE2 (RR 0.65, 95% CI 0.44 to 0.94; 2675 women, 8 studies; Analysis
1.22). However, numbers occurred infrequently in both groups (35
per 1000 versus 56 per 1000, respectively).
Balloon (single or double) versus cervical prostaglandin E2 (10
trials involving 1428 women)
Primary outcomes
Vaginal delivery not achieved within 24 hours
It is uncertain whether there is a difference in vaginal deliveries
achieved within 24 hours between induction of labour with a bal-
loon catheter and cervical PGE2 (average RR 1.01, 95% CI 0.35 to
2.91; 200 women; 2 studies; Analysis 4.1). There also was substan-
tial heterogeneity for this outcome (Tau2 = 0.53; Chi2 = 10.35, df = 1
(P = 0.001); I2 = 90%). Even though data were pooled, both studies
may be incompatible as no overlap of CIs is present. No sensitivity
analysis was conducted as no potential high-risk studies were in-
cluded for this outcome.
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Uterine hyperstimulation with FHR changes
It is uncertain whether there is a difference in uterine hyperstimu-
lation with FHR changes between both induction methods (RR 0.37,
95% CI 0.02 to 8.90; 447 women; 4 studies; Analysis 4.2).
Only one small study (53 women) reported this outcome for the
subgroups of primiparous and multiparous women. No events were
reported in primiparous women (Analysis 5.1). For multiparous
women, it is uncertain whether there is a difference for this out-
come between both induction methods (RR 0.30, 95% CI 0.01 to
7.02; 53 women; 1 study; Analysis 6.1).
Caesarean section
There probably is little or no difference in caesarean sections be-
tween both induction methods (RR 0.97, 95% CI 0.81 to 1.15; 1309
women; 9 studies; Analysis 4.3). Visual inspection of the funnel plot
associated with this outcome does not suggest any evidence of
publication bias (Figure 11).
It is uncertain whether there is a difference in caesarean sections
between both induction methods on subgroup comparisons for
both primiparous women (RR 1.30, 95% CI 0.86 to 1.95; 245 women;
3 studies; Analysis 5.2) and multiparous women (average RR 0.66,
95% CI 0.16 to 2.78; 136 women; 3 studies; Analysis 6.2) as the re-
sults for both comparisons were imprecise. For the multiparous
group, there also was substantial heterogeneity (Tau2 = 0.90; Chi2 =
4.78, df = 2 (P = 0.09); I2 = 58%).
Serious neonatal morbidity or perinatal death
It is uncertain whether there is a difference in serious neonatal mor-
bidity or perinatal death between both induction methods (RR 0.78,
95% CI 0.29 to 2.05; 500 women; 2 studies; Analysis 4.4). Of the 10
studies included for this comparison, two studies (Benzineb 1996;
Laddad 2013) reported on this composite outcome. All reported
events in these studies were cases of perinatal death.
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For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Serious maternal morbidity or death
Not reported.
Secondary outcomes
Cervix unfavourable/unchanged aLer 24 hours
It is uncertain whether there is a difference in an unfavourable
cervix after 24 hours between both induction methods (RR 0.96,
95% CI 0.70 to 1.34; 219 women; 2 studies; Analysis 4.5).
Oxytocin augmentation
There may be little or no difference in oxytocin augmentation be-
tween both induction methods (RR 1.08, 95% CI 0.93 to 1.26; 400
women; 1 study; Analysis 4.6).
Uterine hyperstimulation without FHR changes
It is uncertain whether there is a difference in uterine hyperstimu-
lation without FHR changes between both induction methods (av-
erage RR 0.99, 95% CI 0.09 to 10.38; 654 women; 5 studies; Analy-
sis 4.7). Also, there was substantial heterogeneity for this outcome
(Tau2 = 2.92; Chi2 = 6.33, df = 2 (P = 0.04); I2 = 68%).
A sensitivity analysis, after eliminating the two trials assessed as
having a potentially higher risk of allocation or attrition bias (Scis-
cione 1999; Yuen 1996) did not alter the result, nor did it lower het-
erogeneity (average RR 0.56, 95% CI 0.01 to 39.31; 430 women; 3
studies; I2 = 76%).
Uterine rupture
Not reported.
Epidural analgesia
There may be little or no difference in epidural analgesia during
labour between both induction methods (RR 0.91, 95% CI 0.81 to
1.02; 149 women; 1 study; Analysis 4.8).
Instrumental vaginal delivery
It is uncertain whether there is a difference in instrumental vaginal
deliveries between both induction methods (RR 1.18, 95% CI 0.68
to 2.05; 337 women; 3 studies; Analysis 4.9).
Meconium-stained liquor
It is uncertain whether there is a difference in meconium-stained
liquor between both induction methods (RR 1.17, 95% CI 0.42 to
3.26; 118 women; 1 study; Analysis 4.10).
Apgar score less than seven at five minutes
It is uncertain whether there is a difference in Apgar scores less than
seven at five minutes (RR 0.79, 95% CI 0.41 to 1.53; 475 women; 2
studies; Analysis 4.11).
Neonatal intensive care unit admission
It is uncertain whether there is a difference in NICU admissions be-
tween both methods (RR 0.88, 95% CI 0.60 to 1.31; 400 women; 1
study; Analysis 4.12).
Neonatal encephalopathy
Not reported.
Perinatal death
It is uncertain whether there is difference in perinatal death be-
tween both induction methods (RR 0.78, 95% CI 0.29 to 2.05; 500
women; 2 studies. Analysis 4.13). Noteworthy, there was a relative-
ly high number of neonatal deaths reported in the study of Laddad
2013 for the balloon group (6/200), as well as in the cervical PGE2
group (8/200), for which no explanation was given by the authors.
Disability in childhood
Not reported.
Maternal side e>ects
It is uncertain whether there is a difference in maternal side effects
(RR 0.15, 95% CI 0.02 to 1.24; 211 women; 2 studies; Analysis 4.14).
The nature of the side effects was not specified in both included
studies.
Maternal nausea
Not reported.
Maternal vomiting
Not reported.
Maternal diarrhoea
Not reported.
Other maternal side e>ects
Not reported.
Postpartum haemorrhage
It is uncertain whether there is a difference in postpartum haem-
orrhage between both induction methods (RR 0.20, 95% CI 0.01 to
4.06; 100 women; 1 study; Analysis 4.15).
Serious maternal complications
Not reported.
Maternal death
Not reported.
Woman not satisfied
Not reported.
Caregiver not satisfied
Not reported.
Other outcomes (not pre-specified)
Maternal fever during labour
Not reported.
Antibiotics during labour
Not reported.
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Chorioamnionitis
It is uncertain whether there is a difference in chorioamnionitis be-
tween both induction methods (RR 1.00, 95% CI 0.21 to 4.75; 118
women; 1 study; Analysis 4.16).
Endometritis
It is uncertain whether there is a difference in endometritis between
both induction methods (RR 1.00, 95% CI 0.06 to 15.61; 118 women;
1 study; Analysis 4.17).
Fetal distress
A balloon catheter probably reduces the risk of fetal distress for
which a caesarean section is indicated when compared to cervical
PGE2 (RR 0.61, 95% CI 0.42 to 0.89; 1023 women; 6 studies; Analysis
4.18).
Umbilical artery pH < 7.10
Not reported.
Balloon (single or double) versus low-dose vaginal misoprostol
(13 trials involving 1818 women)
Primary outcomes
Vaginal delivery not achieved within 24 hours
It is uncertain whether there is a difference in vaginal deliveries not
achieved within 24 hours between induction of labour with a bal-
loon catheter and vaginal misoprostol (RR 1.09, 95% CI 0.85 to 1.39;
340 women; 2 studies; low-quality evidence; Analysis 7.1).
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Uterine hyperstimulation with FHR changes
A balloon catheter probably reduces the risk of uterine hyperstim-
ulation with FHR changes when compared to vaginal misoprostol
(RR 0.39, 95% CI 0.18 to 0.85; 1322 women; moderate-quality evi-
dence; 8 studies; Analysis 7.2), the absolute effect being 22 fewer
cases per 1000 deliveries.
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Caesarean section
A balloon catheter may increase the risk of a caesarean section
when compared to vaginal misoprostol (average RR 1.28, 95% CI
1.02 to 1.60; 1756 women; 12 studies; low-quality evidence; Analy-
sis 7.3), the absolute effect being 53 more caesarean sections per
1000 deliveries. However, there was moderate heterogeneity for
this outcome (Tau2 = 0.06; Chi2 = 19.86, df = 11 (P = 0.05); I2 = 45%).
A sensitivity analysis, after eliminating the three trials assessed as
having a potentially higher risk of allocation or attrition bias (Deo
2012; Kandil 2012; Sheikher 2009), did not alter the result, nor did
it lower heterogeneity (average RR 1.34, 95% CI 1.05 to 1.71; 1492
women; 10 studies; I2 = 48%). Visual inspection of the funnel plot as-
sociated with this outcome does not suggest any evidence of pub-
lication bias (Figure 12).
For the subgroup of primiparous women, it is uncertain whether
there is a difference in caesarean sections between both induction
methods (RR 0.82, 95% CI 0.59 to 1.13; 255 women; 1 study; Analysis
8.1). For multiparous women, no outcomes were reported.
Serious neonatal morbidity or perinatal death
It is uncertain whether there is a difference in serious neonatal mor-
bidity or perinatal death between both induction methods (RR 0.58,
95% CI 0.12 to 2.66; 381 women; 3 studies; very low-quality evi-
dence; Analysis 7.4). All of the cases included for this composite out-
come were cases of perinatal asphyxia (2/187 versus 4/194, respec-
tively).
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Serious maternal morbidity or death
It is uncertain whether there is a difference in serious maternal mor-
bidity or death between both induction methods (very low-quali-
ty evidence; Analysis 7.5). Of the 13 studies included for this com-
parison, four studies (464 women) reported on this composite out-
come. No events of maternal morbidity or death occurred in one of
these studies.
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Secondary outcomes
Cervix unfavourable/unchanged aLer 12 hours
It is uncertain whether there is a difference in an unfavourable
cervix after 12 hours between both induction methods (average RR
2.66, 95% CI 0.60 to 11.89; 200 women; 2 studies; Analysis 7.6). Also,
there was moderate heterogeneity for this outcome (Tau2 = 0.63;
Chi2 = 1.56, df = 1 (P = 0.21); I2 = 36%). No studies reported on a time
period of 24 hours.
A sensitivity analysis, after eliminating one trial assessed as hav-
ing a potentially higher risk of allocation or attrition bias (Sheikher
2009), did not change the result, but did narrow the CI (RR 1.82, 95%
CI 0.94 to 3.51; 1 study).
Oxytocin augmentation
A balloon catheter probably increases the risk of oxytocin augmen-
tation when compared to vaginal misoprostol (average RR 1.62,
95% CI 1.38 to 1.90; 911 women; 9 studies; Analysis 7.7), although
there was substantial heterogeneity for this outcome (Tau2 = 0.03;
Chi2 = 21.93, df = 8 (P = 0.005); I2 = 64%).
In the sensitivity analysis, after eliminating two trial assessed as
having a potentially higher risk of allocation or attrition bias (Kandil
2012 and Sheikher 2009), heterogeneity was lost without alter-
ing the effect observed (average RR 1.50, 95% CI 1.36 to 1.64; 751
women, 7 studies; I2 = 0%).
Uterine hyperstimulation without FHR changes
A balloon catheter probably reduces the risk of uterine hyperstimu-
lation without FHR changes when compared to vaginal misoprostol
(RR 0.25, 95% CI 0.14 to 0.44; 1139 women; 9 studies; Analysis 7.8).
Uterine rupture
It is uncertain whether there is a difference in uterine rupture be-
tween both induction methods (Analysis 7.9). Of the 13 studies in-
cluded for this comparison, only three studies (364 women) report-
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ed on this outcome. No events of uterine rupture occurred in one
of these studies.
Epidural analgesia
A balloon catheter probably slightly increases the use of epidural
analgesia during labour when compared to vaginal misoprostol (RR
1.22, 95% CI 1.06 to 1.41; 517 women; 2 studies; Analysis 7.10).
Instrumental vaginal delivery
It is uncertain whether there is a difference in instrumental vaginal
deliveries between both induction methods (RR 0.72, 95% CI 0.50
to 1.05; 721 women; 4 studies; Analysis 7.11).
Meconium-stained liquor
A balloon catheter probably reduces the risk of meconium-stained
liquor when compared to vaginal misoprostol (RR 0.64, 95% CI 0.48
to 0.87; 1268 women; 7 studies; Analysis 7.12).
Apgar score less than seven at five minutes
It is uncertain whether there is a difference in Apgar scores less than
seven at five minutes between both induction methods (RR 1.00,
95% CI 0.50 to 1.97; 941 women; 7 studies; low-quality evidence;
Analysis 7.13).
Neonatal intensive care unit admission
It is uncertain whether there is a difference in NICU admissions be-
tween both induction methods (RR 1.00, 95% CI 0.61 to 1.63; 1302
women; 9 studies; low-quality evidence; Analysis 7.14).
Neonatal encephalopathy
Not reported.
Perinatal death
It is uncertain whether there is difference in perinatal death be-
tween both induction methods (Analysis 7.15). Of the 13 studies in-
cluded for this comparison, only one study (121 women) pre-speci-
fied this outcome. No cases of perinatal death were reported in this
study.
Disability in childhood
Not reported.
Maternal side e>ects (all)
Not reported.
Maternal nausea
Not reported.
Maternal vomiting
It is uncertain whether there is difference in maternal vomiting be-
tween both induction methods (Analysis 7.16). Of all the 13 studies
included for this comparison, only one study (60 women) pre-spec-
ified this outcome. No cases of maternal vomiting were reported in
this study.
Maternal diarrhoea
Not reported.
Other maternal side e>ects
Not reported.
Postpartum haemorrhage
It is uncertain whether there is difference in postpartum haemor-
rhage between both induction methods (RR 1.14, 95% CI 0.24 to
5.44; 120 women; 1 study; (Analysis 7.17).
Serious maternal complications
Not reported.
Maternal death
Not reported.
Woman not satisfied
One study (Chavakula 2015) reported on patient satisfaction, but
could not be included in the meta-analysis. In this study, satisfac-
tion was assessed by a visual analogue score ranging from zero to
five (0 = very poor; 5 = very good), in which no difference between
both induction methods was seen (100 women; 4.5 [4-5] versus 4.45
[3-5], respectively; P = 0.488).
Caregiver not satisfied
Not reported.
Not pre-specified outcomes
Maternal fever during labour
It is uncertain whether there is a difference in maternal fever dur-
ing labour between both methods (average RR 1.84, 95% CI 0.22
to 15.62; 617 women; 3 studies; Analysis 7.18). Also, there was sub-
stantial heterogeneity for this outcome (Tau2 = 1.86; Chi2 = 3.95, df
= 1 (P = 0.05); I2 = 75%). No sensitivity analysis was performed as no
potential high-risk studies were included for this outcome.
Antibiotics during labour
Not reported.
Chorioamnionitis
It is uncertain whether there is a difference in chorioamnionitis be-
tween both induction methods (RR 1.24, 95% CI 0.31 to 4.88; 200
women; 2 studies; Analysis 7.19).
Endometritis
It is uncertain whether there is a difference in endometritis between
both induction methods (RR 2.95, 95% CI 0.12 to 71.72; 240 women;
1 study; Analysis 7.20).
Fetal distress
It is uncertain whether there is a difference in fetal distress for
which a caesarean section is indicated (RR 0.84, 95% CI 0.67 to 1.05;
1127 women; 7 studies; Analysis 7.21).
Umbilical artery pH < 7.10
It is uncertain whether there is a difference in umbilical artery pH
less than 7.10 directly postpartum between both induction meth-
ods (RR 1.14, 95% CI 0.35 to 3.74; 120 women; 1 study; Analysis 7.22).
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Balloon (single or double) versus low-dose oral misoprostol
(seven trials involving 3178 women)
Primary outcomes
Vaginal delivery not achieved within 24 hours
A balloon catheter probably increases the risk of a vaginal delivery
not achieved within 24 hours when compared to oral misoprostol
(RR 1.28, 95% CI 1.13 to 1.46; 782 women, 2 studies. moderate-qual-
ity evidence, Analysis 9.1), the absolute effect being 133 more per
1000 deliveries.
The same results were seen on parity subgroup comparisons for
primiparous women (RR 1.19, 95% CI 1.04 to 1.37; 573 women; 2
studies; Analysis 10.1) and multiparous women (RR 1.55, 95% CI
1.17 to 2.06; 209 women; 2 studies; Analysis 11.1).
Uterine hyperstimulation with FHR changes
It is uncertain whether there is a difference in uterine hyperstimu-
lation with FHR changes between both induction methods (RR 0.81,
95% CI 0.48 to 1.38; 2033 women; 2 studies; low-quality evidence;
Analysis 9.2).
The same results were seen on parity subgroup comparisons for
primiparous women (RR 0.81, 95% CI 0.45 to 1.46; 1206 women; 1
study; Analysis 10.2 and multiparous women (RR 1.45, 95% CI 0.24
to 8.61; 639 women; 1 study; Analysis 11.2).
Caesarean section
A balloon catheter probably slightly increases the risk of a caesare-
an section when compared to oral misoprostol (RR 1.17, 95% CI 1.04
to 1.32; 3178 women; 7 studies; moderate-quality evidence; Analy-
sis 9.3), the absolute effect being 37 more caesarean sections per
1000 deliveries.
The same result was seen on the subgroup of primiparous women
(RR 1.21, 95% CI 1.06 to 1.38; 1778 women; 3 studies; Analysis 10.3).
For multiparous women, it is uncertain whether there is a difference
in caesarean sections between both methods (RR 1.22, 95% CI 0.79
to 1.87; 848 women; 3 studies; Analysis 11.3).
Serious neonatal morbidity or perinatal death
It is uncertain whether there is a difference in serious neonatal mor-
bidity or perinatal death between both induction methods (RR 1.11,
95% CI 0.60 to 2.06; 2627 women; 3 studies; low-quality evidence;
Analysis 9.4).
The same results were seen on parity subgroup comparisons for
primiparous women (RR 4.49, 95% CI 0.77 to 26.14; 1296 women;
2 studies; Analysis 10.4) and multiparous women (RR 0.98, 95% CI
0.14 to 6.86; 729 women; 2 studies; Analysis 11.4).
Serious maternal morbidity or death
It is uncertain whether there is a difference in serious maternal
morbidity or death between both induction methods (RR 0.50, 95%
CI 0.05 to 5.52; 2627 women; 3 studies; very low-quality evidence;
Analysis 9.5).
The same results were seen on parity subgroup comparisons for
primiparous women (RR 0.51, 95% CI 0.05 to 5.63; 1296 women; 2
studies; Analysis 10.5) and multiparous women (Analysis 11.5). In
the latter group, no events of maternal morbidity or death were re-
ported (2 studies; 729 women).
Secondary outcomes
Cervix unfavourable/unchanged aLer 24 hours
It is uncertain whether there is a difference in an unfavourable
cervix after 24 hours between both induction methods (average RR
0.98, 95% CI 0.61 to 1.56; 994 women; 4 studies; Analysis 9.6). Also,
there was moderate heterogeneity for this outcome (Tau2 = 0.06;
Chi2 = 2.96, df = 2 (P = 0.23); I2 = 33%).
A sensitivity analysis, after eliminating the two trials assessed
as having a potentially higher risk of allocation or attrition bias
(Goonewardene 2014; Sheikher 2009), did not change the result, al-
though heterogeneity was lost (RR 1.31, 95% CI 0.81 to 2.15; 782
women; 2 studies; I2 = 0%).
Oxytocin augmentation
A balloon catheter may increase the risk of oxytocin augmenta-
tion when compared to oral misoprostol (average RR 1.28, 95% CI
1.09 to 1.49; 2847 women; 5 studies; Analysis 9.7) although there
was substantial heterogeneity for this outcome (Tau2 = 0.03; Chi2 =
31.32, df = 4 (P < 0.000001); I2 = 87%).
A sensitivity analysis, after eliminating the three trials assessed
as having a potentially higher risk of allocation or attrition bias
(Goonewardene 2014; Kruit 2016; Sheikher 2009), did not change
this result, nor did it lower heterogeneity (average RR 1.35, 95% CI
1.02 to 1.79; 2447 women; 2 studies; I2 = 95%).
Uterine hyperstimulation without FHR changes
It is uncertain whether there is a difference in uterine hyperstimu-
lation without FHR changes between both induction methods (av-
erage RR 0.50, 95% CI 0.12 to 2.07; 2838 women; 5 studies; Analy-
sis 9.8). Also, there was substantial heterogeneity for this outcome
(Tau2 = 1.26; Chi2 = 8.12, df = 4 (P = 0.09); I2 = 51%).
A sensitivity analysis, after eliminating the one trial assessed as
having a potentially higher risk of allocation or attrition bias
(Sheikher 2009), did not change the effect observed, nor did it lower
heterogeneity (average RR 0.49, 95% CI 0.09 to 2.64; 2778 women;
4 studies; I2 = 60%).
Uterine rupture
It is uncertain whether there is a difference in uterine rupture be-
tween both induction methods (Analysis 9.9). Of the seven stud-
ies included for this comparison, three studies (2627 women) pre-
specified this outcome. No events of uterine rupture occurred in
any of these studies.
Epidural analgesia
A balloon catheter may slightly increase the risk for epidural anal-
gesia when compared to oral misoprostol (average RR 1.08, 95% CI
0.96 to 1.22; 2635 women; 3 studies; Analysis 9.10). However, the
result is still too imprecise to make a valid judgement on this out-
come. Also, there was substantial heterogeneity for this outcome
(Chi2 = 4.73, df = 2 (P = 0.09); I2 = 58%).
A sensitivity analysis, after eliminating the one trial assessed as
having a potentially higher risk of allocation or attrition bias (Kruit
2016), did not change this result, but did lower heterogeneity for
this outcome (RR 1.13, 95% CI 1.03 to 1.24; 2447; 2 studies; I2 = 5%).
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Instrumental vaginal delivery
A balloon catheter probably reduces the risk of an instrumental
vaginal delivery when compared to oral misoprostol (RR 0.71, 95%
CI 0.55 to 0.92; 2627 women; 3 studies; Analysis 9.11).
Meconium-stained liquor
It is uncertain whether there is a difference in meconium-stained
liquor between both induction methods (average RR 0.77, 95% CI
0.44 to 1.35; 2627 women; 3 studies; Analysis 9.12). Also, there was
moderate heterogeneity for this outcome (Tau2 = 0.11; Chi2 = 3.09,
df = 2 (P = 0.21); I2 = 35%). No sensitivity analysis was conducted as
no potential high-risk studies were included for this outcome.
Apgar score less than seven at five minutes
It is uncertain whether there is a difference in Apgar scores less than
seven at five minutes between both induction methods (RR 0.71,
95% CI 0.38 to 1.32; 2693 women; 4 studies; low-quality evidence;
Analysis 9.13).
Neonatal intensive care unit admission
It is uncertain whether there is a difference in NICU admissions be-
tween both induction methods (RR 0.82, 95% CI 0.58 to 1.17; 2873
women; 5 studies; low-quality evidence; Analysis 9.14).
Neonatal encephalopathy
It is uncertain whether there is a difference in neonatal en-
cephalopathy between both induction methods (RR 0.81, 95% CI
0.32 to 2.03; 600 women; 1 study; Analysis 9.15).
Perinatal death
It is uncertain whether there is difference in perinatal death be-
tween both induction methods (RR 1.28, 95% CI 0.49 to 3.30; 2627
women; 3 studies; Analysis 9.16) as the result was imprecise and
events occurred infrequently (9/1310 versus 7/1317, respectively).
In the balloon group, two cases of perinatal death were related to
asphyxia, compared to one case in the misoprostol group.
Disability in childhood
Not reported.
Maternal side e>ects (all)
It is uncertain whether there is a difference in maternal side effects
between both induction methods (RR 0.61, 95% CI 0.33 to 1.13; 662
women; 2 studies; Analysis 9.17).
Maternal nausea
Not reported.
Maternal vomiting
It is uncertain whether there is a difference in maternal vomiting
between both induction methods (RR 0.73, 95% CI 0.37 to 1.46; 662
women; 2 studies; Analysis 9.18).
Maternal diarrhoea
It is uncertain whether there is a difference in maternal diarrhoea
between both induction methods (RR 0.29, 95% CI 0.06 to 1.37; 602
women; 1 study; Analysis 9.19).
Other maternal side e>ects
Not reported.
Postpartum haemorrhage
It is uncertain whether there is difference in postpartum haemor-
rhage between both induction methods (RR 1.03, 95% CI 0.79 to
1.34; 2966 women; 5 studies; Analysis 9.20).
Serious maternal complications
Not reported.
Maternal death
It is uncertain whether there is a difference in maternal death be-
tween both induction methods (Analysis 9.21). Of the 13 studies in-
cluded for this comparison, three studies (2627 women) pre-speci-
fied this outcome. No events of maternal death occurred in one of
these studies.
Woman not satisfied
A balloon catheter may increase the risk of women not being sat-
isfied when compared to oral misoprostol (RR 1.70, 95% CI 1.15 to
2.50; 602 women; 1 study; Analysis 9.22), the absolute effect being
80 more women not satisfied per 1000 deliveries. In the one study
included for this outcome, women were asked if they would choose
the same induction method again in a future induction of labour.
Caregiver not satisfied
Not reported.
Not pre-specified outcomes
Maternal fever during labour
There probably is little or no difference in maternal fever during
labour between both induction methods (RR 0.98, 95% CI 0.78 to
1.24; 2033 women; 2 studies; Analysis 9.23).
Antibiotics during labour
It is uncertain whether there is a difference in antibiotics during
labour between both induction methods (RR 1.22, 95% CI 0.75 to
2.00; 2033 women; 2 studies; Analysis 9.24).
Chorioamnionitis
Not reported.
Endometritis
It is uncertain whether there is a difference in endometritis between
both induction methods (RR 0.56, 95% CI 0.05 to 6.03; 188 women;
1 study; Analysis 9.25).
Fetal distress
It is uncertain whether there is a difference in fetal distress for
which a caesarean section is indicated between both induction
methods (RR 0.82, 95% CI 0.61 to 1.09; 2966 women; 5 studies;
Analysis 9.26).
Umbilical artery pH < 7.10
It is uncertain whether there is a difference in umbilical artery pH
less than 7.10 directly postpartum between both induction meth-
ods (RR 0.77, 95% CI 0.53 to 1.12; 1535 women; 2 studies; Analysis
9.27).
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Balloon (single or double) versus oxytocin (eight trials
involving 781 women)
Primary outcomes
Vaginal delivery not achieved within 24 hours
Not reported.
Uterine hyperstimulation with FHR changes
It is uncertain whether there is a difference in uterine hyperstim-
ulation with FHR changes between induction of labour with a bal-
loon and oxytocin (RR 0.20, 95% CI 0.01 to 4.11; 200 women; 1 study;
Analysis 12.1).
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Caesarean section
A balloon catheter probably reduces the risk of a caesarean sec-
tion when compared to oxytocin (RR 0.68, 95% CI 0.56 to 0.83; 781
women; 8 studies; Analysis 12.2), the absolute effect being 126 few-
er caesarean sections per 1000 deliveries.
For women with a previous caesarean section, a balloon catheter
may slightly reduce the risk of a caesarean section when compared
to oxytocin (RR 0.80, 95% CI 0.64 to 1.00; 364 women; 3 studies;
Analysis 13.1). However, the result is still too imprecise to make a
valid judgement on this outcome.
For primiparous women, it is uncertain whether there is a differ-
ence in effect as the result of this outcome was imprecise (RR 0.43,
95% CI 0.12 to 1.50; 60 women; 1 study; Analysis 14.1). For multi-
parous women, no outcomes were reported.
Serious neonatal morbidity or perinatal death
It is uncertain whether there is a difference in serious neonatal mor-
bidity or perinatal death between both induction methods (Analy-
sis 12.3). Of the eight studies included for this comparison, one
study (100 women) reported on this composite outcome. No events
of neonatal morbidity or perinatal death occurred in this study.
The same result was seen on a subgroup of women with a previous
caesarean section. One study (100 women) reported on this out-
come, in which no events of serious neonatal morbidity of perinatal
death occurred (Analysis 13.2).
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Serious maternal morbidity or death
It is uncertain whether there is a difference in serious maternal mor-
bidity or death between both induction methods (Analysis 12.4).
Of the eight studies included for this comparison, two studies (160
women) reported on this composite outcome. No events of serious
maternal morbidity or death occurred in these studies.
The same result was seen on a subgroup of women with a previous
caesarean section. One study (100 women) reported on this out-
come, in which no events of serious maternal morbidity of death
occurred (Analysis 13.3).
On parity subgroup comparisons, one study (60 women) reported
on this outcome in primiparous women, in which no events were
seen (Analysis 14.2). For multiparous women, no outcomes were re-
ported.
Secondary outcomes
Cervix unfavourable/unchanged aLer 24 hours
It is uncertain whether there is a difference in an unfavourable
cervix after 24 hours between both induction methods (RR 0.56,
95% CI 0.20 to 1.54; 100 women; 1 study; Analysis 12.5).
Oxytocin augmentation
Not a relevant outcome because all women in the comparison
group received oxytocin.
Uterine hyperstimulation without FHR changes
It is uncertain whether there is a difference in uterine hyperstimu-
lation without FHR changes between both induction methods (RR
1.00, 95% CI 0.23 to 4.29; 192 women; 3 studies; Analysis 12.6).
Uterine rupture
It is uncertain whether there is a difference in uterine rupture be-
tween both induction methods (Analysis 12.7). Of the eight studies
included for this comparison, one study (100 women) pre-specified
this outcome. No events of uterine rupture occurred in this study.
Epidural analgesia
Not reported.
Instrumental vaginal delivery
It is uncertain whether there is a difference in instrumental vaginal
deliveries between both induction methods (RR 1.19, 95% CI 0.55
to 2.57; 220 women; 3 studies; Analysis 12.8).
Meconium-stained liquor
It is uncertain whether there is a difference in meconium-stained
liquor between both induction methods (RR 0.53, 95% CI 0.23 to
1.21; 272 women; 2 studies; Analysis 12.9).
Apgar score less than seven at five minutes
It is uncertain whether there is a difference in Apgar scores less than
seven at five minutes between both induction methods (RR 0.71,
95% CI 0.14 to 3.53; 300 women; 2 studies; Analysis 12.10).
Neonatal intensive care unit admission
It is uncertain whether there is difference in NICU admissions be-
tween both induction methods (RR 0.80, 95% CI 0.32 to 1.98; 372
women; 3 studies; Analysis 12.11).
Neonatal encephalopathy
Not reported.
Perinatal death
It is uncertain whether there is a difference in perinatal death be-
tween both induction methods (Analysis 12.12). Of the eight studies
included for this comparison, one study (100 women) pre-specified
this outcome. No cases of perinatal death occurred in this study.
Disability in childhood
Not reported.
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Maternal side e>ects (all)
Not reported.
Maternal nausea
Not reported.
Maternal vomiting
Not reported.
Maternal diarrhoea
Not reported.
Other maternal side e>ects
Not reported.
Postpartum haemorrhage
It is uncertain whether there is difference in postpartum haemor-
rhage between both induction methods (RR 1.26, 95% CI 0.51 to
3.11; 396 women; 4 studies; Analysis 12.13).
Serious maternal complications
Not reported.
Maternal death
Not reported.
Woman not satisfied
Not reported.
Caregiver not satisfied
Not reported.
Other outcomes (not pre-specified)
Maternal fever during labour
It is uncertain whether there is difference in maternal fever during
labour between both induction methods (RR 0.20, 95% CI 0.01 to
4.00; 60 women; 1 study; Analysis 12.14).
Antibiotics during labour
Not reported.
Chorioamnionitis
Not reported.
Endometritis
Not reported.
Fetal distress
A balloon catheter probably reduces the risk of fetal distress for
which a caesarean section is indicated when compared to oxytocin
(RR 0.43, 95% CI 0.19 to 0.98; 332 women; 3 studies; Analysis 12.15).
Umbilical artery pH < 7.10
Not reported.
Balloon (single or double) versus amniotomy (one trial
involving 20 women)
The only outcome of interest reported for this comparison was cae-
sarean section. Other outcomes were not reported.
Caesarean section
It is uncertain whether there is difference in caesarean sections be-
tween induction of labour with a balloon and amniotomy (RR 0.25,
95% CI 0.03 to 1.86; 20 women; 1 study; Analysis 15.1).
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Singe balloon (Foley) versus double balloon (ATAD/Cook) (five
trials involving 826 women)
Primary outcomes
Vaginal delivery not achieved within 24 hours
There may be little or no difference in vaginal deliveries not
achieved within 24 hours between induction of labour with a single
balloon and a double balloon (average RR 0.97, 95% CI 0.75 to 1.25;
608 women; 3 studies; Analysis 16.1), although there was substan-
tial heterogeneity for this outcome (Chi2 = 5.64, df = 2 (P = 0.06); I2 =
65%). No sensitivity analysis was performed as no high-risk studies
were included for this outcome.
It is uncertain whether there is a difference in vaginal deliveries not
achieved within 24 hours between both induction methods on sub-
groups for both primiparous women (RR 1.14, 95% CI 0.95 to 1.38;
50 women; 1 study; Analysis 17.1) and multiparous women (RR 1.24,
95% CI 0.80 to 1.93; 48 women; 1 study; Analysis 18.1) as the results
for these outcomes were imprecise.
Uterine hyperstimulation with FHR changes
It is uncertain whether there is a difference in uterine hyperstimu-
lation with FHR changes (Analysis 16.2), as events seem to occur in-
frequently after the use of both induction methods. Of the five stud-
ies included for this comparison, one study (217 women) reported
on this outcome. No events of uterine hyperstimulation with FHR
occurred in this study.
Caesarean section
It is uncertain whether there is a difference in caesarean sections
between both induction methods (average RR 0.97, 95% CI 0.71 to
1.33; 862 women; 5 studies; Analysis 16.3). Also, there was moder-
ate heterogeneity for this outcome (Chi2 = 6.99, df = 4 (P = 0.14); I2
= 43%).
A sensitivity analysis, after eliminating the one trial assessed as
having a potentially higher risk of concealment or attrition bias
(Ahmed 2016), did not change the effect observed, nor did it lower
heterogeneity (average RR 0.92, 95% CI 0.65 to 1.32; 788 women; 5
studies; I2 = 50%).
The same result was seen on parity subgroup comparisons for
primiparous women (average RR 1.30, 95% CI 0.76 to 2.22; 374
women; 4 studies; Analysis 17.2) and multiparous women (RR 0.74,
95% CI 0.30 to 1.84; 186 women; 2 studies; Analysis 18.2). Further-
more, for the primiparous group, there was also substantial hetero-
geneity (Tau2 = 0.18; Chi2 = 7.96, df = 3 (P = 0.05); I2 = 62%).
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Serious neonatal morbidity or perinatal death
Not reported.
Serious maternal morbidity or death
It is uncertain whether there is a difference in serious maternal mor-
bidity or death between both induction methods (Analysis 16.4).
Of the five studies included for this comparison, one study (217
women) reported on this composite outcome. No events of serious
maternal morbidity or death occurred in this study.
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Secondary outcomes
Cervix unfavourable/unchanged aLer 24 hours
Not reported.
Oxytocin augmentation
There probably is little or no difference in oxytocin augmentation
between both induction methods (RR 0.94, 95% CI 0.82 to 1.08; 278
women; 2 studies; Analysis 16.5).
Uterine hyperstimulation without FHR changes
It is uncertain whether there is a difference in uterine hyperstimula-
tion without FHR changes (Analysis 16.6), although events seem to
occur infrequently after the use of both induction methods. Of the
five studies included for this comparison, one study (217 women)
reported on this outcome. No events of uterine hyperstimulation
without FHR occurred in this study.
Uterine rupture
It is uncertain whether there is a difference in uterine rupture be-
tween both induction methods (Analysis 16.7). Of the five studies
included for this comparison, one study (217 women) reported on
this outcome. No events of uterine rupture occurred in this study.
Epidural analgesia
There probably is little or no difference in epidural analgesia be-
tween both induction methods (RR 0.93, 95% CI 0.83 to 1.03; 608
women; 3 studies; Analysis 16.8).
Instrumental vaginal delivery
It is uncertain whether there is a difference in instrumental vaginal
deliveries between both induction methods (RR 0.86, 95% CI 0.61
to 1.20; 690 women; 3 studies; Analysis 16.9).
Meconium-stained liquor
A single balloon may reduce the risk of meconium-stained liquor
when compared to a double balloon (RR 0.40, 95% CI 0.15 to 1.04;
98 women; 1 study; Analysis 16.10). However, the result is still too
imprecise to make a valid judgement on this outcome.
Apgar score less than seven at five minutes
It is uncertain whether there is a difference in Apgar scores less than
seven at five minutes between both induction methods (RR 0.84,
95% CI 0.25 to 2.79; 608 women; 3 studies; Analysis 16.11).
Neonatal intensive care unit admission
It is uncertain whether there is a difference in NICU admissions be-
tween both induction methods (RR 1.67, 95% CI 0.71 to 3.93; 391
women; 2 studies; Analysis 16.12).
Neonatal encephalopathy
Not reported.
Perinatal death
Not reported.
Disability in childhood
Not reported.
Maternal side e>ects (all)
Not reported.
Maternal nausea
Not reported.
Maternal vomiting
Not reported.
Maternal diarrhoea
Not reported.
Other maternal side e>ects: pain aLer insertion
It is uncertain whether there is a difference in pain after insertion
of the catheter between both induction methods (RR 0.67, 95% CI
0.20 to 2.17; 74 women; 1 study; Analysis 16.13).
Postpartum haemorrhage
It is uncertain whether there is a difference in postpartum haem-
orrhage between both induction methods (RR 0.83, 95% CI 0.27 to
2.52; 291 women; 2 studies; Analysis 16.14).
Serious maternal complications
Not reported.
Maternal death
Not reported.
Woman not satisfied
Not reported.
Caregiver not satisfied
Not reported.
Other outcomes (not pre-specified)
Maternal fever during labour
It is uncertain whether there is a difference in maternal fever during
labour between both induction methods (average RR 0.61, 95% CI
0.16 to 2.34; 584 women; 3 studies; Analysis 16.15). Also, there was
substantial heterogeneity for this outcome (Chi2 = 2.85, df = 1 (P =
0.09); I2 = 65%).
A sensitivity analysis, after eliminating the one trial assessed as
having a potentially higher risk of allocation or attrition bias
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(Ahmed 2016), did not alter the result, nor did it lower heterogene-
ity (average RR 0.61, 95% CI 0.16 to 2.34; 510 women; 2 studies; I2
= 65%).
Antibiotics during labour
It is uncertain whether there is a difference in antibiotics during
labour between both induction methods (RR 0.97, 95% CI 0.61 to
1.56; 217 women; 1 study; Analysis 16.16).
Chorioamnionitis
It is uncertain whether there is a difference in chorioamnionitis be-
tween both induction methods (RR 1.56, 95% CI 0.47 to 5.20; 98
women;1 study; Analysis 16.17).
Endometritis
It is uncertain whether there is a difference in endometritis between
both induction methods (RR 1.95, 95% CI 0.18 to 21.14; 217 women;
1 study; Analysis 16.18).
Fetal distress
It is uncertain whether there is a difference in fetal distress for
which a caesarean section is indicated (RR 0.98, 95% CI 0.70 to 1.36;
682 women; 4 studies; Analysis 16.19).
Umbilical artery pH < 7.10
It is uncertain whether there is a difference in umbilical artery pH
less than 7.10 directly postpartum between both induction meth-
ods (RR 0.42, 95% CI 0.11 to 1.57; 217 women; 1 study; Analysis
16.20).
Laminaria tent versus vaginal prostaglandin E2 (five trials
involving 263 women)
Primary outcomes
Vaginal delivery not achieved within 24 hours
Not reported.
Uterine hyperstimulation with FHR changes
A laminaria tent probably reduces the risk of uterine hyperstimula-
tion with FHR changes when compared to vaginal prostaglandin E2
(RR 0.11, 95% CI 0.02 to 0.60; 188 women; 3 studies; Analysis 19.1),
the absolute effect being 118 fewer per 1000 deliveries.
For primiparous women, it is uncertain whether there is a differ-
ence in effect as the result of this outcome was imprecise (RR 0.33,
95% CI 0.01 to 7.95; 80 women; 1 study; Analysis 20.1). For multi-
parous women, this outcome was not reported.
Caesarean section
It is uncertain whether there is a difference in caesarean sections
between both induction methods (RR 0.91, 95% CI 0.56 to 1.48; 263
women; 5 studies; Analysis 19.2).
The same result was seen on parity subgroup comparisons for
primiparous women (average RR 1.07, 95% CI 0.24 to 4.89; 90
women; 2 studies; Analysis 20.2) and multiparous women (RR 0.50,
95% CI 0.06 to 3.91; 10 women; 1 study; Analysis 21.1). Furthermore,
for the primiparous group, there was also substantial heterogene-
ity (Chi2 = 2.25, df = 1 (P = 0.13); I2 = 56%).
Serious neonatal morbidity or perinatal death
It is uncertain whether there is a difference in serious neonatal mor-
bidity or perinatal death between both induction methods (Analy-
sis 19.3). Of the five studies included for this comparison, one study
(80 women) reported on this composite outcome. No events of
neonatal morbidity or perinatal death occurred in this study.
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Serious maternal morbidity or death
It is uncertain whether there is a difference in serious maternal mor-
bidity or death between both induction methods (Analysis 19.4). Of
the five studies included for this comparison, one study (28 women)
reported on this composite outcome. No events of serious mater-
nal morbidity or death occurred in this study.
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Secondary outcomes
Cervix unfavourable/unchanged aLer 24 hours
Not reported.
Oxytocin augmentation
Not reported.
Uterine hyperstimulation without FHR changes
A laminaria tent may reduce the risk of uterine hyperstimulation
without FHR changes when compared to vaginal PGE2 (RR 0.22,
95% CI 0.09 to 0.49; 180 women; 3 studies; Analysis 19.5).
Uterine rupture
Not reported.
Epidural analgesia
It is uncertain whether there is a difference in epidural analgesia
between both induction methods (RR 0.91, 95% CI 0.74 to 1.13; 80
women; 1 study; Analysis 19.6).
Instrumental vaginal delivery
It is uncertain whether there is a difference in instrumental vaginal
deliveries between both induction methods (RR 0.71, 95% CI 0.43
to 1.17; 80 women; 1 study; Analysis 19.7).
Meconium-stained liquor
It is uncertain whether there is a difference in meconium-stained
liquor between both induction methods (RR 0.14, 95% CI 0.01 to
2.68; 80 women; 1 study; Analysis 19.8).
Apgar score less than seven at five minutes
It is uncertain whether there is a difference in Apgar scores less than
seven at five minutes between both induction methods (Analysis
19.9). Of the five studies included for this comparison, two studies
(160 women) reported on this outcome. No events of Apgar scores
less than seven at five minutes occurred in these studies.
Neonatal intensive care unit admission
Not reported.
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Neonatal encephalopathy
Not reported.
Perinatal death
It is uncertain whether there is a difference in perinatal death be-
tween both induction methods (Analysis 19.10). Of the five studies
included for this comparison, one study (80 women) reported on
this outcome. No events of perinatal deaths occurred in this study.
Disability in childhood
Not reported.
Maternal side e>ects (all)
It is uncertain whether there is a difference in maternal side effects
between both induction methods (RR 0.29, 95% CI 0.01 to 6.60; 28
women; 1 study; Analysis 19.11).
Maternal nausea
It is uncertain whether there is a difference in maternal nausea be-
tween both induction methods (RR 0.29, 95% CI 0.01 to 6.60; 28
women; 1 study; Analysis 19.12).
Maternal vomiting
Not reported.
Maternal diarrhoea
Not reported.
Other maternal side e>ects
Not reported.
Postpartum haemorrhage
Not reported.
Serious maternal complications
Not reported.
Maternal death
Not reported.
Woman not satisfied
Not reported.
Caregiver not satisfied
Not reported.
Other outcomes (not pre-specified)
Maternal fever during labour
Not reported.
Antibiotics during labour
Not reported.
Chorioamnionitis
Not reported.
Endometritis
Not reported.
Fetal distress
It is uncertain whether there is a difference in fetal distress for
which a caesarean section is indicated between both induction
methods (RR 0.62, 95% CI 0.34 to 1.15; 188 women; 3 studies; Analy-
sis 19.13).
Umbilical artery pH < 7.10
Not reported.
Laminaria tent versus cervical prostaglandin E2 (five trials
involving 920 women)
Primary outcomes
Vaginal delivery not achieved within 24 hours
Not reported.
Uterine hyperstimulation with FHR changes
It is uncertain whether there is a difference in uterine hyperstimula-
tion with FHR changes between induction of labour with a laminar-
ia tent and cervical PGE2 (RR 0.17, 95% CI 0.02 to 1.42; 350 women;
2 studies; Analysis 22.1).
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Caesarean section
It is uncertain whether there is a difference in caesarean sections
between both induction methods (RR 1.16, 95% CI 0.93 to 1.45; 920
women; 5 studies; Analysis 22.2).
The same results were seen on parity subgroup comparisons for
primiparous women (RR 1.15, 95% CI 0.62 to 2.13; 116 women; 1
study; Analysis 23.1) and multiparous women (RR 1.28, 95% CI 0.45
to 3.65; 69 women; 1 study; Analysis 24.1).
Serious neonatal morbidity or perinatal death
It is uncertain whether there is a difference in serious neonatal mor-
bidity or perinatal death between both induction methods (RR 3.16,
95% CI 0.13 to 76.70; 185 women; 1 study; Analysis 22.3). One event,
a case of perinatal death, was reported in the laminaria group. No
events occurred in the cervical PGE2 group.
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Serious maternal morbidity or death
It is uncertain whether there is a difference in serious maternal mor-
bidity or death between both induction methods (RR 0.35, 95% CI
0.01 to 8.52; 185 women; 1 study; Analysis 22.4). No events occurred
in the laminaria group. One event, a uterine rupture, was reported
in the cervical PGE2 group.
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Secondary outcomes
Cervix unfavourable/unchanged aLer 24 hours
It is uncertain whether there is a difference in an unfavourable
cervix after 24 hours between both induction methods (average RR
0.46, 95% CI 0.11 to 1.96; 218 women; 2 studies; Analysis 22.5). Also,
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there was substantial heterogeneity for this outcome (Tau2 = 0.62;
Chi2 = 1.98, df = 1 (P = 0.16); I2 = 50%).
A sensitivity analysis, after eliminating the one trial assessed as
having a potentially higher risk of allocation or attrition bias (Roz-
tocil 1998), did not alter the result (RR 0.16, 95% CI 0.02 to 1.24; 53
women; 1 study; I2 = 0%).
Oxytocin augmentation
A laminaria tent probably increases the risk of oxytocin augmenta-
tion when compared to cervical PGE2 (RR 1.41, 95% CI 1.21 to 1.64;
185 women; 1 study; Analysis 22.6).
Uterine hyperstimulation without FHR changes
It is uncertain whether there is a difference in uterine hyperstimu-
lation without FHR changes between both induction methods (RR
0.17, 95% CI 0.02 to 1.36; 601 women; 2 studies; Analysis 22.7).
Uterine rupture
It is uncertain whether there is a difference in uterine rupture be-
tween both induction methods (RR 0.35, 95% CI 0.01 to 8.52; 185
women; 1 study; Analysis 22.8). One study reported on this outcome
in which one uterine rupture occurred in the PGE2 group. No uter-
ine ruptures were seen in the laminaria group.
Epidural analgesia
Not reported.
Instrumental vaginal delivery
It is uncertain whether there is a difference in instrumental vaginal
deliveries between both induction methods (RR 1.05, 95% CI 0.65
to 1.69; 424 women; 3 studies; Analysis 22.9).
Meconium-stained liquor
Not reported.
Apgar score less than seven at five minutes
It is uncertain whether there is a difference in Apgar scores less than
seven at five minutes between both induction methods (RR 5.28,
95% CI 0.63 to 44.30; 185 women; 1 study; Analysis 22.10).
Neonatal intensive care unit admission
It is uncertain whether there is a difference in NICU admissions be-
tween both induction methods (RR 1.58, 95% CI 0.58 to 4.33; 259
women; 2 studies; Analysis 22.11).
Neonatal encephalopathy
Not reported.
Perinatal death
It is uncertain whether there is a difference in perinatal death be-
tween both induction methods (RR 3.16, 95% CI 0.13 to 76.70;
185 women; 1 study; Analysis 22.12). One study reported on this
outcome, in which one perinatal death occurred in the laminaria
group. No perinatal death were seen in the cervical PGE2 group.
Disability in childhood
Not reported.
Maternal side e>ects (all)
It is uncertain whether there is a difference in maternal side effects
between both induction methods (RR 0.20, 95% CI 0.01 to 4.15; 165
women; 1 study; Analysis 22.13). The one study included for this
outcome reported on gastro-intestinal symptoms without specify-
ing what the symptoms were.
Maternal nausea
Not reported.
Maternal vomiting
Not reported.
Maternal diarrhoea
Not reported.
Other maternal side e>ects
Not reported.
Postpartum haemorrhage
It is uncertain whether there is a difference in postpartum haem-
orrhage between both induction methods (RR 1.14, 95% CI 0.46 to
2.81; 239 women; 2 studies; Analysis 22.14).
Serious maternal complications
Not reported.
Maternal death
Not reported.
Woman not satisfied
Not reported.
Caregiver not satisfied
Not reported.
Other outcomes (not pre-specified)
Maternal fever during labour
Not reported.
Antibiotics during labour
Not reported.
Chorioamnionitis
It is uncertain whether there is a difference in chorioamnionitis be-
tween both induction methods (RR 3.17, 95% CI 0.35 to 29.06; 74
women; 1 study; Analysis 22.15).
Endometritis
It is uncertain whether there is a difference in endometritis between
both induction methods (average RR 0.30, 95% CI 0.08 to 1.09; 490
women; 2 studies; Analysis 22.16). Also, there was substantial het-
erogeneity for this outcome (Tau2 = 0.54; Chi2 = 2.54, df = 1 (P = 0.11);
I2 = 61%).
A sensitivity analysis, after eliminating the one trial assessed as
having a potentially higher risk of allocation or attrition bias (Kram-
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mer 1995a), did not alter the result (RR 0.63, 95% CI 0.16 to 2.46; 74
women; 1 study; I2 = 0%).
Fetal distress
It is uncertain whether there is a difference in fetal distress for
which a caesarean section is indicated between both induction
methods (RR 0.44, 95% CI 0.07 to 2.90; 128 women; 2 studies; Analy-
sis 22.17).
Umbilical artery pH < 7.10
Not reported.
Laminaria tent versus oxytocin (two trials involving 73
women)
The only outcomes of interest reported for this comparison were
caesarean section and fetal distress. Other outcomes were not re-
ported.
Caesarean section
It is uncertain whether there is a difference in caesarean sections
between induction of labour with a laminaria tent and oxytocin (RR
0.83, 95% CI 0.36 to 1.89; 73 women; 2 studies; Analysis 25.1).
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Fetal distress
It is uncertain whether there is a difference in fetal distress for
which a caesarean section is indicated between both induction
methods (RR 2.69, 95% CI 0.11 to 63.18; 53 women; 1 study; Analy-
sis 25.2).
Laminaria tent versus amniotomy (one trial involving 20
women)
The only outcome of interest reported for this comparison was cae-
sarean section. Other outcomes were not reported.
Caesarean section
It is uncertain whether there is a difference in caesarean sections
between induction of labour with a laminaria tent compared to am-
niotomy (RR 0.75, 95% CI 0.22 to 2.52; 20 women; 1 study; Analysis
26.1).
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Laminaria tent versus other hygroscopic dilators (one trial
involving 41 women)
The only outcome of interest reported for this comparison was cae-
sarean section. Other outcomes were not reported.
Caesarean section
It is uncertain whether there is a difference in caesarean sections
between induction of labour with a laminaria tent and other hygro-
scopic dilators (RR 1.70, 95% CI 0.44 to 6.66; 41 women; 1 study;
Analysis 27.1).
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Extra amniotic saline infusion (EASI) versus vaginal
prostaglandin E2 (two trials involving 221 women)
Primary outcomes
Vaginal delivery not achieved within 24 hours
EASI probably increases the risk of a vaginal delivery not achieved
within 24 hours when compared to vaginal PGE2 (RR 1.74, 95% CI
1.21 to 2.49; 109 women; 1 study; Analysis 28.1).
Uterine hyperstimulation with FHR changes
It is uncertain whether there is a difference in uterine hyperstimu-
lation with FHR changes between both induction methods (RR 0.23,
95% CI 0.03 to 2.07; 221 women; 2 studies; Analysis 28.2).
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Caesarean section
It is uncertain whether there is a difference in caesarean sections
between both induction methods (average RR 1.35, 95% CI 0.94 to
1.96; 221 women; 2 studies; Analysis 28.3). Also, there was substan-
tial heterogeneity for this outcome (Chi2 = 5.24, df = 1 (P = 0.02); I2 =
81%). No sensitivity analysis could be done as both included stud-
ies were assessed as having a potentially higher risk of allocation
or attrition bias.
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Serious neonatal morbidity or perinatal death
Not reported.
Serious maternal morbidity or death
Not reported.
Secondary outcomes
Cervix unfavourable/unchanged aLer 24 hours
Not reported.
Oxytocin augmentation
EASI may increase the risk of oxytocin augmentation when com-
pared to vaginal PGE2 (RR 12.71, 95% CI 3.20 to 50.57; 109 women;
1 study; Analysis 28.4).
Uterine hyperstimulation without FHR changes
It is uncertain whether there is a difference in uterine hyperstimu-
lation without FHR changes between both induction methods (RR
0.23, 95% CI 0.03 to 2.07; 221 women; 2 studies; Analysis 28.5).
Uterine rupture
Not reported.
Epidural analgesia
There may be little or no difference in epidural analgesia between
both induction methods (RR 1.00, 95% CI 0.97 to 1.04; 112 women;
1 study; Analysis 28.6).
Mechanical methods for induction of labour (Review)
Copyright © 2019 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane
Collaboration.
51
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Instrumental vaginal delivery
It is uncertain whether there is a difference in instrumental vaginal
deliveries between both induction methods (RR 0.58, 95% CI 0.30
to 1.14; 109 women; 1 study; Analysis 28.7).
Meconium-stained liquor
It is uncertain whether there is a difference in meconium-stained
liquor between both induction methods (RR 3.00, 95% CI 0.12 to
72.10; 112 women; 1 study; Analysis 28.8).
Apgar score less than seven at five minutes
It is uncertain whether there is a difference in Apgar scores less than
seven at five minutes between both induction methods (RR 4.25,
95% CI 0.21 to 86.51; 109 women; 1 study; Analysis 28.9).
Neonatal intensive care unit admission
It is uncertain whether there is a difference in NICU admissions be-
tween both induction methods (RR 1.50, 95% CI 0.45 to 5.03; 112
women; 1 study; Analysis 28.10).
Neonatal encephalopathy
Not reported.
Perinatal death
Not reported.
Disability in childhood
Not reported.
Maternal side e>ects (all)
Not reported.
Maternal nausea
Not reported.
Maternal vomiting
Not reported.
Maternal diarrhoea
Not reported.
Other maternal side e>ects
Not reported.
Postpartum haemorrhage
Not reported.
Serious maternal complications
Not reported.
Maternal death
Not reported.
Woman not satisfied
It is uncertain whether there is a difference in women not being
satisfied between both induction methods (RR 0.56, 95% CI 0.10 to
3.25; 109 women; 1 study; Analysis 28.11). For this outcome, women
in the included study were asked to comment on the induction
method, for which they could choose between recommendable,
satisfactory and unsatisfactory.
Caregiver not satisfied
Not reported.
Other outcomes (not pre-specified)
Maternal fever during labour
Not reported.
Antibiotics during labour
Not reported.
Chorioamnionitis
Not reported.
Endometritis
Not reported.
Fetal distress
It is uncertain whether there is a difference in fetal distress for
which a caesarean section is indicated between both induction
methods (RR 1.20, 95% CI 0.39 to 3.71; 112 women; 1 study; Analy-
sis 28.12).
Umbilical artery pH < 7.10
Not reported.
Extra amniotic saline infusion versus cervical prostaglandin E2
(two trials involving 155 women)
Primary outcomes
Vaginal delivery not achieved within 24 hours
Not reported.
Uterine hyperstimulation with FHR changes
Not reported.
Caesarean section
It is uncertain whether there is a difference in caesarean sections
between both induction methods (average RR 0.73, 95% CI 0.10 to
5.12; 155 women; 2 studies; Analysis 29.1). Also, there was substan-
tial heterogeneity for this outcome (Tau2 = 1.60; Chi2 = 5.11, df = 1
(P = 0.02); I2 = 80%). As the results for both included studies show
no overlap of CI, this makes the pooled result for this outcome less
meaningful. No sensitivity analysis was performed as no potential
high-risk studies were included for this outcome.
The same result was seen on a subgroup comparison for primi-
parous women (RR 0.25, 95% CI 0.06 to 1.09; 70 women; 1 study;
Analysis 30.1). For multiparous women, no outcomes were report-
ed.
Serious neonatal morbidity or perinatal death
Not reported.
Serious maternal morbidity or death
Not reported.
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Secondary outcomes
Cervix unfavourable/unchanged aLer 24 hours
EASI may reduce the risk of an unfavourable cervix after 24 hours
when compared to cervical PGE2 (RR 0.06, 95% CI 0.00 to 0.97; 85
women; 1 study; Analysis 29.2).
Oxytocin augmentation
It is uncertain whether there is a difference in oxytocin augmenta-
tion between both induction methods (RR 1.10, 95% CI 0.54 to 2.25;
70 women; 1 study; Analysis 29.3).
Uterine hyperstimulation without FHR changes
Not reported.
Uterine rupture
Not reported.
Epidural analgesia
Not reported.
Instrumental vaginal delivery
It is uncertain whether there is a difference in instrumental vaginal
deliveries between both induction methods (RR 0.33, 95% CI 0.04
to 3.01; 85 women; 1 study; Analysis 29.4).
Meconium-stained liquor
Not reported.
Apgar score less than seven at five minutes
It is uncertain whether there is a difference in Apgar scores less than
seven at five minutes between both induction methods (Analysis
29.5). One study (85 women) pre-specified this outcome in which
no Apgar scores less than seven after five minutes were reported.
Neonatal intensive care unit admission
Not reported.
Neonatal encephalopathy
Not reported.
Perinatal death
Not reported.
Disability in childhood
Not reported.
Maternal side e>ects (all)
Not reported.
Maternal nausea
Not reported.
Maternal vomiting
Not reported.
Maternal diarrhoea
Not reported.
Other maternal side e>ects
Not reported.
Postpartum haemorrhage
Not reported.
Serious maternal complications
Not reported.
Maternal death
Not reported.
Woman not satisfied
Not reported.
Caregiver not satisfied
Not reported.
Other outcomes (not pre-specified)
Maternal fever during labour
Not reported.
Antibiotics during labour
Not reported.
Chorioamnionitis
Not reported.
Endometritis
It is uncertain whether there is a difference in endometritis between
both induction methods (Analysis 29.6). One study (85 women) pre-
specified this outcome in which no cases of endometritis were re-
ported.
Fetal distress
It is uncertain whether there is a difference in fetal distress for
which a caesarean section is indicated between both induction
methods (RR 0.29, 95% CI 0.06 to 1.28; 70 women; 1 study; Analysis
29.7).
Umbilical artery pH < 7.10
Not reported.
Any mechanical method and prostaglandin E2 versus
prostaglandin E2 alone (eight trials involving 639 women)
Primary outcomes
Vaginal delivery not achieved within 24 hours
It is uncertain whether there is a difference in vaginal deliveries not
achieved within 24 hours between induction of labour with a me-
chanical method combined with PGE2 and PGE2 alone (RR 0.84,
95% CI 0.53 to 1.33; 39 women; 1 study; Analysis 31.1).
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
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Uterine hyperstimulation with FHR changes
It is uncertain whether there is a difference in uterine hyperstimu-
lation with FHR changes between both induction methods (RR 0.26,
95% CI 0.01 to 5.12; 122 women; 2 studies; Analysis 31.2).
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Caesarean section
It is uncertain whether there is a difference in caesarean sections
between both induction methods (average RR 0.96, 95% CI 0.66 to
1.40; 517 women; 7 studies; Analysis 31.3). Also, there was moder-
ate heterogeneity for this outcome (Tau2 = 0.11; Chi2 = 11.16, df = 6
(P = 0.08); I2 = 46%).
A sensitivity analysis, after eliminating three trials assessed as hav-
ing a potentially higher risk of allocation or attrition bias (Browne
2011; Lyndrup 1989; Turnquest 1997), did not alter the result nor
did it lower heterogeneity (average RR 1.02, 95% CI 0.56 to 1.84; 364
women; 4 studies; I2 = 70%).
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Serious neonatal morbidity or perinatal death
Not reported.
Serious maternal morbidity or death
Not reported.
Secondary outcomes
Cervix unfavourable/unchanged aLer 24 hours
A mechanical method combined with PGE2 may reduce the risk
of an unfavourable cervix after 24 hours when compared to PGE2
alone (RR 0.52, 95% CI 0.31 to 0.85; 122 women; 1 study; Analysis
31.4).
Oxytocin augmentation
It is uncertain whether there is a difference in oxytocin augmenta-
tion between both induction methods (RR 0.95, 95% CI 0.64 to 1.41;
44 women; 1 study; Analysis 31.5).
Uterine hyperstimulation without FHR changes
It is uncertain whether there is a difference in uterine hyperstimula-
tion without FHR changes between both induction methods (Analy-
sis 31.6). Of the eight studies included for this comparison, three
studies (239 women) pre-specified this outcome. No events of uter-
ine hyperstimulation without FHR changes occurred in these stud-
ies.
Uterine rupture
Not reported.
Epidural analgesia
There may be little or no difference in epidural analgesia during
labour between both induction methods (RR 0.98, 95% CI 0.77 to
1.24; 39 women; 1 study; Analysis 31.7).
Instrumental vaginal delivery
It is uncertain whether there is a difference in instrumental vaginal
deliveries between both induction methods (RR 0.56, 95% CI 0.22
to 1.45; 78 women; 2 studies; Analysis 31.8).
Meconium-stained liquor
It is uncertain whether there is a difference in meconium-stained
liquor between both induction methods (RR 0.97, 95% CI 0.33 to
2.83; 120 women; 1 study; Analysis 31.9).
Apgar score less than seven at five minutes
Not reported.
Neonatal intensive care unit admission
It is uncertain whether there is a difference in NICU admissions be-
tween both methods (RR 0.26, 95% CI 0.01 to 5.12; 44 women; 1
study; Analysis 31.10).
Neonatal encephalopathy
Not reported.
Perinatal death
Not reported.
Disability in childhood
Not reported.
Maternal side e>ects
Not reported.
Maternal nausea
Not reported.
Maternal vomiting
Not reported.
Maternal diarrhoea
Not reported.
Other maternal side e>ects
Not reported.
Postpartum haemorrhage
It is uncertain whether there is a difference in postpartum haem-
orrhage between both induction methods (Analysis 31.11). Of the
eight studies included for this comparison, one study (39 women)
pre-specified this outcome. No events of postpartum haemorrhage
occurred in this study.
Serious maternal complications
Not reported.
Maternal death
Not reported.
Woman not satisfied
Not reported.
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Caregiver not satisfied
Not reported.
Other outcomes (not pre-specified)
Maternal fever during labour
Not reported.
Antibiotics during labour
Not reported.
Chorioamnionitis
It is uncertain whether there is a difference in chorioamnionitis be-
tween both induction methods (RR 1.56, 95% CI 0.45 to 5.45; 122
women; 2 studies; Analysis 31.12).
Endometritis
It is uncertain whether there is a difference in endometritis between
both induction methods (RR 1.07, 95% CI 0.41 to 2.78; 237 women;
3 studies; Analysis 31.13).
Fetal distress
It is uncertain whether there is a difference fetal distress for which
a caesarean section is indicated between both induction methods
(RR 2.28, 95% CI 0.54 to 9.69; 140 women; 2 studies; Analysis 31.14).
Umbilical artery pH < 7.10
Not reported.
Any mechanical method and prostaglandin E2 versus low-dose
misoprostol alone (one trial involving 127 women)
Primary outcomes
Vaginal delivery not achieved within 24 hours
A mechanical method combined with PGE2 probably reduces the
risk of a vaginal delivery not achieved within 24 hours when com-
pared to misoprostol (RR 0.32, 95% CI 0.12 to 0.82; 127 women; 1
study; Analysis 32.1). the absolute effect being 165 less per 1000 de-
liveries.
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Uterine hyperstimulation with FHR changes
Not reported.
Caesarean section
It is uncertain whether there is a difference in caesarean sections
between both induction methods (RR 1.09, 95% CI 0.58 to 2.04; 127
women; 1 study; Analysis 32.2).
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Serious neonatal morbidity or perinatal death
It is uncertain whether there is a difference in serious neonatal mor-
bidity or perinatal death between both induction methods (RR 0.19,
95% CI 0.01 to 3.90; 127 women; 1 study; Analysis 32.3). Two events
occurred in the misoprostol group, both being cases of perinatal
death.
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Serious maternal morbidity or death
Not reported.
Secondary outcomes
Cervix unfavourable/unchanged aLer 24 hours
A mechanical method combined with PGE2 probably reduces the
risk of an unfavourable cervix after 24 hours when compared to
misoprostol (RR 0.41, 95% CI 0.25 to 0.67; 127 women; 1 study;
Analysis 32.4).
Oxytocin augmentation
A mechanical method combined with PGE2 probably slightly in-
creases the risk of oxytocin augmentation when compared to miso-
prostol (RR 1.21, 95% CI 1.01 to 1.46; 127; 1 study; Analysis 32.5).
Uterine hyperstimulation without FHR changes
A mechanical method combined with PGE2 probably increases the
risk of uterine hyperstimulation without FHR changes when com-
pared to misoprostol (RR 4.05, 95% CI 1.44 to 11.38; 127; 1 study;
Analysis 32.6).
Uterine rupture
Not reported.
Epidural analgesia
Not reported.
Instrumental vaginal delivery
It is uncertain whether there is a difference in instrumental vaginal
deliveries between both induction methods (RR 1.26, 95% CI 0.77
to 2.04; 127 women; 1 study; Analysis 32.7).
Meconium-stained liquor
It is uncertain whether there is a difference in meconium-stained
liquor between both induction methods (RR 0.56, 95% CI 0.23 to
1.32; 127 women; 1 study; Analysis 32.8).
Apgar score less than seven at five minutes
It is uncertain whether there is a difference in Apgar scores less than
seven at five minutes between both induction methods (RR 1.91,
95% CI 0.18 to 20.51; 127 women; 1 study; Analysis 32.9).
Neonatal intensive care unit admission
It is uncertain whether there is a difference in NICU admissions be-
tween both methods (RR 0.64, 95% CI 0.31 to 1.31; 127 women; 1
study; Analysis 32.10).
Neonatal encephalopathy
Not reported.
Perinatal death
It is uncertain whether there is a difference in perinatal death be-
tween both methods (RR 0.19, 95% CI 0.01 to 3.90; 127 women; 1
study; Analysis 32.11). Two cases of neonatal death were reported
by Perry 1998, both were born to women randomised to misopros-
tol. The authors describe that in both cases the neonates died as a
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result of complications of congenital malformations and were un-
related to the induction method.
Disability in childhood
Not reported.
Maternal side e>ects
Not reported.
Maternal nausea
Not reported.
Maternal vomiting
Not reported.
Maternal diarrhoea
Not reported.
Other maternal side e>ects
Not reported.
Postpartum haemorrhage
Not reported.
Serious maternal complications
Not reported.
Maternal death
Not reported.
Woman not satisfied
Not reported.
Caregiver not satisfied
Not reported.
Other outcomes (not pre-specified)
Maternal fever during labour
Not reported.
Antibiotics during labour
Not reported.
Chorioamnionitis
It is uncertain whether there is a difference in chorioamnionitis be-
tween both induction methods (RR 1.91, 95% CI 0.18 to 20.51; 127
women; 1 study; Analysis 32.12).
Endometritis
It is uncertain whether there is a difference in endometritis between
both induction methods (RR 1.91, 95% CI 0.36 to 10.05; 127 women;
1 study; Analysis 32.13).
Fetal distress
Not reported.
Umbilical artery pH < 7.10
Not reported.
Any mechanical method and prostaglandin E2 versus oxytocin
alone (one trial involving 44 women)
The only outcomes of interest reported for this comparison were
caesarean section, instrumental vaginal delivery and endometritis.
Other outcomes were not reported.
Caesarean section
It is uncertain whether there is a difference in caesarean sections
between induction of labour with a mechanical method combined
with PGE2 versus oxytocin (RR 0.30, 95% CI 0.04 to 2.47; 44 women;
1 study; Analysis 33.1).
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Instrumental vaginal delivery
It is uncertain whether there is a difference in instrumental vaginal
deliveries between both induction methods (RR 0.60, 95% CI 0.12
to 2.94; 44 women; 1 study; Analysis 33.2).
Endometritis
It is uncertain whether there is a difference in endometritis between
both induction methods (RR 3.57, 95% CI 0.15 to 83.14; 44 women;
1 study; Analysis 33.3).
Any mechanical method and low-dose misoprostol versus
prostaglandin E2 alone (one trial involving 350 women)
Primary outcomes
Vaginal delivery not achieved within 24 hours
It is uncertain whether there is a difference in vaginal deliveries not
achieved within 24 hours between induction of labour with a me-
chanical method combined with misoprostol and prostaglandin E2
(RR 1.14, 95% CI 0.89 to 1.46; 350 women; 1 study; Analysis 34.1).
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Uterine hyperstimulation with FHR changes
It is uncertain whether there is a difference in uterine hyperstimu-
lation with FHR changes between both induction methods (RR 0.75,
95% CI 0.27 to 2.13; 327 women; 1 study; Analysis 34.2).
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Caesarean section
It is uncertain whether there is a difference in caesarean sections
between both induction methods (RR 0.85, 95% CI 0.57 to 1.25; 350
women; 1 study; Analysis 34.3).
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Serious neonatal morbidity or perinatal death
It is uncertain whether there is a difference in serious neonatal mor-
bidity or perinatal death between both induction methods (RR 2.04,
95% CI 0.19 to 22.24; 345 women; 1 study; Analysis 34.4).
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For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Serious maternal morbidity or death
It is uncertain whether there is a difference in serious maternal mor-
bidity or death between both induction methods (Analysis 34.5). No
events of maternal morbidity or death occurred in the one included
study (350 women).
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Secondary outcomes
Cervix unfavourable/unchanged aLer 24 hours
Not reported.
Oxytocin augmentation
A mechanical method combined with misoprostol probably re-
duces the risk of oxytocin augmentation when compared to PGE2
(RR 0.54, 95% CI 0.34 to 0.86; 350 women; 1 study; Analysis 34.6).
Uterine hyperstimulation without FHR changes
It is uncertain whether there is a difference in uterine hyperstimu-
lation without FHR changes between both induction methods (RR
0.54, 95% CI 0.22 to 1.32; 327 women; 1 study; Analysis 34.7).
Uterine rupture
It is uncertain whether there is a difference in uterine rupture be-
tween both induction methods (Analysis 34.8). No events of uterine
rupture occurred in the one included study (350 women).
Epidural analgesia
Not reported.
Instrumental vaginal delivery
It is uncertain whether there is a difference in instrumental vaginal
deliveries between both induction methods (RR 1.01, 95% CI 0.26
to 3.98; 350 women; 1 study; Analysis 34.9).
Meconium-stained liquor
It is uncertain whether there is a difference in meconium-stained
liquor between both induction methods (RR 1.15, 95% CI 0.60 to
2.23; 339 women; 1 study; Analysis 34.10).
Apgar score less than seven at five minutes
It is uncertain whether there is a difference in Apgar scores less than
seven at five minutes between both induction methods (RR 0.68,
95% CI 0.25 to 1.88; 346 women; 1 study; Analysis 34.11).
Neonatal intensive care unit admission
It is uncertain whether there is a difference in NICU admissions be-
tween both methods (RR 0.68, 95% CI 0.12 to 4.03; 346 women; 1
study; Analysis 34.12).
Neonatal encephalopathy
Not reported.
Perinatal death
It is uncertain whether there is a difference in perinatal death be-
tween both induction methods (RR 1.02, 95% CI 0.06 to 16.14; 345
women; 1 study; Analysis 34.13). Two cases of perinatal death were
reported by Matonhodze 2003, one in each group. No further infor-
mation was given on timing or cause of the demise.
Disability in childhood
Not reported.
Maternal side e>ects
It is uncertain whether there is a difference in maternal side effects
between both induction methods (RR 1.16, 95% CI 0.95 to 1.43; 314
women; 1 study; Analysis 34.14).
Maternal nausea
A mechanical method combined with misoprostol may increase the
risk of maternal nausea when compared to PGE2 (RR 1.65, 95% CI
0.98 to 2.79; 300 women; 1 study; Analysis 34.15). However, the re-
sult is still too imprecise to make a valid judgement on this out-
come.
Maternal vomiting
Not reported.
Maternal diarrhoea
A mechanical method combined with misoprostol probably in-
creases the risk of maternal diarrhoea when compared to PGE2 (RR
3.72, 95% CI 1.53 to 9.00; 313 women; 1 study; Analysis 34.16).
Other maternal side e>ects
Not reported.
Postpartum haemorrhage
It is uncertain whether there is a difference in postpartum haem-
orrhage between both induction methods (RR 0.98, 95% CI 0.67 to
1.41; 348 women; 1 study; Analysis 34.17).
Serious maternal complications
It is uncertain whether there is a difference in serious maternal
complications between both induction methods (Analysis 34.18).
One study (350 women) was included for this outcome in which no
cases of septicaemia or intensive care unit admission were report-
ed.
Maternal death
Not reported.
Woman not satisfied
Not reported.
Caregiver not satisfied
Not reported.
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Other outcomes (not pre-specified)
Maternal fever during labour
It is uncertain whether there is a difference in maternal fever during
labour between both induction methods (RR 1.53, 95% CI 0.26 to
9.02; 347 women; 1 study; Analysis 34.19).
Antibiotics during labour
Not reported.
Chorioamnionitis
Not reported.
Endometritis
Not reported.
Fetal distress
Not reported.
Umbilical artery pH < 7.10
Not reported.
Any mechanical method and low dose misoprostol versus
misoprostol alone (seven trials involving 1422 women)
Primary outcomes
Vaginal delivery not achieved within 24 hours
It is uncertain whether there is a difference in vaginal deliveries not
achieved within 24 hours between any mechanical method com-
bined with misoprostol and misoprostol alone (average RR 0.70,
95% CI 0.25 to 1.95; 668 women; 2 studies; Analysis 35.1). Also, there
was substantial heterogeneity for this outcome (Tau2 = 0.51; Chi2 =
14.00, df = 1 (P = 0.0002); I2 = 93%).
A sensitivity analysis, after eliminating one trial assessed as having
a potentially higher risk of allocation or attrition bias (Husain 2017),
did not alter the result (average RR 1.14, 95% CI 0.89 to 1.46; 350
women; 1 study).
The same results were seen on a subgroup comparison for primi-
parous women (RR 0.83, 95% CI 0.23 to 2.96; 53 women; 1 study;
Analysis 36.1). For multiparous women, a mechanical method com-
bined with misoprostol may reduce the risk of a vaginal delivery not
achieved within 24 hours (RR 0.37, 95% CI 0.21 to 0.63; 265 women;
1 study; Analysis 37.1).
Uterine hyperstimulation with FHR changes
It is uncertain whether there is a difference in uterine hyperstimu-
lation with FHR changes between both induction methods (average
RR 0.54, 95% CI 0.20 to 1.45; 707 women; 4 studies; Analysis 35.2).
Also, there was substantial heterogeneity for this outcome (Tau2 =
0.57; Chi2 = 7.40, df = 2 (P = 0.02); I2 = 73%). No sensitivity analysis
was performed as no potential high-risk studies were included for
this outcome.
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Caesarean section
It is uncertain whether there is a difference in caesarean sections
between both induction methods (average RR 0.87, 95% CI 0.66 to
1.15; 1422 women; 7 studies; Analysis 35.3). Also, there was sub-
stantial heterogeneity for this outcome (Tau2 = 0.07; Chi2 = 13.33, df
= 6 (P = 0.04); I2 = 55%).
A sensitivity analysis, after eliminating one trial assessed as hav-
ing a potentially higher risk of allocation or attrition bias (Husain
2017), showed there probably is little or no difference in caesarean
sections between both induction methods (RR 0.96, 95% CI 0.79 to
1.17; 1104 women; 6 studies; I2 = 5%).
The same results were seen on a subgroup comparison for primi-
parous women (RR 0.62, 95% CI 0.15 to 2.51; 53 women; 1 study;
Analysis 36.2). For multiparous women, a mechanical method com-
bined with misoprostol may reduce the risk a caesarean section (RR
0.35, 95% CI 0.18 to 0.68; 265 women; 1 study; Analysis 37.2).
Serious neonatal morbidity or perinatal death
It is uncertain whether there is a difference in serious neonatal mor-
bidity or perinatal death between both induction methods (RR 1.25,
95% CI 0.34 to 4.55; 487 women; 2 studies; Analysis 35.4).
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Serious maternal morbidity or death
It is uncertain whether there is a difference in serious maternal mor-
bidity or death between both induction methods (Analysis 35.5). Of
the seven studies included for this comparison, two studies (490
women) reported on this composite outcome. No events of serious
maternal morbidity or death occurred in these studies.
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Secondary outcomes
Cervix unfavourable/unchanged aLer 24 hours
A mechanical method combined with misoprostol probably re-
duces the risk of an unfavourable cervix after 24 hours when com-
pared to misoprostol alone (RR 0.27, 95% CI 0.08 to 0.94; 140
women; 1 study; Analysis 35.6).
Oxytocin augmentation
It is uncertain whether there is a difference in oxytocin augmenta-
tion between both induction methods (average RR 0.94, 95% CI 0.70
to 1.25; 1051 women; 5 studies; Analysis 35.7). Also, there was sub-
stantial heterogeneity for this outcome (Tau2 = 0.07; Chi2 = 16.91, df
= 4 (P = 0.002); I2 = 76%).
A sensitivity analysis, after eliminating one trial assessed as having
a potentially higher risk of allocation or attrition bias (Husain 2017),
did not alter the result nor did it lower heterogeneity (average RR
0.98, 95% CI 0.66 to 1.48; 733 women; 4 studies; I2 = 82%).
Uterine hyperstimulation without FHR changes
A mechanical method combined with misoprostol probably re-
duces the risk of uterine hyperstimulation without FHR changes
when compared to misoprostol alone (RR 0.53, 95% CI 0.32 to 0.90;
982 women; 4 studies; Analysis 35.8).
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Uterine rupture
It is uncertain whether there is a difference in uterine rupture be-
tween both induction methods (Analysis 35.9). Of the seven studies
included for this comparison, two studies (490 women) reported on
this outcome. No events of uterine rupture occurred in one of these
studies.
Epidural analgesia
There may be little or no difference in epidural analgesia between
both induction methods (average RR 1.00, 95% CI 0.91 to 1.10; 443
women; 3 studies; Analysis 35.10), although there was moderate
heterogeneity for this outcome (Tau2 = 0.00; Chi2 = 3.52, df = 2 (P =
0.17); 43%).
No sensitivity analysis was performed as no potential high-risk
studies were included for this outcome.
Instrumental vaginal delivery
It is uncertain whether there is a difference in instrumental vaginal
deliveries between both induction methods (RR 0.93, 95% CI 0.58
to 1.51; 676 women; 3 studies; Analysis 35.11).
Meconium-stained liquor
A mechanical method combined with misoprostol may reduce the
risk of meconium-stained liquor when compared to misoprostol
alone (average RR 0.61, 95% CI 0.35 to 1.04; 1243 women; 6 studies;
Analysis 35.12). However, the result is still too imprecise to make a
valid judgement on this outcome. Also, there was substantial het-
erogeneity for this outcome (Tau2 = 0.24; Chi2 = 11.55, df = 5 (P =
0.04); I2 = 57%).
A sensitivity analysis, after eliminating one trial assessed as having
a potentially higher risk of allocation or attrition bias (Husain 2017),
did not alter the result nor did it lower heterogeneity (average RR
0.55, 95% CI 0.26 to 1.14; 925 women; 5 studies; I2 = 64%).
Apgar score less than seven at five minutes
It is uncertain whether there is a difference in Apgar score less than
seven at five minutes between both induction methods (average
RR 0.71, 95% CI 0.37 to 1.36; 802 women; 3 studies; Analysis 35.13).
Also, there was substantial heterogeneity for this outcome (Tau2 =
0.11; Chi2 = 2.89, df = 2 (P = 0.24); I2 = 31%).
A sensitivity analysis, after eliminating one trial assessed as having
a potentially higher risk of allocation or attrition bias (Husain 2017),
did not alter the result, although heterogeneity was lost (RR 1.10,
95% CI 0.50 to 2.44; 484 women; 2 studies; I2 = 0%).
Neonatal intensive care unit admission
A mechanical method combined with misoprostol may reduce the
risk of NICU admission when compared to misoprostol alone (RR
0.57, 95% CI 0.36 to 0.91; 1246 women; 6 studies; Analysis 35.14), the
absolute effect being 30 fewer NICU admissions per 1000 deliveries.
Neonatal encephalopathy
Not reported.
Perinatal death
It is uncertain whether there is difference in perinatal death be-
tween both induction methods (RR 3.09, 95% CI 0.13 to 75.26; 347
women; 1 study; Analysis 35.15). One case of perinatal death was
reported by Matonhodze 2003, which occurred in the combined
method group. No further information was given on timing or cause
of the demise.
Disability in childhood
Not reported.
Maternal side e>ects (all)
It is uncertain whether there is a difference in maternal side effects
between both induction methods (RR 1.06, 95% CI 0.87 to 1.30; 300
women; 1 study; Analysis 35.16).
Maternal nausea
It is uncertain whether there is a difference in maternal nausea be-
tween both induction methods (RR 1.37, 95% CI 0.84 to 2.23; 300
women; study; Analysis 35.17).
Maternal vomiting
Not reported.
Maternal diarrhoea
A mechanical method combined with misoprostol probably in-
creases the risk of maternal diarrhoea when compared to miso-
prostol alone (RR 3.38, 95% CI 1.40 to 8.17; 298 women; 1 study;
Analysis 35.18).
Other maternal side e>ects
Not reported.
Postpartum haemorrhage
It is uncertain whether there is difference in postpartum haemor-
rhage between both induction methods (RR 0.93, 95% CI 0.65 to
1.33; 466 women; 2 studies; Analysis 35.19).
Serious maternal complications
It is uncertain whether there is a difference in serious maternal
complications between both induction methods (Analysis 35.20).
One study (350 women) was included for this outcome in which no
cases of septicaemia or intensive care unit admissions were seen.
Maternal death
Not reported.
Woman not satisfied
Not reported.
Caregiver not satisfied
Not reported.
Other outcomes (not pre-specified)
Maternal fever during labour
Not reported.
Antibiotics during labour
Not reported.
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Chorioamnionitis
It is uncertain whether there is a difference in chorioamnionitis be-
tween both induction methods (RR 0.63, 95% CI 0.28 to 1.38; 443
women; 3 studies; Analysis 35.21).
Endometritis
It is uncertain whether there is a difference in endometritis between
both induction methods (RR 0.41, 95% CI 0.08 to 2.08; 435 women;
2 studies; Analysis 35.22).
Fetal distress
It is uncertain whether there is a difference in fetal distress for
which a caesarean section is indicated between both induction
methods (RR 0.78, 95% CI 0.53 to 1.14; 784 women; 4 studies; Analy-
sis 35.23).
Umbilical artery pH < 7.10
Not reported.
Any mechanical method and oxytocin versus prostaglandin E2
alone (four trials involving 713 women)
Primary outcomes
Vaginal delivery not achieved within 24 hours
Not reported.
Uterine hyperstimulation with FHR changes
It is uncertain whether there is a difference in uterine hyperstimu-
lation with FHR changes between a mechanical method combined
with oxytocin and PGE2 (RR 1.48, 95% CI 0.55 to 3.95; 151 women;
1 study; Analysis 38.1).
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Caesarean section
It is uncertain whether there is a difference in caesarean sections
between both induction methods (RR 0.93, 95% CI 0.72 to 1.20; 713
women; 4 studies; Analysis 38.2).
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Serious neonatal morbidity or perinatal death
Not reported.
Serious maternal morbidity or death
It is uncertain whether there is a difference in serious maternal mor-
bidity or death between both induction methods (Analysis 38.3).
One study (200 women) was included for this composite outcome
in which no events of maternal morbidity or death occurred.
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Secondary outcomes
Cervix unfavourable/unchanged aLer 24 hours
Not reported.
Oxytocin augmentation
A mechanical method combined with oxytocin probably increas-
es the risk of oxytocin augmentation when compared to PGE2 (RR
2.48, 95% CI 1.95 to 3.15; 200 women; 1 study; Analysis 38.4).
Uterine hyperstimulation without FHR changes
A mechanical method combined with oxytocin probably increas-
es the risk of uterine hyperstimulation without FHR changes when
compared to PGE2 (RR 2.19, 95% CI 1.39 to 3.46; 151 women; 1
study; Analysis 38.5).
Uterine rupture
Not reported.
Epidural analgesia
Not reported.
Instrumental vaginal delivery
It is uncertain whether there is a difference in instrumental vaginal
deliveries between both induction methods (RR 0.35, 95% CI 0.08
to 1.58; 41 women; 1 study; Analysis 38.6).
Meconium-stained liquor
It is uncertain whether there is a difference in meconium-stained
liquor between both induction methods (RR 1.13, 95% CI 0.43 to
2.95; 151 women; 1 study; Analysis 38.7).
Apgar score less than seven at five minutes
It is uncertain whether there is a difference in Apgar scores less than
seven at five minutes between both induction methods (RR 2.96,
95% CI 0.12 to 71.55; 151 women; 1 study; Analysis 38.8).
Neonatal intensive care unit admission
It is uncertain whether there is a difference in NICU admissions be-
tween both methods (RR 0.85, 95% CI 0.30 to 2.40; 151 women; 1
study; Analysis 38.9).
Neonatal encephalopathy
Not reported.
Perinatal death
Not reported.
Disability in childhood
Not reported.
Maternal side e>ects
Not reported.
Maternal nausea
Not reported.
Maternal vomiting
Not reported.
Maternal diarrhoea
Not reported.
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Other maternal side e>ects
Not reported.
Postpartum haemorrhage
It is uncertain whether there is a difference in postpartum haem-
orrhage between both induction methods (RR 0.14, 95% CI 0.01 to
2.68; 151 women; 1 study; Analysis 38.10).
Serious maternal complications
Not reported.
Maternal death
Not reported.
Woman not satisfied
Not reported.
Caregiver not satisfied
Not reported.
Other outcomes (not pre-specified)
Maternal fever during labour
Not reported.
Antibiotics during labour
Not reported.
Chorioamnionitis
Not reported.
Endometritis
It is uncertain whether there is a difference in endometritis between
both induction methods (Analysis 38.11). One study (41 women) re-
ported on this outcome. No events of endometritis occurred in this
study.
Fetal distress
It is uncertain whether there is a difference in fetal distress for
which a caesarean section is indicated between both induction
methods (average RR 0.97, 95% CI 0.61 to 1.56; 498 women; 3 stud-
ies; Analysis 38.12). Also, there was moderate heterogeneity for this
outcome (Tau2 = 0.06; Chi2 = 2.93, df = 2 (P = 0.23); I2 = 32%).
No sensitivity analysis was performed as no potential high-risk
studies were included for this outcome.
Umbilical artery pH < 7.10
Not reported.
Any mechanical method and oxytocin versus misoprostol
alone (six trials involving 1779 women)
Primary outcomes
Vaginal delivery not achieved within 24 hours
A mechanical method combined with oxytocin probably reduces
the risk of a vaginal delivery not being achieved within 24 hours
when compared to misoprostol (RR 0.48, 95% CI 0.37 to 0.63; 362
women; 2 studies; Analysis 39.1), the absolute effect being 285 few-
er per 1000 deliveries.
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Uterine hyperstimulation with FHR changes
It is uncertain whether there is a difference in uterine hyperstimu-
lation with FHR changes between both induction methods (RR 0.43,
95% CI 0.17 to 1.11; 1463 women; 3 studies; Analysis 39.2).
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Caesarean section
There probably is little or difference in caesarean sections between
both induction methods (RR 0.95, 95% CI 0.80 to 1.12; 1779 women;
5 studies; Analysis 39.3).
For the subgroup of primiparous women, no outcomes were report-
ed. For multiparous women, it is uncertain whether there is a differ-
ence in caesarean sections between both induction methods (RR
0.45, 95% CI 0.19 to 1.11; 136 women; 1 study; Analysis 40.1).
Serious neonatal morbidity or perinatal death
It is uncertain whether there is a difference in serious neonatal mor-
bidity or perinatal death between both induction methods (RR 0.82,
95% CI 0.18 to 3.65;1263 women; 2 studies; Analysis 39.4). All the
events included for this composite outcome were cases of neona-
tal death.
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Serious maternal morbidity or death
Not reported.
Secondary outcomes
Cervix unfavourable/unchanged aLer 24 hours
Not reported.
Oxytocin augmentation
It is uncertain whether there is a difference in oxytocin augmenta-
tion between both induction methods (average RR 3.89, 95% CI 0.70
to 21.72; 336 women; 2 studies; Analysis 39.5). Also, there was sub-
stantial heterogeneity for this outcome (Tau2 = 1.46; Chi2 = 18.47, df
= 1 (P < 0.0001); I2 = 95%).
A sensitivity analysis, after eliminating the one trial assessed as
having a potentially higher risk of allocation or attrition bias (Garba
2016), changed the result in favour of misoprostol as it showed a
mechanical method combined with oxytocin may increase the risk
of oxytocin augmentation (RR 1.91, 95% CI 1.59 to 2.31; 200 women;
1 study).
Uterine hyperstimulation without FHR changes
A mechanical method combined with oxytocin probably reduces
the risk of uterine hyperstimulation without FHR changes when
compared to misoprostol (RR 0.52, 95% CI 0.30 to 0.92; 498 women;
3 studies; Analysis 39.6).
Uterine rupture
Not reported.
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Epidural analgesia
It is uncertain whether there is a difference in epidural analgesia
between both induction methods (RR 1.07, 95% CI 0.90 to 1.27; 162
women; 1 study; Analysis 39.7).
Instrumental vaginal delivery
Not reported.
Meconium-stained liquor
It is uncertain whether there is a difference in meconium-stained
liquor between both induction methods (RR 0.72, 95% CI 0.43 to
1.19; 362 women; 2 studies; Analysis 39.8).
Apgar score less than seven at five minutes
It is uncertain whether there is a difference in Apgar scores less than
seven at five minutes between both induction methods (RR 0.95,
95% CI 0.20 to 4.58; 162 women; 1 study; Analysis 39.9).
Neonatal intensive care unit admission
A mechanical method combined with oxytocin probably reduces
the risk of a NICU admission when compared to misoprostol (RR
0.66, 95% CI 0.49 to 0.90; 1599 women; 4 studies; Analysis 39.10), the
absolute effect being 37 fewer NICU admissions per 1000 deliveries.
Neonatal encephalopathy
Not reported.
Perinatal death
It is uncertain whether there is a difference in perinatal death be-
tween both induction methods (RR 0.82, 95% CI 0.18 to 3.65; 1263
women; 2 studies; Analysis 39.11). Perinatal death occurred in one
of the included studies (Gilson 2017). All were cases of neonatal
death. No further information was given on cause of the demise.
Disability in childhood
Not reported.
Maternal side e>ects
Not reported.
Maternal nausea
Not reported.
Maternal vomiting
Not reported.
Maternal diarrhoea
Not reported.
Other maternal side e>ects
Not reported.
Postpartum haemorrhage
Not reported.
Serious maternal complications
Not reported.
Maternal death
Not reported.
Woman not satisfied
A mechanical method combined with oxytocin may increase the
risk of women not being satisfied when compared to misoprostol
(RR 1.68, 95% CI 1.47 to 1.93; 866 women; 1 study; Analysis 39.12),
the absolute effect being 260 more women not satisfied per 1000
deliveries. For this outcome, women in the study of Gilson 2017
were asked if they would choose the same method again if induc-
tion of labour was needed in a future pregnancy.
Caregiver not satisfied
Not reported.
Other outcomes (not pre-specified)
Maternal fever during labour
A mechanical method combined with oxytocin may reduce the risk
of maternal fever during labour when compared to misoprostol (RR
0.13, 95% CI 0.04 to 0.50; 298 women; 2 studies; Analysis 39.13).
Antibiotics during labour
Not reported.
Chorioamnionitis
It is uncertain whether there is a difference in chorioamnionitis be-
tween both induction methods (RR 0.65, 95% CI 0.32 to 1.31; 200
women; 1 study; Analysis 39.14).
Endometritis
Not reported.
Fetal distress
It is uncertain whether there is a difference in fetal distress for
which a caesarean section is indicated between both induction
methods (RR 0.55, 95% CI 0.25 to 1.21; 362 women; 2 studies; Analy-
sis 39.15).
Umbilical artery pH < 7.10
Not reported.
Any mechanical method and oxytocin versus oxytocin alone
(six trials involving 718 women)
Primary outcomes
Vaginal delivery not achieved within 24 hours
It is uncertain whether there is a difference in a vaginal delivery not
being achieved within 24 hours between induction of labour with
a mechanical method combined with oxytocin and oxytocin alone
(average RR 0.71, 95% CI 0.21 to 2.40; 321 women; 2 studies; Analy-
sis 41.1). Also, there was substantial heterogeneity for this outcome
(Tau2 = 0.72; Chi2 = 19.17, df = 1 (P,0.0001); I2 = 95%).
A sensitivity analysis, after eliminating the one trial assessed as
having a potentially higher risk of allocation or attrition bias (Mac-
keen 2018), changed the result in favour of a mechanical method
combined with oxytocin as it showed it may reduce the risk of vagi-
nal delivery not being achieved within 24 hours (RR 0.39, 95% CI
Mechanical methods for induction of labour (Review)
Copyright © 2019 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane
Collaboration.
62
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
0.27 to 0.55; 120 women; 1 study), the absolute effect being 550 few-
er per 1000 deliveries.
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Uterine hyperstimulation with FHR changes
Not reported.
Caesarean section
It is uncertain whether there is a difference in caesarean sections
between both induction methods (average RR 0.68, 95% CI 0.39 to
1.20; 718 women; 6 studies; Analysis 41.2). Also, there was substan-
tial heterogeneity for this outcome (Tau2 = 0.32; Chi2 = 17.15, df = 5
(P = 0.004); I2 = 71%).
A sensitivity analysis, after eliminating the three trials assessed as
having a potentially higher risk of allocation or attrition bias (Lyn-
drup 1989; Mackeen 2018; Tita 2006), did not alter the result nor did
it lower heterogeneity (average RR 0.57, 95% CI 0.21 to 1.52; 319
women; 3 studies; I2 = 82%).
Serious neonatal morbidity or perinatal death
It is uncertain whether there is a difference in serious neonatal mor-
bidity or perinatal death between both induction methods (RR 0.71,
95% CI 0.12 to 4.13; 321 women; 2 studies; Analysis 41.3). All the
events included for this composite outcome were cases of asphyx-
ia.
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Serious maternal morbidity or death
It is uncertain whether there is a difference in serious maternal mor-
bidity or death between both induction methods (Analysis 41.4).
Of the six included studies for this comparison, two studies (321
women) reported on this composite outcome. No events of mater-
nal morbidity or death occurred in these studies.
For the subgroups of primiparous and multiparous women, no out-
comes were reported.
Secondary outcomes
Cervix unfavourable/unchanged aLer 24 hours
Not reported.
Oxytocin augmentation
Not reported.
Uterine hyperstimulation without FHR changes
It is uncertain whether there is a difference in uterine hyperstimu-
lation without FHR changes between both induction methods (RR
0.85, 95% CI 0.34 to 2.09; 199 women; 2 studies; Analysis 41.5).
Uterine rupture
It is uncertain whether there is a difference in uterine rupture be-
tween both induction methods (Analysis 41.6). Of the six included
studies for this comparison, one study (120 women) reported on
this outcome. No events of uterine rupture occurred in this study.
Epidural analgesia
There probably is little or no difference in epidural analgesia be-
tween both induction methods (RR 1.03, 95% CI 0.98 to 1.09; 127
women; 1 study; Analysis 41.7).
Instrumental vaginal delivery
It is uncertain whether there is a difference in instrumental vaginal
deliveries between both induction methods (RR 0.99, 95% CI 0.48
to 2.02; 293 women; 3 studies; Analysis 41.8).
Meconium-stained liquor
It is uncertain whether there is a difference in meconium-stained
liquor between both induction methods (RR 0.72, 95% CI 0.32 to
1.63; 319 women; 3 studies; Analysis 41.9).
Apgar score less than seven at five minutes
Not reported.
Neonatal intensive care unit admission
It is uncertain whether there is a difference in NICU admissions be-
tween both induction methods (RR 0.98, 95% CI 0.61 to 1.58; 400
women; 3 studies; Analysis 41.10).
Neonatal encephalopathy
Not reported.
Perinatal death
Not reported.
Disability in childhood
Not reported.
Maternal side e>ects
Not reported.
Maternal nausea
Not reported.
Maternal vomiting
Not reported.
Maternal diarrhoea
Not reported.
Other maternal side e>ects
Not reported.
Postpartum haemorrhage
It is uncertain whether there is a difference in postpartum haem-
orrhage between both induction methods (RR 1.18, 95% CI 0.44 to
3.18; 319 women; 3 studies; Analysis 41.11).
Serious maternal complications
It is uncertain whether there is a difference in serious maternal
complications between both induction methods (Analysis 41.12).
Of the six included studies for this comparison, one study (201
women) reported on maternal sepsis. No events occurred in this
study.
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Maternal death
Not reported.
Woman not satisfied
Not reported.
Caregiver not satisfied
Not reported.
Other outcomes (not pre-specified)
Maternal fever during labour
Not reported.
Antibiotics during labour
It is uncertain whether there is a difference in antibiotics during
labour between both induction methods (RR 2.32, 95% CI 0.82 to
6.55; 201 women; 1 study; Analysis 41.13).
Chorioamnionitis
It is uncertain whether there is a difference in chorioamnionitis be-
tween both induction methods (average RR 4.34, 95% CI 0.55 to
34.01; 328 women; 2 studies; Analysis 41.14). Also, there was mod-
erate heterogeneity for this outcome (Tau2 = 1.19; Chi2 = 1.92, df =
1 (P = 0.17); I2 = 48%).
A sensitivity analysis, after eliminating the one trial assessed as
having a potentially higher risk of allocation or attrition bias (Mac-
keen 2018), did not alter the result (RR 2.16, 95% CI 0.57 to 8.28; 127
women; 1 study).
Endometritis
It is uncertain whether there is a difference in endometritis between
both induction methods (RR 1.08, 95% CI 0.16 to 7.45; 374 women;
3 studies; Analysis 41.15).
Fetal distress
It is uncertain whether there is a difference in fetal distress for
which a caesarean section is indicated between both induction
methods (RR 1.37, 95% CI 0.68 to 2.77; 400 women; 3 studies; Analy-
sis 41.16).
Umbilical artery pH < 7.10
Not reported.
D I S C U S S I O N
We set out to explore the effectiveness of mechanical methods for
labour induction and their adverse effects for women and their
babies in comparison to different pharmacological methods. We
included a total of 113 studies, with 105 studies contributing da-
ta involving 22,373 women. This updated review now consists of
21 different comparisons (and 20 subgroup comparisons), where
in most of the comparisons a mechanical method (balloon, lami-
naria or extra-amniotic space infusion (EASI)) was compared with
prostaglandin E2 (PGE2), misoprostol or oxytocin. We explored the
combination of a mechanical method combined with a pharmaco-
logical method, as well as a single versus a double balloon.
Summary of main results
Balloon
Balloon versus PGE2
A balloon catheter is probably as effective for inducing labour as
vaginal PGE2, as there was little or no difference in a vaginal deliv-
ery not achieved within 24 hours (low-quality evidence) and cae-
sarean sections (moderate-quality evidence) between both induc-
tion methods. However, oxytocin augmentation is probably more
often required when labour is induced with a balloon catheter. As
for perinatal outcomes, a balloon catheter appears to have a more
favourable safety profile compared to vaginal PGE2, as it proba-
bly reduces the risk of uterine hyperstimulation with and without
fetal heart rate (FHR) changes (moderate-quality evidence), fetal
distress for which a caesarean section is required and an umbili-
cal artery pH less than 7.10. Also, a balloon catheter may slight-
ly reduce the risk of a neonatal intensive care unit (NICU) admis-
sion (low-quality evidence), although conventional statistical sig-
nificance was not reached as the result was still too imprecise to
make a valid judgement. Of note, a balloon catheter probably re-
duces the risk of serious neonatal morbidity or perinatal death
(moderate-risk evidence). However, this outcome should be inter-
preted with caution as only a few studies (eight out of 28 studies),
reported on this composite outcome and therefore a bias for this
result could exist. Most of the serious perinatal adverse events in
this composite outcome were cases of perinatal asphyxia. Regard-
ing our other main outcomes for this comparison, it was unclear if
there is a difference in five-minute Apgar score less than seven (low-
quality evidence) or serious maternal morbidity or death (very low-
quality evidence).
There was no evidence of a difference in outcomes between induc-
tion of labour with a balloon compared to cervical PGE2, although
the risk of fetal distress for which a caesarean section is indicated
is probably reduced when a balloon is used.
Balloon versus misoprostol
A balloon catheter may be less effective for induction of labour
when compared to low-dose oral misoprostol, as a balloon prob-
ably increases the risk of a vaginal delivery not achieved with-
in 24 hours (moderate-quality evidence), oxytocin augmentation
and probably slightly increases the risk of a caesarean section
(moderate-quality evidence). Regarding safety outcomes for the
neonate, which are hyperstimulation with (low-quality evidence)
and without FHR changes, serious neonatal morbidity or perina-
tal death (low-quality evidence), NICU admission (low-quality ev-
idence), five-minute Apgar score less than seven (low-quality evi-
dence), fetal distress and umbilical artery pH less than 7.10, it is un-
clear if there is a difference between both methods as results were
too imprecise to make a valid judgement. This was also the case for
the composite outcome serious maternal morbidity or death (very
low-quality evidence).
When compared to low-dose vaginal misoprostol, a balloon
catheter may increase the risk of a caesarean section and oxytocin
augmentation (low-quality evidence). However, there was substan-
tial heterogeneity for both outcomes. For the outcome caesare-
an section, heterogeneity was not reduced after sensitivity analy-
sis. The risk of hyperstimulation, with and without FHR changes, is
probably reduced when a balloon catheter is used, as well as the
risk of meconium-stained liquor (moderate-quality evidence). Re-
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garding our other main outcomes for this comparison, it was un-
clear if there was a difference between serious neonatal morbid-
ity or perinatal death (very low-quality evidence), serious mater-
nal morbidity or death (very low-quality evidence), NICU admission
(low-quality evidence) and five-minute Apgar score less than seven
(low-quality evidence) as these results were too imprecise to make
a valid judgement.
Epidural analgesia is probably used slightly more after induction of
labour with a balloon compared to low-dose oral misoprostol, as
well as vaginal misoprostol.
Balloon versus oxytocin
In women with an unfavourable cervix, cervical ripening with a bal-
loon seems to be more effective than induction with oxytocin as it
probably reduces the risk of caesarean section and the risk of fe-
tal distress for which a caesarean section is indicated. For women
with a previous caesarean section, a balloon catheter may slightly
reduce the risk of a caesarean section when compared to oxytocin.
However, the result is too imprecise to make a valid judgement on
this outcome.
Single balloon versus double balloon
There is no evidence of benefit of a double balloon over a single
balloon. There is little or no difference in vaginal deliveries not
achieved within 24 hours and in oxytocin augmentation. No clear
difference in caesarean section rate was seen between these induc-
tion methods. However, the result was still too imprecise to make
a valid judgement. Hyperstimulation seems to occur infrequent-
ly with either balloons, as no events of uterine hyperstimulation
with or without FHR changes were reported in the one study (217
women) which reported on these outcomes.
Laminaria tent
There was no evidence of a difference in outcomes between a lam-
inaria tent compared to vaginal PGE2. However, results were too
imprecise to make a valid judgement. Compared to cervical PGE2, a
laminaria tent probably reduces the risk uterine hyperstimulation
both with and without FHR changes.
EASI
Only a few small studies compared EASI with other methods. When
compared to vaginal PGE2, EASI may increase the risk of a vaginal
delivery not achieved within 24 hours and oxytocin augmentation.
Mechanical method combined with a pharmacological method
There was no evidence of clear benefit for a mechanical method
combined with PGE2 compared to PGE2 alone or to oxytocin. When
compared to low-dose misoprostol, a mechanical method com-
bined with PGE2 may reduce the risk of a vaginal delivery not
achieved within 24 hours. However, only one study (127 women)
reported on this comparison. When a mechanical method is com-
bined with misoprostol or with oxytocin, it may reduce the risk of
a NICU admission when compared to misoprostol alone. Howev-
er, regarding other perinatal outcomes for both comparisons, there
was no evidence for a difference in serious neonatal morbidity or
perinatal death, Apgar scores less than seven at five minutes or fe-
tal distress.
Infection
Risk of infection may theoretically be associated with the inser-
tion of foreign material in the cervix. Most studies did not report
on this outcome, resulting in limited data, reported as various out-
comes (maternal fever during labour, antibiotic use during labour,
chorioamnionitis and endometritis). According to the limited da-
ta available, there is no evidence of an increased risk of infectious
morbidity with mechanical methods. These data should however
be cautiously interpreted as results were imprecise.
Women's view
Data on patient satisfaction or patient preferences are sparse and
not all data could be included in the meta-analyses. When a balloon
catheter was compared to vaginal PGE2, more women who were
randomised to a balloon would choose the allocated induction
method again in a subsequent pregnancy, as compared to women
who were randomised to PGE2. However, when a balloon catheter
was compared to oral misoprostol, more women would choose
misoprostol in a subsequent pregnancy. For both outcomes, only
one study was included.
Overall completeness and applicability of evidence
This review was previously one of a series of Cochrane Reviews ex-
amining various methods for induction of labour and now serves
as a stand-alone review. Other reviews have examined phar-
macological and non-pharmacological methods including vagi-
nal prostaglandins (Thomas 2014); intracervical prostaglandins
(Boulvain 2008); intravenous oxytocin (Alferivic 2009); amnioto-
my (Bricker 2000); intravenous oxytocin with amniotomy (Howarth
2001); vaginal misoprostol (Hofmeyr 2010); oral misoprostol (Alfire-
vic 2014), and other methods.
Despite including 113 studies and including data from 105 studies,
there were relatively few clear results. Only for the comparison of
a balloon versus vaginal prostaglandin E2, including 28 studies in-
volving 6619 women, were there enough data to make a valid judge-
ment on effectiveness and adverse events between these methods.
Most of the outcomes of interest were poorly reported in the in-
cluded studies, especially serious maternal or perinatal morbidity
or death. Also, for some outcomes such as duration from start of
induction to vaginal delivery, Apgar score or umbilical cord pH, on-
ly continuous data were reported and therefore were not included
in this review. Outcomes should therefore be interpreted with cau-
tion. Caesarean section on the other hand, was reported in almost
every study. Therefore, caesarean section may be the most reliable
outcome by which to assess the effectiveness of mechanical meth-
ods for cervical ripening and induction of labour.
The external validity of our results can be questioned as the policy
of labour induction varies across the different settings in which tri-
als took place. There was a difference seen in maximum ripening
time (e.g. the maximum time cervical ripening was awaited, rang-
ing from six hours to 96 hours) and for when induction of labour was
declared as failed. As it may take longer to achieve successful cer-
vical ripening when a balloon is used, this could influence the out-
come measures of effectiveness used, such as caesarean section.
Also, the caesarean rate differs according to the setting in which tri-
als took place, ranging from 9% (Deshmukh 2011) to 70% (Hudon
1999).
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Studies ranged in date of publication from 1982 to 2018. While we
did not consider the potential influence of date on our results, it is
possible that changes in management of labour can mean that for
some comparisons, in which relatively older studies were included,
may not be generalisable to the current clinical context.
Quality of the evidence
Risk of bias varied throughout the included trials (see Figure 2 and
Figure 3). A great proportion of the trial methods were not well re-
ported and were assessed to be at unclear risk of bias in many do-
mains. Three trials were assessed as using inadequate random se-
quence generation, and in five trials no measures were taken to
conceal allocation. In almost all studies, no blinding was done due
to the nature of the intervention. However, blinding of the research
personnel would have been possible, but was only described in four
studies. Two studies reported to have performed a double-blind
study, but did not describe how this was achieved. We rated many
trials at unclear risk of attrition bias, mainly because it was not clear
if intention-to-treat was performed. Although we did attempt to as-
sess reporting bias, lack of trial protocols for most of the older stud-
ies, meant this assessment relied on information available in the
published trial report.
The outcomes were assessed using the GRADE approach. We de-
termined the evidence to be moderate-quality, low-quality or very
low-quality. All evidence was downgraded for lack of blinding. Oth-
er reasons for downgrading were predominately for imprecision
(uncertain effect estimates, small sample sizes and low event rates)
and inconsistencies (heterogeneity). For our three main compar-
isons (balloon versus vaginal PGE2; balloon versus vaginal miso-
prostol; balloon versus oral misoprostol), a 'Summary of findings'
table was produced (Summary of findings for the main comparison;
Summary of findings 2; Summary of findings 3).
Although no publication bias was detected for our main outcomes,
there is still a possibility of publication bias. Most comparisons had
less than 10 studies included and therefore, a funnel plot could
not be produced. Also, for 11 trial registrations the anticipated end
date was overdue by two years and it was not clear if the trials had
started, were ongoing or finished recruiting (Baacke 2006; Behrashi
2013; Cullimore 2009; Dias 2008; EUCTR 2012; Kamilya 2011; Park
2011; Pathiraja 2014; Reif 2012; Yazdani 2011; Zhang 2014). There-
fore, a potential risk exists as results from these studies were not
published.
We acknowledge that with so many comparisons within the review,
there is also a risk of statistical type 1 error, meaning a false-positive
result. The results where there are very few studies included, mod-
erate or substantial heterogeneity, or those where the meta-analy-
sis result is of borderline statistical significance must therefore be
treated with caution.
Potential biases in the review process
We are aware that the possibility of introducing bias was present
at every stage of the reviewing process. We attempted to minimise
bias in a number of ways; two review authors assessed studies for
eligibility, assessed risk of bias and carried out data extraction.
Each review author worked independently. We resolved discrepan-
cies through discussion, or if required we consulted a third review
author. Nevertheless, the process of assessing risk of bias, for ex-
ample, is not an exact science and includes many personal judge-
ments. Four review authors, Mieke ten Eikelder, Marta Jozwiak , Kit-
ty Bloemenkamp and Ben Willem Mol are also trial authors for the
following included studies: Jozwiak 2012; Jozwiak 2013; Jozwiak
2014; ten Eikelder 2016. Data extraction and risk of bias assess-
ments were conducted by other review authors for these studies
(Marieke de Vaan; Kirsten Palmer).
Agreements and disagreements with other studies or
reviews
This review is one the most extensive reviews on mechanical meth-
ods of labour induction as most reviews on this subject only contain
one or two of the comparisons included in this review. We found
eight recent systematic reviews covering one or more of our main
comparisons, being balloon versus vaginal PGE2, balloon versus
vaginal misoprostol or balloon versus oral misoprostol.
Our review was in line with other systematic reviews on induction
of labour with a balloon versus vaginal PGE2. Liu 2018 compared
a double balloon with a vaginal PGE2 insert and they found no dif-
ference in vaginal deliveries achieved within 24 hours or caesare-
an section rate. They also found a reduction in uterine hyperstim-
ulation and umbilical artery pH < 7.10 when a balloon was used.
All of the five studies included in the review of Liu 2018, were also
included in our review. Du 2017 compared a double balloon with
PGE2 (vaginal as well as cervical) and produced the same results as
described in our review and the review of Liu 2018. However, they
found no difference in fetal distress for which a caesarean section
was indicated. All eight studies were also included in this review.
Zhu 2018 compared a Foley catheter with a vaginal PGE2 and in-
cluded eight studies of which one (Ghanaie 2013) was excluded in
our review because oxytocin was administered concurrent to both
induction methods. Just as the other reviews, Zhu 2018 found no
difference in caesarean section rate. They also looked at the induc-
tion to delivery interval on a continuous level and found no differ-
ence between both induction methods. Wang 2016 however, found
a longer induction to delivery interval when a Foley catheter was
used in comparison to PGE2 vaginal insert. The authors did not
compare vaginal delivery rates within 24 hours.
Chen 2016 performed a network meta-analysis in which direct and
indirect comparisons between different induction agents, includ-
ing Foley catheter, vaginal PGE2, vaginal misoprostol and oral miso-
prostol were made. Studies with high-dose misoprostol were in-
cluded in the review of Chen 2016 as opposed to our review and
only indirect comparisons could be made between a Foley catheter
and oral misoprostol in the review of Chen 2016. The outcomes of
interest were vaginal delivery not achieved within 24 hours, uterine
hyperstimulation with FHR changes and caesarean section. Not all
results were in line with our results. In the network meta-analysis,
a Foley catheter increased the risk of vaginal delivery not achieved
within 24 hours compared to vaginal misoprostol, where in our re-
view the outcome was uncertain. When compared to oral misopros-
tol, no clear difference in vaginal deliveries within 24 hours was
seen by Chen 2016 compared to an increased risk in our review.
In our review no clear difference was seen in uterine hyperstimula-
tion with FHR changes, but in the network analysis of Chen 2016, a
reduced risk was seen when a Foley catheter was used compared
to oral misoprostol. For the outcome of caesarean section, the net-
work meta-analyses of Chen 2016 showed the same results as our
review. They found that a Foley catheter may slightly increase the
risk of a caesarean section when compared to vaginal or oral miso-
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prostol, with moderate heterogeneity for the comparison with vagi-
nal misoprostol.
Alfirevic 2016 performed a extensive systematic review on induc-
tion of labour. The authors included 34 active treatment types/reg-
imens including different dose regimens and routes of administra-
tion, and performed a network meta-analysis in which all differ-
ent treatments were ranked in relation to each other, including di-
rect as well as indirect comparisons. Ranking was done on absolute
risks for all pre specified outcomes. Mechanical induction with a
balloon was divided in a single or double balloon. Alfirevic 2016
used other cut-oI points in dividing oral and vaginal tablets in dose
regimens. In our review low dose was defined as ≤ 50 mcg every ≥
four hours, opposed to the cut-of point of ≥ 50 mcg in the review
of Alfirevic 2016. Vaginal PGE2 was divided into tablets, gel, slow-
release and normal-release inserts. For the outcome of a vaginal
delivery not achieved within 24 hours, low-dose vaginal misopros-
tol scored better, as well as all different regimens of vaginal PGE2
compared to induction with a balloon (single as well as double).
For the outcome caesarean section, a single balloon and vaginal
PGE2 gel had a similar mean ranking in the mid regions. Notewor-
thy is that low-dose titrated oral misoprostol had one of the lowest
mean rankings, as compared to oral misoprostol < 50 mcg, which
was ranked relatively high. The same high ranking for this outcome
was seen for a double balloon. In line with our review, all mechani-
cal methods had a low ranking regarding uterine hyperstimulation
with FHR changes. Alfirevic 2016 also looked at neonatal and ma-
ternal mortality and severe morbidity, but for these composite out-
comes no network meta-analysis was possible as events were rare
and poorly reported in studies. For the outcomes of NICU-admis-
sion as well as five-minute Apgar score less than seven, there was
considerable uncertainty on the probability of the mean ranking as
the 95% confidence intervals (CIs) for these rankings were relative-
ly broad.
Ten Eikelder 2016 looked at safety outcomes between induction of
labour with a Foley catheter and misoprostol (any route, any dose)
and found less uterine hyperstimulation with FHR changes and less
fetal distress for which a caesarean section was indicated when a
Foley was used. They found that a Foley catheter may slightly in-
crease the caesarean section rate, although conventional statisti-
cal significance was not reached and there was moderate hetero-
geneity for this outcome. Studies with high-dose misoprostol were
not excluded in the review of Ten Eikelder 2016. In subgroup analy-
ses for 25 mcg and 50 mcg vaginal misoprostol, no evidence for a
difference in safety outcomes were found.
In our review, there was no evidence for a difference in outcomes
related to infection between mechanical induction and other meth-
ods for induction of labour. However, the results of outcomes
covering infection were still too imprecise to make a valid judge-
ment. McMaster 2015 addressed this question by comparing induc-
tion of labour with a balloon versus locally-applied prostaglandin
and included 26 trials. Their results were in line with our results
and found no evidence for a difference in chorioamnionitis, en-
dometritis and neonatal infection. When infection outcomes were
pooled, little or no difference was seen, suggesting a Foley catheter
does not increase the risk of infection compared to locally-applied
prostaglandin.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
Mechanical induction with a balloon is probably as effective as in-
duction of labour with vaginal PGE2 with little or no difference in
vaginal deliveries not achieved within 24 hours and caesarean sec-
tion rate between the two methods. However, a balloon seems to
have a more favourable safety profile compared to vaginal PGE2, as
it probably reduces the risk of uterine hyperstimulation with and
without fetal heart rate (FHR) changes, fetal distress for which a
caesarean section is indicated and serious neonatal morbidity or
perinatal death.
A balloon catheter may be less effective for induction of labour
when compared to low-dose oral misoprostol as a balloon proba-
bly increases the risk of a vaginal delivery not achieved within 24
hours and probably slightly increases the risk of a caesarean sec-
tion. It is unclear if there is a difference in hyperstimulation with
FHR changes. When compared to low-dose vaginal misoprostol, a
balloon catheter may increase the risk of a caesarean section but
probably reduces the risk of hyperstimulation, with and without
FHR change as well as the risk of meconium-stained liquor.
Cervical ripening with a balloon seems to be more effective than
induction with oxytocin as it probably reduces the risk of caesare-
an section and the risk of fetal distress. For women with a previous
caesarean section, a balloon catheter may slightly reduce the risk
of a caesarean section when compared to oxytocin.
There is no evidence of a benefit of a double balloon over a single
balloon. For the comparisons of a laminaria tent or extra-amniotic
space infusion (EASI) with other induction methods, results were
mostly too imprecise to make a valid judgement.
There was no evidence of clear benefit for a mechanical method
combined with PGE2 to PGE2 alone or to oxytocin. When a mechan-
ical method is combined with misoprostol or with oxytocin, it may
reduce the risk of neonatal intensive care unit (NICU) admissions
when compared to misoprostol alone. However, regarding other
perinatal outcomes for both comparisons, there was no evidence
for a difference in serious neonatal morbidity or perinatal death,
Apgar scores less than seven at five minutes or fetal distress.
The advantages of mechanical methods are their wide availability
and the low cost of the devices, especially Foley catheters. Storage
and preservation of mechanical devices is less problematic than
PGE2, which should be kept refrigerated. However, special atten-
tion should be paid to contraindications (e.g. low-lying placenta)
when inserting these devices.
Implications for research
There seems to be sufficient data to make a valid judgement on
the safety and effectiveness of balloon in comparison to vaginal
PGE2. More research on this comparison does not seem warranted
as moderate-quality evidence suggests a balloon is equally effec-
tive, but has a better safety profile. GRADE assessment for impor-
tant outcomes for this comparison can never be assessed as 'high
quality' because blinding is not possible and this is the reason the
evidence being downgraded from high-quality evidence to moder-
ate-quality evidence for key outcomes. Future research could fo-
cus on comparing a balloon with low-dose misoprostol or a com-
bination of mechanical methods with low-dose misoprostol. More
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studies evaluating mechanical methods for induction of labour in
women with a history of prior caesarean section could be of benefit.
To facilitate future meta-analyses of labour induction, we recom-
mend the standardisation of outcomes through core outcome sets.
This would minimise the reporting challenges experienced in this
review, where many included studies reported outcomes in a high-
ly varied manner, resulting in many being excluded from analyses.
Also, while there were many large randomised trials included in
this review, only a few reported on rare but serious adverse events
or included women's views regarding induction methods. As safe-
ty aspects and maternal satisfaction become more and more im-
portant with rising induction rates, large multicentre studies focus-
ing on safety aspects for the neonate and maternal satisfaction,
could help clinicians make a more carefully balanced choice when
arranging an induction of labour.
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Characteristics of included studies [ordered by study ID]
 
Methods RCT
Participants Inclusion: life singleton pregnancy, cephalic presentation, intact membranes, > 37 weeks, indication for
IOL, reactive non stress test. unfavourable cervix (BS < 6)
Exclusion: IFD, no prenatal care in study centre, contraindication for vaginal delivery
Interventions A: Foley catheter: 16F, 30 mL (n = 70), max 12 hours, if necessary another Foley for 12 hours (n = 70)
B: Foley catheter (16F, 30 cc) + vaginal misoprostol 25 ug every 6 hours(n = 70), max dose 100 ug (4 giHs)
(n = 70)
C: Vaginal misoprostol alone 25 ug every 6 hours (n = 70) max dose 100 ug (4 giHs) (n = 70)
Max induction time all groups: 24 hours
Outcomes Vaginal delivery rate, time interval to achieve favourable cervix, induction delivery interval, oxytocin
use, AS at 1 and 5 minutes, asphyxia, NICU admission, uterine tachysystole, uterine hypertonus, hyper-
stimulation, uterine rupture, FHR abnormalities
Notes Setting: Ekiti State University Teaching tertiary healthcare institution; referral centre for primary and
secondary healthcare facilities, 2400 deliveries annually, Nigeria
Study period: 1 September, 2014 and 31 August, 2015.
Funding: no grant or fund was received
Declaration of interest: no conflict of interest
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Blocked randomisation using random table computer-generated numbers
Allocation concealment
(selection bias)
Low risk Sealed opaque envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not mentioned
Aduloju 2016 
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Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT not mentioned, but is probably the case looking at Figure 1. no missing da-
ta or cases.
Selective reporting (re-
porting bias)
Low risk All pre-specified outcome measures were reported,
Other bias Low risk No other bias detected
Aduloju 2016  (Continued)
 
 
Methods RCT
Participants Inclusion: postdate pregnancy (> 40 weeks) singleton gestation, intact membranes, cephalic fetal BS ≤
4
Exclusion: previous caesarean deliveries, EFW > 4000 g, non-reassuring fetal conditions, ruptured mem-
branes, placenta previa, malpresentation
Interventions Foley catheter (n = 39), 18 F, filled with 50 mL
Cook balloon (n = 39), filled with 80/80 mL
Max of 12 hours of priming
Outcomes Cervical ripening and BS after 12 hours, VAS for catheter insertion, catheter insertion (easy, moderate
or difficult), VAS for patient satisfaction after birth, insertion expulsion time, insertion amniotomy time,
insertion delivery time and mode of delivery. Abnormal fetal presentation, cord prolapse, bleeding re-
lated to catheter insertion that required removal of the catheter and AS
Notes Setting: Gynaecology, Suez Canal University
Hospital, Egypt
Study period: March 2013 to April 2014
Funding: not mentioned
Declaration of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Shuffling 78 envelopes, 1:1
Allocation concealment
(selection bias)
Low risk Sealed envelopes, opaque?
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not described
Ahmed 2016 
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Incomplete outcome data
(attrition bias) 
All outcomes
High risk ITT not mentioned, 2 women excluded because of failed placement. no miss-
ing data mentioned
Selective reporting (re-
porting bias)
High risk Pre-specified outcomes bleeding after insertion, cord prolapse and abnormal
fetal presentation not described in results
Other bias Low risk No other bias detected
Ahmed 2016  (Continued)
 
 
Methods RCT
Participants Inclusion: > 37 weeks, singleton fetus, cephalic, BS ≤ 6
Exclusion: rupture of membranes, regular uterine contractions (3 or more contractions per 10 minutes),
prior uterine surgery, multiple gestations, malpresentation, contraindication to PGs, non-reassuring
FHR tracing, vaginal bleeding, fetal demise, anomalous fetus, or any contraindication to vaginal deliv-
ery
Interventions Foley catheter + misoprostol: (n = 100) 30 mL balloon, filled with 60 mL, gentle traction, max 24 hours
and misoprostol vaginal 4-hourly with a max of 6 doses,
Misoprostol (n = 100) 25 ug vaginally, 4-hourly with a max of 6 doses
Outcomes Time from placement of the first misoprostol dose to delivery, time to active phase (6 cm or greater),
time from active phase to delivery, caesarean delivery rate, uterine tachysystole, estimated blood loss,
chorioamnionitis, cord blood pH, 5-minute AS, NICU admission.
Notes Setting: from the Department of Obstetrics and Gynecology, Mount Sinai West Hospital, New York
Study period: September 2015 to July 2016
Funding: not described
Declaration of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated sequence
Allocation concealment
(selection bias)
Low risk Sequentially-numbered opaque, sealed envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Al-Ibraheemi 2018 
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Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT analysis, no missing data or cases
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Low risk No other bias detected
Al-Ibraheemi 2018  (Continued)
 
 
Methods Randomised trial, random number table, blinding unclear.
Participants Grand multiparous women, BS 5 or less, singleton term pregnancy, intact membranes, cephalic presen-
tation, good fetal condition.
Exclusion: previous CS, contraindications for vaginal birth, suspected cephalopelvic disproportion, un-
explained antenatal haemorrhage.
Interventions Foley catheter 50 mL (72).
(PGE2) tablet 3 mg (75), 6-hourly.
Outcomes Route of delivery, change in BS, intrapartum complications, need for augmentation.
Notes Setting: Queen Alia military hospital, Amman, Jordan
Dates of study:September 2001 - August 2003
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random number table.
Allocation concealment
(selection bias)
Unclear risk No information provided.
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not described
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT nor reported, bu seems reasonable as the numbers in both groups are
equal to randomised numbers. missing outcome data mentioned.
Al-Taani 2004 
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Selective reporting (re-
porting bias)
Low risk All primary and secondary outcomes are reported as pre-specified.
Other bias Low risk No other bias detected
Al-Taani 2004  (Continued)
 
 
Methods RCT. No details were given on the method for concealment of the allocation.
Participants BS < 6, vertex, singleton, no previous CS.
Interventions PGE2 (Prepidil 0.5 mg) intracervical (59 women);
Foley 50 mL (60 women);
PGE2 (Prepidil 0.5 mg) and Foley 50 mL extra-amniotic (63 women).
Outcomes Uterine hyperstimulation, discomfort during the procedure, maternal and neonatal infection.
Notes Setting: not reported
Dates of study:between April and December 1992
Funding sources: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Only stated women were randomly allocated
Allocation concealment
(selection bias)
Unclear risk Unclear
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk ITT not mentioned, no missing data or cases reported
Selective reporting (re-
porting bias)
Unclear risk No outcomes pre-specified
Other bias Low risk No other bias detected
Allouche 1993 
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Methods RCT
Participants Inclusion: PROM, age ≥ 18 years, viable fetus, cephalic, singleton, GA > 34 weeks, < 3 cm dilation
Exclusion: multifetal gestation, a known anomalous fetus, malpresentation, latex allergy, unexplained
vaginal bleeding or contraindication to vaginal delivery (such as a placenta previa), antibiotics, previ-
ous uterine surgery, spontaneous labour
Interventions Foley catheter (n = 61) 16F, 30 mL balloon filled with 60 mL saline, traction applied (no max time de-
scribed), oxytocin started after 1 hour
Oxytocin alone directly (n = 68)
Oxytocin in both groups, started 2 mU/minute, max 30 mU/minute
Outcomes The primary outcome measure was time from start of induction to delivery. Secondary outcomes in-
cluded mode of delivery, tachysystole, chorioamnionitis, postpartum haemorrhage, neonatal AS, and
admission to the NICU.
Notes Setting: Mount Sinai Hospital, New York, USA
Study period: August 2014 to September 2016
Funding: not reported
Declaration of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated numbers
Allocation concealment
(selection bias)
Low risk Sequential numbered sealed, opaque envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk Modified ITT, (1 woman excluded who afterwards did not met the inclusion cri-
teria), no missing data or cases
Selective reporting (re-
porting bias)
Low risk All pre-specified outcome measures were reported in results
Other bias Low risk No other bias detected
Amorosa 2017 
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Methods RCT. Computer-generated sequence. No details were given on the method for concealment of the allo-
cation.
Participants Singleton vertex term pregnancies with intact membranes, BS < 5 without previous CS.
Interventions Atad ripening device (35 women);
PGE2 intravaginal tablets 3 mg (30 women); oxytocin (30 women).
Outcomes Need for another method, CS, change in BS.
Notes Also reported as abstract (Abramovici 1994).
Setting: Israel
Study period: not reported
Funding: not reported
Declarations of interest: J Atad has a patent licensing arrangement for Atad ripening device and thus
has the potential gain from its sales
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer random-generated allocation list
Allocation concealment
(selection bias)
Unclear risk Unclear
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk No ITT reported, but seems reasonable as numbers in tables are equal to ran-
domised numbers, no missing data or cases
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes reported
Other bias Low risk No other bias detected
Atad 1996 
 
 
Methods RCT. Random number tables, stratified for parity. No details were given on the method for concealment
of the allocation.
Participants Women with unfavourable cervix (BS < 7).
Interventions Lamicel (40 women);
Bagratee 1990 
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(PGE2) (2 mg tablet) (40 women).
After 6 hours, oxytocin was started in both groups.
Outcomes CS, hyperstimulation, fetal distress, perinatal death.
Notes No outcome reported in subgroups.
setting: king Edward VIII hospital, Durban, South Africa
Study period: for 6 months, no exact dates reported
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random number tables
Allocation concealment
(selection bias)
Unclear risk Unclear, not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
High risk No ITT mentioned, in table 4 cases missing, not clear why.
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes reported
Other bias Low risk No other bias detected
Bagratee 1990  (Continued)
 
 
Methods RCT
Participants Inclusion criteria: GA ≥ 37 weeks, parity 1 to 3, singleton pregnancy with a vertex presentation, BS less
than 5) and intact membranes.
Exclusion criteria: previous CS, lack of prenatal care, contraindication for vaginal delivery
Interventions Foley catheter (n = 150): 22 F, 80 mL balloon (max 18 hours)
Dinoproston (n = 150): 3 mg tablets (every 8 hours, max 2 giHs)
Barda 2018 
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Outcomes Start induction to active labour (4 cm dilatation and 80% effacement), labour within 24 hours, CS rate,
excessive haemorrhage, chorioamnionitis, non-reassuring FHR, fetal pH, NICU admission, early neona-
tal sepsis
Notes Setting: Edith Wolfson Medical Centre, Holon, Israel
Study period: June 2015 - July 2016
Funding: not reported
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Random assigned; not described how this was done. In trial registration =>
parallel assignment.
Allocation concealment
(selection bias)
Unclear risk Random assigned; not described how this was done. In trial registration =>
parallel assignment.
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk ITT, no tables available, so incomplete data can not be judged, no missing data
described
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Unclear risk Full text is an accepted manuscript without tables, therefore risk of bias can-
not properly be determined
Barda 2018  (Continued)
 
 
Methods RCT. Blocks of 10 women. No other details were given on the method for randomisation and on con-
cealment of the allocation.
Participants Singleton vertex term pregnancies with intact membranes, BS < 6.
Interventions Foley catheter inflated with 40 mL of water (50 women); PGE2 intracervical gel 0.5 mg every 24 hours. (n
= 50?)
Outcomes Vaginal delivery not achieved within 24 hours, CS, perinatal deaths, cervix unchanged after 24 hours,
postpartum haemorrhage.
Notes Setting: Charles Nicolle Hospital, Tunis
Dates of study: not reported
Benzineb 1996 
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Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Only reported women were random allocated in blocks of 10
Allocation concealment
(selection bias)
Unclear risk Unclear. not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk ITT not mentioned, no missing data or cases reported
Selective reporting (re-
porting bias)
Unclear risk Outcomes not pre-specified
Other bias Low risk No other bias detected
Benzineb 1996  (Continued)
 
 
Methods Randomised trial.
Participants Term, singleton pregnancy BS 4 or less, medical indication for labour induction.
Interventions PGE 2 gel 2 mg (27).
Double balloon catheter (26)
combined (24)
Outcomes Change in BS, need for oxytocin augmentation.
Notes Outcomes of interest not reported.
Setting: Israel
Study period: not reported
Funding: not reported
Declarations of interest: not reported
Risk of bias
Biron-Shental 2004 
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Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated sequence.
Allocation concealment
(selection bias)
Unclear risk Not mentioned.
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not described
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Brief communication, for the reported data no missing. Incomplete outcome
data not further mentioned in this report.
Selective reporting (re-
porting bias)
Unclear risk Our outcomes of interest are not reported here, main outcome is change in BS.
Other bias Unclear risk Hard to say, very short report, our outcomes of interest not mentioned, not
clear how sample size was calculated.
Biron-Shental 2004  (Continued)
 
 
Methods RCT. Randomisation by drawing a blank envelope from a stack of 50 identical envelopes containing the
group allocation.
Participants Vertex, intact membranes, BS < 5, no previous CS.
Interventions Dilapan (polyacrilonitrile hydrogel) inserted in the cervix, up to 6 sticks (23 women); Laminaria inserted
in the cervix, as many as possible (18 women).
Outcomes CS.
Notes Results for a 3rd group of women with favourable cervix treated with oxytocin are presented. These
women are not be included in the analysis, as they were not randomly allocated to the intervention.
Setting: Michael Reese hospital, Chicago, USA
Study period:January 1987 to January 1988
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Shuffling envelopes
Blumenthal 1990 
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Allocation concealment
(selection bias)
Low risk Women choose from stack of all blank, identical envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
High risk ITT not reported. no explanation what happened to the rest of the randomised
women
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes reported
Other bias Low risk No other bias detected
Blumenthal 1990  (Continued)
 
 
Methods RCT
Participants Inclusion criteria: single, live fetus, cephalic, presentation,reassuring fetal health assessment, GA be-
tween 26 and 42 weeks, Maternal age 18 and above, BS less than 5
Exclusion criteria: multiple gestation (twins, triplets, quadruplets), fetal demise
Fetal malpresentation, EFW less than 500 g or more than 4000 g, placenta previa, non-reassuring fetal
health assessment
Maternal asthma, Latex allergy, spontaneous labour, other contraindication to vaginal delivery
Interventions Balloon: (n = 34): 40 mL, under traction, max 6 hours.
PGE2 vaginal (36): prepidil gel in fornix posterior, no oxytocin in 6 hours after gel is applied
balloon and PGE2 (31): 40 mL, under traction. prepidil gel inserted through catheter.
Outcomes CS
Notes Grey literature: not published. primary outcomes reported in trial registration
Setting: USA
Study period: July 2010 - February 2013
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Browne 2011 
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Random sequence genera-
tion (selection bias)
Low risk Randomisation envelopes prepared by statisticians at the University of South
Carolina Arnold School of Public Health. The investigator was given the next
sequentially-numbered study envelope by the patient's nurse.
Allocation concealment
(selection bias)
Low risk Sealed envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
High risk ITT not reported. case missing for relevant outcome (CS)
Selective reporting (re-
porting bias)
High risk Only primary outcome en adverse events reported
Other bias Unclear risk Study not published, not clear why.
Browne 2011  (Continued)
 
 
Methods RCT
Participants Inclusion: singleton, viable gestation (≥ 24 weeks), cephalic, intact membranes, BS < 7
Exclusion: malpresentation, multifetal gestation, spontaneous labour, contraindication to PGs, fetal
growth restriction, anomalous fetus, fetal demise, previous CS, or other uterine surgery.
Interventions Foley + misoprostol (n = 56): 25 mcg vaginal misoprostol every 4 hours AND Foley catheter filled with 60
mL saline; taped to the inner thigh under gentle traction.
misoprostol alone (n = 61): 25 mcg vaginal misoprostol every 4 hours
Not mentioned for how long misoprostol and/or Foley was given in total.
Outcomes Induction to delivery time, mode of delivery, tachysystole, postpartum haemorrhage (> 500 cc),
chorioamnionitis, neonatal AS and NICU admission.
Notes Setting: USA
Study period: January 2011 to April 2012
Funding: not reported
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Carbone 2013 
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Random sequence genera-
tion (selection bias)
Low risk Computer-generated sequence
Allocation concealment
(selection bias)
Low risk Opaque envelopes, not stated if these were sequential numbered
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT, no missing data or cases
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Low risk No other bias detected
Carbone 2013  (Continued)
 
 
Methods RCT. No details were given on the method for concealment of the allocation.
Participants Singleton term pregnancies, BS < 6.
Interventions PGE2 intracervical gel and intracervical Foley catheter inflated with 50 cc (78 women);
PGE2 intracervical gel (68 women).
Outcomes CS.
Notes Abstract only.
Setting: USA
Study period: not reported, 11-month period
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Only reported it was a RCT
Allocation concealment
(selection bias)
Unclear risk Not reported
Casey 1995 
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Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Too little information to judge
Selective reporting (re-
porting bias)
Unclear risk Too little information to judge
Other bias Unclear risk Abstract only
Casey 1995  (Continued)
 
 
Methods RCT
Participants Inclusion: singleton, cephalic, fetal growth restriction, ≥ 34 weeks.
Exclusion: previous caesarean deliveries, uterine surgery, a multiple pregnancy, ruptured membranes,
a BS > 6, severe fetal growth restriction, abnormal FHR prior to induction, pre-partum haemorrhage.
Interventions 1. Foley catheter (n = 54) 16F, 30 mL, catheter was removed after 12 hours.
2. Vaginal misoprostol (n = 46) every 6 hours, 25 mcg, max 3 doses
Outcomes Hyperstimulation with FHR changes, BS at AROM, duration of induction to delivery, vaginal delivery
within 12 hours and 24 hours, CS, oxytocin, chorioamnionitis, antibiotics, NICU admission, AS < 7 at 5
minutes, patients and caregiver satisfaction (VAS score)
Notes Setting: tertiary care teaching hospital in South India with approximately 13,000 deliveries per year.
Study period:December 2011 to June 2012.
Funding: not stated
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated sequence, block randomisation
Allocation concealment
(selection bias)
Low risk Sequentially-numbered opaque, sealed envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
Unclear risk Not feasible due to nature of intervention
Chavakula 2015 
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All outcomes
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not stated
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT analysis, no missing data or cases
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Low risk No other bias detected
Chavakula 2015  (Continued)
 
 
Methods RCT. Random number table, no details on the method of concealment of the allocation.
Participants Singleton vertex presentation, unfavourable cervix (BS < 6).
185 women recruited (90 in Dilapan group, 95 in PGE2 group).
Interventions Dilapan group: 4 dilators.
PGE2 Gel (Prepidil): 0.5 mg.
In both groups, ripening was followed by rupture of membranes and oxytocin after 12 hours.
Outcomes Need for oxytocin, CS, instrumental delivery, uterine rupture, uterine hyperstimulation, admission to
NICU, perinatal death.
Notes Setting: National University hospital, Singapore
Study period: not reported
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random number table
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Chua 1997 
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Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT not mentioned but seems reasonable as numbers in tables are equal to
randomised numbers, no reporting of missing cases or outcomes
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes reported
Other bias Low risk No other bias detected
Chua 1997  (Continued)
 
 
Methods RCT
Participants Inclusion: singleton gestation, vertex presentation, BS ≤ 6, intact membranes, GA ≥ 34 weeks, reassur-
ing FHR tracing
Exclusion: Women with antepartum bleeding, intrauterine fetal death, previous uterine scars, known
allergy to latex, placenta previa, contraindication to vaginal delivery
Interventions 24-hour Foley (n = 133): 18F, 50cc, 24 hours
12-hour Foley (n = 132): 18F, 50cc, 12 hours
PGE2 vaginal insert 10 mg (n = 132): vaginal fornix, 24 hours
Outcomes vaginal delivery within 24 hours, improvement in BS after ripening, caesarean delivery, ripening-to-de-
livery interval, oxytocin administration, epidural request, neonatal outcomes.
Notes Setting:Obstetrics Department of University of Insubria, Varese, Italy.
Study period: July 2008 to June 2010
Funding: none reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated block randomisation
Allocation concealment
(selection bias)
Unclear risk Allocation not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
Low risk ITT, no missing data or cases.
Cromi 2011 
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All outcomes
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Low risk No other bias detected
Cromi 2011  (Continued)
 
 
Methods RCT
Participants 210 patients.
Inclusion: singleton gestation, vertex presentation, BS ≤ 6, intact membranes, GA > 34 weeks, and reas-
suring fetal heart tracing on admission.
Exclusion:antepartum bleeding, intrauterine fetal death, prior uterine scars, positive vaginal or rectal
group B streptococcus screening cultures, placenta previa, other contraindication to vaginal delivery.
Interventions Double-balloon catheter (n = 105): inflated with 50 mL in either balloon. The double-balloon device was
leH in place for approximately 12 hours.
Dinoprostone vaginal insert 10-mg controlled-release (n = 105): in the vaginal fornix, max 24 hours
Outcomes Vaginal delivery within 24 hours, improvement in the BS after ripening, caesarean delivery rates, ripen-
ing-to-delivery interval, oxytocin administration, epidural request, NICU admission, AS < 7 at 5 minutes,
umbilical artery pH < 7.00.
Notes Setting: University of In-subria, Varese, Italy
Study period: October 2010 to October 2011
Funding: not reported
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated randomisation scheme
Allocation concealment
(selection bias)
Low risk Concealment by keeping random allocation sequence in a file cabinet with ac-
cess restricted to research staI?
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
High risk Not an ITT analysis, women excluded after failed placement balloon or need
for PGE2 gel after suppository expulsion.
Cromi 2012 
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Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in result
Other bias Low risk No other bias detected
Cromi 2012  (Continued)
 
 
Methods RCT, computer-generated block randomisation 4 and 6, consecutively numbered envelopes.
Participants Nulliparous women GA 28 or more weeks, BS < 6, intact membranes, singleton, cephalic presentation,
Exclusion: previous uterine surgery, non-reassuring FHR, latex allergy, contraindication to vaginal birth.
Interventions Foley 30 cc + concurrent oxytocin (83 patients analysed).
Misoprostol 25 mcg intravaginally 4-hourly, oxytocin augmentation after ripening. (79 patients
analysed.)
Outcomes Primary: CS
Secondary: tachysystole, hyperstimulation, abnormal FHR tracing, intrapartum and postpartum fever,
use of antibiotics, estimated blood loss, blood transfusions, AS, neonatal resuscitation, admission to
ICU, meconium aspiration, sepsis, death.
Notes Power analysis showed 266 patients were to be included, 173 were randomised. Study was stopped be-
cause principle investigator moved to other hospital. 11 patients were excluded from analysis, either
received other treatment, or incomplete data.
Setting: North Caroline Women's hospital and WakeMed hospital, North Carolina, USA
Study period: June 1999 to April 2001
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated sequence.
Allocation concealment
(selection bias)
Low risk Consecutively numbered envelopes.
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not described
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk 9 patients had incomplete records (4 and 5 in both groups), they were exclud-
ed.
Culver 2004 
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2 patients (1 in every group) who did not receive the treatment were excluded,
but otherwise ITT.
Selective reporting (re-
porting bias)
Low risk All pre-specified outcome measures are reported.
Other bias High risk Recruitment goal was not reached, because PI moved to another institution.
Culver 2004  (Continued)
 
 
Methods Randomised prospective study, randomisation method unclear.
Participants Singleton live fetus in cephalic presentation, 33-42 weeks GA, intact membranes, BS < 4
Exclusion: APH, scarred uterus, low-located placenta, cervicovaginal infection, history of cardiac dis-
ease, glaucoma, convulsive disorder, asthma, jaundice.
Interventions Foley catheter 30 mL 12 hours, followed by oxytocin (n = 50).
PGE2 gel 0.5 mg endocervically oxytocin augmentation after 12 hours (n = 50).
Outcomes Bischop score after 12 hours, percentage of subjects entering spontaneous labour, insertion-expulsion
interval Foley, induction-delivery interval, amount of oxytocin used, mode of delivery, side effects.
Notes No power calculation, BS lower than most studies, no notes on method of randomisation
Setting: Nehru Hospital, PGIMER, Chandigarh, India
Study period: not reported
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk 'Randomised' method not described.
Allocation concealment
(selection bias)
Unclear risk 'Randomised' method not described.
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not described
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk Although ITT not mentioned, it seems ITT was used. no missing cases or data
Dalui 2005 
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Selective reporting (re-
porting bias)
Low risk All pre=specified data are reported, except for expulsion interval of Foley
catheter (this is not an outcome of interest for this review).
Other bias Low risk No other bias detected
Dalui 2005  (Continued)
 
 
Methods RCT
Participants Inclusion: full-term singleton gestation, cephalic presentation, indication for IOL. BS < 6.
Exclusion: rupture of membranes, antepartum bleeding, placenta praevia, previous induction or pre-
induction agent during the pregnancy.
Interventions Foley catheter (n = 50): 16 F with 30 mL balloon, traction applied. no max hours described.
Misoprostol vaginal (n = 54): 25 ug post fornix, every 4 hours max 8 doses.
Dinoprostone vaginal gel (n = 52), 2 mg, once every 6 hours, max of 3 doses
Outcomes Change in BS, total time for induction, delivery route, uterine tachysystole (defined as 6 contractions in
10 minutes, in 2 consecutive 10 minutes periods), uterine hypertonus (contraction lasting longer than 3
minutes), subject comfort as women were asked to evaluate their discomfort on a visual scale from 0 to
10.
Notes Setting: CSM Medical University (India).
Study period: not reported, 1 year duration
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated random allocation numbers
Allocation concealment
(selection bias)
Low risk Consecutive, opaque envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
High risk As treated analysis (2 or 4 exclusions? (158 cases analysed, but total of includ-
ed patients makes 156)
Primary outcome: unclear how many women in Foley were analysed, in com-
parison groups 4 cases missing without explanation
Deo 2012 
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Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Low risk No other bias detected
Deo 2012  (Continued)
 
 
Methods RCT
Participants Inclusion: full-term singleton gestation, cephalic presentation, indication for IOL. BS < 6.
Exclusion: rupture of membranes, antepartum bleeding, placenta praevia, previous induction or pre-
induction agent during the pregnancy.
Interventions Foley catheter (n = 100): 16 F with 30 mL balloon, traction applied. no max hours described.
dinoprostone vagina gel (n = 104), 2 mg, once every 6 hours, max of 3 doses
Outcomes post induction BS at 6 and 13 hours,
Notes Abstract only, no outcomes of interested reported
Setting: KGMU Lucknow India
Study period: not reported
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Only described women were randomly allocated, no more information avail-
able
Allocation concealment
(selection bias)
Unclear risk Only described women were randomly allocated, no more information avail-
able
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk ITT not reported, too little information to judge
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to judge
Other bias Unclear risk Abstract only, too little information to judge risk of bias
Deo 2013 
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Methods RCT
Participants Inclusion: primigravida > 37 weeks of gestation, singleton pregnancy, cephalic presentation BS ≤ 3, In-
tact membranes
Exclusion: multiple pregnancy, malpresentation, absent membranes, APH, medical disease, e.g. heart
disease, renal disease
Interventions Intracervical Foley (n = 200): if BS < 7 after 6 hours, PGE2 was given
PGE2 gel vaginal (n = 200), dose repeated after 6 hours
Failure of induction was declared if patient failed to go in active phase of labour within 24 hours of in-
duction
Outcomes Improvement of BS, induction-delivery interval, mode of delivery and feto-maternal outcomes
Notes Setting: India
Study period:July 2005 to January 2008
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Only reported women were randomly assigned
Allocation concealment
(selection bias)
Unclear risk Allocation concealment not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT. no missing cases or data. no women excluded
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes reported
Other bias Low risk No other bias detected
Deshmukh 2011 
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Methods RCT, stratified for parity
Participants Inclusion: indication for induction, BS < 6
Interventions Foley catheter with oxytocin (n = 93)
Foley catheter with intravaginal misoprostol (n = 84)
Intravaginal misoprostol (n = 87)
Outcomes Delivery within 24 hours, CS rate, maternal or fetal complications
Notes Abstract only, no information about dosage misoprostol
Setting: UK
Study period: October 2001 to October 2004
Funding: no information
Declaration of interest: no information
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Randomisation not described
Allocation concealment
(selection bias)
Unclear risk No information
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk No information
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk ITT not mentioned, too little information to judge
Selective reporting (re-
porting bias)
Unclear risk Pre-specified outcome CS reported, too little information to judge
Other bias Unclear risk Abstract only, too little information to judge risk of bias
Dionne 2011 
 
 
Methods RCT
Participants Inclusion criteria: GA > 36 weeks, live singleton fetus in cephalic presentation, unfavourable cervix (less
than 3 cm dilated; if 2 cm dilated, less than 80% effaced).
Edwards 2014c 
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Exclusion criteria: < 18 years, no informed consent in English, > 1 contraction/5 minutes, ruptured
membranes, a prior caesarean delivery or any other prior uterine incision, a temperature of 38°C or
higher, lethal fetal anomalies, placenta previa, other contraindication to vaginal delivery, suspected
placental abruption or undiagnosed bleeding, a category II or III FHR pattern, HIV infection or any other
immune dysfunction, an allergy to latex or dinoprostone, previous attempt of cervical ripening.
Interventions Foley catheter (n = 185): 16F, 30 mL, minimal tension, removed after 12 hours
Dinoprostone vaginal insert (n = 191): removed after 12 hours
Outcomes Induction to delivery time, (vaginal) delivery within 12 hours, (vaginal) delivery within 24 hours,
tachysystole, clinical chorioamnionitis, endometritis, other postpartum complications, caesarean de-
livery, early neonatal outcomes
Notes Setting: multicentre, USA
period: July 2010 to February 2013
Funding: not reported
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Allocated by an online randomisation system 1 to 1
Allocation concealment
(selection bias)
Low risk Allocation web-based
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT analyses reported, but women who did not deliver and went home were
excluded (5 to 77. Patients with missing values for arterial cord pH level. prop-
erly described how this was dealt with
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Low risk No other bias detected
Edwards 2014c  (Continued)
 
 
Methods RCT
Participants Inclusion criteria: singleton pregnancy, cephalic presentation, GA > 28 weeks and the BS < 6.
El Khouly 2017 
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Exclusion criteria: contraindication vaginal delivery, EFW > 4500 g, a previous uterine scar, clinically sig-
nificant cervical or vaginal infection, chorioamnionitis, unexplained vaginal bleeding, low-lying placen-
ta, abnormal cervical anatomy or cervical cerclage.
Interventions Foley catheter (n = 36): 18F, 30 mL, max of 12 hours
Foley catheter + oxytocin (n = 36): 18F, 30 mL balloon, oxytocin, Foley max of 12 hours)
Oxytocin alone (n = 36): increased by 2 mU/minute at 30-minute intervals until adequate uterine activi-
ty was maintained, max dose 32 mU/minute, AROM at 3 cm
Outcomes Duration and dose of required oxytocin, induction to delivery interval, mode of delivery and reason (in
case of CS), maternal and neonatal complications
Notes Setting: Menoufia University Hospital, Egypt
Study period: between January 2015 and February 2016.
Funding: no funding
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated sequence
Allocation concealment
(selection bias)
Low risk Sequentially-numbered opaque, sealed envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk Although ITT is not mentioned, figure 1 and results are plausible for ITT, all cas-
es analysed, no missing data described
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Low risk No other bias detected
El Khouly 2017  (Continued)
 
 
Methods RCT.
Participants Term or post-term, live, singleton fetus in cephalic presentation, intact membranes, BS < 6, not in
labour, medically indicated for labour induction.
Filho 2002 
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Exclusion criteria: multiple gestations, non-cephalic presentation, previous caesarean delivery or uter-
ine scar, rupture of membranes, antepartum bleeding, genital herpes infection, fetal death, placenta
previa or previous attempts to induce labour.
Interventions Misoprostol (n = 119): 25 mcg 6-hourly, max 4 doses.
Foley (n = 121): 30cc traction applied 24 hours followed by oxytocin.
Outcomes Induction-to-vaginal delivery time, deliveries within 24 hours, mode of delivery, uterine contraction ab-
normalities, puerperal infection or neonatal outcomes.
Notes Setting: Maternidade Monteiro de Morais, Recife, Brazil
Dates of study: between September 2000 and December 2001
Funding sources: financial support from CAPES
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated sequence.
Allocation concealment
(selection bias)
Low risk Consecutively numbered sealed opaque envelopes.
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not described
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk No loss to follow up, analysis ITT.
Selective reporting (re-
porting bias)
Low risk All pre-specified data reported.
Other bias Low risk No other bias detected
Filho 2002  (Continued)
 
 
Methods RCT
Participants Inclusion: multiparae, postdate (41+3), singleton, unfavourable cervix
Exclusion: not mentioned
Interventions Foley catheter + oxytocin (n = 66) (no more info available)
Garba 2016 
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Vaginal misoprostol (n = 70), (no more information available
Outcomes Mode of delivery, maternal and perinatal outcomes, induction to delivery interval, AS, maternal vital
signs, estimated blood loss.
Notes Setting: antenatal clinic at Aminu Kano Teaching Hospital, Nigeria
Study period: February to May, 2015
Funding: no funding
Declaration of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated sequence
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk ITT not reported, in table 4 there are cases missing, not reported why. no miss-
ing data reported
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Unclear risk All eligible patients where randomised. Inclusion rate of 100% of all eligible pa-
tients is doubtful
Garba 2016  (Continued)
 
 
Methods RCT, randomisation by sealed opaque envelopes, no mentioning of sequence.
Participants Singleton live pregnancy, GA 41 completed weeks, BS < 5, no contractions, AFI > 5, estimated fetal body
weight < 4500 g.
Exclusion: known hypersensitivity to PG, previous caesarean delivery or other uterine surgery, MBI > 30,
parity > 4, low-lying placenta.
Interventions Foley catheter 50 mL (n = 100).
Vaginal misoprostol 50 mcg 6-hourly, max 24 hours (n = 100). (group excluded because of high dose)
Oxytocin low dose protocol (n = 100).
Gelisen 2005 
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Spontaneous follow-up (n = 300). (not in analyses)
Outcomes CS rate, neonatal outcomes: meconium, arterial pH, acidaemia, admissions to NICU
secondary, tachysystole, hyperstimulation, fetal distress.
Notes Primary goals of study is to compare induction versus expectant management.
Setting: tertiary training centre in Turkey
Study period: not reported
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk 600 opaque envelopes, 1 was drawn every time.
Allocation concealment
(selection bias)
Low risk Opaque envelopes.
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Blinded assessment of fetal monitor strips. (to assess hyperstimulation).
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Not addressed, seems like all data complete.
Selective reporting (re-
porting bias)
Low risk All pre-specified outcome measures are reported.
Other bias Low risk No other bias detected
Gelisen 2005  (Continued)
 
 
Methods RCT
Participants Patients eligible for medical induction
Interventions Foley catheter + oxytocin (n = 526)
Low dose titrated oral misoprostol (n = 575) dose not mentioned in abstract
Outcomes Effectiveness, safety
Notes Abstract only
Gilson 2017 
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Setting: Rwanda
Study period: not reported
Funding: not reported
Declaration of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Randomisation not described
Allocation concealment
(selection bias)
Unclear risk No information
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk No information
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk ITT mentioned, not clear why groups are different in size.
Selective reporting (re-
porting bias)
Unclear risk Insufficient information
Other bias Unclear risk Abstract only, to little information to judge risk of bias
Gilson 2017  (Continued)
 
 
Methods RCT. No details were given on the method for concealment of the allocation.
Participants BS < 5. Women with a past history of CS were excluded.
Interventions Dilapan (4 tents) removed after 12 hours (27 women).
PGE2 intracervical gel 0.5 mg (1-2 doses) (26 women).
Outcomes CS.
Notes Abstract only
Setting: Russia
Dates of study: not reported
Funding sources: not reported
Declarations of interest: not reported
Glagoleva 1999 
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Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Only reported women were randomly assigned.
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Insufficient information to judge
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to judge
Other bias Unclear risk Abstract only, insufficient information to judge risk of bias
Glagoleva 1999  (Continued)
 
 
Methods RCT
Participants Inclusion: singleton pregnancy, cephalic, cervix unfavourable (MBS < 6), 40 weeks and 6 days
Exclusion: multiple pregnancies, malpresentation, previous CS or any contraindication for normal de-
livery or misoprostol, prior intervention for ripening of the cervix, non-reactive CTG after fetal acoustic
stimulation test.
Interventions Oral misoprostol (n = 74) 25 ug, every 4 hours, max of 2 giHs
Foley catheter (n = 78) max 24 hours
Outcomes Modified BS ≥ 6 day 2 after the intervention; Induction to delivery interval, mode of delivery, side ef-
fects of misoprostol (only reported in trial register)
Notes Setting: Academic Obstetric Unit, Teaching Hospital, Mahamodara, Galle, India
Study period: January 2011 to March 2012
Funding: not reported
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Goonewardene 2014 
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Random sequence genera-
tion (selection bias)
Low risk Computer-generated sequence, block randomisation, stratified for parity
Allocation concealment
(selection bias)
Low risk Sequentially-numbered opaque, sealed envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
High risk ITT not mentioned, no FIgure 1, cases excluded for some selective outcomes
because of spontaneous labour after intervention, no missing data reported.
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results, except secondary out-
come 'side effects misoprostol' not reported.
Other bias Low risk No other bias detected
Goonewardene 2014  (Continued)
 
 
Methods RCT. Computer-generated sequence. Opaque, sealed, sequentially numbered envelopes.
Participants Singleton, vertex presentation, intact membranes. Unfavourable cervix (< 2 cm dilated and effacement
< 75%). Exclusion: bleeding, labour, asthma. prior vertical uterine incision, acute fetal compromise
Interventions Laminaria and IV oxytocin: as many laminaria as possible were kept for 12 hours, unless expelled or
membranes ruptured. IV oxytocin was simultaneously given (165 women);
EASI + IV oxytocin: Foley catheter balloon filled with 30 mL of water followed by saline infusion 30 mL/
hour. IV oxytocin was simultaneously given (169 women);
PGE2 intracervical gel 0.5 mg/6H, max 2 doses. IV oxytocin was started if not in labour after 2 doses of
PGE2 (110 women).
Outcomes CS, delay to delivery, delivery within 24 hours, infections, haemorrhage.
Notes After interim analysis, the authors stopped recruiting in the PGE2 group. 68 protocol violations, but ITT
analysis was conducted.
Setting: University of Alabama and Cooper Green Hospitals Birmingham, Alabama
Dates of study: January 1994 to August 1997
Funding sources: UpJohn Pharmaceuticals provided funds to purchase study drugs
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Guinn 2000 
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Random sequence genera-
tion (selection bias)
Low risk Computer-generated random number table
Allocation concealment
(selection bias)
Low risk Opaque sealed envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT
Selective reporting (re-
porting bias)
Unclear risk All pre-specified outcomes reported for laminaria and EASI
Other bias Unclear risk After interim analysis, the authors stopped recruiting in the PGE2 group.
Guinn 2000  (Continued)
 
 
Methods RCT
Participants Uncomplicated primipara with singleton pregnancies who underwent IOL at 40 weeks + 5 days
Interventions PGE2 intracervical (72)
Foley (73)
Outcomes Change in mean MBS, uterine hyper-stimulation, Broncho-constriction, nausea and vomiting, postpar-
tum haemorrhage and maternal fever, meconium at membrane rupture, AS at 5 minutes and PBU ad-
mission
Notes Abstract only
Setting: Ward 5, Teaching Hospital, Kandy, India
Study period: not reported
Funding: not reported
Declaration of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Gunawardena 2012 
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Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk ITT not mentioned, no missing data or cases reported
Selective reporting (re-
porting bias)
Unclear risk Maternal and neonatal adverse outcomes were not given in numbers
Other bias Low risk No other bias detected
Gunawardena 2012  (Continued)
 
 
Methods RCT
Participants Inclusion: singleton pregnancy, > 37 weeks, indication to induce birth, BS < 2 cm, term date set by US
before week 21
Exclusion: IUFD, fetal malformations, low lying placenta, rupture of membranes, no understanding of
Norwegian language
Interventions Foley catheter (n = 90), 16-19 hours
Cook double balloon (n = 88), 16-19 hours
Outcomes Cervix dilatation ≥ 3 cm after removal or active labour
Notes Abstract only
Setting: Haukeland university hospital, Bergen, Norway
Study period: March 2010 - January 2011
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Randomisation not described
Allocation concealment
(selection bias)
Unclear risk No information
Haugland 2012 
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Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Double-blind, says in the protocol that participants and outcome assessor will
be blind to allocated treatment, but not clinicians
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Double-blind, in the study protocol says participant and outcome assessor will
be blind to allocated treatment
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk ITT not described mentioned, to little information to judge
Selective reporting (re-
porting bias)
Unclear risk Insufficient information
Other bias Unclear risk Abstract only, too little information to judge risk of bias
Haugland 2012  (Continued)
 
 
Methods RCT. No details were given on the method for concealment of the allocation.
Participants 28 women in the comparison between Dilapan and PGE2, with a total of 39 women recruited (15 Dila-
pan group, 13 PGE2 group, 11 amniotomy).
Interventions Dilapan versus PGE2, no details on dosage provided.
Outcomes CS, hyperstimulation, nausea.
Notes Abstract only.
Setting: UK
Study period: not reported
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
Unclear risk Not reported
Hay 1995 
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All outcomes
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Insufficient information to judge
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to judge
Other bias Unclear risk Abstract only
Hay 1995  (Continued)
 
 
Methods RCT
Participants Singleton vertex term pregnancies, BS < 5
Interventions EASI 30 to 60 mL/hour infusion (43 women)
PGE2 0.5 mg intracervical (42 women)
Outcomes CS, instrumental delivery, painful contractions, vaginal delivery achieved within 12 to 24 h0urs.
Notes Setting: County hospital of Ekinstuna, Sweden
Study period: November 1990 to November 1995
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Only reported women were randomised using sealed envelopes
Allocation concealment
(selection bias)
Low risk Sealed envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk ITT not mentioned, women delivered by CS and women with quote: “ unsuc-
cessful” treatment were excluded for some of the outcome measures. no miss-
ing cases of missing data for outcomes of interest.
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes reported
Hemlin 1998 
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Other bias Low risk No other bias detected
Hemlin 1998  (Continued)
 
 
Methods RCT
Participants Inclusion: women ≥ 18 years gestational > 37 weeks requiring IOL with a cervical preparation procedure
Exclusion: unsuitable for outpatient management, unsuitable for randomisation to either PGE2 (e.g.
previous CS) or catheter use (e.g. latex allergy), or prior attempted IOL in this pregnancy, ruptured
membranes, regular uterine contractions, multiple pregnancy or non-vertex presentation, unable to
give informed consent
Interventions Foley catheter (n = 50): 30 mL, slight traction, spigot inserted to occlude the lumen, PCM 1 g/60 mg
codeine, 20 mg temazepam., went home. Next morning AROM or priming by choice of clinician (n = 50)
PG gel (n = 51): (2 mg nulliparous – 1 mg multi parous), fornix posterior, repeated if necessary after 6
hours (1 mg), PCM 1 g/60 codeine, temazepam 20 mg, next morning AROM or priming by choice of clini-
cian
Outcomes Delivering vaginally within 12 hours of admission to Delivery Unit; total inpatient hours from induc-
tion to delivery, syntocinon for induction or augmentation of labour, mode of delivery, vaginal deliv-
ery within 24 hours of insertion of Foley catheter or first dose PGE2 gel, Induction to delivery interval,
i.e. time from commencement of cervical ripening to delivery, delivery within 24 hours of insertion of
Foley catheter or first dose PGE2 gel, requirement for second method of cervical ripening or (in Prostin
group) 3rd dose of PG, patient satisfaction using questionnaire created for purposes of this study, re-
turn to hospital (Foleys group) prior to planned readmission and not in labour, maternal febrile morbid-
ity, non-reassuring FHR trace, CS or instrumental delivery for fetal distress, Admission to newborn care,
AS 1 and 5 minutes, epidural.
Notes Setting: Australian metropolitan tertiary teaching hospital, Australia
Time period: June 2009 to December 2010
Funding: not reported
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random number table was performed prior to trial commencement.
Allocation concealment
(selection bias)
Low risk Sealed in sequentially-numbered, opaque envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Henry 2013 
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Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT, no missing data reported, no missing cases
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results, except secondary out-
come 'epidural' (pre specified in trial registration)
Other bias Low risk No other bias detected
Henry 2013  (Continued)
 
 
Methods RCT. Computer-generated sequence. Opaque, sequentially-numbered envelopes.
Participants Vertex, > 34 weeks, intact membranes, BS < 5. Exclusion of previous CS, cervicitis, macrosomia.
Interventions PGE2 (Prepidil) gel (17 women); PGE2 (Prepidil) and Dilapan (22 women).
Outcomes CS, instrumental delivery, painful contractions, vaginal delivery not achieved in 24 hours, uterine hy-
perstimulation, infection.
Notes Setting: University of Chicago, USA
Study period: August 1994 - May 1995
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated randomisation chart
Allocation concealment
(selection bias)
Low risk Sequential opaque envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk ITT not mentioned, no missing cases or data
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported
Other bias High risk Study ended prematurely (before power was reached) as Dilapan was removed
of the USA market
Hibbard 1998 
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Methods RCT
Participants Inclusion: ≥ 18 years, singleton, vertex, BS of ≤ 5, < 4 contractions in 10 minutes, category I fetal moni-
toring.
Exclusion: contraindication for vaginal delivery, planned or received exogenous PG administration, un-
explained vaginal bleeding, active herpes simplex, previous caesarean delivery, previous attempt at
IOL, non-English speaking
Interventions Single balloon 18F Foley, 30 mL, traction applied, max 12 hours
Double balloon, Cook 80 mL/80 mL, max 12 hours
Outcomes BS of > 6 at time of catheter removal, change in BS, time from catheter insertion to spontaneous expul-
sion or removal, mean time from catheter insertion to vaginal
delivery, vaginal delivery in 24 hours, the use of pharmacologic methods for further cervical ripening or
augmentation of labour, AROM, epidural use, mode of delivery, indications
for CS, chorioamnionitis, AS at 5 minutes < 7, meconium, NICU admissions
Notes Setting: University of Washington Medical Center Labor and Delivery, USA
Study period: January 2010 and November 2013
Funding: no funding by Cook
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Block randomisation, stratified for parity, not clear how this was done.
Allocation concealment
(selection bias)
Low risk Sequentially-numbered opaque, sealed envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk No ITT reported, most likely per protocol, missing data in baseline characteris-
tic, not in outcomes, no cases missing
Selective reporting (re-
porting bias)
Low risk All pre-specified outcome data reported
Other bias Low risk No other bias detected
Hoppe 2016 
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Methods RCT. No details on the method of randomisation or on concealment of the allocation.
Participants Term, unfavourable cervix (BS < 5).
Interventions Foley catheter placed above the internal os and inflated with 40 mL leH in place for a max of 16 hours
(56 women); intracervical PGE2 (0.5 mg), repeated if BS unfavourable (55 women). Oxytocin was given
after achievement of cervical ripening.
Outcomes CS.
Notes Setting: USA
Study period: not reported
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Only reported women were randomised
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Insufficient information to judge
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to judge
Other bias Unclear risk Abstract only
Hudon 1999 
 
 
Methods Randomised trial.
Participants Singleton gestation, cephalic presentation, intact membranes, GA 36-42, indicated labour induction.
Interventions PGE 2 pessary (n = 34).
Hughes 2002 
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Foley + EASI + oxytocin (n = 33).
Outcomes Change in BS, induction-delivery time.
Notes Outcomes of interest not reported in this abstract.
Setting: USA
Study period: not reported
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Randomly assigned, no further details
Allocation concealment
(selection bias)
Unclear risk Randomly assigned, no further details
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk 2 patients excluded after randomisation in Foley group, unclear
Selective reporting (re-
porting bias)
Unclear risk Study protocol/predefined outcomes not available
Other bias Unclear risk Only reported as abstract
Hughes 2002  (Continued)
 
 
Methods RCT
Participants Inclusion: age 20 to 40 years, singleton pregnancy, cephalic presentation ≥ 37 weeks
Exclusion: BS of > 4, cephalopelvic disproportion on examination, history of placenta previa or unex-
plained vaginal bleeding, history of previous CS or other uterine surgery, active herpes simplex infec-
tion, chorioamnionitis, contraindication to use of PGs, acute pelvic inflammatory disease, contraindi-
cation to vaginal delivery, a non reassuring FHR pattern prior to induction.
Interventions Oral misoprostol (n = 157): 50 mcg, every 4 hours, max 4 giHs
Husain 2017 
Mechanical methods for induction of labour (Review)
Copyright © 2019 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane
Collaboration.
132
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Foley catheter + oral misoprostol (n = 161): 16 or 18F, filled with 30 mL + oral misoprostol (50 mcg) every
4 hours, max 4 giHs both groups: if labour was not established within 4 hours of the 4th dose of miso-
prostol, induction was considered to have failed and such cases were then delivered by CS.
Outcomes Failure to achieve vaginal delivery after 24 hours, induction-to-delivery interval, mode of delivery, rea-
son for CS maternal complications, NICU admissions
Notes Setting: Abbasi Shaheed Hospital in Karachi, Pakistan, tertiary care centre
Study period: May 2016 to October 2016.
Funding: no funding reported
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated sequence, block randomisation
Allocation concealment
(selection bias)
Low risk Sequentially-numbered opaque, sealed envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
High risk ITT analysis not reported, cases excluded because of protocol violation. no
missing data or cases
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Low risk No other bias detected
Husain 2017  (Continued)
 
 
Methods RCT. Randomisation based on case number. No measure taken to conceal the allocation.
Participants Intact membranes.
Interventions 5 groups: no treatment (n = 10; exclude); laminaria n = 10 (as many as possible); Foley catheter n = 10
(inflated with 70 - 80 mL water) under traction; amniotomy (n = 10); oxytocin (n = 10) increased by 5
mU/minute every 10 -15 minutes. In all groups, each of 10 women, an extraovular catheter with a 5 mL
balloon was used to record uterine activity.
Outcomes CS.
Notes Setting: USA
Jagani 1982 
Mechanical methods for induction of labour (Review)
Copyright © 2019 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane
Collaboration.
133
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Study period: not reported
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk Method selected by last digit of the chart number
Allocation concealment
(selection bias)
High risk Inadequate.No measure taken to conceal the allocation.
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk ITT not mentioned, not clear how many women were actually included.
Selective reporting (re-
porting bias)
Low risk All outcome measures were reported
Other bias Low risk No other bias detected
Jagani 1982  (Continued)
 
 
Methods RCT
Participants Inclusion criteria: singleton gestation, cephalic presentation, reactive FHR pattern, intact membranes
and GA between 37-41 weeks
Exclusion criteria: BS at least 7 or cervical dilatation greater than 3 cm, EFW > 4500 g or < 2000 g, evi-
dence of cephalopelvic disproportion, placenta previa or unexplained vaginal bleeding, previous sec-
tion caesarean or uterine surgery and contraindications to PG
Interventions Intravaginal dinoprostone (n = 20), 3 mg every 6 hours, max 4 doses
Foley catheter, 16F, 30 mL (n = 20), removed after 12 hours
Outcomes Not mentioned in method section
Notes Article is submitted as letter to the editor. no relevant outcomes reported
Setting: Iran
Study period: not reported
Funding: not reported
Jalilian 2011 
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Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Only described women were randomly allocated, no more info available
Allocation concealment
(selection bias)
Unclear risk Only described women were randomly allocated, no more info available
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk ITT not reported, too little information to judge
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to judge
Other bias Unclear risk Abstract only (letter to editor), too little information to judge risk of bias
Jalilian 2011  (Continued)
 
 
Methods RCT. No details on the method of randomisation or on concealment of the allocation.
Participants No description of inclusion/exclusion criteria. 10 primigravidas and 10 multigravidas.
Interventions Laminaria tents (2 - 3 tents) (10 women); (PGE2) 4 mg tablets vaginally.
Outcomes Change in BS after 16 hours, CS.
Notes Setting: South Africa
Dates of study: not reported
Funding sources: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Only reported women were randomised
Jeeva 1982 
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Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT not mentioned, but seems reasonable as numbers in tables are equal to
randomised numbers, no cases missing
Selective reporting (re-
porting bias)
Unclear risk Insufficient information as no outcome measures were pre-specified in report
Other bias Low risk No other bias detected
Jeeva 1982  (Continued)
 
 
Methods RCT. Sequence based on a random number table. No details were given on the method for conceal-
ment of the allocation.
Participants Term, primiparas, BS < 6.
Interventions Lamicel (40 women);
PGE2 vaginal gel (4 mg) (40 women).
Outcomes Epidural analgesia, CS, instrumental delivery, uterine hyperstimulation, fetal distress.
Notes Setting: UK
Dates of study: not reported
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random number table
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Johnson 1985 
Mechanical methods for induction of labour (Review)
Copyright © 2019 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane
Collaboration.
136
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk ITT unclear, no missing cases or data
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes reported
Other bias Low risk No other bias detected
Johnson 1985  (Continued)
 
 
Methods RCT
Participants Inclusion criteria: 1 previous low transverse CS, singleton live pregnancy with cephalic presentation, re-
assuring fetal status, > 37 weeks and BS < 6
Exclusion criteria: placenta praevia, CPD, various mal presentations, short interconceptional period
of 18 months, previous 2 caesareans, in a case of previous myomectomy or hysterectomy, patient de-
mands repeat elective CS
Interventions Foley catheter (n = 100), 16F, 30 mL, max 24 hours in situ
Oxytocin (n = 100): starting from 1 mU/minute, increased to 2 mU/minute and max up to 32 mU/minute
Outcomes Induction delivery interval, indications for CS, mode of delivery, neonatal outcome and NICU admis-
sions were studied in both groups
Notes Setting: Swami Dayanand Hospital Dilshad Garden New Delhi, India
Study period: January 2015 - June 2015
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Only stated that women were randomly allocated
Allocation concealment
(selection bias)
Unclear risk Only stated that women were randomly allocated
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
Unclear risk Not reported
Joshi 2016 
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All outcomes
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk ITT not reported, no figure 1 to check allocation, all cases analysed, no missing
data described
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Low risk No other bias detected
Joshi 2016  (Continued)
 
 
Methods RCT
Participants Inclusion criteria: pregnant women scheduled for IOL beyond 37 weeks of gestation with a vital single-
ton pregnancy in cephalic presentation, intact membranes, and an unfavourable cervix (BS < 6). Exclu-
sion criteria: women younger than 18 years, with a previous CS, placenta praevia, lethal fetal congenital
anomaly, or known hypersensitivity for one of the products used for induction were ineligible
Interventions Foley catheter (n = 411): 18F, 30 cc sterile saline.
PG E2 gel (408): 1 mg, followed by 1 mg after 6 hours, with a max of 2 doses per 24 hours inserted into
the posterior vaginal fornix. An initial dose of 2 mg was allowed in nulliparous women.
2 days of induction, 1 day of " rest" followed by 2 more days of induction in case of BS < 6
Outcomes CS, maternal and neonatal morbidity and time from start induction to birth.
Notes Setting: multicentre, the Netherlands
Study period: Feb 2009 - May 2010
Funding: none
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated randomisation
Allocation concealment
(selection bias)
Low risk Web-based
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Jozwiak 2012 
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Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT, missing outcome data (pH and BMI) balanced in numbers across interven-
tion groups, with similar reasons for missing data across groups. no missing
cases
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Low risk No other bias detected
Jozwiak 2012  (Continued)
 
 
Methods RCT
Participants Women > 18 years with term pregnancy and unfavourable cervix, requiring IOL. Exclusion criteria were
previous CS, non-vertex presentation of the fetus, ruptured membranes, hypersensitivity for one of the
products used for induction, or a lethal congenital anomaly of the fetus
Interventions Foley catheter (107),18F 30 cc sterile saline.
10 mg slow release PG vaginal insert (n = 119). Removed after 12 hours, if BS < 6, after 24 hours new PG
vaginal insert was used
2 days of induction, 1 day of " rest" followed by 2 more days of induction in case of BS < 6
Outcomes CS, maternal and neonatal morbidity and time from start induction to birth.
Notes Setting: multicentre, the Netherlands
Study period: February 2009 - May 2010
Funding: none
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated randomisation
Allocation concealment
(selection bias)
Low risk Web-based
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not stated
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT analysis, missing outcome data (pH and BMI) balanced in numbers across
intervention groups, with similar reasons for missing data across groups. no
missing cases
Jozwiak 2013 
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Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Low risk No other bias detected
Jozwiak 2013  (Continued)
 
 
Methods Pilot study within RCT
Participants Women > 18 years, ≥ 37 weeks, BS < 6, planned for IOL.
Exclusion:previous CS, non vertex presentation, ruptured membranes, hypersensitivity for one of the
products used for induction, lethal congenital anomaly
Interventions Foley catheter (n = 56), 16 or 18F, 30 mL
Vaginal misoprostol (n = 64) 25 mcg tablets every 4 hours, max 3 doses in 24 hours.
In both groups, if the cervix was still unfavourable for amniotomy after 48 hours of treatment, women
were generally assigned a day of rest followed by another 48 hours of induction
Outcomes CS, instrumental vaginal delivery, reasons for operative delivery, time from induction to delivery, uter-
ine hyperstimulation, uterine rupture, analgesics, antibiotics, maternal suspected intrapartum infec-
tion, maternal postpartum infection, postpartum haemorrhage (> 1000 cc) postpartum blood transfu-
sion, AS of < 7 at 1 minute and 5 minutes, arterial cord blood pH < 7·10, neonatal admissions neonatal
ward/NICU
Notes Setting:multicenter, the Netherlands
Study period: February 2009 and May 2010
Funding: no funding reported
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated sequence, block randomisation
Allocation concealment
(selection bias)
Low risk Sequentially-numbered opaque, sealed envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT analysis, missing data reported, but even distributed over groups and like-
ly for the same reasons. no missing cases
Jozwiak 2014 
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Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results, except secondary out-
come maternal postpartum infection
Other bias Low risk No other bias detected
Jozwiak 2014  (Continued)
 
 
Methods Prospective quasi-RCT
Participants Inclusion criteria: 41 weeks or more, primigravida, BS < 4, singleton living fetus, vertex presentation, no
evidence of active labour, a reassuring FHR pattern, no evidence of intrauterine infection. 
Exclusion criteria: contra-indication for vaginal delivery, previous uterine surgery, non-reassuring FHR,
IUFD, ruptured membranes, vaginal infection, malpresentation, macrosomic fetus, cephalopelvic dis-
proportion, history of APH, contra-indication to PGs
Interventions 1. 18F Foley catheter, 30 cc sterile saline. Taped to the inner thigh. Each patient received 1 g of ampi-
cillin/6 hours. Removed after 12 hours. (N = 50)
2. 25 ug misoprostol vaginally every 4 hours (N = 50)
Outcomes Induction to delivery time, oxytocin use, route of delivery, occurrence of chorioamnionitis, AS, admis-
sion to NICU, tachysystole, hypertonus, hyperstimulation
Notes 9 patients were insertion of Foley was not possible were replaced by 9 other patients!
Setting: Menofyia University Hospital, Egypt
Study period: from January 2010 to October 2010
Funding: not reported
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk Randomisation by odd or even admission date
Allocation concealment
(selection bias)
High risk Randomisation by odd or even admission date
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
High risk ITT was not mentioned. 9 patients in Foley group were replaced by 9 others be-
cause insertion of Foley was not possible. No flow chart, no description of lost
to follow-up.
Kandil 2012 
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Selective reporting (re-
porting bias)
Low risk All pre-described outcome measures were mentioned.
Other bias Low risk No other bias detected
Kandil 2012  (Continued)
 
 
Methods RCT
Participants Inclusion criteria: age 15 years or more, term, singleton, live fetus in vertex presentation, intact mem-
branes and BS < 6.
Exclusion criteria: previous CS or history of other uterine surgery, history of ante partum haemorrhage,
cephalopelvic disproportion, acute fetal distress revealed by a non stress test prior to induction, signs
of infection, ruptured membranes, EFW > 4300, or known allergy to PG
Interventions PG E2 (n = 204) tablets 3 mg, max 2 dose. AROM performed if labour did not commence after 2 doses
Foley catheter (n = 210): 22/24F, 50-60 mL in balloon.Removed after 24 hours and AROM if possible
Outcomes Mode of delivery, time interval between the start of induction and delivery, oxytocin requirement, the
indications for CS and adverse neonatal and maternal reactions to the cervical ripening agent. Hyper-
stimulation with and without FHR changes, failed induction.
Notes Setting: King Hussein Medical Centre and Prince Ali Bin Al-Hussein hospital, Jordan
Study period: July 2009 - July 2010
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random sequence generated by computer
Allocation concealment
(selection bias)
Unclear risk Not described, only description: Randomisation was done by a computer-gen-
erated list of random numbers
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk ITT analysis not reported and not clear if used, no missing data or cases
Khamaiseh 2012 
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Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Low risk No other bias detected
Khamaiseh 2012  (Continued)
 
 
Methods RCT. Computer-generated sequence. No details were given on the method for concealment of the allo-
cation.
Participants Term women with a BS < 9, absence of contraindication for labour and fetal distress. 441 women (224 in
the Dilapan group and 217 in the PGE2 group).
Interventions Dilapan, as many dilators as possible (224 randomised, 214 analysed);
intracervical PGE2 0.5 mg (217 women randomised, 202 analysed). In both groups, ripening was fol-
lowed 6 hours later by oxytocin.
Outcomes CS, uterine hyperstimulation, fetal and neonatal infection.
Notes 25 women excluded: 10 in the Dilapan group (8 protocol violations, 2 entered spontaneous labour be-
fore insertion) and 15 in the PG group (10 protocol violations, 3 entered labour before ripening and 2
delivered before the 6-hour interval). Authors stated that including these excluded women do not alter
the results. Numbers of CS derived from Williams 1997.
Setting: Tampa general hospital, USA
Dates of study: June 1991 - December 1993
Funding sources: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated sequence
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
High risk ITT was performed, but 25 women excluded: 10 in the Dilapan group (8 proto-
col violations, 2 entered spontaneous labour before insertion) and 15 in the PG
group (10 protocol violations, 3 entered labour before ripening and 2 delivered
before the 6-hour interval)
Krammer 1995a 
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Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes reported
Other bias Low risk No other bias detected
Krammer 1995a  (Continued)
 
 
Methods RCT
Participants Inclusion: PROM > 18 hours, ≥ 37 weeks, BS < 6, vital singleton pregnancy, cephalic
Exclusion: previous CS, placenta previa, vaginal bleeding, HIV, hepatitis B or C, maternal infection, fetal
anomaly
Interventions Foley (n = 89): 22ch Rush balloon, traction, 40-50 cc, max 8 hours. if unripe, further management by dis-
cretion of clinician
oral misoprostol (n = 99): 50 mcg misoprostol every 4 hours, after 3 giHs dosis increased to 100 mcg or
25 to 50 mcg vaginal every 3-4 hours
Outcomes CS rate, maternal and neonatal infections. Reason for CS (fetal distress, suspected infection, prolonged
labour, failed induction, postpartum infection, postpartum haemorrhage, uterine hyperstimulation, fe-
tal tachycardia, use of analgesics, AS, umbilical arterial pH, admission to neonatal care, induction to
delivery interval.
Notes Trial stopped prematurely due to insufficient patient enrolment
Setting: multicentre, Finland
Study period: March 2012 to September 2014
Funding: grant from the Finnish medical society duodecim and Helsinky University Central Hospital re-
search grant
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported how this was done (only that they used sealed envelopes)
Allocation concealment
(selection bias)
Low risk Sealed, opaque envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
High risk Seems to be per protocol analysis. Patients excluded after enrolment for
cross-over during analysing data, 3rd arm formed
Kruit 2016 
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All outcomes
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes reported
Other bias High risk Trial stopped prematurely due to insufficient patient enrolment
Kruit 2016  (Continued)
 
 
Methods RCT
Participants Not mentioned
Interventions intracervical dinoprostone (n = 100): 0.5 mg, 6-hourly, max 2 doses
Foley catheter (n = 100), 30 mL, max 12 hours in place.
Outcomes Vaginal delivery within 24 hours, improvement in BS, induction to onset of active labour and induction
to delivery interval, mode of delivery, occurrence of maternal complications and fetal outcome, cost-ef-
fectiveness
Notes Setting: India
Study period: June 2015 - July 2016
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Only described that patients were randomly allocated
Allocation concealment
(selection bias)
Unclear risk Only described that patients were randomly allocated
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk No missing data described, difficult to judge how selection of patients was
done, if there was ITT, if patients were excluded. no numbers of analysed pa-
tient in result section
Selective reporting (re-
porting bias)
Low risk Pre specified outcomes reported in method section were all reported
Other bias Low risk No other bias detected
Kuppulakshmi 2016 
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Methods RCT
Participants Inclusion criteria: primigravida, > 37 weeks of gestation, singleton pregnancy, cephalic presentation,
BS < 4, Intact membranes
Exclusion criteria: multiple pregnancy, mal-presentation, absent membranes, APH, medical disease
e.g. heart disease, renal disease, previous LSCS
Interventions Foley catheter (n = 200):
PGE2 gel intracervical (n = 200), max 2 doses, failed induction declared if patient was not in active
labour after 48 hours
Outcomes Not mentioned in method section
Notes PGE2 dose not described
Setting: KIMSDU; India,
Study period: January 2011 - December 2012
Funding: none
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Only stated that women were randomly assigned
Allocation concealment
(selection bias)
Unclear risk Only stated that women were randomly assigned
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Unclear if analysis was ITT, (no figure 1) all cases analysed, no missing data de-
scribed
Selective reporting (re-
porting bias)
Unclear risk No pre -specified outcome measures reported, so cannot be determined
Other bias Low risk No other bias detected
Laddad 2013 
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Methods RCT
Participants Inclusion: GA > 28 weeks, singletons, intact membranes, absence of labour, cephalic presentation, BS <
5.
Exclusion: multifetal gestations, congenital malformations, Gravidity > 4, non-reassuring FHR trace,
ruptured membranes, active genital infection, previous uterine surgery (including CS), low-lying pla-
centa, chorioamnionitis, EFW > 4000 g, IUFD, known allergies to latex or PGs
Interventions Foley + misoprostol (n = 63): 16F Foley catheter, 30 cc, traction applied, max 12 hours - 25 mcg vaginal
misoprostol, every 4 hours up to a max of 8 doses.
vaginal misoprostol (n = 63): 25 mcg vaginal misoprostol every 4 hours, with a max of 8 doses
Outcomes induction to delivery interval, rate of vaginal deliveries, hyperstimulation, CS rate, neonatal outcome,
chorioamnionitis, oxytocin use
Notes Setting: tertiary care centre, India
Study period: 2-year period
Funding: no funding
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated sequence, block randomisation
Allocation concealment
(selection bias)
Low risk Sequentially-numbered opaque, sealed envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT analysis, no missing data or cases
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Low risk No other bias detected
Lanka 2014 
 
 
Methods RCT.
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Mechanical methods for induction of labour (Review)
Copyright © 2019 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane
Collaboration.
147
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Participants Term pregnancy requiring cervical ripening.
Interventions Foley catheter for 12 hours (n = 31).
Vaginal misoprostol 25 mcg 4-hourly (n = 31).
Outcomes Induction-active labour, induction-delivery, delivery within 12 and 20 hours, oxytocin, obstetric out-
come, maternal and neonatal morbidity
Notes Reported as abstract, only outcome of interest reported is oxytocin infusion.
Setting: Canada
Study period: not reported
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Randomly assigned, no details on sequence generation.
Allocation concealment
(selection bias)
Unclear risk No details on allocation concealment given.
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Not reported in this abstract.
Selective reporting (re-
porting bias)
Unclear risk In this abstract from the outcomes of interest only oxytocin infusion reported,
other outcomes not reported.
Other bias Unclear risk Only abstract available.
Lemyre 2006  (Continued)
 
 
Methods RCT. No details were given on the method for concealment of the allocation.
Participants Singleton vertex term pregnancy, unfavourable cervix.
Interventions Vaginal pessary 3 mg PGE2 (22 women);
Foley catheter in the extra-amniotic space 30 mL (22 women);
Control group with no treatment (22 women; exclude)
Lewis 1983 
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Outcomes Change in BS, CS, uterine hyperstimulation, AS.
Notes Data on induction-delivery intervals not interpretable to derive proportion of women with vaginal de-
livery not achieved in 24 hours.
Setting: Manchester, UK
Study period: not reported
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Random allocation, no more details reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Unclear if ITT was performed. no missing cases or data reported
Selective reporting (re-
porting bias)
Unclear risk No specific pre specified outcomes reported in method section.
Other bias Low risk No other bias detected
Lewis 1983  (Continued)
 
 
Methods RCT
Participants Inclusion criteria: intact membranes, cephalic position, BS ≤ 6, indication of IOL.
Exclusion criteria: ruptured membranes, spontaneous labour, placenta praevia, acute fetal distress,
asthma, glaucoma, latex allergy, infections (acute herpes, GBS, condylomata), previous CS
Interventions 1. Double balloon catheter (n = 412); 80 mL, max 12 hours, thereafter either AROM or start of oxytocin.
2. PGE2 3 mg tablet (n = 413), 2 dose a day (4-5 hourly), max 2 days
Outcomes Failed inductions, time interval from induction to delivery, mode of delivery, neonatal outcome as as-
sessed by the AS after 5 minutes and referral to a neonatal care unit, subgroups by parity and indica-
Lokkegaard 2015 
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tion for induction. Post hoc analyses included the percentage of women who gave birth within 24 hours
and the need for additional oxytocin stimulation
Notes Setting: multicentre, Denmark
Study period: September 2002 to December 2005
Funding: the randomisation procedure was funded by ‘ Snedkermester Sophus Jacobsen & Astrid Ja-
cobsens fond and the Danish Toyota Foundation.
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated and was stratified for parity and department.
Allocation concealment
(selection bias)
Low risk Central allocation by telephone
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT, missing data reported, but evenly distributed.
Selective reporting (re-
porting bias)
Low risk All pre-specified outcome measures were reported
Other bias Low risk No other bias detected
Lokkegaard 2015  (Continued)
 
 
Methods RCT.
Participants Woman with unfavourable cervix.
Interventions 4 groups:
1. oxytocin without Lamicel (according to a fixed schedule, with a max of 32 mU per minute) (24 women);
2. oxytocin with Lamicel (1 unit) (22 women);
3. PGs without Lamicel (2.5 mg PGE2) (19 women);
4. PGs with Lamicel (1 unit) (20 women).
Outcomes CS, forceps or vacuum extraction, endometritis.
Notes Setting: Denmark
Lyndrup 1989 
Mechanical methods for induction of labour (Review)
Copyright © 2019 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane
Collaboration.
150
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Study period: not reported
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Only reported women were randomised by sealed envelope method
Allocation concealment
(selection bias)
Low risk Sealed envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
High risk 6 women excluded for protocol violation.
Selective reporting (re-
porting bias)
Unclear risk No outcomes were pre specified in method section.
Other bias Low risk No other bias detected
Lyndrup 1989  (Continued)
 
 
Methods RCT
Participants Singleton vertex pregnancy, intact membranes with unfavourable cervix.
Interventions Foley extra-amniotic 30 mL (59 women)
PGE2 2.5 mg pessaries (50 women)
Outcomes Vaginal delivery not achieved within 24 hours, CS, instrumental delivery, women not satisfied, caregiver
not satisfied, pH, AS.
Notes Setting: Denmark
Study:period: June 1990 - March 1993
Funding sources: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Lyndrup 1994 
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Random sequence genera-
tion (selection bias)
Unclear risk No details on the method of generation of the sequence.
Allocation concealment
(selection bias)
Low risk Concealment of allocation by sealed envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
High risk ITT reported, but 4 women were lost to follow-up. Women were excluded if de-
livered after 48 hours
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes reported
Other bias Low risk No other bias detected
Lyndrup 1994  (Continued)
 
 
Methods RCT
Participants Inclusion criteria: women with a live, singleton gestation in cephalic presentation at 34 weeks of gesta-
tion or greater with PROM (at least 60 minutes prior to randomisation), an unfavourable cervical exami-
nation (less than 2 cm or 80% effaced), and no contraindication to labour. English speaking with a plan
for vaginal delivery.
Exclusion criteria: active labour and those with suspected intra-amniotic infection, abruption or signif-
icant haemorrhage, latex allergy, greater than 1 prior caesarean delivery, any contraindication to vagi-
nal delivery, or human immunodeficiency virus or acquired immunodeficiency syndrome, multifetal
gestations, lethal fetal anomalies, intrauterine fetal demise, and category II or III FHR tracings.
Interventions Oxytocin only (n = 108): start 2 mUh/minute, increase 2 mUh/minute every 30 minute, max 30 mUh/
minute
Foley catheter + oxytocin (n = 93): 16F, 30 mL, traction applied, max 12 hours, oxytocin concurrent (as
above)
If not in labour after 24 hours, management per discretion of clinician
Outcomes Interval from induction to delivery, interval from induction to vaginal delivery, induction to delivery
excluding patients with PPROM before 34 weeks of GA, CS rate, rate of vaginal delivery within 12 or 24
hours, indication for CS, infection complications, maternal LOS, 5-minute AS < 5, neonatal infectious
evaluation and diagnosis of sepsis, maternal and neonatal length of stay, NICU admission, chorioam-
nionitis, fetal tachycardia, endomyometritis,
Notes Setting: multicentre, USA
Study period: March 2014 to July 2016
Funding: small internal grants to assist with the conduct and statistical analyses for the entire study.
Mackeen 2018 
Mechanical methods for induction of labour (Review)
Copyright © 2019 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane
Collaboration.
152
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated schema in random-sized blocks stratified by multiparity
or primiparity, preterm or term gestation, and hospital site.
Allocation concealment
(selection bias)
High risk Not concealed.
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT, no missing data or cases
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Low risk No other bias detected
Mackeen 2018  (Continued)
 
 
Methods RCT: Computer-generated random sequence, sealed opaque envelopes.
Participants Inclusion: completed 34 weeks GA, intact membranes
Exclusion: uterine scar, uncontrolled medical complication, non-vertex presentation, multiple preg-
nancy, fetal distress, APH.
Interventions Foley catheter + misoprostol (n = 174): 50 mL, traction, max 24 hours, followed by oral misoprostol so-
lution 20 mcg every 2 hours, 40 mcg 2-hourly after 3 doses, until active labour had started. If after es-
tablished labour contractions became inadequate: augmentation with misoprostol solution 5-20 mcg
hourly. If ineffective: oxytocin.
Titrated oral misoprostol (n = 176): as described above
Dinoprostone vaginal (n = 176). 2 mg in posterior fornix, repeated after 6 hours. If no active labour after
12 hours: oxytocin
Outcomes Failed vaginal delivery within 24 hours, augmentation, tachysystole, hypersystole, hyperstimulation
syndrome, tocolysis, analgesia, meconium, CS, instrumental delivery, maternal side effects, AS < 7,
NICU admission, perinatal death, neonatal sepsis.
Notes It is not clear if all patients had an unfavourable cervix (not mentioned in baseline characteristics. Data
reported for different numbers of subjects depending on outcome (selective reporting or missing out-
come data?).
Matonhodze 2003 
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Setting: Pakistan
Study period: October 2000 - December 2001
Funding: not reported
Declaration of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated random sequence,
Allocation concealment
(selection bias)
Low risk Sequentially-numbered opaque, sealed envelopes out of a dispenser. intact
membranes/unfavourable cervix, intact membranes/favourable cervix
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk ITT analysis, data reported for different numbers of subjects depending on
outcome. not clear why
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Low risk No other bias detected
Matonhodze 2003  (Continued)
 
 
Methods RCT randomisation: computer-generated random numbers, concealed.
Participants Inclusion: singleton pregnancy, cephalic presentation, reassuring fetal status, GA 37 completed weeks,
BS 6 or lower.
Exclusion: placenta praevia, chorioamnionitis, polyhydramnios, parity > 5, SROM, previous CS, con-
traindication to labour induction.
Interventions (PGE2) vaginal pessary max 2 x 6 hours (dose not mentioned) followed by ARM and oxytocin infusion (n
= 100).
Foley catheter 45 mL + EASI for 12 hours followed by ARM and oxytocin infusion (n = 100).
Outcomes Primary: time from insertion to delivery, mode of delivery.
secondary: change is BS after 6 hours, neonatal AS.
Notes No sample size calculation.
Mazhar 2003 
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4 patients were excluded (1 leH against medical advice, 1 had SROM, 2 failed inductions were induced
at later stage).
Setting: Pakistan
Dates of study: October 2000 to December 2001
Funding sources: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated sequence.
Allocation concealment
(selection bias)
Unclear risk Randomised numbers concealed in the delivery suite?
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk No mention of incomplete data, however unlikely due to nature of outcome
measures.
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes reported.
Other bias Low risk No other bias detected
Mazhar 2003  (Continued)
 
 
Methods RCT
Participants Inclusion: 1 previous low transverse CS, singleton live pregnancy, cephalic presentation, > 28 weeks
and BS < 5.
Exclusion: previous classical or T-shaped incision, unknown scar, transfundal uterine surgery, medical
or obstetric complications that preclude vaginal delivery, placenta previa, low-lying placenta undiag-
nosed vaginal bleeding, maternal heart disease, rupture of membranes, interval between previous CS
and present pregnancy/conception < 6 months, cervico-vaginal infection, unclean vaginal examination,
infection in previous CS
Interventions 1. Foley catheter (n = 30): 16F, 30 mL balloon, max 12 hours, thereafter start of oxytocin augmentation
2. Oxytocin (n = 30): 1 mUh/minute, after 1 hour 2/mUh/minute, after 1 hour 4 mUh/minute (max 12
hours). oxytocin augmentation as above
Meetei 2015 
Mechanical methods for induction of labour (Review)
Copyright © 2019 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane
Collaboration.
155
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Outcomes Change in BS before and after 12 hours of ripening, percentage and time interval of spontaneous
labour, insertion and expulsion interval of Foley catheter, route of delivery/outcome of delivery, time
required from the beginning of cervical ripening to delivery, hyperstimulation, fetal distress, scar dehis-
cence, uterine rupture
Notes Setting: Department of Obstetrics and Gynecology, PGIMER, Chandigarh, India
Study period: July 2004 and November 2005,
Funding: no funding
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomisation by Tippet's table
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Analysing method not reported and not clear, no missing data or cases
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Low risk No other bias detected
Meetei 2015  (Continued)
 
 
Methods RCT: quote: "randomly assigned".
Participants Singleton gestation, cephalic presentation, GA between 37 and 42 weeks, BS < 6.
Exclusion: malpresentation, ruptured membranes, active genial herpes, antepartum bleeding, fetal
death, cephalopelvic disproportion, indication for emergency termination of pregnancy, history of in-
fertility or CS, women who had undergone induction before presenting.
Interventions Dinoprostone intracervical 0.5 mg, oxytocin infusion after 6 hours (n = 35).
Foley catheter 30 mL + EASI (n = 35).
Moini 2003 
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Outcomes Change in BS (after 6 hours), induction-delivery interval, need for oxytocin, mode of delivery, fetal com-
plications, maternal complications.
Notes No sample size calculation.
Setting: Roointan-Arash Maternity Hospital, Iran
Dates of study: April 2000 - April 2001
Funding sources: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Insufficient information about sequence generation process quote: "randomly
assigned".
Allocation concealment
(selection bias)
Unclear risk Insufficient information.
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Not mentioned.
Selective reporting (re-
porting bias)
Unclear risk All pre-specified outcomes are reported, it is however unclear what is meant
by 'fetal complications', and it is likely that there were more outcomes noted.
Other bias Low risk No other bias detected
Moini 2003  (Continued)
 
 
Methods RCT: randomisation by computerised random number generator, consecutively-numbered sealed en-
velopes.
Participants Singleton gestation, cephalic presentation intact membranes, BS 4 or less, < 8 contractions per hour,
reactive FHR tracing.
EFW > 4500 g or < 1800 g, low-lying placenta, placenta praevia, unexplained vaginal bleeding, active
genital herpes, vasa praevia, chorioamnionitis, contraindication for PGs, previous uterine surgical pro-
cedure, parity > 5.
Interventions Foley 30 mL+ EASI (max 12 hours) + IV oxytocin infusion (n = 100).
Vaginal misoprostol 25 mcg every 4 hours max 24 hours (n = 100).
Mullin 2002 
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Outcomes Primary: mean time from start induction to delivery.
Secondary: route of delivery, success of induction (vaginal delivery within 24 hours), uterine contrac-
tion abnormalities, chorioamnionitis, route of delivery, AS < 7, NICU admission, neonatal resuscitation.
Notes Power calculation states that 140 patients were necessary, yet 200 were included
Setting: Los Angeles County–University of Southern California Medical Center, USA
Dates of study: February 1999 to July 2001
Funding sources: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computerised random number generator.
Allocation concealment
(selection bias)
Low risk Sealed opaque envelopes.
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk No withdrawals from protocol, no mention of incomplete data.
Selective reporting (re-
porting bias)
Low risk All predefined outcomes are reported.
Other bias Unclear risk Unclear why 200 patients were included, while 140 were calculated in the pow-
er calculation.
Mullin 2002  (Continued)
 
 
Methods RCT
Participants Inclusion: age ≥ 18 years, ≥ 20 weeks’ gestation or later with a live fetus, decision made to induce vagi-
nal birth because of pre-eclampsia or hypertension
Exclusion: unable to give informed consent, previous CS, multiple pregnancy, ruptured membranes,
chorioamnionitis, allergy to misoprostol.
Interventions 1. Foley catheter (n = 300): 18F, 30 mL balloon, traction applied, max 12 hours, afterward start oxytocin
or AROM
Mundle 2017 
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2. Oral misoprostol (n = 302) 25 mcg, 2-hourly, max of 12 dose (24 hours). In primigravid women the
dose could be increased to 50 mcg 2-hourly after the first 2 doses
oxytocin administered through gravity infusion set
Outcomes Vaginal birth within 24 hours, induction to birth interval (vaginal births, CSs, and all births), vaginal
births within 12 hours, cervix unchanged at 12 hours and 24 hours, need for oxytocin augmentation,
time from randomisation to start of induction and birth, total dose of misoprostol used and the number
of participants given a 50 μg dose. Maternal complications, satisfaction, fetal/neonatal complications
Notes Fetal surveillance with doptone
Setting: 2 public hospitals in Nagpur, India
Study period: December 2013 to June 2015
Funding: Department for International Development, Medical Research Council, and Wellcome Trust
Joint Global Health Trials Scheme. The funder of the study had no role in data collection
Declarations of interest: ADW is a scientific adviser to Azanta, a Danish pharmaceutical company,
MAT has provided consultancy services to Chiesi, Bristol–Myers Squibb, Novartis, Shire, Janssen, and
Grunenthal. both authors received no personal payment,
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated pseudo-random numbers, block randomisation, strati-
fied by centre
Allocation concealment
(selection bias)
Low risk Sequentially-numbered, sealed, opaque envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT, missing data reported, but small numbers and not in outcomes of interest
for this review, no cases missing
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Low risk No other bias detected
Mundle 2017  (Continued)
 
 
Methods Quote:"randomly assigned".
Participants BS < 5, maternal age 20 to 30 years, gravidity 1 - 3, parity 1 - 2, < 6 contractions per hour, singleton preg-
nancy.
Niromanesh 2003 
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Exclusion: history of preterm labour, antepartum bleeding, low-lying placenta, history of caesarean
deliveries, active herpes infection, acute poly or oligohydramnios, high blood pressure, IUFD, GA < 40
weeks, chronic condition or contraindication for use of PGs.
Interventions Foley catheter 30 mL max 8 hours (n = 45).
(PGE2) tablet 6-hourly, max 6 doses (n = 44).
Outcomes Primary: BS (after ripening).
Secondary: ripening time, induction time, total time, delivery route, uterine hyperstimulation, adverse
side effects, non-reassuring FHR tracing, AS.
Notes No sample size calculation.
1 patient withdrew due to 'complications'.
Time of ripening in Foley group 8 hours, PG group 12 hours
Setting: Mirza Kochkhan Hospital, Tehran, Iran.
Study period: March 2000 to May 2001
Funding sources: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random number table.
Allocation concealment
(selection bias)
Low risk Sealed opaque envelope.
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk No mention of incomplete data, insufficient information to permit judgment.
Selective reporting (re-
porting bias)
Unclear risk 1 patient was withdrawn due to 'complications', data for this patient not re-
ported, other than this, data reported for all patients on the prespecified out-
comes.
Other bias Low risk No other bias detected
Niromanesh 2003  (Continued)
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Methods RCT
Participants Singleton pregnancies, cephalic presentation, > 37 weeks, intact membranes, BS ≤ 4
Exclusion: rupture of the membranes, chorioamnionitis, APH, cervical dilatation > 2.5 cm, temperature
> 38 degrees Celsius, contracted pelvis, fetal distress, polyhydramnios, indication for immediate deliv-
ery previous CS or other uterine surgeries.
Interventions 1. Vaginal misoprostol (n = 60): 25 mcg, 4-hourly, with a max of 6 doses. no effective uterine contrac-
tions after the 6th dose, then it was considered as failure of induction.
2. Foley catheter (n = 44): 18F Foley 50 mL, traction applied, no max time period reported
Outcomes induction to delivery interval, uterine tachysystole, uterine hypertonus, uterine hyperstimulation
(tachysystole + FHR changes), meconium-stained liquor, mode of delivery, maternal and neonatal out-
come, AS.
Notes Setting: Department of Obstetrics and Gynaecology in collaboration with the Department of Paedi-
atrics, JNMCH,AMU, Aligarh (UP), India
Study period: May 2013–August 2014.
Funding: not reported
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Only reported they were randomly assigned, unequal numbers in groups? (60
vs 44)
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT not reported, although this is likely as numbers are equal to randomised
numbers. no missing data or cases
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Low risk No other bias detected
Noor 2015 
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Methods RCT
Participants Singleton vertex presentation with intact membranes, BS < 6, no previous CS.
Interventions Intracervical PGE2 (0.5 mg) (59 women)
Foley catheter with a 30 mL balloon extra-amniotic (53 women)
Outcomes Change in BS, CS, uterine hyperstimulation, fever, neonatal sepsis, fetal distress.
Notes Setting: KIng Henry 8th hospital, Durban, South Africa
Study period: not reported
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk No other details on the randomisation process.
Allocation concealment
(selection bias)
Low risk Sealed envelopes.
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk No ITT reported (although it's likely as numbers are equal as randomised num-
bers), no missing cases or data
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes reported.
Other bias Low risk No other bias detected
Ntsaluba 1997 
 
 
Methods RCT
Participants Inclusion: singletons in cephalic presentation, GA > 37 weeks, live fetus, BS ≤ 4.
Exclusion: ruptured membranes, uterine scar, placenta praevia, chorioamnionitis, EFW > 4000 g, hyper-
sensitivity for products used in intervention
Interventions 1. Foley catheter (n = 80): 14 or 16F, 30 cc, max 48 hours
Oliveira 2010 
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2. Misoprostol (n = 80) 25 mcg a 6 hours, with a max dose of 200 mcg max 48 hours of induction
Outcomes Oxytocin use, tachysystole, hypertonus of the uterus, BS > 6, total time until cervical modification, de-
livery route, FHR abnormalities, meconium stained liquor, AS
Notes In Portuguese, but translated
Setting: Maternidade Escola de Vila Nova Cachoeirinha, public institution which is administrated by the
Secretaria Municipal da Saúde de São Paulo, Brazil
Study period:January 2006 to January 2008.
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated random number sequence.
Allocation concealment
(selection bias)
Low risk Sequentially-numbered, sealed, opaque envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT, no missing data or cases reported
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Unclear risk Based on translated article
Oliveira 2010  (Continued)
 
 
Methods RCT
Participants Singleton vertex presentation, BS 0-4.
Interventions PGE2 (6 tablets 0.5 mg) intravaginally (27 women);
Foley catheter with a balloon filled with 40 mL water (27 women).
Outcomes CS
Notes Setting: Israel
Ophir 1992 
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Study period: not reported
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Allocation sequence from a random numbers table
Allocation concealment
(selection bias)
High risk Allocation by odd and even number
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
High risk ITT not reported, 8 women missing in Foley group and 7 in PGE2 group. not
clear why.
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes reported
Other bias Low risk No other bias detected
Ophir 1992  (Continued)
 
 
Methods RCT
Participants Singleton, vertex, term fetus, adequate pelvis, maternal height > 155 cm, BS < 5. Exclusion if previous
uterine scar, placenta praevia or abruptio, age > 35 years.
Interventions (PGE2) 3 mg every 6 hours, max 3 doses (34 women randomised, 30 women analysed)
oxytocin (2 mU/minute, doubled every 30 minutes, max 32 mU/minute) and ARM (30 women)
Foley 30 mL (30 women)
Outcomes CS, instrumental delivery, uterine hyperstimulation, fetal distress, postpartum haemorrhage.
Notes 4 women excluded in PG group were re-included for CS results only.
Setting: University of Benin Teaching Hospital, Benin City, Nigeria
Study period: April 1990 - October 1991
Funding: not reported
Declarations of interest: not reported
Orhue 1995 
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Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Allocation sequence from a table of random numbers
Allocation concealment
(selection bias)
Low risk Concealment of allocation by sequentially numbered, sealed, opaque en-
velopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
High risk ITT not reported, 4 women excluded in PG group were because of unripe cervix
after 12 hours
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes reported
Other bias Low risk No other bias detected
Orhue 1995  (Continued)
 
 
Methods Randomised equivalence trial
Participants Primigravid, requiring IOL, BS < 5
Interventions n = 60 'randomised into 2 groups'
Foley 12 hours
PGE2 intracervically
Outcomes Change in BS, ripening to delivery interval
Notes None of our outcomes of interest were reported
Setting: tertiary level teaching hospital, India
Dates of study: not reported
Funding sources: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Peedicayil 1998 
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Random sequence genera-
tion (selection bias)
Unclear risk Not described.
Allocation concealment
(selection bias)
Low risk Sequentially-numbered opaque sealed envelopes.
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Person assessing BS was blinded to what agent was used (after 12 hours and
removal of agent I presume).
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Not reported how many women were randomised to which group, thus un-
clear.
Selective reporting (re-
porting bias)
Unclear risk The methods section states that only BS and ripening to delivery interval were
the outcomes of interest, which is questionable.
Other bias High risk Retrospective power calculation, unclear how many women in which group.
Peedicayil 1998  (Continued)
 
 
Methods RCT: generation of sequence unclear, sealed opaque envelopes, patient chose from a selection of 12.
Participants Inclusion: primipara, GA > 36 weeks, intact membranes, BS < 4.singleton fetus, cephalic presentation,
intact membranes.
Exclusion criteria were age < 16 years, previous uterine surgery, low-lying placenta, any active or puru-
lent infection of the lower vaginal tract, or an abnormal pre-induction FHR tracing
Interventions Foley catheter 30cc. (110).
Atad catheter 80 cc. (107).
PGE 2 gel 2 mg, 6-hourly. (113).
Outcomes Vaginal delivery within 24 hours, uterine hyperstimulation with/without FHR changes, CS, epidural
analgesia, instrumental vaginal delivery, antibiotics during labour, postpartum haemorrhage, maternal
fever during labour, pH < 7.10, placental abruption, endometritis, wound infection.
Notes Data for Foley catheter and double balloon catheter were entered in 1 comparison (any mechanical
method versus PG).
Setting: King Edward Memorial Hospital (KEMH) in Perth, Western Australia
Dates of study: July 2001 to December 2003
Funding sources: supported by a grant from the Women and Infants Research Foundation, King Edward
Memorial Hospital, Perth, Australia. Adeza Biomedical Corporation contributed support for the fetal fi-
bronectin test kits.
Declarations of interest: none declared
Pennell 2009 
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Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Insufficient information about sequence generation process in the paper.
Allocation concealment
(selection bias)
Low risk Sealed opaque envelopes (but why selection of 12??).
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention.
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Research midwives were blinded to treatment allocation, especially important
for satisfaction questionnaires.
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT, loss to follow-up is described, incomplete data not mentioned.
Selective reporting (re-
porting bias)
Low risk All outcomes prespecified in methods were reported, report includes all ex-
pected outcomes.
Other bias Low risk No other bias detected.
Pennell 2009  (Continued)
 
 
Methods RCT.
Participants Inclusion: singleton gestation, cephalic presentation, BS of ≤ 4.
Exclusion: spontaneous uterine contractions, rupture of membranes, placenta previa, unexplained
vaginal bleeding, a non-reactive nonstress test, an EFW > 4500 g, a prior vertical uterine incision, parity
of > 5, active genital herpes infection, or a contraindication to receiving PGs
Interventions Vaginal misoprostol 25 mcg every 4 hours (65 women)
intracervical Foley of 50cc and PGE2 (4 mg) every 4 hours (62 women)
Outcomes CS, instrumental delivery, uterine hyperstimulation, AS, NICU admission, chorioamnionitis, perinatal
death.
Notes Setting: University of Mississippi Medical Center Labor and Delivery Unit, Jackson, USA
Study period: August 1996 - April 1997
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Perry 1998 
Mechanical methods for induction of labour (Review)
Copyright © 2019 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane
Collaboration.
167
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Random sequence genera-
tion (selection bias)
Low risk Computer-generated random schedule.
Allocation concealment
(selection bias)
Low risk The allocation of assignment was concealed by placement in a numbered,
opaque, sealed envelope
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT not reported, although this is likely as numbers are equal to randomised
numbers. No missing cases or data in outcomes of interest
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported
Other bias Low risk No other bias detected
Perry 1998  (Continued)
 
 
Methods RCT
Participants Inclusion criteria: obese (BMI > 30 before 20 weeks' GA). Singleton pregnancy. Vertex presentation, BS <
6, Intact membranes,GA 37 + 0 to 42 + 0. Normal fetal heart tracing on admission for ripening
Exclusion: IOL for intrauterine fetal demise, Intrauterine growth restriction, Suspected abruption at the
start of induction, contraindication for a vaginal delivery
Interventions Foley catheter (n = 20):
PGE2 (n = 21): dinoprostone 10 mg slow release for 24 hours
Outcomes Time from initiation of IOL to vaginal delivery, number of vaginal deliveries within 24 hours in each
group, CS operative vaginal deliveries chorioamnionitis oxytocin administration, epidural, ICU (NICU)
admission, arterial pH < 7, AS < 7 at 5 minutes
Notes Abstract only
Setting: Canada
Study period: not reported
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Pineda Rivas 2016 
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Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk insufficient information to judge
Selective reporting (re-
porting bias)
Unclear risk insufficient information to judge
Other bias Unclear risk Abstract only
Pineda Rivas 2016  (Continued)
 
 
Methods RCT, not blinded.
Participants Term pregnancy, BS 6 or less, different indication for IOL, including PROM
Exclusion criteria: previous CS, malpresentation, immediate delivery indicated, contraindication to
vaginal delivery, contraindication to PGs.
Interventions Foley catheter 30 cc (199).
Dinoproston 2 mg 6-hourly (191).
Misoprostol 25 mcg vaginally 4-hourly (199).
Outcomes Uterine hyperstimulation, CS, epidural analgesia, instrumental delivery, meconium, AS, NICU admis-
sions, fever during delivery.
Notes Hyperstimulation is not further specified (with of without FHR changes).
Patients who did not meet inclusion criteria were not excluded retrospectively
Setting: Karolinska university Hospital, Sweden
Dates of study: December 2004 to March 2008
Funding sources: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Prager 2008 
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Random sequence genera-
tion (selection bias)
Low risk Computer-generated sequence.
Allocation concealment
(selection bias)
Low risk Opaque numbered envelopes.
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk Missing data described: 3 dinoprostone and 1 catheter. these were excluded.
Selective reporting (re-
porting bias)
Low risk All outcomes prespecified in methods were reported, report includes all ex-
pected outcomes.
Other bias Unclear risk Patients who did not meet inclusion criteria were not excluded retrospectively
(n = 32).
Prager 2008  (Continued)
 
 
Methods Quasi-experimental
Participants Inclusion: singleton alive fetus, cephalic presentation, gestation at or beyond 37 weeks, para 4 or less,
BS less than 5, obstetric and medical indication for induction
Exclusion: congenital anomalies, multiple pregnancies, mal-presentation, CPD, placenta praevia or
APH, previous CS, and PROM
Interventions PGE2 pessary (80) dosage not known, failure of improvement of modified BS after 6 hours (< 5), a sec-
ond PG E2 gel/pessary was applied and patient reassessed again after 6 hours. If still there was no im-
provement in BS (< 5) a 3rd PG E2 gel/pessary was applied.
PGE2 intracervical (80): as above
EASI with oxytocin IV (80) Foleys catheter of 24 or 26 Fr, inflated with 45 mL of distilled water. Traction
applied and then saline infusion was started extra-amniotically at 30 mL per hour for 12 hours. oxytocin
infusion was started at 2 mU/minute and the dose was doubled at half-hourly interval up to the max
dose of 40 mU/minute
Outcomes induction labour interval, induction delivery interval, mode of delivery, AS at 1 and 5 minutes, and
neonatal morbidity and mortality including ICU admission.
Notes No relevant outcomes reported in article
Setting: Pakistan
Study period: not reported
Funding: not reported
Qamar 2012 
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Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk Allocation in order of admission
Allocation concealment
(selection bias)
High risk Method of induction could be foreseen as a rotation was used
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Unclear if ITT was used, missing cases or outcomes not reported
Selective reporting (re-
porting bias)
High risk Neonatal mortality not reported in numbers, only reported they dit not differ.
neonatal morbidity not reported in results
Other bias Low risk No other bias detected
Qamar 2012  (Continued)
 
 
Methods RCT. No details were given on the method for generating the allocation sequence or for the conceal-
ment of the allocation.
Participants BS < 5.
Interventions Intracervical PGE2 (0.5 mg) and Lamicel (52 women);
intracervical PGE2 (0.5 mg) alone (49 women).
Outcomes CS.
Notes Setting: San Antonio, USA
Study period: not reported
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Ridgway 1991 
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Random sequence genera-
tion (selection bias)
Unclear risk Randomisation not described
Allocation concealment
(selection bias)
Unclear risk No information
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk No information
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk ITT not mentioned, insufficient information to judge
Selective reporting (re-
porting bias)
Unclear risk Insufficient information to judge
Other bias Unclear risk Abstract only, insufficient information to judge risk of bias
Ridgway 1991  (Continued)
 
 
Methods RCT
Participants Unfavourable cervix (BS < 5). Women with previous history of uterine surgery, fetal malpresentation or
multiple gestation were excluded.
Interventions 4 groups:
PGE1 in Tylose gel 3 mg (27 women) (exclude);
laminaria tents (28 women);
oxytocin 1 mU/minute (25 women);
no treatment (24 women exclude).
Then oxytocin was given in all groups.
Outcomes CS.
Notes Successful IOL and fetal distress not defined.
Setting: Jackson, USA
Dates of study: not reported
Funding: supported by the Vicksburg hospital medical foundation:
Declarations of interest: not reported
Risk of bias
Roberts 1986 
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Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Randomly ordered envelopes, not clear how
Allocation concealment
(selection bias)
Low risk Drawing a sealed envelope by a third party
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk No information
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT not reported, although this is likely as numbers are equal to randomised
numbers. no missing cases or data
Selective reporting (re-
porting bias)
Unclear risk No outcomes pre specified in method section
Other bias Low risk No other bias detected
Roberts 1986  (Continued)
 
 
Methods RCT. Allocation sequence from a table of random numbers. Blocks of 6 women. Concealment of alloca-
tion by sequentially-numbered, sealed, opaque envelopes.
Participants Singleton vertex term pregnancies, intact membranes, BS < 6. Excluded if non-reassuring FHR, placenta
praevia.
Interventions Foley catheter inflated with 30 mL water and extra-amniotic infusion of 1 mL/minute saline during up
to 8 hours (56 women);
PGE2 vaginal gel 2.85 mg (56 women).
Outcomes BS change, CS, uterine hyperstimulation, NICU admission, chorioamnionitis, spontaneous labour, fail-
ure of induction, endometritis.
Notes Also reported as abstract (Arias 1993).
Setting: St. Louis, USA
Dates of study period: not reported
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Rouben 1993 
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Random sequence genera-
tion (selection bias)
Low risk Random number table
Allocation concealment
(selection bias)
Low risk Consecutively-numbered, opaque, sealed envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk No information
Incomplete outcome data
(attrition bias) 
All outcomes
High risk ITT not reported, women with failed induction excluded from further analysis
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes reported
Other bias Low risk No other bias detected
Rouben 1993  (Continued)
 
 
Methods RCT
Participants Indication for IOL, GA > 37 weeks, BS < 7, singleton, gestational diabetes mellitus, reassuring FHR trac-
ing, cephalic presentation, intact membranes, low-located placenta (no definition), and mild pre-
eclampsia. Excluded hypersensitivity to PG, temp > 38, previous CS delivery or other uterine surgery,
placenta previa, chorioamnionitis, vaginal bleeding, fetal distress, macrosomia and polyhydramnios.
Interventions Low-dose vaginal misoprostol: 25 mcg, repeated up to 6 doses every 4 hours. If no BS > 7 after 24 hours,
oxytocin was started
Foley catheter (n = 59) 18 F, 50 mL. After 12 hours oxytocin was started.
Outcomes interval time from the first intervention to the time of delivery. Uterine tachysystole, uterine hyperstim-
ulation
Notes Setting: Department of Obstetrics, teaching hospitals, Mashhad University of Medical Sciences, Iran
Study period: September 2007 to March 2008
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported how
Roudsari 2011 
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Allocation concealment
(selection bias)
Unclear risk Not reported how
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk No ITT mentioned, no missing data, 1 woman excluded because of bad partici-
pation?
Selective reporting (re-
porting bias)
Unclear risk Time to delivery: not clear from when till delivery, most likely from active
phase. primary outcome was for first intervention to delivery. other pre-speci-
fied outcomes reported
Other bias Low risk No other bias detected
Roudsari 2011  (Continued)
 
 
Methods Allocation according to the week of admission. No concealment of allocation.
Participants Singleton vertex term pregnancies, BS < 5. Excluded if labour, fetal hypoxia, previous CS.
Interventions Dilapan S 4 units, removed after 14 hours (82 women);
PGE2 intracervical gel 0.5 mg, 1 dose (83 women).
In both groups, PGE2 vaginal tablets were administered after 14 hours for labour induction.
Outcomes CS, hyperstimulation with FHR changes, instrumental vaginal delivery, AS < 7, GI side effects, haemor-
rhage.
Notes Inadequate method of random allocation and of concealment of allocation.
Setting: obstetrics department Brno, Chech Republic
Study period: January 1994 to December 1996
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
High risk Allocation according to the week of admission.
Allocation concealment
(selection bias)
High risk No concealment of allocation
Roztocil 1998 
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Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT not reported, but seems reasonable as numbers are equal to randomised
numbers. no missing cases or data
Selective reporting (re-
porting bias)
Low risk Pre-specified outcomes reported
Other bias Low risk No other bias detected
Roztocil 1998  (Continued)
 
 
Methods RCT
Participants Inclusion criteria: low BS, AROM not possible
Exclusion criteria: grande multiparas, preterm induction
Interventions 1. Foley catheter (n = 200), 40 mL, 24 hours
2. PGE2 vaginal; 2 mg
Outcomes Duration of labour, mode of delivery, postpartum infection and haemorrhage and perinatal, AS
Notes Abstract only
Setting: Batticaloa General Hospital, Sri Lanka
Study period: 18 months from 2004
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Low risk Double-blind? Not clear how this is possible
Rudra 2012 
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Blinding of outcome as-
sessment (detection bias) 
All outcomes
Low risk Double-blind? Not clear how this is possible
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Too little information to judge
Selective reporting (re-
porting bias)
Unclear risk Too little information to judge
Other bias Unclear risk Abstract only
Rudra 2012  (Continued)
 
 
Methods Patients randomly selected, randomisation method not described.
Participants Singleton live pregnancy BS 5 or lower, requiring induction between 37 and 42 weeks of gestation.
Interventions Foley catheter 40-45 mL, after 8-10 hours oxytocin infusion was started (n = 78).
Dinoprostone pessary 3 mg 6-hourly max 2 doses, followed by oxytocin infusion (n = 75).
Oral misoprostol 50 mcg 4-hourly, max 4 doses, followed by oxytocin infusion (n = 73).
Outcomes Vaginal delivery rate, Induction to delivery interval < 12 hours, postpartum haemorrhage, tachysystole.
Notes Methods describe random selection of patients, not randomisation.
No neonatal outcomes.
Setting: Hamdard University Hospital and Patel Hospital, Pakistan
Dates of study: July 2005 - June 2005
Funding sources: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk 'Random selection' of patients, insufficient information for judgement.
Allocation concealment
(selection bias)
Unclear risk 'Random selection' of patients, insufficient information for judgement.
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Saleem 2006 
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Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk It is unclear how many patients were assessed for randomisation or ran-
domised, therefore it is also unclear if incomplete data were reported. There is
no mention of this in the paper.
Selective reporting (re-
porting bias)
Unclear risk All outcomes mentioned in the methods section are reported, it is however in-
teresting why they did not report any neonatal data.
Other bias Unclear risk No sample size calculated
Saleem 2006  (Continued)
 
 
Methods RCT
Participants Inclusion: viable singleton pregnancy, cephalic presentation, intact membranes, BS of ≤ 6.
Exclusion: contraindication for vaginal delivery, previous caesarean delivery, a low-lying placenta, fetal
malformations that were incompatible with postpartum life, intrauterine fetal death, clinical amnioni-
tis, carriers of hepatitis B/C, HIV, allergy to latex.
Interventions 1. Foley: (n = 145) 24 F, 60 mL, max 12 hours
2. Double balloon (n = 148), 80/80 mL, max 12 hours
Outcomes Time from insertion of the catheter to delivery, mode of delivery, vaginal deliveries within 24 hours,
abnormal fetal presentation, cord prolapse, intrapartum fever more than 38°C, bleeding related to
catheter insertion, AS.
Notes Setting: Emek medical centre, Afula, Israel. (teaching medical centre)
Study period: June 2008 and December 2010
Funding: Department of obstetrics, Emek medical centre
Declarations of interest: none reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated numbers, block randomisation
Allocation concealment
(selection bias)
Low risk Sequentially-numbered allocation, stored in a box.
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
Unclear risk ITT not reported and not clear if done, no missing data or cases.
Salim 2011 
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All outcomes
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Low risk No other bias detected
Salim 2011  (Continued)
 
 
Methods RCT. Computer-generated allocation sequence. No details on concealment of allocation.
Participants Singleton vertex term pregnancies, intact membranes, BS < 6. Excluded if non-reassuring FHR, placenta
praevia, previous uterine scar, cervicitis.
Interventions Hygroscopic cervical dilators (as many as possible) (36 women); (PGE2) 4 mg gel applied to the cervical
os (n = 38). After 8-12 hours, repeat in both groups if cervix unfavourable. Followed by oxytocin and am-
niotomy.
Outcomes CS, instrumental vaginal delivery, haemorrhage, admission to NICU, infection.
Notes Unclear whether PG was intracervical or intravaginal.
Setting: Univerity medical Center of Jacksonville, USA. largely high risk, low income obstetric popula-
tion
Study period: June 1988 to July 1989
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated randomisation list
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk ITT not reported and not clear if done, no missing data or cases reported
Selective reporting (re-
porting bias)
Unclear risk No outcomes pre specified in method section
Sanchez-Ramos 1992 
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Other bias Low risk No other bias detected
Sanchez-Ramos 1992  (Continued)
 
 
Methods RCT
Participants Inclusion: indication for IOL, vertex, singleton, > 37 weeks of GA, previous CS (transverse incision), BS <
5, no premature rupture of membranes, singleton in vertex presentation.
Exclusion: < 18 years, placenta praevia, cervical infection, malpresentation, latex allergy, induction for
CS
Interventions 1. Foley catheter (n = 101): 50 mL, max 12 hours (N = 101)
2. oxytocin (N = 103), low-dose perfusion
Outcomes Vaginal birth rate, maternal and neonatal complications
Notes Abstract only (awaiting publication)
Setting: France, multicentre
Study period: December 2010 tot December 2013
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk ITT, too little information to judge incomplete outcome data
Selective reporting (re-
porting bias)
Unclear risk Too little information to judge
Other bias Unclear risk Abstract only
Sarreau 2016 
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Methods RCT. Computer-generated allocation sequence. Concealment of allocation by opaque, sealed, consecu-
tively-numbered envelopes.
Participants Singleton vertex pregnancies with intact membranes, BS < 6. Term > 28 weeks. Inclusion of women with
previous CS.
Interventions Intracervical PGE2 (0.5 mg) every 6 hours (72 women).
Intracervical Foley catheter inflated with 30 mL (77 women).
Outcomes Spontaneous onset of labour, nausea, maternal discomfort measured with an analogue scale 0-10,
non-reassuring FHR, hyperstimulation, use of epidural, use of oxytocin, shoulder dystocia, vaginal de-
livery.
Notes 12 women excluded (6 women in PGE2 group because of use of Foley catheter, 2 removed consent, 1
pre-eclampsia, 1 BS of 7 and 2 breech).
Setting: Medical centre of Delaware, USA. tertiary referral centre,
Study period: July 1995 to July 1996
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated random allocation.
Allocation concealment
(selection bias)
Low risk Sealed, opaque envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
High risk No ITT, women excluded because of protocol violation. no missing data.
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes reported
Other bias Low risk No other bias detected
Sciscione 1999 
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Methods Randomised trial: computer-generated random number table, blocks of 4, sequentially-numbered
opaque sealed envelopes.
Participants Nulliparous women, admitted for induction, between 34 and 42 weeks GA, singleton in cephalic pre-
sentation, BS < 4, intact membranes, reassuring FHR tracing, < 6 contractions per hour
Exclusion: significant vaginal bleeding, fetal chorioamnionitis, any contraindication to vaginal delivery,
previous uterine scar, FHR abnormalities, severe pre-eclampsia, contraindication to PG.
Interventions Foley 30 mL + EASI + concurrent IV oxytocin for 12 hours (n = 76).
PGE2 gel 0.5 mg intracervical 6-hourly, max 3 doses (n = 75).
Outcomes Interval from start induction to active phase, abnormal FHR tracing, tachysystole, hyperstimulation,
meconium passage, caesarean delivery, chorioamnionitis, endometritis, AS < 7, admission NICU
Secondary: start induction to delivery, change in dilation at 1, 6, 12 hours, CS for failed induction.
Notes No sample size calculation.
Prophylactic antibiotics after 12 hours of start induction
Setting: Prenatal Clinic in Al-Zahra Maternity
Hospital, Iran
Dates of study: March 2002 - September 2003
Funding sources: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated sequence.
Allocation concealment
(selection bias)
Low risk Sequentially-numbered opaque sealed envelopes.
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Good description of excluded patients, quite evenly spread over the groups.
There is no information about missing/incomplete outcome data.
Selective reporting (re-
porting bias)
Low risk It seems that all outcomes prespecified in methods were reported, report in-
cludes all expected outcomes.
Other bias Low risk No other bias detected
Sharami 2005 
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Methods RCT
Participants Inclusion criteria: singleton, GA 37 weeks or more, cephalic presentation, intact membranes, un-
favourable cervix (BS =/< 6), oligohydramnios (AFI =/< 5)
Exclusion criteria: multifetal gestation, fetal malpresentation, spontaneous labour, contraindication to
PGs or a vaginal delivery (e.g. placenta previa), non-reassuring FHR tracing, a fetus with major anom-
alies or previous CS
Interventions 1. Propess (10 mg slow release PGE), n = 26
2. Double balloon (Cook), n = 26
Outcomes Time from induction to active labour (defined as cervical dilation of at least 5 cm), induction to delivery
time, CS and operative delivery rates, oxytocin augmentation, uterine tachysystole (defined as greater
than 5 uterine contractions in 5 minutes), meconium passage, FHR changes, AS and maternal satisfac-
tion
Notes Setting: Israël
Study period: not reported
Funding: none received
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Using computer-generated, random sequences
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk ITT not reported, no missing data described. No figure 1, all women analysed
Selective reporting (re-
porting bias)
High risk All pre-specified outcomes reported but secondary outcome 'AS'
Other bias Unclear risk Not mentioned in method section how long balloon/dinoprostone was given
and what happened after ripening process.
Shechter-Maor 2015 
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Methods RCT
Participants Inclusion: 1st or 2nd gravida, single, live fetus, cephalic, indication for IOL, GA 37-42 weeks, BS ≤ 5, ab-
sence of uterine contractions.
Exclusion: previous uterine surgery, non reassuring FHR tracing, IUGR, oligohydramnios, placenta prae-
via, multifetal pregnancy, chorioamnionitis, active herpes, EFW > 4 kg, renal or hepatic disease
Interventions 1. Oral misoprostol (n = 30):, 50 mcg, repeated every 4 hours to a max of 5 doses.
2. Vaginal misoprostol (n = 30): 25 mcg, repeated every 4 hours to a max of 5 dosis. n = 30
3. Foley catheter (n = 30): 16 or 18 F, 35 mL. max of 16 hours
In all 3 groups after 16 hours oxytocin was started.
Outcomes interval from induction to birth, mode of delivery, maternal complication, neonatal outcome, failed in-
duction
Notes Setting: SMGS hospital, Jammu, India
Study period: over 1 year
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Random assigned, no more information reported
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
High risk No ITT reported, cases missing in table 2, not clear why
Selective reporting (re-
porting bias)
High risk No outcome measures were mentioned in the method section, induction to
delivery interval is given but no SDs,
Other bias Low risk No other bias detected
Sheikher 2009 
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Methods RCT
Participants 100 primiparae and 100 multiparae women with an unfavourable BS
Interventions Foley catheter:(nulliparae n = 50)
Double balloon:(nulliparae n = 45)
Outcomes Primary outcomes were BS increment, time from catheter withdrawal to delivery, CS rate and post cae-
sarean febrile morbidity.
Notes Abstract only, numbers only given for nulliparae
Setting: Israel
Study period: not reported
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated numbers
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Reported it was a single-blinded study, not how blinding was performed.
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk 20 women excluded from analyses, not clear why
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes reported
Other bias Unclear risk Abstract only
Solt 2009 
 
 
Methods RCT
Participants Inclusion criteria: not delivered by 40 weeks + 5 days gestation, having uncomplicated pregnancies
with a singleton fetus, longitudinal lie and cephalic presentation.
Somirathne 2017 
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Exclusion criteria were pregnancy-induced hypertension, gestational diabetes mellitus, multiple preg-
nancies, planned CS, fetal growth restriction and scarred uterus
Interventions 1. Foley catheter, (n = 89), 60 mL, max 24 hours
2. Low dose oral misoprostol (n = 91), 50 mcg, 3 giHs, 4 hourly (N = 91)
In both groups, if cervix is unfavourable after 24 hours Foley group PGE2, oral misoprostol group Foley
catheter)
Outcomes The induction delivery interval following IOL, the mode of delivery, the reasons for operative delivery,
maternal morbidity, hyperstimulation, uterine rupture, peripartum hysterectomy, postpartum blood
transfusion or crystalloid transfusion, IV antibiotics, maternal pyrexia of > 38°C, fetal and neonatal out-
come and morbidity, suspicious or pathological CTG according NICE guidelines, meconium-stained
liquor, birthweight, 1 minute AS, NICU and reason for admission
Notes Setting: University Unit of the THMG, Sri Lanka
Study period: September 2014 to April 2015.
Funding: none
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated numbers, block randomisation,stratified by parity
Allocation concealment
(selection bias)
Low risk Sequentially-numbered, sealed, opaque envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk ITT not reported, no missing data or cases. referred to Figure 1, but not avail-
able
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Low risk No other bias detected
Somirathne 2017  (Continued)
 
 
Methods RCT. Computer-generated allocation sequence. Concealment of allocation by sealed envelopes.
St Onge 1995 
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Participants Singleton vertex term pregnancies with intact membranes, BS < 5. Exclusion of women with previous
CS, low-lying placenta.
Interventions Intracervical PGE2 (0.5 mg) (30 women).
Intracervical Foley catheter inflated with 30 mL (36 women).
Outcomes CS, instrumental delivery, maternal side effects, maternal pyrexia, fetal distress.
Notes 2 women excluded in each group. Also reported as abstract (Lange 1994).
Setting: Foothills Hospital in Calgary, Alberta, Canada
Study period: October 1991 to November 1993
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated allocation sequence.
Allocation concealment
(selection bias)
Low risk Concealment of allocation by sealed envelopes.
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk 2 women in each group excluded (not meeting inclusion criteria or in labour
directly after randomisation). no missing cases or data
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes reported
Other bias Low risk No other bias detected
St Onge 1995  (Continued)
 
 
Methods RCT
Participants Inclusion criteria: nulliparous, 18 years or older, GA 37 weeks or more, singleton, cephalic presentation,
intact membranes, BS < 6, admission for IOL.
Exclusion criteria: contraindication for vaginal delivery (placenta praevia, non vertex presenta-
tion), ruptured membranes, severe pre-eclampsia, suspected fetal growth restriction with abnormal
dopplers, presence of a uterine scar, non reassuring FHR trace requiring medical intervention.
Su>ecool 2014 
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Interventions 1. 10 mg dinoprostone vaginal insert (n = 31), max 12 hours, if after 12 hours unfavourable cervix start
with oxytocin
2. Double balloon (Cook) (n = 31), 80 mL, oxytocin started 6 hours after placement. Balloon removed af-
ter max 12 hours.
Outcomes Time from insertion of ripening method until delivery, delivery rate < 24 hours, CS rate, time to active
labour, rate of operative vaginal delivery, maternal or fetal adverse events
Notes Setting: USA
Study period: February 2011 - September 2012
Funding: not reported
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated numbers
Allocation concealment
(selection bias)
Low risk The allocation assignment was sealed in sequentially-numbered, opaque en-
velopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT, no missing data or cases.
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Low risk No other bias detected
Su>ecool 2014  (Continued)
 
 
Methods RCT. Concealment of allocation by opaque, sealed envelopes.
Participants BS < 6 and indication/no contraindication for IOL.
Interventions Intracervical PGE2 (0.5 mg) and Foley catheter inflated with 50 mL of water (41 women); intracervical
PGE2 (0.5 mg) repeated after 4 to 6 hours if needed (37 women).
Outcomes CS, uterine hyperstimulation with and without FHR changes, infection.
Notes Setting: Jackson, USA
Sullivan 1996 
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Study period: October 1993 - May 1994
Funding: supported by the Vicksburg hospital medical foundation
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not reported
Allocation concealment
(selection bias)
Low risk Concealment of allocation by opaque, sealed envelopes.
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT not reported, but is reasonable as numbers are equal to randomised num-
bers, no missing cases or data
Selective reporting (re-
porting bias)
Low risk All pre-specified outcome reported.
Other bias Low risk No other bias detected
Sullivan 1996  (Continued)
 
 
Methods Random number table, opaque sealed envelopes.
Participants Term pregnancy, singleton fetus in cephalic presentation, BS < 4.
Exclusion: ruptured membranes, placenta praevia, non-reactive non-stress test, EFW > 4000 g, prior
uterine incision, parity > 4, contraindication to PGs.
Interventions Foley 50 mL max 12 hours (n = 61).
Vaginal misoprostol 25 mcg every 4 hours, max 6 doses (n = 60).
Outcomes Failure to achieve ripening within 12 hours, vaginal delivery within 24 hours, need for oxytocin augmen-
tation, CS rate, tachysystole, hypertonus, meconium, maternal and neonatal complications, AS < 7,
NICU admissions, febrile morbidity.
Notes Prior uterine incision is exclusion criterion, but 18 women with previous CS included.
Setting: Zonal general hospital, Nigeria
Study period: June 1998 to May 2001
Funding: not reported
Tabowei 2003 
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Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random number table.
Allocation concealment
(selection bias)
Low risk Opaque sealed envelopes.
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Unclear risk Incomplete outcome data were not mentioned in the report.
Selective reporting (re-
porting bias)
Low risk All outcomes prespecified in methods were reported, report includes all ex-
pected outcomes.
Other bias Unclear risk Prior uterine incision is exclusion criterion, but 18 women with previous CS in-
cluded, they were evenly divided between the groups.
Tabowei 2003  (Continued)
 
 
Methods RCT
Participants Inclusion criteria: pregnant women aged 21 to 40 years old with a singleton pregnancy with no ma-
jor fetal anomaly who were suitable for vaginal delivery and scheduled for a planned IOL at 37-41 + 6
weeks of gestation.
Exclusion criteria: spontaneous labour, had a cervical dilatation of 3 cm or more, confirmed rupture of
membrane, had abnormal cardiotocogram, a scarred uterus such as previous CS, malpresentation in
labour, or if CS delivery was indicated
Interventions 1. Double balloon (80 mL, balloon started with 40 mL, every following hour 20 mL inserted until 80 mL
total), max 12 hours (N = 31)
2. PG 3 mg tablet, repeat once after 6 hours (N = 54)
If not in labour or AROM possible after 12 hours, further management by local physician.
Outcomes Not clearly mentioned in method section
Notes Setting: tertiary referral maternity unit in Singapore.
Study period: not reported
Funding: double balloons provided by Cook Medica
Tan 2015 
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Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Shuffling of 150 envelopes with equal numbers of chance for intervention or
control, labelled sequentially
Allocation concealment
(selection bias)
Low risk Sealed envelope, next allocated number of envelope
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
High risk ITT not described, seems per protocol as woman in pain and breech during
labour were excluded; no missing data described
Selective reporting (re-
porting bias)
Unclear risk No pre specified outcomes reported, so cannot be judged
Other bias Low risk No other bias detected
Tan 2015  (Continued)
 
 
Methods RCT
Participants Inclusion: singleton, scheduled for labour induction, GA ≥ 37 wk; BS < 6, vertex presentation, intact
membranes.
Exclusion: placenta previa, previous uterine scar. contraindication to receive or known allergy to latex
or PG.
Interventions 1. Foley catheter (n = 921): 30 mL, no traction, replaced after 48 hours, max 4 days
2. Low dose oral misoprostol (n = 924): 50 mg every 4 hours, max 3 times a day, max 4 days
Outcomes Primary outcome for safety was composite of fluxus postpartum and asphyxia, and for effectiveness CS
rate. Secondary outcomes included maternal and neonatal outcomes, total induction time, interval be-
tween randomisation and active phase
Notes Setting: multicentre, 6 tertiary-care and 23 secondary-care hospitals, the Netherlands
Study period: July 2012 to October 2013,
Funding: FondsNutsOhra, no role in study design, data collection, data analysis, data interpretation,
writing of the report or publication
Declarations of interest: none declared
ten Eikelder 2016 
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Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated numbers, block randomisation, stratified by parity and
centre
Allocation concealment
(selection bias)
Low risk Web-based allocation
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT, no missing cases. missing data in primary outcome (pH in umbilical
artery). similar reasons for missing data across groups, pre-specified in proto-
col, anticipated on as followed: data missing for umbilical artery pH and a 5-
minute AS of less than 7, the outcome was classified as abnormal; for patients
with missing data for umbilical artery pH and a 5-minute AS of 7 or more, the
neonatal outcome was classified as normal.
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported in results
Other bias Low risk No other bias detected
ten Eikelder 2016  (Continued)
 
 
Methods RCT. Concealment of allocation by envelopes.
Participants Singleton vertex term pregnancies. Favourable cervix (BS > 5).
Interventions Foley catheter with a balloon inflated with 30 mL saline and PGE2 0.5 mg extra-amniotic (48 women);
PGE2 0.5 mg extra-amniotic (43 women);
amniotomy and oxytocin if needed (52 women).
Outcomes No outcomes reported.
Notes No relevant outcomes reported.
Setting: Belgium
Study period: not reported
Funding: received free PGE2. not clear if this giH is related to a pharmaceutical company
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Thiery 1981 
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Random sequence genera-
tion (selection bias)
Unclear risk Prepared envelopes with numbers
Allocation concealment
(selection bias)
Low risk Concealment of allocation by envelopes.
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk Unclear if ITT was performed, but is reasonable as numbers are equal to ran-
domised numbers), no missing cases or data
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes reported
Other bias Low risk No other bias detected
Thiery 1981  (Continued)
 
 
Methods RCT
Participants Inclusion: preterm rupture of membranes, cervix ≤ 2 cm
GA ≥ 34 weeks, singleton gestation, cephalic,
Exclusion: regular uterine contractions (contractions more frequent than every 5 minutes), 2 prior
transverse uterine incisions/vertical uterine incision/transmural myomectomy or any obstetric con-
traindication to labour, evidence of chorioamnionitis, lethal fetal anomalies, intrauterine fetal demise,
placenta previa, suspected abruption/significant haemorrhage, non-reassuring FHR pattern
Interventions Foley + oxytocin (n = 87)
oxytocin only (n = 82)
Outcomes Reported outcomes: hours from placement of Foley or initiation of oxytocin to delivery, rate of delivery
(vaginal or caesarean) within 24 hours caesarean rate, induction to vaginal delivery interval.
Notes Grey literature: study terminated, primary outcomes reported in trial registration.
Setting; USA
Study period: December 2005 - May 2008
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Tita 2006 
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Random sequence genera-
tion (selection bias)
Unclear risk Randomisation process unclear
Allocation concealment
(selection bias)
Unclear risk Unclear
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
High risk Unclear if ITT analyses was used. for CS there are missing cases
Selective reporting (re-
porting bias)
High risk Only primary outcomes were reported in trial registration
Other bias Unclear risk Study was terminated (not clear why)
Tita 2006  (Continued)
 
 
Methods RCT
Participants Term women with unfavourable cervix (BS < 5), intact membranes.
Interventions Laminaria (as many as possible) and (PGE2) vaginal gel (4 mg) (21 women);
(PGE2) vaginal gel (4 mg) alone (27 women).
Outcomes Need for oxytocin, CS, uterine hyperstimulation, admission to NICU, chorioamnionitis.
Notes Setting: memorial hospital Indianapolis, USA
Study period: October 1994 to May 1995
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated allocation sequence.
Allocation concealment
(selection bias)
Low risk Concealment of allocation by consecutively-numbered, opaque, sealed en-
velopes.
Blinding of participants
and personnel (perfor-
mance bias) 
Unclear risk Not feasible due to nature of intervention
Turnquest 1997 
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All outcomes
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
High risk 4 women excludes because of protocol violation, no missing cases or data
Selective reporting (re-
porting bias)
Low risk All outcomes reported
Other bias Low risk No other bias detected
Turnquest 1997  (Continued)
 
 
Methods RCT
Participants Inclusion criteria: primiparae, full-term, singleton with cephalic presentation; indication for labour in-
duction; intact membranes; BS < 6; no contra indication for vaginal delivery
Interventions Foley catheter (n = 138); 16F Foley, 80cc fluid, max 24 hours
Propess: (n = 124), 10 mg slow release dinoprostone, fornix posterior, max 24 hours
afterwards started with oxytocin. if after 3 days labour did not started, IOL was declared failed
Outcomes The duration of placement (of Propess or catheter, mode of delivery and time from IOL to delivery; us-
age of oxytocin, postpartum haemorrhage; meconium-stained amnion fluid, AS, post-delivery tempera-
ture monitoring (for a total of 10 days); 42 days after delivery follow-up interview to check for lochia ap-
pearance or signs of infection.
Notes Article in Chinese => translated by native speaker
Setting: China
Study period; not reported
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Random number table
Allocation concealment
(selection bias)
Unclear risk Not reported
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Wang 2012 
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Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
High risk No ITT, women were excluded for different reasons during the trial (n = 8)
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes reported
Other bias Unclear risk Judged from a translated article
Wang 2012  (Continued)
 
 
Methods RCT
Participants Inclusion: oligohydramnios (AFI < 5 cm). GA beyond 37 0/7 weeks’, singleton pregnancy, vertex presen-
tation, BS ≤ 6, intact membranes, the absence of documented uterine contractions, the absence of pri-
or CS delivery, reassuring antenatal fetal testing (non-stress test) active, and oxytocin challenge test
negative upon study entry.
Exclusion: antepartum bleeding, chorioamnionitis, placenta previa, or any other contraindication to
vaginal delivery, women with documented PG allergy, maternal asthma history, vaginitis or cervicitis at
presentation, and/or glaucoma history were not eligible for the pharmacological treatment arm
Interventions Double balloon (n = 67): 80/80cc, no traction, max 12 hours. After 24 hours unsuccessful ripening start
oxytocin
10 mg dinoprostone insert (n = 59), fornix posterior, max 24 hours, After 24 hours unsuccessful ripening
start oxytocin
Outcomes Pregnancy outcomes and success of induction
Notes Setting: The People’s Liberation Army 174th Hospital, Xiamen, China,
Study period: April 2010 - February 2011
Funding: financial support of The People’s Liberation Army Nanjing Military Area Command Medicine
Health Department in China.
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not described how random sequence was generated.
Allocation concealment
(selection bias)
Low risk Sealed envelope randomisation, opaque?
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Wang 2014 
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Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
High risk No ITT => 5 woman reassigned after randomisation (non re-assuring FHR,
failed placement) no missing data or cases
Selective reporting (re-
porting bias)
Unclear risk No pre specified outcomes reported, so can't be judged
Other bias Low risk No other bias detected
Wang 2014  (Continued)
 
 
Methods RCT
Participants Inclusion: 18–40 years old; 37 + 0-41 + 6 gestational weeks; BS ≤ 6; single alive fetus with cephalic pre-
sentation; in cephalopelvic proportion; without premature rupture of membrane; NST reaction type
before labour induction. The indications of labour induction included delayed pregnancy, oligohy-
dramnios (AFI = 3.0–8.0 cm), gestational diabetes mellitus, intrahepatic cholestasis of pregnancy, good
control of gestational hypertension, with vaginal trial production condition and required pregnancy
termination.
Exclusion: placenta previa, vasa previa and APH; invasive cervical carcinoma; untreated HIV infection;
allergic to induction drugs.
Interventions Double-balloon combined with IV drip of oxytocin (n = 60) AROM after 12 hours.
IV drip of oxytocin at a concentration of 0.5% (n = 60); AROM after 12 hours
If the patients did not enter the stage of active labour within 48 hours, the labour induction was regard-
ed as failing, and other methods for pregnancy termination were used
Outcomes Postpartum haemorrhage, cervical laceration, uterine rupture, puerperal infection, neonatal asphyxia,
neonatal infection and meconium aspiration syndrome
Notes Setting: China
Study period: January 2014 - June 2015
Funding: grants received from the Nature Science Foundation of China, the Science and Technolo-
gy Project of Special Funds of Guangzhou, Guangdong Science and Technology Project, the Natural
Science Foundation of Guangdong Province and Guangzhou Science and Technology Project
Declarations of interest: none declared
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Women randomly divided, no information given
Allocation concealment
(selection bias)
Unclear risk No information reported on allocation concealment
Wu 2017 
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Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
Low risk ITT not mentioned, but is reasonable as numbers are equal to randomised
numbers. no missing cases or data
Selective reporting (re-
porting bias)
Low risk All pre-specified outcomes were reported
Other bias Low risk No other bias detected
Wu 2017  (Continued)
 
 
Methods RCT
Participants Singleton vertex presentation, intact membranes, BS < 5, no previous CS.
Interventions Atad device (100 mL) (36 women);
intracervical PGE2 (0.5 mg) (39 women);
vaginal pessary 0.5 mg PGE2 (39 women).
Outcomes Change in BS, vaginal delivery achieved within 12 and 24 hours, CS, instrumental delivery, vaginal
bleeding, uterine hyperstimulation, AS.
Notes 5 women were excluded (2, 2 and 1, respectively).
Setting: Prince of Wales Hospital, Honkong teaching hospital, China
Dates of study: period of 18 months
Funding sources: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated number
Allocation concealment
(selection bias)
Low risk Sealed, opaque envelopes
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Yuen 1996 
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Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk Not reported
Incomplete outcome data
(attrition bias) 
All outcomes
High risk 5 women excluded because of protocol violation, no other missing cases or
data
Selective reporting (re-
porting bias)
Low risk All pre-specified outcome reported
Other bias Low risk No other bias detected
Yuen 1996  (Continued)
 
 
Methods RCT
Participants Women requiring IOL for common indications, no previous CS
Interventions PGE2 tablets (n = 100) dosage of 2 mg, every 6 hours, max of 4 doses
transcervical balloon catheter(n = 100) filled with 60 mL of saline.
Outcomes Induction to delivery interval, mode of delivery, meconium staining, CTG abnormalities, admission in
NICU, low AS
Notes No relevant outcomes were reported in the abstract
Setting: Pakistan
Study period: not reported
Funding: not reported
Declarations of interest: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Randomisation not described
Allocation concealment
(selection bias)
Unclear risk No information
Blinding of participants
and personnel (perfor-
mance bias) 
All outcomes
Unclear risk Not feasible due to nature of intervention
Blinding of outcome as-
sessment (detection bias) 
All outcomes
Unclear risk No information
Incomplete outcome data
(attrition bias) 
Unclear risk ITT not reported, insufficient information.
Zahoor 2014 
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All outcomes
Selective reporting (re-
porting bias)
Unclear risk Insufficient information.
Other bias Unclear risk Abstract only, too little information to judge risk of bias
Zahoor 2014  (Continued)
AFI: amniotic fluid index
APH: antepartum haemorrhage
ARM/AROM: artificial rupture of membranes
AS: Apgar score
BMI: body mass index
BS: Bishop score
CPD: cephalopelvic disproportion
CS: caesarean section
CTG: Cardiotocography
EASI: extra-amniotic saline infusion
EFW: estimated fetal weight
FHR: fetal heart rate
GA: gestational age
GBS: group B Streptococcus
GI: gastrointestinal
ICU: intensive care unit
IOL: induction of labour
IFD/IUFD intrauterine fetal death
ITT: intention-to-treat
IV: intravenous
LSCS: lower segment caesarian section
max: maximum
Mbs: modified Bishop Score
mcg: microgram
mL: millilitre
mg: milligram
mU: milliunits
NICU: neonatal intensive care unit
NST: non-stress test
PBU: premature baby unit
PCM:
PG: prostaglandin
PGE2: prostaglandin E2
PROM: pre labour rupture of membranes
RCT: randomised controlled trial
SROM: spontaneous rupture of membranes
US: ultrasound
 
Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
Abramovici 1999 It is unclear whether all women had Foley catheter (included as 'intention to ripe the cervix' with
Foley catheter). Women only received a Foley catheter when they had no dilation at the start of in-
duction (for this study this was the control group), and concurrent oxytocin was started. It is un-
clear how many women received a Foley catheter.
Adeniji 2005a Primary outcome fibronectin, other outcomes not mentioned.
Adeniji 2005b High-dose misoprostol
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Study Reason for exclusion
Adeniji 2006 Outcome cervical scores, other outcomes not mentioned.
Afolabi 2005 Only reports outcomes for the successfully induced, thus not useful.
Ahmad 2015 laminaria vs Foley => not within scope of review
Anabosy 2014 Trial stopped before start patient inclusion because of technical issues
Arsenijevic 2012 No dilatator vs hegar vs continues, controlled, balloon dilator => not within scope of review
Arshad 2016 Laminaria prior to PGE2 vs nothing prior to PGE2 => not within scope of review
Atad 1991 No randomised comparison of mechanical methods. A subgroup of women were randomised to re-
ceive PGE2 or placebo.
Atad 1999 Compares 2 mechanical regimens.
Baacke 2006 Trial registration, expected end date expired > 2 years. no information could be obtained (authors
were contacted)
Barrilleaux 2002a High-dose misoprostol
Behrashi 2013 Trial registration with no publication. anticipated end date 2013 => no information could be ob-
tained (authors were contacted)
Ben-Aroya 2001 There is no mention of randomisation in the abstract. Retrospective cohort study.
Buccellato 2000 High-dose misoprostol
Cahill 1988 Alternate randomisation.
Caughey 2007 Balloon high vs low volume => not within scope of review
Chipato 1997 2 regimens of extra-amniotic infusion compared.
Chung 2003 High-dose misoprostol
Connolly 2016 Foley+ oxytocin vs Foley => not within scope of review
Connolly 2017 Foley + oxytocin vs Foley (multiparae) => not within scope of review
Cross 1978 Randomisation based on the last digit of the hospital chart number. 6 women were excluded in the
laminaria group, and 1 in the control group. No clinical outcomes were reported.
Cullimore 2009 Trial registration. study terminated after n = 5).no information could be obtained (authors were
contacted)
De Oliveira 2003 Foley vs no ripening => not in scope
Delaney 2010 Comparison of 2 mechanical methods.
Demirel 2015 Nipple stimulation, no mechanical method included
Dias 2008 Trial registration, expected end date expired > 2 years. no information could be obtained (authors
were contacted)
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Study Reason for exclusion
Du 2015 Not randomised. women could choose induction method
Edwards 2017 Foley + PGE2 vs Foley => not within scope of review
El Sharkwy 2017 Foley + miso vs Foley (and miso after 12 hours) => not within scope of review
El-Khayat 2016 Foley + isorbide mononitrate vs misoprostol => not within scope of review
El-Torkey 1995 Foley + EASI vs Foley => not in scope
Emery 1988 No information.
EUCTR 2012 Trial registration, expected end date expired > 2 years. no information obtained (authors were con-
tacted)
Filshie 1992 Insufficient information.
Forgie 2016 Placement stylette vs no stylette => not within scope of review
Forooshani 2011 Foley vs laminaria => not within scope of review
Fruhman 2017 Tension vs no tension => not within scope of review
Gadel 2015 Cervical ripening in case of stillbirth
Garebedian 2016 Foley vs expectative management
Ghanaei 2009 Foley + oxytocin vs EASI + oxytocin
Ghanaie 2013 Foley +oxytocin vs EASI + oxytocin vs PGE2 + oxytocin => not within scope of review
Gibson 2013 different kind of traction applied => not within scope of review
Gilson 1996 Dilapan vs no treatment => not in scope
Gonsoulin 1989 No clinical outcome reported.
Gower 1982 Laminaria vs placebo => not in scope
Greybush 2001 High-dose misoprostol
Gu 2015 Low- vs high-volume balloon => not within scope of review
Guinn 2004 Compares 2 mechanical regimens.
Haghighi 2015 EASI vs isoniazide => not within scope of review
Hallak 2008 Foley vs Foley + EASI vs ATAD + EASI => not in scope
He 2000 Air vesicle odinopoeia => not within scope of review
Hill 2009 High-dose misoprostol
Hill 2013 Balloon + miso vs balloon + placebo => not within scope of review
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Hussein 2012 Induction for fetal demise or early PE (begin third trimester), so no viable fetus
Ifnan 2006 Hydrostatic membrane sweeping vs Foley => not within scope of review
Jagani 1984 An extra-amniotic catheter is used in all groups to record the uterine activity. This catheter uses a
5 mL balloon, which is much lower than the volume used by the other authors (30 mL to 40 mL).
Thus, this study is a comparison between oxytocin and PG, with a control group without interven-
tion.
Jasper 2000 No clinical outcome reported (reported as abstract).
Jindal 2007 Methods are interchanged after 24 hours, outcomes are given for the totals.
Jonsson 2011 Digital vs manual placement Foley => not within scope of review
Kamilya 2011 Trial registration, expected end date expired > 2 years. no information could be obtained (authors
were contacted)
Karjane 2006 Compares 2 mechanical regimens.
Kasdaglis 2007 The randomisation scheme is unclear and the numbers in both groups are very different (32 and
24).
Kashanian 2006 High-dose misoprostol
Kashanian 2009a Comparison of 2 mechanical regimens.
Kehl 2012 2 hours cook balloon before vaginal miso vs no balloon before vaginal miso => not within scope of
review
Kehl 2015 Balloon before oral misoprostol vs no balloon before oral misoprostol => not within scope of re-
view
Keirse 1983 No clinical outcome reported.
Lackritz 1979 Laminaria vs no treatment => not in scope
Lam 2006 Foley +oxytocin vs EASI + oxytocin => not within scope of review
Leiberman 1977 Alternate inclusion in each group. Imbalance between groups in numbers and prognostic factors.
Leong 2017 Menbrane sweeping vs Foley => not within scope of review
Levine 2016 High-dose misoprostol
Levy 2000 Comparison between early and late amniotomy.
Levy 2004 Comparison between 2 mechanical regimens.
Lin 1995 Laminaria vs EASI => not in scope
Lin 2006 Trial registration only, study terminated.
Lin 2007 Compares 2 mechanical regimens.
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Lutgendorf 2012 Traction vs no traction => not within scope of review
Macpherson 1983 No clinical outcomes mentioned.
Mahomed 1988 Foley catheter under traction compared with Foley catheter with extra-amniotic PGE2.
Manabe 1985 No clinical outcomes.
Manish 2016 High- vs low-volume balloon
Manyonda 2007 Balloon vs expectant management => not in scope
Martin 1989 Comparison of induction of labour vs surveillance in post-term pregnancy.
Mattingly 2015 Double balloon 12 hours vs double balloon 24 hours
Mawire 1999 EASI vs PGE f2 alpha => not in scope
McGee 2016 Foley silicone vs Foley latex
Mei-Dan 2009 Comparison of 2 mechanical regimens.
Mei-Dan 2012 Trial terminated before start.
Mei-Dan 2012a Foley +EASI vs Cook balloon
Mei-Dan 2014 Single balloon + EASI vs double balloon + EASI
Miller 2015 Induction vs expectant management. (choice of induction method was up to clinician.)
Moise 1991 Duplicate information, already included.
Morrison 1993 Insufficient information.
Movahed 2016 Foley vs laminaria vs isorbide mononitrate
Mullin 2014 Direct removal of Foley or not
Naseem 2007 Quasi-experimental, every second patient gets Foley
Nasir 2012 Quasi-experimental
Neethurani 2013 Foley + EASI followed by miso vs miso
Owolabi 2005 High-dose misoprostol
Park 2011 Trial registration, expected end date expired > 2 years. No information could be obtained (authors
were contacted)
Pathiraja 2014 Trial registration, anticipated end date (2014) has expired > 2 years. No information could be ob-
tained (authors were contacted)
Pedersen 1981 Comparison of the addition or not of estradiol to Foley catheter.
Pettker 2008 Comparison of 2 mechanical regimens.
Mechanical methods for induction of labour (Review)
Copyright © 2019 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane
Collaboration.
204
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Study Reason for exclusion
Rameez 2007 Nitric oxide vs vitamin C
Reif 2012 Trial registration, anticipated end date (2015) has expired > 2 years. No information could be ob-
tained (authors were contacted)
Rezk 2014 Foley vs isorbide mononitrate
Rust 2001 High-dose misoprostol
Saad 2016 Foley vs laminaria
Saito 1999 Comparison of 2 mechanical regimens.
Salmeen 2012 Outpatient, pre-induction Foley before pharmacological hospital induction
Sanchez-Ramos 1990 Insufficient information.
Sandberg 2017 High vs low volume
Schoen 2017 Foley + oxytocin vs Foley
Schreyer 1989 Allocation of women was performed according to alternate weeks.
Sciscione 2001 High-dose misoprostol
Sharma 2015a Foley: direct removal or not.
Sharma 2017 Foley vs mifepristone => not in scope
Sherman 2001 Comparison of PGE2 infusion vs saline infusion extra-amniotically. This comparison is not included
in this review.
Siddiqui 2013 Placement Foley: stylette vs no stylette
Suri 2000 No clinical outcome reported (reported only as abstract).
Thigpen 2004 Compares a mechanical method with very high dose misoprostol (250 mcg).
Thomas 1986 Randomisation by odd and even numbers of hospital charts
Torbenson 2015 Outpatient Foley vs inpatient miso or Foley. Choice of inpatient method by clinician, so no RCT
Ugwu 2013 Balloon vs misoprostol, crossover after 24 hours
Vengalil 1998 High-dose misoprostol
Walfisch 2014 Foley vs expectative management
Walfisch 2015 Balloon + EASI vs balloon
Welt 1987 Insufficient information.
Wickramasinghe 2014 Foley 24 hours vs Foley 48 hours
Wilkinson 2015 Inpatient vs outpatient double balloon
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Yaddehige 2015 Membrane sweeping vs massage => not in scope
Yazdani 2011 Trial registration of which anticipated end date (2008) has expired > 2 years. Trial was registered
in retrospect. not clear why there is no publication. no information could be obtained (author con-
tacted)
Zakaria 2017 Different charriere Foley catheter
Zhang 2014 Trial registration, anticipated end date (2015) has expired > 2 years. No information could be ob-
tained (authors contacted)
Zimmer 1996 No outcomes reported. The authors focused on breathing movements of the fetus.
EASI: extra-amniotic space infusion
PG: prostaglandin
PGE2: prostaglandin E2
RCT: randomised controlled trial
vs: versus
 
Characteristics of studies awaiting assessment [ordered by study ID]
 
Methods  
Participants  
Interventions  
Outcomes  
Notes Found in search update of March 2019 => classification will be done in next update
ACTRN12618000510246 2018 
 
 
Methods  
Participants  
Interventions  
Outcomes  
Notes Publication could not be obtained. To try again in next update
Agboghoroma 2015 
 
 
Methods  
Participants  
Amorosa 2017a 
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Interventions  
Outcomes  
Notes Found in search update of March 2019 => classification will be done in next update
Amorosa 2017a  (Continued)
 
 
Methods  
Participants  
Interventions  
Outcomes  
Notes Found in search update of March 2019 => classification will be done in next update
Bauer 2018 
 
 
Methods  
Participants  
Interventions  
Outcomes  
Notes Found in search update of March 2019 => classification will be done in next update
Chai 2018 
 
 
Methods  
Participants  
Interventions  
Outcomes  
Notes Found in search update of March 2019 => classification will be done in next update
Cherian 2018 
 
 
Methods  
Participants  
CTRI/2018/01/011574 
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Interventions  
Outcomes  
Notes Found in search update of March 2019 => classification will be done in next update
CTRI/2018/01/011574  (Continued)
 
 
Methods  
Participants  
Interventions  
Outcomes  
Notes Found in search update of March 2019 => classification will be done in next update
de Vaan 2019 
 
 
Methods  
Participants  
Interventions  
Outcomes  
Notes Found in search update of March 2019 => classification will be done in next update
DeCesare 2018 
 
 
Methods  
Participants  
Interventions  
Outcomes  
Notes Found in search update of March 2019 => classification will be done in next update
Diguisto 2017 
 
 
Methods  
Participants  
EUCTR2017-001914-27-GB 2018 
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Interventions  
Outcomes  
Notes Found in search update of March 2019 => classification will be done in next update
EUCTR2017-001914-27-GB 2018  (Continued)
 
 
Methods  
Participants  
Interventions  
Outcomes  
Notes Found in search update of March 2019 => classification will be done in next update
IRCT20170326033142N2 2018 
 
 
Methods  
Participants  
Interventions  
Outcomes  
Notes Found in search update of March 2019 => classification will be done in next update
IRCT20170513033941N39 2018 
 
 
Methods  
Participants  
Interventions  
Outcomes  
Notes Found in search update of March 2019 => classification will be done in next update
IRCT20181123041731N1 2019 
 
 
Methods  
Participants  
Khatib 2019 
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Lim 2018 
 
 
Methods  
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Outcomes  
Notes Authors contacted. outcomes reported in Iranian magazine, asked authors for refer-
ence
Mallah 2011 
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NCT03588585 2018 
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NCT03629548 2018 
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NCT03744078 2018 
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Saad 2019 
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Notes Found in search update of March 2019 => classification will be done in next update
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Notes Found in search update of March 2019 => classification will be done in next update
Tulek 2018 
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Notes Found in search update of March 2019 => classification will be done in next update
Viteri 2019  (Continued)
 
Characteristics of ongoing studies [ordered by study ID]
 
Trial name or title Comparison of vaginal misoprostol plus supracervical balloon versus vaginal misoprostol
alone for induction of labor
Methods RCT
Participants  
Interventions Foley + vaginal misoprostol
Vaginal misoprostol
Outcomes  
Starting date Unknown
Contact information  
Notes Author contacted: still recruiting
Argilagos 2016 
 
 
Trial name or title Prostaglandin Inpatient iNduction of labour Compared with BALLOon Outpatient iNduc-
tion of labour: a randomised controlled trial - The PINC BALLOON Study
Methods RCT
Participants  
Interventions Foley
Vaginal PGE2
Outcomes  
Starting date Unknown
Contact information  
Notes Author contacted: recruiting
Beckmann 2013 
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Trial name or title A randomised controlled trial of sequential versus simultaneous use of Foley balloon and
oxytocin for induction of labour in nulliparous pregnant women
Methods  
Participants Foley + oxytocin
Foley
Interventions  
Outcomes  
Starting date 9 August 2017
Contact information  
Notes Status unknown. author contacted
Bekele 2017 
 
 
Trial name or title High volume Foleys increasing vaginal birth (high 5 birth) pilot trial
Methods  
Participants  
Interventions Balloon
Prostaglandin
Outcomes  
Starting date December 2016
Contact information  
Notes Recruiting (estimated end date: September 2019)
Berndl 2016 
 
 
Trial name or title Prostaglandin insert (propess) versus trans-cervical balloon catheter for out-patient labour
induction: a randomised controlled trial of feasibility
Methods  
Participants  
Interventions Foley
Vaginal PGE2
Outcomes  
Bhide 2017 
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Starting date September 2017
Contact information  
Notes Recruiting (anticipated end date: August 2018)
Bhide 2017  (Continued)
 
 
Trial name or title Compare prostaglandin e2 against to combined transcervical Foley catheter balloon and vagi-
nal prostaglandin e2 for induction of labour at term: a randomised study
Methods  
Participants  
Interventions Foley + vaginal PGE2
Vaginal PGE2
Outcomes January 2016
Starting date  
Contact information  
Notes Recruitment completed in January 2018
Eser 2016 
 
 
Trial name or title Comparison the results of induction of vaginal misoprostol with Foley catheter in pro-
longed pregnancy with unripe cervix
Methods  
Participants  
Interventions Foley
Vaginal misoprostol
Outcomes  
Starting date March 2017
Contact information  
Notes Estimated end date: June 2017 => author contacted. status unknown
Goli 2017 
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Trial name or title Oral misoprostol for 48 hours versus an intracervical Foley catheter for 48 hours for induc-
tion of labour in post dated pregnancies: a randomised control trial
Methods  
Participants  
Interventions Foley catheter
Oral misoprostol
Outcomes  
Starting date October 2016
Contact information  
Notes Recruitment completed
Goonewardene 2016 
 
 
Trial name or title A randomised controlled trial of a synthetic osmotic cervical dilator for induction of
labour in comparison to dinoprostone vaginal insErt: the SOLVE Trial
Methods  
Participants  
Interventions Laminaria
Vagina PGE2
Outcomes  
Starting date  
Contact information  
Notes Not yet recruiting
Gupta 2016 
 
 
Trial name or title Misoprostol versus Foley catheter for cervical ripening in women with pre-eclampsia
or gestational hypertension
Methods  
Participants  
Interventions Foley
Misoprostol
Hassanzadeh 2017 
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Outcomes  
Starting date February 2017
Contact information  
Notes Authors contacted. Still recruiting?
Hassanzadeh 2017  (Continued)
 
 
Trial name or title Comparison between intravaginal misoprostol tablet and intracervical Foley's catheter
in a low resource setting
Methods  
Participants  
Interventions Foley
Vaginal misoprostol (dosage unclear)
Outcomes  
Starting date  
Contact information  
Notes Recruitment completed in April 2018
Igwe 2017 
 
 
Trial name or title Comparison between two strategies of induction in case of unfavourable cervix after 12 hours of
premature rupture of membranes (prom) at term: cook cervical ripening + oxytocine from 6 hours
versus dinoprostone vaginal insert
Methods  
Participants  
Interventions Foley
Vaginal PGE2
Outcomes  
Starting date October 2017
Contact information  
Notes Expected end date: July 2020
Lacarin 2017 
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Trial name or title A comparison between labour induction with dinoprostone and a cervical ripening bal-
loon in women with a BMI > 30 as oppose with a BMI < 30
Methods  
Participants  
Interventions Balloon
PGE2
Outcomes  
Starting date January 2017
Contact information  
Notes Expected end date: January 2019
Lauterbach 2017 
 
 
Trial name or title A randomised controlled study comparing cervical Foley catheter, vaginal dinoprostone
and a combination of the two methods for induction of labor
Methods  
Participants  
Interventions Foley + PGE2
PGE2
Outcomes  
Starting date February 2016
Contact information  
Notes Not yet recruiting
Levy 2016 
 
 
Trial name or title A combination of Foley balloon and misoprostol versus misoprostol alone for induction of
labour at Kenyatta national hospital, a randomised controlled trial
Methods  
Participants  
Interventions Foley + misoprostol
Misoprostol
Osoti 2016 
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Outcomes  
Starting date March 2016
Contact information  
Notes Recruitment completed
Osoti 2016  (Continued)
 
 
Trial name or title Foley catheter versus dinoprostone vaginal insert for induction of labour in parous
women at term: a randomised trial
Methods  
Participants  
Interventions  
Outcomes  
Starting date May 2012
Contact information  
Notes Trial status unclear. expected end date 2017 => authors contacted
Park 2012 
 
 
Trial name or title Propess® versus double balloon for cervical ripening of prolonged pregnancies: a ran-
domised controlled trial
Methods  
Participants  
Interventions Double balloon
Vaginal PGE2
Outcomes  
Starting date September 2016
Contact information  
Notes Expected end date: January 2020
Perrotin 2016 
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Trial name or title Cervical ripening balloon in induction of labour at term (crbii) - a prospective ran-
domised controlled trial
Methods  
Participants  
Interventions PGE2
Balloon
Outcomes  
Starting date December 2015
Contact information  
Notes Expected end date: March 2018 => recruiting
Tagore 2015 
 
 
Trial name or title The efficacy of transcervical Foley balloon plus vaginal misoprostol versus vaginal misoprostol
alone for cervical ripening in nulliparous obese women: a randomised, comparative effective-
ness trial
Methods  
Participants  
Interventions Foley + misoprostol
Misoprostol
Outcomes  
Starting date December 2015
Contact information  
Notes Recruiting
Viteri 2015 
 
 
Trial name or title Comparison of low-risk pregnant women undergoing induction of labour at term by outpa-
tient balloon or inpatient prostaglandin in order to assess vaginal birth rate; a randomised
controlled trial
Methods  
Participants  
Interventions Balloon
Wise 2016 
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PGE2
Outcomes  
Starting date March 2016
Contact information  
Notes Not yet recruiting
Wise 2016  (Continued)
 
 
Trial name or title Dinoprostone vaginal insert versus double balloon catheter for preinduction
cervical ripening
Methods  
Participants  
Interventions Double balloon
PGE2
Outcomes  
Starting date January 2017
Contact information  
Notes Recruitment completed
Yildirim 2017 
BMI: body, mass index
PGE2: prostaglandin E2
RCT: randomised controlled trial
 
 
D A T A   A N D   A N A L Y S E S
 
Comparison 1.   Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all women
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Vaginal delivery not achieved in 24 hours 7 1685 Risk Ratio (M-H, Random, 95%
CI)
1.01 [0.82, 1.26]
2 Uterine hyperstimulation with FHR
changes
6 1966 Risk Ratio (M-H, Fixed, 95% CI) 0.35 [0.18, 0.67]
3 Caesarean section 28 6619 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.92, 1.09]
4 Serious neonatal morbidity/perinatal
death
8 2757 Risk Ratio (M-H, Fixed, 95% CI) 0.48 [0.25, 0.93]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
5 Serious maternal morbidity or death 4 1481 Risk Ratio (M-H, Fixed, 95% CI) 0.20 [0.01, 4.12]
6 Oxytocin augmentation 16 4828 Risk Ratio (M-H, Random, 95%
CI)
1.54 [1.35, 1.76]
7 Uterine hyperstimulation without fetal
heart rate changes
15 2444 Risk Ratio (M-H, Random, 95%
CI)
0.27 [0.11, 0.66]
8 Uterine rupture 2 1045 Risk Ratio (M-H, Fixed, 95% CI) 0.20 [0.01, 4.12]
9 Epidural analgesia 8 2828 Risk Ratio (M-H, Random, 95%
CI)
1.14 [1.00, 1.29]
10 Instrumental vaginal delivery 16 4514 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.79, 1.09]
11 Meconium-stained liquor 4 964 Risk Ratio (M-H, Fixed, 95% CI) 0.89 [0.67, 1.19]
12 Apgar score < 7 at 5 minutes 14 4271 Risk Ratio (M-H, Fixed, 95% CI) 0.74 [0.49, 1.14]
13 Neonatal intensive care unit admission 12 3647 Risk Ratio (M-H, Fixed, 95% CI) 0.82 [0.65, 1.04]
14 Perinatal death 5 1036 Risk Ratio (M-H, Fixed, 95% CI) 0.21 [0.01, 4.27]
15 Postpartum haemorrhage 8 2215 Risk Ratio (M-H, Fixed, 95% CI) 0.82 [0.63, 1.06]
16 Women not satisfied 1 93 Risk Ratio (M-H, Fixed, 95% CI) 0.61 [0.39, 0.97]
17 Maternal fever during labour 7 2362 Risk Ratio (M-H, Fixed, 95% CI) 0.87 [0.65, 1.17]
18 Antibiotics during labour 1 330 Risk Ratio (M-H, Fixed, 95% CI) 1.43 [0.89, 2.29]
19 Chorioamnionitis 1 376 Risk Ratio (M-H, Fixed, 95% CI) 0.69 [0.32, 1.49]
20 Endometritis 2 706 Risk Ratio (M-H, Fixed, 95% CI) 0.49 [0.19, 1.27]
21 Fetal distress 20 4753 Risk Ratio (M-H, Fixed, 95% CI) 0.71 [0.60, 0.83]
22 Umbilical artery pH < 7.10 8 2675 Odds Ratio (M-H, Fixed, 95%
CI)
0.65 [0.44, 0.94]
 
 
Analysis 1.1.   Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin
E2: all women, Outcome 1 Vaginal delivery not achieved in 24 hours.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Al-Taani 2004 21/72 5/75 4.37% 4.38[1.74,10.98]
Cromi 2011 158/265 68/132 17.67% 1.16[0.95,1.4]
Cromi 2012 33/105 52/103 13.62% 0.62[0.44,0.88]
Edwards 2014c 103/185 134/191 18.52% 0.79[0.68,0.93]
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
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Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Henry 2013 41/50 36/51 16.97% 1.16[0.93,1.45]
Pennell 2009 124/217 64/113 17.54% 1.01[0.83,1.23]
Wang 2014 27/67 23/59 11.31% 1.03[0.67,1.59]
   
Total (95% CI) 961 724 100% 1.01[0.82,1.26]
Total events: 507 (Balloon), 382 (Vaginal PGE2)  
Heterogeneity: Tau2=0.06; Chi2=29.06, df=6(P<0.0001); I2=79.35%  
Test for overall effect: Z=0.12(P=0.9)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 1.2.   Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin
E2: all women, Outcome 2 Uterine hyperstimulation with FHR changes.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Henry 2013 0/50 2/51 7.64% 0.2[0.01,4.14]
Jozwiak 2012 8/411 12/408 37.15% 0.66[0.27,1.6]
Pennell 2009 0/217 5/113 22.28% 0.05[0,0.85]
Prager 2008 2/198 6/191 18.84% 0.32[0.07,1.57]
Wang 2012 0/128 4/124 14.1% 0.11[0.01,1.98]
Yuen 1996 0/36 0/39   Not estimable
   
Total (95% CI) 1040 926 100% 0.35[0.18,0.67]
Total events: 10 (Balloon), 29 (Vaginal PGE2)  
Heterogeneity: Tau2=0; Chi2=4.61, df=4(P=0.33); I2=13.31%  
Test for overall effect: Z=3.17(P=0)  
Favours balloon 200.05 50.2 1 Favours PGE2
 
 
Analysis 1.3.   Comparison 1 Balloon (Foley or ATAD) versus vaginal
prostaglandin E2: all women, Outcome 3 Caesarean section.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Al-Taani 2004 12/72 10/75 1.24% 1.25[0.58,2.71]
Atad 1996 7/35 4/30 0.55% 1.5[0.49,4.63]
Barda 2018 17/150 26/150 3.3% 0.65[0.37,1.15]
Browne 2011 14/35 10/31 1.35% 1.24[0.65,2.38]
Cromi 2011 84/265 40/132 6.78% 1.05[0.76,1.43]
Cromi 2012 25/105 27/103 3.46% 0.91[0.57,1.46]
Deo 2012 9/50 12/52 1.49% 0.78[0.36,1.69]
Deshmukh 2011 28/200 37/200 4.7% 0.76[0.48,1.19]
Edwards 2014c 53/185 72/191 9% 0.76[0.57,1.02]
Henry 2013 17/50 15/51 1.89% 1.16[0.65,2.05]
Jozwiak 2012 93/411 82/408 10.46% 1.13[0.87,1.47]
Jozwiak 2013 21/107 26/119 3.13% 0.9[0.54,1.5]
Khamaiseh 2012 72/210 70/204 9.02% 1[0.77,1.3]
Lewis 1983 7/22 3/22 0.38% 2.33[0.69,7.88]
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
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Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Lokkegaard 2015 114/412 107/413 13.58% 1.07[0.85,1.34]
Niromanesh 2003 11/45 12/44 1.54% 0.9[0.44,1.81]
Ophir 1992 4/27 5/27 0.64% 0.8[0.24,2.66]
Orhue 1995 3/30 6/34 0.71% 0.57[0.16,2.07]
Pennell 2009 86/217 42/113 7.02% 1.07[0.8,1.43]
Prager 2008 45/198 50/191 6.47% 0.87[0.61,1.23]
Rudra 2012 22/200 18/200 2.29% 1.22[0.68,2.21]
Saleem 2006 11/78 11/75 1.43% 0.96[0.44,2.08]
Shechter-Maor 2015 2/26 4/26 0.51% 0.5[0.1,2.5]
Suffecool 2014 17/31 16/31 2.03% 1.06[0.67,1.7]
Tan 2015 9/31 11/52 1.04% 1.37[0.64,2.94]
Wang 2012 36/128 28/124 3.61% 1.25[0.81,1.91]
Wang 2014 11/67 13/59 1.76% 0.75[0.36,1.53]
Yuen 1996 10/36 5/39 0.61% 2.17[0.82,5.73]
   
Total (95% CI) 3423 3196 100% 1[0.92,1.09]
Total events: 840 (Balloon), 762 (Vaginal PGE2)  
Heterogeneity: Tau2=0; Chi2=20.03, df=27(P=0.83); I2=0%  
Test for overall effect: Z=0.06(P=0.95)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 1.4.   Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin
E2: all women, Outcome 4 Serious neonatal morbidity/perinatal death.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Cromi 2011 0/265 0/132   Not estimable
Deshmukh 2011 7/200 9/200 34.05% 0.78[0.3,2.05]
Edwards 2014c 0/185 2/191 9.31% 0.21[0.01,4.27]
Jozwiak 2012 1/411 6/408 22.78% 0.17[0.02,1.37]
Jozwiak 2013 1/107 4/119 14.33% 0.28[0.03,2.45]
Pennell 2009 0/217 1/113 7.45% 0.17[0.01,4.24]
Tan 2015 0/31 0/52   Not estimable
Wang 2014 3/67 3/59 12.07% 0.88[0.18,4.2]
   
Total (95% CI) 1483 1274 100% 0.48[0.25,0.93]
Total events: 12 (Balloon), 25 (Vaginal PGE2)  
Heterogeneity: Tau2=0; Chi2=3.43, df=5(P=0.63); I2=0%  
Test for overall effect: Z=2.18(P=0.03)  
Favours balloon 1000.01 100.1 1 Favours PGE2
 
 
Analysis 1.5.   Comparison 1 Balloon (Foley or ATAD) versus vaginal
prostaglandin E2: all women, Outcome 5 Serious maternal morbidity or death.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Edwards 2014c 0/185 0/191   Not estimable
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
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Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Jozwiak 2012 0/411 2/408 100% 0.2[0.01,4.12]
Jozwiak 2013 0/107 0/119   Not estimable
Orhue 1995 0/30 0/30   Not estimable
   
Total (95% CI) 733 748 100% 0.2[0.01,4.12]
Total events: 0 (Balloon), 2 (Vaginal PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.04(P=0.3)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 1.6.   Comparison 1 Balloon (Foley or ATAD) versus vaginal
prostaglandin E2: all women, Outcome 6 Oxytocin augmentation.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Al-Taani 2004 35/72 15/75 3.59% 2.43[1.46,4.05]
Barda 2018 133/150 82/150 7.26% 1.62[1.39,1.9]
Cromi 2011 216/265 71/132 7.14% 1.52[1.28,1.79]
Cromi 2012 90/105 56/103 6.88% 1.58[1.3,1.91]
Deo 2012 32/50 21/52 4.68% 1.58[1.07,2.34]
Deshmukh 2011 134/200 122/200 7.35% 1.1[0.95,1.27]
Edwards 2014c 171/185 162/191 7.91% 1.09[1.01,1.17]
Henry 2013 44/50 30/51 6.22% 1.5[1.16,1.92]
Jozwiak 2012 353/411 239/408 7.81% 1.47[1.34,1.61]
Jozwiak 2013 83/107 78/119 7.17% 1.18[1,1.4]
Khamaiseh 2012 165/210 134/204 7.58% 1.2[1.06,1.35]
Lokkegaard 2015 329/412 215/413 7.71% 1.53[1.38,1.7]
Shechter-Maor 2015 22/26 14/26 4.67% 1.57[1.06,2.33]
Tan 2015 24/31 26/52 5.31% 1.55[1.11,2.16]
Wang 2012 112/128 26/124 5.13% 4.17[2.95,5.91]
Wang 2014 43/67 13/59 3.59% 2.91[1.75,4.86]
   
Total (95% CI) 2469 2359 100% 1.54[1.35,1.76]
Total events: 1986 (Balloon), 1304 (Vaginal PGE2)  
Heterogeneity: Tau2=0.05; Chi2=141.47, df=15(P<0.0001); I2=89.4%  
Test for overall effect: Z=6.53(P<0.0001)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 1.7.   Comparison 1 Balloon (Foley or ATAD) versus vaginal prostaglandin E2:
all women, Outcome 7 Uterine hyperstimulation without fetal heart rate changes.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Deo 2012 0/50 3/52 6.13% 0.15[0.01,2.8]
Edwards 2014c 0/185 5/191 6.28% 0.09[0.01,1.69]
Jozwiak 2013 2/107 2/119 9.81% 1.11[0.16,7.76]
Khamaiseh 2012 1/210 6/204 9.06% 0.16[0.02,1.33]
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
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Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Lewis 1983 0/22 0/22   Not estimable
Niromanesh 2003 6/45 3/44 13.09% 1.96[0.52,7.34]
Orhue 1995 1/30 0/30 5.55% 3[0.13,70.83]
Pennell 2009 0/217 11/113 6.47% 0.02[0,0.38]
Saleem 2006 0/78 1/75 5.49% 0.32[0.01,7.75]
Shechter-Maor 2015 0/26 2/26 5.99% 0.2[0.01,3.97]
Suffecool 2014 0/31 8/31 6.5% 0.06[0,0.98]
Tan 2015 0/31 1/52 5.53% 0.55[0.02,13.15]
Wang 2012 0/128 18/124 6.54% 0.03[0,0.43]
Wang 2014 3/67 10/59 13.55% 0.26[0.08,0.91]
Yuen 1996 0/36 0/39   Not estimable
   
Total (95% CI) 1263 1181 100% 0.27[0.11,0.66]
Total events: 13 (Balloon), 70 (Vaginal PGE2)  
Heterogeneity: Tau2=1.13; Chi2=22.28, df=12(P=0.03); I2=46.13%  
Test for overall effect: Z=2.88(P=0)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 1.8.   Comparison 1 Balloon (Foley or ATAD) versus
vaginal prostaglandin E2: all women, Outcome 8 Uterine rupture.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Jozwiak 2012 0/411 2/408 100% 0.2[0.01,4.12]
Jozwiak 2013 0/107 0/119   Not estimable
   
Total (95% CI) 518 527 100% 0.2[0.01,4.12]
Total events: 0 (Balloon), 2 (Vaginal PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.04(P=0.3)  
Favours balloon 1000.01 100.1 1 Favours PGE2
 
 
Analysis 1.9.   Comparison 1 Balloon (Foley or ATAD) versus vaginal
prostaglandin E2: all women, Outcome 9 Epidural analgesia.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Cromi 2011 211/265 71/132 13.79% 1.48[1.25,1.75]
Cromi 2012 87/105 63/103 13.49% 1.35[1.14,1.62]
Edwards 2014c 158/185 166/191 17.13% 0.98[0.91,1.07]
Jozwiak 2012 122/411 120/408 12.08% 1.01[0.82,1.25]
Jozwiak 2013 30/107 29/119 5.65% 1.15[0.74,1.78]
Pennell 2009 176/217 92/113 16.19% 1[0.89,1.11]
Prager 2008 145/198 117/191 14.96% 1.2[1.04,1.38]
Tan 2015 18/31 29/52 6.72% 1.04[0.71,1.53]
   
Total (95% CI) 1519 1309 100% 1.14[1,1.29]
Favours balloon 50.2 20.5 1 Favours PGE2
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Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Total events: 947 (Balloon), 687 (Vaginal PGE2)  
Heterogeneity: Tau2=0.02; Chi2=32.09, df=7(P<0.0001); I2=78.19%  
Test for overall effect: Z=2.04(P=0.04)  
Favours balloon 50.2 20.5 1 Favours PGE2
 
 
Analysis 1.10.   Comparison 1 Balloon (Foley or ATAD) versus vaginal
prostaglandin E2: all women, Outcome 10 Instrumental vaginal delivery.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Cromi 2011 9/265 7/132 3.57% 0.64[0.24,1.68]
Cromi 2012 6/105 1/103 0.39% 5.89[0.72,48.04]
Deo 2012 1/50 3/52 1.12% 0.35[0.04,3.22]
Deshmukh 2011 8/200 6/200 2.29% 1.33[0.47,3.77]
Henry 2013 18/50 11/51 4.16% 1.67[0.88,3.17]
Jozwiak 2012 45/411 54/408 20.71% 0.83[0.57,1.2]
Jozwiak 2013 13/107 20/119 7.24% 0.72[0.38,1.38]
Khamaiseh 2012 10/210 5/204 1.94% 1.94[0.68,5.59]
Lokkegaard 2015 45/412 45/413 17.18% 1[0.68,1.48]
Ophir 1992 1/27 2/27 0.76% 0.5[0.05,5.19]
Orhue 1995 6/30 4/30 1.53% 1.5[0.47,4.78]
Pennell 2009 48/217 28/113 14.07% 0.89[0.59,1.34]
Prager 2008 45/198 50/191 19.45% 0.87[0.61,1.23]
Shechter-Maor 2015 1/26 1/26 0.38% 1[0.07,15.15]
Suffecool 2014 2/31 4/31 1.53% 0.5[0.1,2.53]
Yuen 1996 3/36 10/39 3.67% 0.33[0.1,1.09]
   
Total (95% CI) 2375 2139 100% 0.93[0.79,1.09]
Total events: 261 (Balloon), 251 (Vaginal PGE2)  
Heterogeneity: Tau2=0; Chi2=15.51, df=15(P=0.42); I2=3.29%  
Test for overall effect: Z=0.92(P=0.36)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 1.11.   Comparison 1 Balloon (Foley or ATAD) versus vaginal
prostaglandin E2: all women, Outcome 11 Meconium-stained liquor.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Al-Taani 2004 13/72 15/75 17.89% 0.9[0.46,1.76]
Edwards 2014c 24/185 19/191 22.76% 1.3[0.74,2.3]
Prager 2008 33/198 42/191 52.05% 0.76[0.5,1.14]
Shechter-Maor 2015 3/26 6/26 7.3% 0.5[0.14,1.79]
   
Total (95% CI) 481 483 100% 0.89[0.67,1.19]
Total events: 73 (Balloon), 82 (Vaginal PGE2)  
Heterogeneity: Tau2=0; Chi2=3.12, df=3(P=0.37); I2=3.87%  
Test for overall effect: Z=0.8(P=0.42)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
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Analysis 1.12.   Comparison 1 Balloon (Foley or ATAD) versus vaginal
prostaglandin E2: all women, Outcome 12 Apgar score < 7 at 5 minutes.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Barda 2018 0/150 0/150   Not estimable
Cromi 2011 1/265 2/132 5.64% 0.25[0.02,2.72]
Cromi 2012 1/105 0/103 1.07% 2.94[0.12,71.43]
Deshmukh 2011 15/200 16/200 33.79% 0.94[0.48,1.84]
Edwards 2014c 2/185 2/191 4.16% 1.03[0.15,7.25]
Jozwiak 2012 5/411 8/408 16.96% 0.62[0.2,1.88]
Jozwiak 2013 4/107 6/119 12% 0.74[0.22,2.56]
Lewis 1983 0/22 0/22   Not estimable
Lokkegaard 2015 3/412 3/413 6.33% 1[0.2,4.94]
Pennell 2009 2/217 3/113 8.33% 0.35[0.06,2.05]
Suffecool 2014 1/31 0/31 1.06% 3[0.13,70.92]
Tan 2015 0/31 0/52   Not estimable
Wang 2014 0/67 2/59 5.61% 0.18[0.01,3.6]
Yuen 1996 0/36 2/39 5.07% 0.22[0.01,4.36]
   
Total (95% CI) 2239 2032 100% 0.74[0.49,1.14]
Total events: 34 (Balloon), 44 (Vaginal PGE2)  
Heterogeneity: Tau2=0; Chi2=5.29, df=10(P=0.87); I2=0%  
Test for overall effect: Z=1.37(P=0.17)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 1.13.   Comparison 1 Balloon (Foley or ATAD) versus vaginal
prostaglandin E2: all women, Outcome 13 Neonatal intensive care unit admission.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Al-Taani 2004 6/72 5/75 3.7% 1.25[0.4,3.92]
Cromi 2011 11/265 7/132 7.07% 0.78[0.31,1.97]
Cromi 2012 8/105 5/103 3.82% 1.57[0.53,4.64]
Deshmukh 2011 37/200 42/200 31.76% 0.88[0.59,1.31]
Edwards 2014c 29/185 34/191 25.3% 0.88[0.56,1.38]
Jozwiak 2012 3/411 4/408 3.04% 0.74[0.17,3.31]
Jozwiak 2013 4/107 8/119 5.73% 0.56[0.17,1.79]
Khamaiseh 2012 6/210 9/204 6.91% 0.65[0.23,1.79]
Prager 2008 7/198 12/191 9.24% 0.56[0.23,1.4]
Suffecool 2014 0/31 0/31   Not estimable
Tan 2015 0/31 2/52 1.42% 0.33[0.02,6.68]
Wang 2014 0/67 2/59 2.01% 0.18[0.01,3.6]
   
Total (95% CI) 1882 1765 100% 0.82[0.65,1.04]
Total events: 111 (Balloon), 130 (Vaginal PGE2)  
Heterogeneity: Tau2=0; Chi2=4.77, df=10(P=0.91); I2=0%  
Test for overall effect: Z=1.61(P=0.11)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
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Analysis 1.14.   Comparison 1 Balloon (Foley or ATAD) versus
vaginal prostaglandin E2: all women, Outcome 14 Perinatal death.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Cromi 2011 0/265 0/132   Not estimable
Edwards 2014c 0/185 2/191 100% 0.21[0.01,4.27]
Ophir 1992 0/27 0/27   Not estimable
Tan 2015 0/31 0/52   Not estimable
Wang 2014 0/67 0/59   Not estimable
   
Total (95% CI) 575 461 100% 0.21[0.01,4.27]
Total events: 0 (Balloon), 2 (Vaginal PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.02(P=0.31)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 1.15.   Comparison 1 Balloon (Foley or ATAD) versus vaginal
prostaglandin E2: all women, Outcome 15 Postpartum haemorrhage.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Henry 2013 8/50 11/51 9.61% 0.74[0.33,1.69]
Jozwiak 2012 26/411 38/408 33.67% 0.68[0.42,1.1]
Jozwiak 2013 8/107 7/119 5.85% 1.27[0.48,3.39]
Orhue 1995 3/30 1/30 0.88% 3[0.33,27.23]
Pennell 2009 10/217 12/113 13.93% 0.43[0.19,0.97]
Rudra 2012 29/200 26/200 22.95% 1.12[0.68,1.82]
Saleem 2006 1/78 1/75 0.9% 0.96[0.06,15.1]
Wang 2014 11/67 13/59 12.2% 0.75[0.36,1.53]
   
Total (95% CI) 1160 1055 100% 0.82[0.63,1.06]
Total events: 96 (Balloon), 109 (Vaginal PGE2)  
Heterogeneity: Tau2=0; Chi2=6.71, df=7(P=0.46); I2=0%  
Test for overall effect: Z=1.55(P=0.12)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 1.16.   Comparison 1 Balloon (Foley or ATAD) versus vaginal
prostaglandin E2: all women, Outcome 16 Women not satisfied.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Henry 2013 17/48 26/45 100% 0.61[0.39,0.97]
   
Total (95% CI) 48 45 100% 0.61[0.39,0.97]
Total events: 17 (Balloon), 26 (Vaginal PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.1(P=0.04)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
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Analysis 1.17.   Comparison 1 Balloon (Foley or ATAD) versus vaginal
prostaglandin E2: all women, Outcome 17 Maternal fever during labour.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Henry 2013 5/50 4/51 4.63% 1.27[0.36,4.48]
Jozwiak 2012 12/411 18/408 21.11% 0.66[0.32,1.36]
Jozwiak 2013 5/107 8/119 8.85% 0.7[0.23,2.06]
Khamaiseh 2012 12/210 14/204 16.6% 0.83[0.39,1.76]
Pennell 2009 37/217 20/113 30.73% 0.96[0.59,1.58]
Prager 2008 13/198 13/191 15.46% 0.96[0.46,2.03]
Tan 2015 2/31 3/52 2.62% 1.12[0.2,6.33]
   
Total (95% CI) 1224 1138 100% 0.87[0.65,1.17]
Total events: 86 (Balloon), 80 (Vaginal PGE2)  
Heterogeneity: Tau2=0; Chi2=1.41, df=6(P=0.97); I2=0%  
Test for overall effect: Z=0.9(P=0.37)  
Favours balloon 1000.01 100.1 1 Favours PGE2
 
 
Analysis 1.18.   Comparison 1 Balloon (Foley or ATAD) versus vaginal
prostaglandin E2: all women, Outcome 18 Antibiotics during labour.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Pennell 2009 52/217 19/113 100% 1.43[0.89,2.29]
   
Total (95% CI) 217 113 100% 1.43[0.89,2.29]
Total events: 52 (Balloon), 19 (Vaginal PGE2)  
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=1.47(P=0.14)  
Favours balloon 1000.01 100.1 1 Favours PGE2
 
 
Analysis 1.19.   Comparison 1 Balloon (Foley or ATAD) versus vaginal
prostaglandin E2: all women, Outcome 19 Chorioamnionitis.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Edwards 2014c 10/185 15/191 100% 0.69[0.32,1.49]
   
Total (95% CI) 185 191 100% 0.69[0.32,1.49]
Total events: 10 (Balloon), 15 (Vaginal PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.95(P=0.34)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
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Analysis 1.20.   Comparison 1 Balloon (Foley or ATAD) versus
vaginal prostaglandin E2: all women, Outcome 20 Endometritis.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Edwards 2014c 4/185 10/191 78.91% 0.41[0.13,1.29]
Pennell 2009 3/217 2/113 21.09% 0.78[0.13,4.61]
   
Total (95% CI) 402 304 100% 0.49[0.19,1.27]
Total events: 7 (Balloon), 12 (Vaginal PGE2)  
Heterogeneity: Tau2=0; Chi2=0.35, df=1(P=0.55); I2=0%  
Test for overall effect: Z=1.47(P=0.14)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 1.21.   Comparison 1 Balloon (Foley or ATAD) versus
vaginal prostaglandin E2: all women, Outcome 21 Fetal distress.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Barda 2018 5/150 8/150 2.55% 0.63[0.21,1.87]
Cromi 2011 40/265 37/132 15.73% 0.54[0.36,0.8]
Cromi 2012 11/105 16/103 5.14% 0.67[0.33,1.38]
Deshmukh 2011 17/200 21/200 6.69% 0.81[0.44,1.49]
Edwards 2014c 22/185 24/191 7.52% 0.95[0.55,1.63]
Henry 2013 8/50 5/51 1.58% 1.63[0.57,4.65]
Jozwiak 2012 28/411 38/408 12.14% 0.73[0.46,1.17]
Jozwiak 2013 11/107 12/119 3.62% 1.02[0.47,2.21]
Khamaiseh 2012 32/210 42/204 13.57% 0.74[0.49,1.12]
Niromanesh 2003 7/45 5/44 1.61% 1.37[0.47,3.99]
Ophir 1992 0/27 1/27 0.48% 0.33[0.01,7.84]
Orhue 1995 0/30 0/30   Not estimable
Pennell 2009 29/217 20/113 8.37% 0.76[0.45,1.27]
Prager 2008 17/198 30/191 9.72% 0.55[0.31,0.96]
Saleem 2006 3/78 4/75 1.3% 0.72[0.17,3.11]
Shechter-Maor 2015 0/26 9/26 3.02% 0.05[0,0.86]
Suffecool 2014 8/31 5/31 1.59% 1.6[0.59,4.35]
Tan 2015 1/31 3/52 0.71% 0.56[0.06,5.14]
Wang 2014 1/67 9/59 3.05% 0.1[0.01,0.75]
Yuen 1996 3/36 8/78 1.61% 0.81[0.23,2.88]
   
Total (95% CI) 2469 2284 100% 0.71[0.6,0.83]
Total events: 243 (Balloon), 297 (Vaginal PGE2)  
Heterogeneity: Tau2=0; Chi2=18.69, df=18(P=0.41); I2=3.69%  
Test for overall effect: Z=4.25(P<0.0001)  
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Analysis 1.22.   Comparison 1 Balloon (Foley or ATAD) versus vaginal
prostaglandin E2: all women, Outcome 22 Umbilical artery pH < 7.10.
Study or subgroup Balloon Vaginal PGE2 Odds Ratio Weight Odds Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Barda 2018 0/150 0/150   Not estimable
Cromi 2011 1/265 1/132 1.97% 0.5[0.03,8]
Edwards 2014c 3/185 1/191 1.43% 3.13[0.32,30.38]
Henry 2013 2/50 4/51 5.63% 0.49[0.09,2.8]
Jozwiak 2012 25/411 31/408 43.29% 0.79[0.46,1.36]
Jozwiak 2013 6/107 8/119 10.59% 0.82[0.28,2.46]
Pennell 2009 10/217 8/113 14.87% 0.63[0.24,1.65]
Wang 2014 4/67 15/59 22.22% 0.19[0.06,0.6]
   
Total (95% CI) 1452 1223 100% 0.65[0.44,0.94]
Total events: 51 (Balloon), 68 (Vaginal PGE2)  
Heterogeneity: Tau2=0; Chi2=7.04, df=6(P=0.32); I2=14.77%  
Test for overall effect: Z=2.27(P=0.02)  
Favours balloon 1000.01 100.1 1 Favours PGE2
 
 
Comparison 2.   Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all primiparae
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Vaginal delivery not achieved in 24
hours
1 330 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.83, 1.23]
2 Uterine hyperstimulation with
FHR changes
1 330 Risk Ratio (M-H, Fixed, 95% CI) 0.05 [0.00, 0.85]
3 Caesarean section 5 828 Risk Ratio (M-H, Random, 95% CI) 0.89 [0.59, 1.33]
4 Serious neonatal morbidity/peri-
natal death
1 330 Risk Ratio (M-H, Fixed, 95% CI) 0.17 [0.01, 4.24]
5 Serious maternal morbidity or
death
1 60 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 
 
Analysis 2.1.   Comparison 2 Balloon (Foley or ATAD) versus vaginal prostaglandin
E2: all primiparae, Outcome 1 Vaginal delivery not achieved in 24 hours.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Pennell 2009 124/217 64/113 100% 1.01[0.83,1.23]
   
Total (95% CI) 217 113 100% 1.01[0.83,1.23]
Total events: 124 (Balloon), 64 (Vaginal PGE2)  
Heterogeneity: Not applicable  
Favours balloon 1000.01 100.1 1 Favours PGE2
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Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Test for overall effect: Z=0.09(P=0.93)  
Favours balloon 1000.01 100.1 1 Favours PGE2
 
 
Analysis 2.2.   Comparison 2 Balloon (Foley or ATAD) versus vaginal prostaglandin
E2: all primiparae, Outcome 2 Uterine hyperstimulation with FHR changes.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Pennell 2009 0/217 5/113 100% 0.05[0,0.85]
   
Total (95% CI) 217 113 100% 0.05[0,0.85]
Total events: 0 (Balloon), 5 (Vaginal PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.07(P=0.04)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 2.3.   Comparison 2 Balloon (Foley or ATAD) versus vaginal
prostaglandin E2: all primiparae, Outcome 3 Caesarean section.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Barda 2018 9/72 22/69 18.45% 0.39[0.19,0.79]
Orhue 1995 3/30 6/34 8.01% 0.57[0.16,2.07]
Pennell 2009 86/217 42/113 33.41% 1.07[0.8,1.43]
Prager 2008 40/120 45/131 31.2% 0.97[0.69,1.37]
Yuen 1996 7/20 3/22 8.93% 2.57[0.77,8.6]
   
Total (95% CI) 459 369 100% 0.89[0.59,1.33]
Total events: 145 (Balloon), 118 (Vaginal PGE2)  
Heterogeneity: Tau2=0.11; Chi2=10.01, df=4(P=0.04); I2=60.02%  
Test for overall effect: Z=0.58(P=0.56)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 2.4.   Comparison 2 Balloon (Foley or ATAD) versus vaginal prostaglandin
E2: all primiparae, Outcome 4 Serious neonatal morbidity/perinatal death.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Pennell 2009 0/217 1/113 100% 0.17[0.01,4.24]
   
Total (95% CI) 217 113 100% 0.17[0.01,4.24]
Total events: 0 (Balloon), 1 (Vaginal PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.07(P=0.28)  
Favours balloon 1000.01 100.1 1 Favours PGE2
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Analysis 2.5.   Comparison 2 Balloon (Foley or ATAD) versus vaginal prostaglandin
E2: all primiparae, Outcome 5 Serious maternal morbidity or death.
Study or subgroup Balloon Vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Orhue 1995 0/30 0/30   Not estimable
   
Total (95% CI) 30 30 Not estimable
Total events: 0 (Balloon), 0 (Vaginal PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Comparison 3.   Balloon (Foley or ATAD) versus vaginal prostaglandin E2: all multiparae
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Vaginal delivery not achieved in 24
hours
1 147 Risk Ratio (M-H, Fixed, 95% CI) 4.38 [1.74, 10.98]
2 Caesarean section 2 180 Risk Ratio (M-H, Fixed, 95% CI) 1.31 [0.65, 2.63]
 
 
Analysis 3.1.   Comparison 3 Balloon (Foley or ATAD) versus vaginal prostaglandin
E2: all multiparae, Outcome 1 Vaginal delivery not achieved in 24 hours.
Study or subgroup balloon vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Al-Taani 2004 21/72 5/75 100% 4.38[1.74,10.98]
   
Total (95% CI) 72 75 100% 4.38[1.74,10.98]
Total events: 21 (balloon), 5 (vaginal PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=3.14(P=0)  
Favours balloon 1000.01 100.1 1 Favours PGE2
 
 
Analysis 3.2.   Comparison 3 Balloon (Foley or ATAD) versus vaginal
prostaglandin E2: all multiparae, Outcome 2 Caesarean section.
Study or subgroup balloon vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Al-Taani 2004 12/72 10/75 83.47% 1.25[0.58,2.71]
Yuen 1996 3/16 2/17 16.53% 1.59[0.3,8.33]
   
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
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Study or subgroup balloon vaginal PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Total (95% CI) 88 92 100% 1.31[0.65,2.63]
Total events: 15 (balloon), 12 (vaginal PGE2)  
Heterogeneity: Tau2=0; Chi2=0.07, df=1(P=0.79); I2=0%  
Test for overall effect: Z=0.75(P=0.45)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Comparison 4.   Balloon (Foley or ATAD) versus intracervical prostaglandin E2: all women
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Vaginal delivery not achieved in 24 hours 2 200 Risk Ratio (M-H, Random,
95% CI)
1.01 [0.35, 2.91]
2 Uterine hyperstimulation with FHR changes 4 447 Risk Ratio (M-H, Fixed, 95%
CI)
0.37 [0.02, 8.90]
3 Caesarean section 9 1309 Risk Ratio (M-H, Fixed, 95%
CI)
0.97 [0.81, 1.15]
4 Serious neonatal morbidity/perinatal death 2 500 Risk Ratio (M-H, Fixed, 95%
CI)
0.78 [0.29, 2.05]
5 Cervix unfavourable/unchanged after 24
hours
2 219 Risk Ratio (M-H, Fixed, 95%
CI)
0.96 [0.70, 1.34]
6 Oxytocin augmentation 1 400 Risk Ratio (M-H, Fixed, 95%
CI)
1.08 [0.93, 1.26]
7 Uterine hyperstimulation without FHR
changes
5 654 Risk Ratio (M-H, Random,
95% CI)
0.99 [0.09, 10.38]
8 Epidural analgesia 1 149 Risk Ratio (M-H, Fixed, 95%
CI)
0.91 [0.81, 1.02]
9 Instrumental vaginal delivery 3 337 Risk Ratio (M-H, Fixed, 95%
CI)
1.18 [0.68, 2.05]
10 Meconium-stained liquor 1 118 Risk Ratio (M-H, Fixed, 95%
CI)
1.17 [0.42, 3.26]
11 Apgar score < 7 at 5 minutes 2 475 Risk Ratio (M-H, Fixed, 95%
CI)
0.79 [0.41, 1.53]
12 Neonatal intensive care unit admission 1 400 Risk Ratio (M-H, Fixed, 95%
CI)
0.88 [0.60, 1.31]
13 Perinatal death 2 500 Risk Ratio (M-H, Fixed, 95%
CI)
0.78 [0.29, 2.05]
14 Maternal side effects 2 211 Risk Ratio (M-H, Fixed, 95%
CI)
0.15 [0.02, 1.24]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
15 Postpartum haemorrhage 1 100 Risk Ratio (M-H, Fixed, 95%
CI)
0.2 [0.01, 4.06]
16 Chorioamnionitis 1 118 Risk Ratio (M-H, Fixed, 95%
CI)
1.0 [0.21, 4.75]
17 Endometritis 1 118 Risk Ratio (M-H, Fixed, 95%
CI)
1.0 [0.06, 15.61]
18 Fetal distress 6 1023 Risk Ratio (M-H, Fixed, 95%
CI)
0.61 [0.42, 0.89]
 
 
Analysis 4.1.   Comparison 4 Balloon (Foley or ATAD) versus intracervical
prostaglandin E2: all women, Outcome 1 Vaginal delivery not achieved in 24 hours.
Study or subgroup Balloon Intracervi-
cal PGE2
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Benzineb 1996 34/50 20/50 51.45% 1.7[1.15,2.51]
Dalui 2005 14/50 24/50 48.55% 0.58[0.34,0.99]
   
Total (95% CI) 100 100 100% 1.01[0.35,2.91]
Total events: 48 (Balloon), 44 (Intracervical PGE2)  
Heterogeneity: Tau2=0.53; Chi2=10.35, df=1(P=0); I2=90.34%  
Test for overall effect: Z=0.02(P=0.98)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 4.2.   Comparison 4 Balloon (Foley or ATAD) versus intracervical
prostaglandin E2: all women, Outcome 2 Uterine hyperstimulation with FHR changes.
Study or subgroup Balloon Intracervi-
cal PGE2
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hudon 1999 0/56 0/55   Not estimable
Ntsaluba 1997 0/53 1/59 100% 0.37[0.02,8.9]
Sciscione 1999 0/77 0/72   Not estimable
Yuen 1996 0/36 0/39   Not estimable
   
Total (95% CI) 222 225 100% 0.37[0.02,8.9]
Total events: 0 (Balloon), 1 (Intracervical PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.61(P=0.54)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
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Analysis 4.3.   Comparison 4 Balloon (Foley or ATAD) versus intracervical
prostaglandin E2: all women, Outcome 3 Caesarean section.
Study or subgroup Balloon Intracervi-
cal PGE2
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Benzineb 1996 9/50 6/50 3.55% 1.5[0.58,3.9]
Dalui 2005 8/50 13/50 7.69% 0.62[0.28,1.35]
Hudon 1999 39/56 37/55 22.09% 1.04[0.8,1.33]
Kuppulakshmi 2016 28/100 29/100 17.16% 0.97[0.62,1.5]
Laddad 2013 35/200 40/200 23.67% 0.88[0.58,1.32]
Ntsaluba 1997 8/53 9/59 5.04% 0.99[0.41,2.38]
Sciscione 1999 21/77 21/72 12.84% 0.94[0.56,1.56]
St Onge 1995 6/34 7/28 4.54% 0.71[0.27,1.86]
Yuen 1996 10/36 6/39 3.41% 1.81[0.73,4.46]
   
Total (95% CI) 656 653 100% 0.97[0.81,1.15]
Total events: 164 (Balloon), 168 (Intracervical PGE2)  
Heterogeneity: Tau2=0; Chi2=4.84, df=8(P=0.77); I2=0%  
Test for overall effect: Z=0.39(P=0.7)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 4.4.   Comparison 4 Balloon (Foley or ATAD) versus intracervical
prostaglandin E2: all women, Outcome 4 Serious neonatal morbidity/perinatal death.
Study or subgroup Balloon Intracervi-
cal PGE2
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Benzineb 1996 1/50 1/50 11.11% 1[0.06,15.55]
Laddad 2013 6/200 8/200 88.89% 0.75[0.27,2.12]
   
Total (95% CI) 250 250 100% 0.78[0.29,2.05]
Total events: 7 (Balloon), 9 (Intracervical PGE2)  
Heterogeneity: Tau2=0; Chi2=0.04, df=1(P=0.85); I2=0%  
Test for overall effect: Z=0.51(P=0.61)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 4.5.   Comparison 4 Balloon (Foley or ATAD) versus intracervical prostaglandin
E2: all women, Outcome 5 Cervix unfavourable/unchanged aLer 24 hours.
Study or subgroup Balloon Intracervi-
cal PGE2
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Allouche 1993 30/60 29/59 69.23% 1.02[0.71,1.46]
Benzineb 1996 11/50 13/50 30.77% 0.85[0.42,1.71]
   
Total (95% CI) 110 109 100% 0.96[0.7,1.34]
Total events: 41 (Balloon), 42 (Intracervical PGE2)  
Heterogeneity: Tau2=0; Chi2=0.22, df=1(P=0.64); I2=0%  
Test for overall effect: Z=0.22(P=0.83)  
Favours balloon 1000.01 100.1 1 Favours PGE2
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Analysis 4.6.   Comparison 4 Balloon (Foley or ATAD) versus intracervical
prostaglandin E2: all women, Outcome 6 Oxytocin augmentation.
Study or subgroup Balloon Intracervi-
cal PGE2
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Laddad 2013 132/200 122/200 100% 1.08[0.93,1.26]
   
Total (95% CI) 200 200 100% 1.08[0.93,1.26]
Total events: 132 (Balloon), 122 (Intracervical PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.04(P=0.3)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 4.7.   Comparison 4 Balloon (Foley or ATAD) versus intracervical prostaglandin
E2: all women, Outcome 7 Uterine hyperstimulation without FHR changes.
Study or subgroup Balloon Intracervi-
cal PGE2
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Allouche 1993 2/60 0/59 27.21% 4.92[0.24,100.31]
Hudon 1999 0/56 0/55   Not estimable
Kuppulakshmi 2016 0/100 7/100 28.58% 0.07[0,1.15]
Sciscione 1999 9/77 4/72 44.2% 2.1[0.68,6.53]
Yuen 1996 0/36 0/39   Not estimable
   
Total (95% CI) 329 325 100% 0.99[0.09,10.38]
Total events: 11 (Balloon), 11 (Intracervical PGE2)  
Heterogeneity: Tau2=2.92; Chi2=6.33, df=2(P=0.04); I2=68.39%  
Test for overall effect: Z=0.01(P=0.99)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 4.8.   Comparison 4 Balloon (Foley or ATAD) versus intracervical
prostaglandin E2: all women, Outcome 8 Epidural analgesia.
Study or subgroup Balloon Intracervi-
cal PGE2
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Sciscione 1999 65/77 67/72 100% 0.91[0.81,1.02]
   
Total (95% CI) 77 72 100% 0.91[0.81,1.02]
Total events: 65 (Balloon), 67 (Intracervical PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.66(P=0.1)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
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Analysis 4.9.   Comparison 4 Balloon (Foley or ATAD) versus intracervical
prostaglandin E2: all women, Outcome 9 Instrumental vaginal delivery.
Study or subgroup Balloon Intracervi-
cal PGE2
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Laddad 2013 7/100 5/100 26.92% 1.4[0.46,4.26]
St Onge 1995 13/34 8/28 47.24% 1.34[0.65,2.76]
Yuen 1996 3/36 5/39 25.84% 0.65[0.17,2.53]
   
Total (95% CI) 170 167 100% 1.18[0.68,2.05]
Total events: 23 (Balloon), 18 (Intracervical PGE2)  
Heterogeneity: Tau2=0; Chi2=0.95, df=2(P=0.62); I2=0%  
Test for overall effect: Z=0.58(P=0.57)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 4.10.   Comparison 4 Balloon (Foley or ATAD) versus intracervical
prostaglandin E2: all women, Outcome 10 Meconium-stained liquor.
Study or subgroup Balloon Intracervi-
cal PGE2
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Allouche 1993 7/59 6/59 100% 1.17[0.42,3.26]
   
Total (95% CI) 59 59 100% 1.17[0.42,3.26]
Total events: 7 (Balloon), 6 (Intracervical PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.29(P=0.77)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 4.11.   Comparison 4 Balloon (Foley or ATAD) versus intracervical
prostaglandin E2: all women, Outcome 11 Apgar score < 7 at 5 minutes.
Study or subgroup Balloon Intracervi-
cal PGE2
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Laddad 2013 14/200 17/200 92.18% 0.82[0.42,1.63]
Yuen 1996 0/36 1/39 7.82% 0.36[0.02,8.57]
   
Total (95% CI) 236 239 100% 0.79[0.41,1.53]
Total events: 14 (Balloon), 18 (Intracervical PGE2)  
Heterogeneity: Tau2=0; Chi2=0.25, df=1(P=0.62); I2=0%  
Test for overall effect: Z=0.71(P=0.48)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
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Analysis 4.12.   Comparison 4 Balloon (Foley or ATAD) versus intracervical
prostaglandin E2: all women, Outcome 12 Neonatal intensive care unit admission.
Study or subgroup Balloon Intracervi-
cal PGE2
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Laddad 2013 38/200 43/200 100% 0.88[0.6,1.31]
   
Total (95% CI) 200 200 100% 0.88[0.6,1.31]
Total events: 38 (Balloon), 43 (Intracervical PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.62(P=0.53)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 4.13.   Comparison 4 Balloon (Foley or ATAD) versus
intracervical prostaglandin E2: all women, Outcome 13 Perinatal death.
Study or subgroup Balloon Intracervi-
cal PGE2
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Benzineb 1996 1/50 1/50 11.11% 1[0.06,15.55]
Laddad 2013 6/200 8/200 88.89% 0.75[0.27,2.12]
   
Total (95% CI) 250 250 100% 0.78[0.29,2.05]
Total events: 7 (Balloon), 9 (Intracervical PGE2)  
Heterogeneity: Tau2=0; Chi2=0.04, df=1(P=0.85); I2=0%  
Test for overall effect: Z=0.51(P=0.61)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 4.14.   Comparison 4 Balloon (Foley or ATAD) versus intracervical
prostaglandin E2: all women, Outcome 14 Maternal side e>ects.
Study or subgroup Balloon Intracervi-
cal PGE2
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Sciscione 1999 0/77 4/72 73.92% 0.1[0.01,1.9]
St Onge 1995 0/34 1/28 26.08% 0.28[0.01,6.53]
   
Total (95% CI) 111 100 100% 0.15[0.02,1.24]
Total events: 0 (Balloon), 5 (Intracervical PGE2)  
Heterogeneity: Tau2=0; Chi2=0.21, df=1(P=0.65); I2=0%  
Test for overall effect: Z=1.76(P=0.08)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
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Analysis 4.15.   Comparison 4 Balloon (Foley or ATAD) versus intracervical
prostaglandin E2: all women, Outcome 15 Postpartum haemorrhage.
Study or subgroup Balloon Intracervi-
cal PGE2
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Benzineb 1996 0/50 2/50 100% 0.2[0.01,4.06]
   
Total (95% CI) 50 50 100% 0.2[0.01,4.06]
Total events: 0 (Balloon), 2 (Intracervical PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.05(P=0.29)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 4.16.   Comparison 4 Balloon (Foley or ATAD) versus intracervical
prostaglandin E2: all women, Outcome 16 Chorioamnionitis.
Study or subgroup Balloon Intracervi-
cal PGE2
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Allouche 1993 3/59 3/59 100% 1[0.21,4.75]
   
Total (95% CI) 59 59 100% 1[0.21,4.75]
Total events: 3 (Balloon), 3 (Intracervical PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 4.17.   Comparison 4 Balloon (Foley or ATAD) versus
intracervical prostaglandin E2: all women, Outcome 17 Endometritis.
Study or subgroup Balloon Intracervi-
cal PGE2
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Allouche 1993 1/59 1/59 100% 1[0.06,15.61]
   
Total (95% CI) 59 59 100% 1[0.06,15.61]
Total events: 1 (Balloon), 1 (Intracervical PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
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Analysis 4.18.   Comparison 4 Balloon (Foley or ATAD) versus
intracervical prostaglandin E2: all women, Outcome 18 Fetal distress.
Study or subgroup Balloon Intracervi-
cal PGE2
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Dalui 2005 3/50 8/50 12.85% 0.38[0.11,1.33]
Kuppulakshmi 2016 0/100 9/100 15.26% 0.05[0,0.89]
Laddad 2013 18/200 21/200 33.72% 0.86[0.47,1.56]
Ntsaluba 1997 6/53 8/59 12.16% 0.83[0.31,2.25]
Sciscione 1999 3/77 4/72 6.64% 0.7[0.16,3.03]
St Onge 1995 8/34 11/28 19.37% 0.6[0.28,1.28]
   
Total (95% CI) 514 509 100% 0.61[0.42,0.89]
Total events: 38 (Balloon), 61 (Intracervical PGE2)  
Heterogeneity: Tau2=0; Chi2=5.11, df=5(P=0.4); I2=2.23%  
Test for overall effect: Z=2.58(P=0.01)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Comparison 5.   Balloon (Foley or ATAD) versus intracervical prostaglandin E2: all primiparae
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Uterine hyperstimulation with FHR
changes
1 53 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Caesarean section 3 245 Risk Ratio (M-H, Fixed, 95% CI) 1.30 [0.86, 1.95]
 
 
Analysis 5.1.   Comparison 5 Balloon (Foley or ATAD) versus intracervical prostaglandin
E2: all primiparae, Outcome 1 Uterine hyperstimulation with FHR changes.
Study or subgroup Balloon Intracervi-
cal PGE2
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Ntsaluba 1997 0/25 0/28   Not estimable
   
Total (95% CI) 25 28 Not estimable
Total events: 0 (Balloon), 0 (Intracervical PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
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Analysis 5.2.   Comparison 5 Balloon (Foley or ATAD) versus intracervical
prostaglandin E2: all primiparae, Outcome 2 Caesarean section.
Study or subgroup Balloon Intracervi-
cal PGE2
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Kuppulakshmi 2016 25/74 20/78 66.58% 1.32[0.8,2.16]
Ntsaluba 1997 5/25 4/28 12.9% 1.4[0.42,4.64]
Yuen 1996 7/20 6/20 20.51% 1.17[0.48,2.86]
   
Total (95% CI) 119 126 100% 1.3[0.86,1.95]
Total events: 37 (Balloon), 30 (Intracervical PGE2)  
Heterogeneity: Tau2=0; Chi2=0.07, df=2(P=0.96); I2=0%  
Test for overall effect: Z=1.25(P=0.21)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Comparison 6.   Balloon (Foley or ATAD) versus intracervical prostaglandin E2: all multiparae
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Uterine hyperstimulation with FHR
changes
1 53 Risk Ratio (M-H, Fixed, 95% CI) 0.30 [0.01, 7.02]
2 Caesarean section 3 136 Risk Ratio (M-H, Random, 95% CI) 0.66 [0.16, 2.78]
 
 
Analysis 6.1.   Comparison 6 Balloon (Foley or ATAD) versus intracervical prostaglandin
E2: all multiparae, Outcome 1 Uterine hyperstimulation with FHR changes.
Study or subgroup Balloon Intracervi-
cal PGE2
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Ntsaluba 1997 0/28 1/25 100% 0.3[0.01,7.02]
   
Total (95% CI) 28 25 100% 0.3[0.01,7.02]
Total events: 0 (Balloon), 1 (Intracervical PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.75(P=0.45)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 6.2.   Comparison 6 Balloon (Foley or ATAD) versus intracervical
prostaglandin E2: all multiparae, Outcome 2 Caesarean section.
Study or subgroup Balloon Intracervi-
cal PGE2
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Kuppulakshmi 2016 3/26 9/22 42.76% 0.28[0.09,0.92]
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
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Study or subgroup Balloon Intracervi-
cal PGE2
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Ntsaluba 1997 3/28 5/25 39.71% 0.54[0.14,2.02]
Yuen 1996 3/16 0/19 17.54% 8.24[0.46,148.45]
   
Total (95% CI) 70 66 100% 0.66[0.16,2.78]
Total events: 9 (Balloon), 14 (Intracervical PGE2)  
Heterogeneity: Tau2=0.9; Chi2=4.78, df=2(P=0.09); I2=58.13%  
Test for overall effect: Z=0.57(P=0.57)  
Favours balloon 100.1 50.2 20.5 1 Favours PGE2
 
 
Comparison 7.   Balloon (Foley or ATAD) versus low dose vaginal misoprostol: all women
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Vaginal delivery not achieved in 24 hours 2 340 Risk Ratio (M-H, Fixed, 95%
CI)
1.09 [0.85, 1.39]
2 Uterine hyperstimulation with FHR changes 8 1322 Risk Ratio (M-H, Fixed, 95%
CI)
0.39 [0.18, 0.85]
3 Caesarean section 12 1756 Risk Ratio (M-H, Random,
95% CI)
1.28 [1.02, 1.60]
4 Serious neonatal morbidity/perinatal death 3 381 Risk Ratio (M-H, Fixed, 95%
CI)
0.58 [0.12, 2.66]
5 Serious maternal morbidity or death 4 464 Risk Ratio (M-H, Fixed, 95%
CI)
0.0 [0.0, 0.0]
6 Cervix unfavourable/unchanged after 12
hours
2 200 Risk Ratio (M-H, Random,
95% CI)
2.66 [0.60, 11.89]
7 Oxytocin augmentation 9 911 Risk Ratio (M-H, Random,
95% CI)
1.62 [1.38, 1.90]
8 Uterine hyperstimulation without FHR
changes
9 1139 Risk Ratio (M-H, Fixed, 95%
CI)
0.25 [0.14, 0.44]
9 Uterine rupture 3 364 Risk Ratio (M-H, Fixed, 95%
CI)
0.0 [0.0, 0.0]
10 Epidural analgesia 2 517 Risk Ratio (M-H, Fixed, 95%
CI)
1.22 [1.06, 1.41]
11 Instrumental vaginal delivery 4 721 Risk Ratio (M-H, Fixed, 95%
CI)
0.72 [0.50, 1.05]
12 Meconium-stained liquor 7 1268 Risk Ratio (M-H, Fixed, 95%
CI)
0.64 [0.48, 0.87]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
13 Apgar score < 7 at 5 minutes 7 941 Risk Ratio (M-H, Fixed, 95%
CI)
1.00 [0.50, 1.97]
14 Neonatal intensive care unit admission 9 1302 Risk Ratio (M-H, Fixed, 95%
CI)
1.00 [0.61, 1.63]
15 Perinatal death 1 121 Risk Ratio (M-H, Fixed, 95%
CI)
0.0 [0.0, 0.0]
16 Maternal vomiting 1 60 Risk Ratio (M-H, Fixed, 95%
CI)
0.0 [0.0, 0.0]
17 Postpartum haemorrhage 1 120 Risk Ratio (M-H, Fixed, 95%
CI)
1.14 [0.24, 5.44]
18 Maternal fever during labour 3 617 Risk Ratio (M-H, Random,
95% CI)
1.84 [0.22, 15.62]
19 Chorioamnionitis 2 200 Risk Ratio (M-H, Fixed, 95%
CI)
1.24 [0.31, 4.88]
20 Endometritis 1 240 Risk Ratio (M-H, Fixed, 95%
CI)
2.95 [0.12, 71.72]
21 Fetal distress 7 1127 Risk Ratio (M-H, Fixed, 95%
CI)
0.84 [0.67, 1.05]
22 Umbilical artery pH <7.10 1 120 Risk Ratio (M-H, Fixed, 95%
CI)
1.14 [0.35, 3.74]
 
 
Analysis 7.1.   Comparison 7 Balloon (Foley or ATAD) versus low dose vaginal
misoprostol: all women, Outcome 1 Vaginal delivery not achieved in 24 hours.
Study or subgroup Balloon vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Chavakula 2015 21/54 17/46 26.31% 1.05[0.64,1.74]
Filho 2002 57/121 51/119 73.69% 1.1[0.83,1.46]
   
Total (95% CI) 175 165 100% 1.09[0.85,1.39]
Total events: 78 (Balloon), 68 (vaginal misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.02, df=1(P=0.88); I2=0%  
Test for overall effect: Z=0.66(P=0.51)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 7.2.   Comparison 7 Balloon (Foley or ATAD) versus low dose vaginal
misoprostol: all women, Outcome 2 Uterine hyperstimulation with FHR changes.
Study or subgroup Balloon vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Aduloju 2016 0/70 0/70   Not estimable
Chavakula 2015 0/54 1/46 7.2% 0.28[0.01,6.83]
Filho 2002 2/121 3/119 13.47% 0.66[0.11,3.85]
Jozwiak 2014 2/56 1/64 4.16% 2.29[0.21,24.54]
Kandil 2012 0/50 1/50 6.68% 0.33[0.01,7.99]
Noor 2015 0/44 7/60 28.36% 0.09[0.01,1.54]
Prager 2008 2/198 6/199 26.65% 0.34[0.07,1.64]
Tabowei 2003 1/61 3/60 13.47% 0.33[0.04,3.06]
   
Total (95% CI) 654 668 100% 0.39[0.18,0.85]
Total events: 7 (Balloon), 22 (vaginal misoprostol)  
Heterogeneity: Tau2=0; Chi2=3.6, df=6(P=0.73); I2=0%  
Test for overall effect: Z=2.38(P=0.02)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 7.3.   Comparison 7 Balloon (Foley or ATAD) versus low dose
vaginal misoprostol: all women, Outcome 3 Caesarean section.
Study or subgroup Balloon vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Aduloju 2016 22/70 19/70 10.1% 1.16[0.69,1.94]
Chavakula 2015 16/54 7/46 5.89% 1.95[0.88,4.32]
Deo 2012 9/50 16/54 6.77% 0.61[0.3,1.25]
Filho 2002 44/121 32/119 13.3% 1.35[0.93,1.97]
Jozwiak 2014 14/56 11/64 6.99% 1.45[0.72,2.94]
Kandil 2012 9/50 8/50 5.19% 1.13[0.47,2.68]
Noor 2015 19/44 14/60 9.07% 1.85[1.05,3.27]
Oliveira 2010 41/80 34/80 14.52% 1.21[0.86,1.68]
Prager 2008 45/198 56/199 14.33% 0.81[0.58,1.13]
Roudsari 2011 22/60 5/50 4.95% 3.67[1.5,8.98]
Sheikher 2009 8/30 4/30 3.62% 2[0.67,5.94]
Tabowei 2003 10/61 8/60 5.27% 1.23[0.52,2.9]
   
Total (95% CI) 874 882 100% 1.28[1.02,1.6]
Total events: 259 (Balloon), 214 (vaginal misoprostol)  
Heterogeneity: Tau2=0.06; Chi2=19.86, df=11(P=0.05); I2=44.61%  
Test for overall effect: Z=2.11(P=0.03)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 7.4.   Comparison 7 Balloon (Foley or ATAD) versus low dose vaginal
misoprostol: all women, Outcome 4 Serious neonatal morbidity/perinatal death.
Study or subgroup Balloon vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Aduloju 2016 2/70 3/70 68.16% 0.67[0.11,3.87]
Jozwiak 2014 0/56 1/64 31.84% 0.38[0.02,9.15]
Tabowei 2003 0/61 0/60   Not estimable
   
Total (95% CI) 187 194 100% 0.58[0.12,2.66]
Total events: 2 (Balloon), 4 (vaginal misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.09, df=1(P=0.76); I2=0%  
Test for overall effect: Z=0.71(P=0.48)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 7.5.   Comparison 7 Balloon (Foley or ATAD) versus low dose vaginal
misoprostol: all women, Outcome 5 Serious maternal morbidity or death.
Study or subgroup Balloon vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Aduloju 2016 0/70 0/70   Not estimable
Chavakula 2015 0/54 0/46   Not estimable
Jozwiak 2014 0/56 0/64   Not estimable
Noor 2015 0/44 0/60   Not estimable
   
Total (95% CI) 224 240 Not estimable
Total events: 0 (Balloon), 0 (vaginal misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 7.6.   Comparison 7 Balloon (Foley or ATAD) versus low dose vaginal
misoprostol: all women, Outcome 6 Cervix unfavourable/unchanged aLer 12 hours.
Study or subgroup Balloon vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Aduloju 2016 20/70 11/70 78.78% 1.82[0.94,3.51]
Sheikher 2009 5/30 0/30 21.22% 11[0.64,190.53]
   
Total (95% CI) 100 100 100% 2.66[0.6,11.89]
Total events: 25 (Balloon), 11 (vaginal misoprostol)  
Heterogeneity: Tau2=0.63; Chi2=1.56, df=1(P=0.21); I2=35.99%  
Test for overall effect: Z=1.28(P=0.2)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 7.7.   Comparison 7 Balloon (Foley or ATAD) versus low dose
vaginal misoprostol: all women, Outcome 7 Oxytocin augmentation.
Study or subgroup Balloon vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Aduloju 2016 66/70 43/70 15.15% 1.53[1.26,1.86]
Chavakula 2015 46/54 28/46 12.95% 1.4[1.08,1.81]
Deo 2012 32/50 20/54 8.61% 1.73[1.15,2.59]
Jozwiak 2014 46/56 32/64 12.38% 1.64[1.25,2.16]
Kandil 2012 34/50 11/50 5.77% 3.09[1.77,5.39]
Lemyre 2006 30/31 21/31 13.15% 1.43[1.11,1.84]
Noor 2015 34/44 29/60 11.32% 1.6[1.18,2.17]
Sheikher 2009 26/30 7/30 4.43% 3.71[1.91,7.21]
Tabowei 2003 58/61 44/60 16.24% 1.3[1.1,1.53]
   
Total (95% CI) 446 465 100% 1.62[1.38,1.9]
Total events: 372 (Balloon), 235 (vaginal misoprostol)  
Heterogeneity: Tau2=0.03; Chi2=21.93, df=8(P=0.01); I2=63.52%  
Test for overall effect: Z=5.95(P<0.0001)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 7.8.   Comparison 7 Balloon (Foley or ATAD) versus low dose vaginal
misoprostol: all women, Outcome 8 Uterine hyperstimulation without FHR changes.
Study or subgroup Balloon vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Aduloju 2016 0/70 0/70   Not estimable
Deo 2012 0/50 6/54 11.13% 0.08[0,1.44]
Filho 2002 3/121 6/119 10.77% 0.49[0.13,1.92]
Kandil 2012 0/50 2/50 4.45% 0.2[0.01,4.06]
Noor 2015 0/44 0/60   Not estimable
Oliveira 2010 5/80 18/80 32.04% 0.28[0.11,0.71]
Roudsari 2011 0/60 2/50 4.85% 0.17[0.01,3.4]
Sheikher 2009 0/30 1/30 2.67% 0.33[0.01,7.87]
Tabowei 2003 4/61 19/60 34.1% 0.21[0.07,0.57]
   
Total (95% CI) 566 573 100% 0.25[0.14,0.44]
Total events: 12 (Balloon), 54 (vaginal misoprostol)  
Heterogeneity: Tau2=0; Chi2=1.83, df=6(P=0.93); I2=0%  
Test for overall effect: Z=4.85(P<0.0001)  
Favours balloon 1000.01 100.1 1 Favours misoprostol
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Analysis 7.9.   Comparison 7 Balloon (Foley or ATAD) versus low
dose vaginal misoprostol: all women, Outcome 9 Uterine rupture.
Study or subgroup Balloon vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Aduloju 2016 0/70 0/70   Not estimable
Jozwiak 2014 0/56 0/64   Not estimable
Noor 2015 0/44 0/60   Not estimable
   
Total (95% CI) 170 194 Not estimable
Total events: 0 (Balloon), 0 (vaginal misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 7.10.   Comparison 7 Balloon (Foley or ATAD) versus low dose
vaginal misoprostol: all women, Outcome 10 Epidural analgesia.
Study or subgroup Balloon vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Jozwiak 2014 19/56 17/64 11.7% 1.28[0.74,2.21]
Prager 2008 145/198 120/199 88.3% 1.21[1.06,1.4]
   
Total (95% CI) 254 263 100% 1.22[1.06,1.41]
Total events: 164 (Balloon), 137 (vaginal misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.03, df=1(P=0.86); I2=0%  
Test for overall effect: Z=2.8(P=0.01)  
Favours balloon 1000.01 100.1 1 Favours misoprostol
 
 
Analysis 7.11.   Comparison 7 Balloon (Foley or ATAD) versus low dose
vaginal misoprostol: all women, Outcome 11 Instrumental vaginal delivery.
Study or subgroup Balloon vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Deo 2012 1/50 6/54 10.04% 0.18[0.02,1.44]
Jozwiak 2014 8/56 18/64 29.22% 0.51[0.24,1.08]
Kandil 2012 3/50 2/50 3.48% 1.5[0.26,8.6]
Prager 2008 29/198 33/199 57.26% 0.88[0.56,1.4]
   
Total (95% CI) 354 367 100% 0.72[0.5,1.05]
Total events: 41 (Balloon), 59 (vaginal misoprostol)  
Heterogeneity: Tau2=0; Chi2=3.96, df=3(P=0.27); I2=24.27%  
Test for overall effect: Z=1.71(P=0.09)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 7.12.   Comparison 7 Balloon (Foley or ATAD) versus low dose
vaginal misoprostol: all women, Outcome 12 Meconium-stained liquor.
Study or subgroup Balloon vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Aduloju 2016 1/70 2/70 2.17% 0.5[0.05,5.39]
Filho 2002 7/121 5/119 5.48% 1.38[0.45,4.22]
Kandil 2012 0/50 3/50 3.81% 0.14[0.01,2.7]
Oliveira 2010 11/80 14/80 15.22% 0.79[0.38,1.62]
Prager 2008 33/198 51/199 55.32% 0.65[0.44,0.96]
Roudsari 2011 3/60 5/50 5.93% 0.5[0.13,1.99]
Tabowei 2003 4/61 11/60 12.06% 0.36[0.12,1.06]
   
Total (95% CI) 640 628 100% 0.64[0.48,0.87]
Total events: 59 (Balloon), 91 (vaginal misoprostol)  
Heterogeneity: Tau2=0; Chi2=4.37, df=6(P=0.63); I2=0%  
Test for overall effect: Z=2.88(P=0)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 7.13.   Comparison 7 Balloon (Foley or ATAD) versus low dose
vaginal misoprostol: all women, Outcome 13 Apgar score < 7 at 5 minutes.
Study or subgroup Balloon vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Aduloju 2016 5/70 5/70 31.42% 1[0.3,3.3]
Chavakula 2015 1/54 0/46 3.39% 2.56[0.11,61.45]
Filho 2002 1/121 0/119 3.17% 2.95[0.12,71.72]
Jozwiak 2014 0/56 2/64 14.68% 0.23[0.01,4.65]
Oliveira 2010 3/80 3/80 18.85% 1[0.21,4.81]
Sheikher 2009 1/30 0/30 3.14% 3[0.13,70.83]
Tabowei 2003 3/61 4/60 25.35% 0.74[0.17,3.16]
   
Total (95% CI) 472 469 100% 1[0.5,1.97]
Total events: 14 (Balloon), 14 (vaginal misoprostol)  
Heterogeneity: Tau2=0; Chi2=2.33, df=6(P=0.89); I2=0%  
Test for overall effect: Z=0.01(P=1)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 7.14.   Comparison 7 Balloon (Foley or ATAD) versus low dose vaginal
misoprostol: all women, Outcome 14 Neonatal intensive care unit admission.
Study or subgroup Balloon vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Aduloju 2016 3/70 5/70 16.5% 0.6[0.15,2.41]
Chavakula 2015 4/54 1/46 3.56% 3.41[0.39,29.42]
Jozwiak 2014 2/56 1/64 3.08% 2.29[0.21,24.54]
Kandil 2012 0/50 0/50   Not estimable
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
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Study or subgroup Balloon vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Noor 2015 6/44 8/60 22.34% 1.02[0.38,2.74]
Oliveira 2010 3/80 5/80 16.5% 0.6[0.15,2.43]
Prager 2008 7/198 7/199 23.05% 1.01[0.36,2.81]
Sheikher 2009 1/30 0/30 1.65% 3[0.13,70.83]
Tabowei 2003 3/61 4/60 13.31% 0.74[0.17,3.16]
   
Total (95% CI) 643 659 100% 1[0.61,1.63]
Total events: 29 (Balloon), 31 (vaginal misoprostol)  
Heterogeneity: Tau2=0; Chi2=3.37, df=7(P=0.85); I2=0%  
Test for overall effect: Z=0.01(P=0.99)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 7.15.   Comparison 7 Balloon (Foley or ATAD) versus low
dose vaginal misoprostol: all women, Outcome 15 Perinatal death.
Study or subgroup Balloon vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Tabowei 2003 0/61 0/60   Not estimable
   
Total (95% CI) 61 60 Not estimable
Total events: 0 (Balloon), 0 (vaginal misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 7.16.   Comparison 7 Balloon (Foley or ATAD) versus low dose
vaginal misoprostol: all women, Outcome 16 Maternal vomiting.
Study or subgroup Balloon vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Sheikher 2009 0/30 0/30   Not estimable
   
Total (95% CI) 30 30 Not estimable
Total events: 0 (Balloon), 0 (vaginal misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 7.17.   Comparison 7 Balloon (Foley or ATAD) versus low dose
vaginal misoprostol: all women, Outcome 17 Postpartum haemorrhage.
Study or subgroup Balloon vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Jozwiak 2014 3/56 3/64 100% 1.14[0.24,5.44]
   
Total (95% CI) 56 64 100% 1.14[0.24,5.44]
Total events: 3 (Balloon), 3 (vaginal misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.17(P=0.87)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 7.18.   Comparison 7 Balloon (Foley or ATAD) versus low dose
vaginal misoprostol: all women, Outcome 18 Maternal fever during labour.
Study or subgroup Balloon vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Chavakula 2015 0/54 0/46   Not estimable
Jozwiak 2014 6/56 1/64 39.86% 6.86[0.85,55.24]
Prager 2008 13/198 17/199 60.14% 0.77[0.38,1.54]
   
Total (95% CI) 308 309 100% 1.84[0.22,15.62]
Total events: 19 (Balloon), 18 (vaginal misoprostol)  
Heterogeneity: Tau2=1.86; Chi2=3.95, df=1(P=0.05); I2=74.67%  
Test for overall effect: Z=0.56(P=0.58)  
Favours balloon 1000.01 100.1 1 Favours misoprostol
 
 
Analysis 7.19.   Comparison 7 Balloon (Foley or ATAD) versus low
dose vaginal misoprostol: all women, Outcome 19 Chorioamnionitis.
Study or subgroup Balloon vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Chavakula 2015 1/54 0/46 15.24% 2.56[0.11,61.45]
Kandil 2012 3/50 3/50 84.76% 1[0.21,4.72]
   
Total (95% CI) 104 96 100% 1.24[0.31,4.88]
Total events: 4 (Balloon), 3 (vaginal misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.27, df=1(P=0.6); I2=0%  
Test for overall effect: Z=0.31(P=0.76)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 7.20.   Comparison 7 Balloon (Foley or ATAD) versus low
dose vaginal misoprostol: all women, Outcome 20 Endometritis.
Study or subgroup Balloon vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Filho 2002 1/121 0/119 100% 2.95[0.12,71.72]
   
Total (95% CI) 121 119 100% 2.95[0.12,71.72]
Total events: 1 (Balloon), 0 (vaginal misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.66(P=0.51)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 7.21.   Comparison 7 Balloon (Foley or ATAD) versus low
dose vaginal misoprostol: all women, Outcome 21 Fetal distress.
Study or subgroup Balloon vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Aduloju 2016 7/70 7/70 5.66% 1[0.37,2.7]
Chavakula 2015 17/54 15/46 13.1% 0.97[0.54,1.71]
Jozwiak 2014 6/56 8/64 6.04% 0.86[0.32,2.32]
Kandil 2012 1/50 3/50 2.43% 0.33[0.04,3.1]
Oliveira 2010 16/80 17/80 13.75% 0.94[0.51,1.73]
Prager 2008 54/198 71/199 57.27% 0.76[0.57,1.03]
Roudsari 2011 4/60 2/50 1.76% 1.67[0.32,8.73]
   
Total (95% CI) 568 559 100% 0.84[0.67,1.05]
Total events: 105 (Balloon), 123 (vaginal misoprostol)  
Heterogeneity: Tau2=0; Chi2=2.19, df=6(P=0.9); I2=0%  
Test for overall effect: Z=1.53(P=0.13)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 7.22.   Comparison 7 Balloon (Foley or ATAD) versus low dose
vaginal misoprostol: all women, Outcome 22 Umbilical artery pH <7.10.
Study or subgroup Balloon vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Jozwiak 2014 5/56 5/64 100% 1.14[0.35,3.74]
   
Total (95% CI) 56 64 100% 1.14[0.35,3.74]
Total events: 5 (Balloon), 5 (vaginal misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.22(P=0.83)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
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Comparison 8.   Balloon (Foley or ATAD versus low dose vaginal misoprostol: all primiparae
Outcome or subgroup title No. of
studies
No. of partici-
pants
Statistical method Effect size
1 Caesarean section 1 255 Risk Ratio (M-H, Fixed, 95% CI) 0.82 [0.59, 1.13]
 
 
Analysis 8.1.   Comparison 8 Balloon (Foley or ATAD versus low dose
vaginal misoprostol: all primiparae, Outcome 1 Caesarean section.
Study or subgroup Balloon Vaginal
misoprostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Prager 2008 40/120 55/135 100% 0.82[0.59,1.13]
   
Total (95% CI) 120 135 100% 0.82[0.59,1.13]
Total events: 40 (Balloon), 55 (Vaginal misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.21(P=0.23)  
Favours balloon 1000.01 100.1 1 Favours misoprostol
 
 
Comparison 9.   Balloon (Foley or ATAD) versus low dose oral misoprostol: all women
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Vaginal delivery not achieved within 24
hours
2 782 Risk Ratio (M-H, Fixed, 95%
CI)
1.28 [1.13, 1.46]
2 Uterine hyperstimulation with FHR
changes
2 2033 Risk Ratio (M-H, Fixed, 95%
CI)
0.81 [0.48, 1.38]
3 Caesarean section 7 3178 Risk Ratio (M-H, Fixed, 95%
CI)
1.17 [1.04, 1.32]
4 Serious perinatal morbidity/perinatal
death
3 2627 Risk Ratio (M-H, Fixed, 95%
CI)
1.11 [0.60, 2.06]
5 Serious maternal morbidity or death 3 2627 Risk Ratio (M-H, Fixed, 95%
CI)
0.50 [0.05, 5.52]
6 Cervix unfavourable after 24 hours 4 994 Risk Ratio (M-H, Random,
95% CI)
0.98 [0.61, 1.56]
7 Oxytocin augmentation 5 2847 Risk Ratio (M-H, Random,
95% CI)
1.28 [1.09, 1.49]
8 Uterine hyperstimulation without FHR
changes
5 2838 Risk Ratio (M-H, Random,
95% CI)
0.50 [0.12, 2.07]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
9 Uterine rupture 3 2627 Risk Ratio (M-H, Fixed, 95%
CI)
0.0 [0.0, 0.0]
10 Epidural 3 2635 Risk Ratio (M-H, Random,
95% CI)
1.08 [0.96, 1.22]
11 Instrumental vaginal delivery 3 2627 Risk Ratio (M-H, Fixed, 95%
CI)
0.71 [0.55, 0.92]
12 Meconium-stained liquor 3 2627 Risk Ratio (M-H, Random,
95% CI)
0.77 [0.44, 1.35]
13 Apgar score < 7 after 5 minutes 4 2693 Risk Ratio (M-H, Fixed, 95%
CI)
0.71 [0.38, 1.32]
14 Neonatal intensive care unit admission 5 2873 Risk Ratio (M-H, Fixed, 95%
CI)
0.82 [0.58, 1.17]
15 Neonatal encephalopathy 1 600 Risk Ratio (M-H, Fixed, 95%
CI)
0.81 [0.32, 2.03]
16 Perinatal death 3 2627 Risk Ratio (M-H, Fixed, 95%
CI)
1.28 [0.49, 3.30]
17 Maternal side effects (all) 2 662 Risk Ratio (M-H, Fixed, 95%
CI)
0.61 [0.33, 1.13]
18 Maternal vomiting 2 662 Risk Ratio (M-H, Fixed, 95%
CI)
0.73 [0.37, 1.46]
19 Maternal diarrhoea 1 602 Risk Ratio (M-H, Fixed, 95%
CI)
0.29 [0.06, 1.37]
20 Postpartum haemorrhage 5 2966 Risk Ratio (M-H, Fixed, 95%
CI)
1.03 [0.79, 1.34]
21 Maternal death 3 2627 Risk Ratio (M-H, Fixed, 95%
CI)
0.0 [0.0, 0.0]
22 Women not satisfied 1 602 Risk Ratio (M-H, Fixed, 95%
CI)
1.70 [1.15, 2.50]
23 Maternal fever during labour 2 2033 Risk Ratio (M-H, Fixed, 95%
CI)
0.98 [0.78, 1.24]
24 Antibiotics during labour 2 2033 Risk Ratio (M-H, Fixed, 95%
CI)
1.22 [0.75, 2.00]
25 Endometritis 1 188 Risk Ratio (M-H, Fixed, 95%
CI)
0.56 [0.05, 6.03]
26 Fetal distress 5 2966 Risk Ratio (M-H, Fixed, 95%
CI)
0.82 [0.61, 1.09]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
27 Umbilical artery pH < 7.10 2 1535 Risk Ratio (M-H, Fixed, 95%
CI)
0.77 [0.53, 1.12]
 
 
Analysis 9.1.   Comparison 9 Balloon (Foley or ATAD) versus low dose oral
misoprostol: all women, Outcome 1 Vaginal delivery not achieved within 24 hours.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Mundle 2017 159/300 130/302 69.68% 1.23[1.04,1.46]
Somirathne 2017 78/89 57/91 30.32% 1.4[1.17,1.67]
   
Total (95% CI) 389 393 100% 1.28[1.13,1.46]
Total events: 237 (Balloon), 187 (Oral misoprostol)  
Heterogeneity: Tau2=0; Chi2=1.16, df=1(P=0.28); I2=13.88%  
Test for overall effect: Z=3.82(P=0)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 9.2.   Comparison 9 Balloon (Foley or ATAD) versus low dose oral
misoprostol: all women, Outcome 2 Uterine hyperstimulation with FHR changes.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Kruit 2016 2/89 4/99 12.73% 0.56[0.1,2.96]
ten Eikelder 2016 22/921 26/924 87.27% 0.85[0.48,1.49]
   
Total (95% CI) 1010 1023 100% 0.81[0.48,1.38]
Total events: 24 (Balloon), 30 (Oral misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.22, df=1(P=0.64); I2=0%  
Test for overall effect: Z=0.77(P=0.44)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 9.3.   Comparison 9 Balloon (Foley or ATAD) versus low
dose oral misoprostol: all women, Outcome 3 Caesarean section.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Goonewardene 2014 17/78 24/74 6.99% 0.67[0.39,1.15]
Kruit 2016 21/89 18/99 4.84% 1.3[0.74,2.27]
Mundle 2017 151/300 124/302 35.1% 1.23[1.03,1.46]
Saleem 2006 11/78 9/73 2.64% 1.14[0.5,2.6]
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
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Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Sheikher 2009 8/30 8/30 2.27% 1[0.43,2.31]
Somirathne 2017 18/89 15/91 4.21% 1.23[0.66,2.28]
ten Eikelder 2016 185/921 155/924 43.94% 1.2[0.99,1.45]
   
Total (95% CI) 1585 1593 100% 1.17[1.04,1.32]
Total events: 411 (Balloon), 353 (Oral misoprostol)  
Heterogeneity: Tau2=0; Chi2=4.76, df=6(P=0.57); I2=0%  
Test for overall effect: Z=2.57(P=0.01)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 9.4.   Comparison 9 Balloon (Foley or ATAD) versus low dose oral
misoprostol: all women, Outcome 4 Serious perinatal morbidity/perinatal death.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Mundle 2017 8/300 11/302 57.88% 0.73[0.3,1.79]
Somirathne 2017 4/89 1/91 5.22% 4.09[0.47,35.88]
ten Eikelder 2016 9/921 7/924 36.9% 1.29[0.48,3.45]
   
Total (95% CI) 1310 1317 100% 1.11[0.6,2.06]
Total events: 21 (Balloon), 19 (Oral misoprostol)  
Heterogeneity: Tau2=0; Chi2=2.3, df=2(P=0.32); I2=13.21%  
Test for overall effect: Z=0.34(P=0.73)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 9.5.   Comparison 9 Balloon (Foley or ATAD) versus low dose oral
misoprostol: all women, Outcome 5 Serious maternal morbidity or death.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Mundle 2017 0/300 0/302   Not estimable
Somirathne 2017 0/89 0/91   Not estimable
ten Eikelder 2016 1/921 2/924 100% 0.5[0.05,5.52]
   
Total (95% CI) 1310 1317 100% 0.5[0.05,5.52]
Total events: 1 (Balloon), 2 (Oral misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.56(P=0.57)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 9.6.   Comparison 9 Balloon (Foley or ATAD) versus low dose oral
misoprostol: all women, Outcome 6 Cervix unfavourable aLer 24 hours.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Goonewardene 2014 14/78 20/74 37.55% 0.66[0.36,1.22]
Mundle 2017 0/300 0/302   Not estimable
Sheikher 2009 5/30 5/30 14.65% 1[0.32,3.1]
Somirathne 2017 27/89 21/91 47.79% 1.31[0.81,2.15]
   
Total (95% CI) 497 497 100% 0.98[0.61,1.56]
Total events: 46 (Balloon), 46 (Oral misoprostol)  
Heterogeneity: Tau2=0.06; Chi2=2.96, df=2(P=0.23); I2=32.51%  
Test for overall effect: Z=0.1(P=0.92)  
Favours balloon 1000.01 100.1 1 Favours misoprostol
 
 
Analysis 9.7.   Comparison 9 Balloon (Foley or ATAD) versus low dose
oral misoprostol: all women, Outcome 7 Oxytocin augmentation.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Goonewardene 2014 66/78 48/74 18.56% 1.3[1.08,1.58]
Kruit 2016 78/89 85/99 22.71% 1.02[0.91,1.14]
Mundle 2017 244/300 157/302 22.26% 1.56[1.39,1.77]
Sheikher 2009 26/30 17/30 11.61% 1.53[1.09,2.16]
ten Eikelder 2016 740/921 632/924 24.87% 1.17[1.11,1.24]
   
Total (95% CI) 1418 1429 100% 1.28[1.09,1.49]
Total events: 1154 (Balloon), 939 (Oral misoprostol)  
Heterogeneity: Tau2=0.03; Chi2=31.32, df=4(P<0.0001); I2=87.23%  
Test for overall effect: Z=3.01(P=0)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 9.8.   Comparison 9 Balloon (Foley or ATAD) versus low dose oral
misoprostol: all women, Outcome 8 Uterine hyperstimulation without FHR changes.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Mundle 2017 1/300 2/302 19.22% 0.5[0.05,5.52]
Saleem 2006 0/78 5/73 15.5% 0.09[0,1.51]
Sheikher 2009 0/30 1/30 13.71% 0.33[0.01,7.87]
Somirathne 2017 0/89 3/91 15.02% 0.15[0.01,2.79]
ten Eikelder 2016 16/921 8/924 36.56% 2.01[0.86,4.67]
   
Total (95% CI) 1418 1420 100% 0.5[0.12,2.07]
Total events: 17 (Balloon), 19 (Oral misoprostol)  
Heterogeneity: Tau2=1.26; Chi2=8.12, df=4(P=0.09); I2=50.75%  
Favours balloon 1000.01 100.1 1 Favours misoprostol
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Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Test for overall effect: Z=0.96(P=0.34)  
Favours balloon 1000.01 100.1 1 Favours misoprostol
 
 
Analysis 9.9.   Comparison 9 Balloon (Foley or ATAD) versus low
dose oral misoprostol: all women, Outcome 9 Uterine rupture.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Mundle 2017 0/300 0/302   Not estimable
Somirathne 2017 0/89 0/91   Not estimable
ten Eikelder 2016 0/921 0/924   Not estimable
   
Total (95% CI) 1310 1317 Not estimable
Total events: 0 (Balloon), 0 (Oral misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 9.10.   Comparison 9 Balloon (Foley or ATAD) versus
low dose oral misoprostol: all women, Outcome 10 Epidural.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Kruit 2016 74/89 84/99 34.94% 0.98[0.86,1.11]
Mundle 2017 150/300 124/302 25.08% 1.22[1.02,1.45]
ten Eikelder 2016 421/921 386/924 39.98% 1.09[0.99,1.21]
   
Total (95% CI) 1310 1325 100% 1.08[0.96,1.22]
Total events: 645 (Balloon), 594 (Oral misoprostol)  
Heterogeneity: Tau2=0.01; Chi2=4.73, df=2(P=0.09); I2=57.68%  
Test for overall effect: Z=1.31(P=0.19)  
Favours balloon 1000.01 100.1 1 Favours misoprostol
 
 
Analysis 9.11.   Comparison 9 Balloon (Foley or ATAD) versus low dose
oral misoprostol: all women, Outcome 11 Instrumental vaginal delivery.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Mundle 2017 3/300 2/302 1.55% 1.51[0.25,8.97]
Somirathne 2017 0/89 1/91 1.16% 0.34[0.01,8.25]
ten Eikelder 2016 88/921 125/924 97.29% 0.71[0.55,0.91]
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
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Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
   
Total (95% CI) 1310 1317 100% 0.71[0.55,0.92]
Total events: 91 (Balloon), 128 (Oral misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.89, df=2(P=0.64); I2=0%  
Test for overall effect: Z=2.6(P=0.01)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 9.12.   Comparison 9 Balloon (Foley or ATAD) versus low dose
oral misoprostol: all women, Outcome 12 Meconium-stained liquor.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Mundle 2017 6/300 10/302 22.32% 0.6[0.22,1.64]
Somirathne 2017 2/89 7/91 11.26% 0.29[0.06,1.37]
ten Eikelder 2016 108/921 110/924 66.42% 0.99[0.77,1.26]
   
Total (95% CI) 1310 1317 100% 0.77[0.44,1.35]
Total events: 116 (Balloon), 127 (Oral misoprostol)  
Heterogeneity: Tau2=0.11; Chi2=3.09, df=2(P=0.21); I2=35.37%  
Test for overall effect: Z=0.91(P=0.36)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 9.13.   Comparison 9 Balloon (Foley or ATAD) versus low dose
oral misoprostol: all women, Outcome 13 Apgar score < 7 aLer 5 minutes.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Kruit 2016 0/89 0/99   Not estimable
Mundle 2017 1/298 6/302 24.9% 0.17[0.02,1.39]
Sheikher 2009 1/30 1/30 4.18% 1[0.07,15.26]
ten Eikelder 2016 15/921 17/924 70.92% 0.89[0.44,1.76]
   
Total (95% CI) 1338 1355 100% 0.71[0.38,1.32]
Total events: 17 (Balloon), 24 (Oral misoprostol)  
Heterogeneity: Tau2=0; Chi2=2.23, df=2(P=0.33); I2=10.29%  
Test for overall effect: Z=1.08(P=0.28)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 9.14.   Comparison 9 Balloon (Foley or ATAD) versus low dose oral
misoprostol: all women, Outcome 14 Neonatal intensive care unit admission.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Kruit 2016 7/89 9/99 13.06% 0.87[0.34,2.23]
Mundle 2017 19/298 28/302 42.62% 0.69[0.39,1.2]
Sheikher 2009 1/30 1/30 1.53% 1[0.07,15.26]
Somirathne 2017 2/89 3/91 4.55% 0.68[0.12,3.98]
ten Eikelder 2016 24/921 25/924 38.25% 0.96[0.55,1.67]
   
Total (95% CI) 1427 1446 100% 0.82[0.58,1.17]
Total events: 53 (Balloon), 66 (Oral misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.78, df=4(P=0.94); I2=0%  
Test for overall effect: Z=1.1(P=0.27)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 9.15.   Comparison 9 Balloon (Foley or ATAD) versus low dose
oral misoprostol: all women, Outcome 15 Neonatal encephalopathy.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Mundle 2017 8/298 10/302 100% 0.81[0.32,2.03]
   
Total (95% CI) 298 302 100% 0.81[0.32,2.03]
Total events: 8 (Balloon), 10 (Oral misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.45(P=0.65)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 9.16.   Comparison 9 Balloon (Foley or ATAD) versus low
dose oral misoprostol: all women, Outcome 16 Perinatal death.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Mundle 2017 5/300 6/302 80.02% 0.84[0.26,2.72]
Somirathne 2017 1/89 0/91 6.62% 3.07[0.13,74.29]
ten Eikelder 2016 3/921 1/924 13.36% 3.01[0.31,28.88]
   
Total (95% CI) 1310 1317 100% 1.28[0.49,3.3]
Total events: 9 (Balloon), 7 (Oral misoprostol)  
Heterogeneity: Tau2=0; Chi2=1.33, df=2(P=0.51); I2=0%  
Test for overall effect: Z=0.5(P=0.62)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 9.17.   Comparison 9 Balloon (Foley or ATAD) versus low dose
oral misoprostol: all women, Outcome 17 Maternal side e>ects (all).
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Mundle 2017 15/300 24/302 94.1% 0.63[0.34,1.18]
Sheikher 2009 0/30 1/30 5.9% 0.33[0.01,7.87]
   
Total (95% CI) 330 332 100% 0.61[0.33,1.13]
Total events: 15 (Balloon), 25 (Oral misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.15, df=1(P=0.7); I2=0%  
Test for overall effect: Z=1.57(P=0.12)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 9.18.   Comparison 9 Balloon (Foley or ATAD) versus low
dose oral misoprostol: all women, Outcome 18 Maternal vomiting.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Mundle 2017 13/300 17/302 91.87% 0.77[0.38,1.56]
Sheikher 2009 0/30 1/30 8.13% 0.33[0.01,7.87]
   
Total (95% CI) 330 332 100% 0.73[0.37,1.46]
Total events: 13 (Balloon), 18 (Oral misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.26, df=1(P=0.61); I2=0%  
Test for overall effect: Z=0.88(P=0.38)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 9.19.   Comparison 9 Balloon (Foley or ATAD) versus low
dose oral misoprostol: all women, Outcome 19 Maternal diarrhoea.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Mundle 2017 2/300 7/302 100% 0.29[0.06,1.37]
   
Total (95% CI) 300 302 100% 0.29[0.06,1.37]
Total events: 2 (Balloon), 7 (Oral misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.56(P=0.12)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 9.20.   Comparison 9 Balloon (Foley or ATAD) versus low dose
oral misoprostol: all women, Outcome 20 Postpartum haemorrhage.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Kruit 2016 12/89 13/99 12.79% 1.03[0.49,2.13]
Mundle 2017 2/300 2/302 2.07% 1.01[0.14,7.1]
Saleem 2006 1/78 2/73 2.15% 0.47[0.04,5.05]
Somirathne 2017 1/89 1/91 1.03% 1.02[0.06,16.1]
ten Eikelder 2016 82/921 79/924 81.96% 1.04[0.78,1.4]
   
Total (95% CI) 1477 1489 100% 1.03[0.79,1.34]
Total events: 98 (Balloon), 97 (Oral misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.43, df=4(P=0.98); I2=0%  
Test for overall effect: Z=0.19(P=0.85)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 9.21.   Comparison 9 Balloon (Foley or ATAD) versus low
dose oral misoprostol: all women, Outcome 21 Maternal death.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Mundle 2017 0/300 0/302   Not estimable
Somirathne 2017 0/89 0/91   Not estimable
ten Eikelder 2016 0/921 0/924   Not estimable
   
Total (95% CI) 1310 1317 Not estimable
Total events: 0 (Balloon), 0 (Oral misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 9.22.   Comparison 9 Balloon (Foley or ATAD) versus low
dose oral misoprostol: all women, Outcome 22 Women not satisfied.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Mundle 2017 59/300 35/302 100% 1.7[1.15,2.5]
   
Total (95% CI) 300 302 100% 1.7[1.15,2.5]
Total events: 59 (Balloon), 35 (Oral misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.68(P=0.01)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 9.23.   Comparison 9 Balloon (Foley or ATAD) versus low dose
oral misoprostol: all women, Outcome 23 Maternal fever during labour.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Kruit 2016 2/89 2/99 1.54% 1.11[0.16,7.73]
ten Eikelder 2016 118/921 121/924 98.46% 0.98[0.77,1.24]
   
Total (95% CI) 1010 1023 100% 0.98[0.78,1.24]
Total events: 120 (Balloon), 123 (Oral misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.02, df=1(P=0.9); I2=0%  
Test for overall effect: Z=0.16(P=0.87)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 9.24.   Comparison 9 Balloon (Foley or ATAD) versus low dose
oral misoprostol: all women, Outcome 24 Antibiotics during labour.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Kruit 2016 1/89 2/99 6.8% 0.56[0.05,6.03]
ten Eikelder 2016 33/921 26/924 93.2% 1.27[0.77,2.11]
   
Total (95% CI) 1010 1023 100% 1.22[0.75,2]
Total events: 34 (Balloon), 28 (Oral misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.44, df=1(P=0.51); I2=0%  
Test for overall effect: Z=0.81(P=0.42)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 9.25.   Comparison 9 Balloon (Foley or ATAD) versus low
dose oral misoprostol: all women, Outcome 25 Endometritis.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Kruit 2016 1/89 2/99 100% 0.56[0.05,6.03]
   
Total (95% CI) 89 99 100% 0.56[0.05,6.03]
Total events: 1 (Balloon), 2 (Oral misoprostol)  
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=0.48(P=0.63)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 9.26.   Comparison 9 Balloon (Foley or ATAD) versus low
dose oral misoprostol: all women, Outcome 26 Fetal distress.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Kruit 2016 5/89 10/99 10.19% 0.56[0.2,1.57]
Mundle 2017 40/300 41/302 44% 0.98[0.65,1.47]
Saleem 2006 3/78 4/73 4.45% 0.7[0.16,3.03]
Somirathne 2017 0/89 2/91 2.66% 0.2[0.01,4.2]
ten Eikelder 2016 27/921 36/924 38.7% 0.75[0.46,1.23]
   
Total (95% CI) 1477 1489 100% 0.82[0.61,1.09]
Total events: 75 (Balloon), 93 (Oral misoprostol)  
Heterogeneity: Tau2=0; Chi2=2.28, df=4(P=0.68); I2=0%  
Test for overall effect: Z=1.37(P=0.17)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 9.27.   Comparison 9 Balloon (Foley or ATAD) versus low dose
oral misoprostol: all women, Outcome 27 Umbilical artery pH < 7.10.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Kruit 2016 3/89 6/99 9.43% 0.56[0.14,2.16]
ten Eikelder 2016 43/668 55/679 90.57% 0.79[0.54,1.17]
   
Total (95% CI) 757 778 100% 0.77[0.53,1.12]
Total events: 46 (Balloon), 61 (Oral misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.25, df=1(P=0.62); I2=0%  
Test for overall effect: Z=1.37(P=0.17)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Comparison 10.   Balloon (Foley or ATAD) versus low dose oral misoprostol: all primiparae
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Vaginal delivery not achieved in 24
hours
2 573 Risk Ratio (M-H, Fixed, 95% CI) 1.19 [1.04, 1.37]
2 Uterine hyperstimulation with FHR
changes
1 1206 Risk Ratio (M-H, Fixed, 95% CI) 0.81 [0.45, 1.46]
3 Caesarean section 3 1778 Risk Ratio (M-H, Fixed, 95% CI) 1.21 [1.06, 1.38]
4 Serious neonatal morbidity/perina-
tal death
2 1296 Risk Ratio (M-H, Fixed, 95% CI) 4.49 [0.77, 26.14]
5 Serious maternal morbidity or
death
2 1296 Risk Ratio (M-H, Fixed, 95% CI) 0.51 [0.05, 5.63]
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Analysis 10.1.   Comparison 10 Balloon (Foley or ATAD) versus low dose oral
misoprostol: all primiparae, Outcome 1 Vaginal delivery not achieved in 24 hours.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Mundle 2017 142/247 117/236 79.27% 1.16[0.98,1.37]
Somirathne 2017 40/44 32/46 20.73% 1.31[1.06,1.62]
   
Total (95% CI) 291 282 100% 1.19[1.04,1.37]
Total events: 182 (Balloon), 149 (Oral misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.83, df=1(P=0.36); I2=0%  
Test for overall effect: Z=2.45(P=0.01)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 10.2.   Comparison 10 Balloon (Foley or ATAD) versus low dose oral
misoprostol: all primiparae, Outcome 2 Uterine hyperstimulation with FHR changes.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
ten Eikelder 2016 19/596 24/610 100% 0.81[0.45,1.46]
   
Total (95% CI) 596 610 100% 0.81[0.45,1.46]
Total events: 19 (Balloon), 24 (Oral misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.7(P=0.49)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 10.3.   Comparison 10 Balloon (Foley or ATAD) versus low
dose oral misoprostol: all primiparae, Outcome 3 Caesarean section.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Mundle 2017 138/246 112/236 43.88% 1.18[0.99,1.41]
Somirathne 2017 13/44 9/46 3.38% 1.51[0.72,3.17]
ten Eikelder 2016 164/596 139/610 52.74% 1.21[0.99,1.47]
   
Total (95% CI) 886 892 100% 1.21[1.06,1.38]
Total events: 315 (Balloon), 260 (Oral misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.4, df=2(P=0.82); I2=0%  
Test for overall effect: Z=2.81(P=0)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 10.4.   Comparison 10 Balloon (Foley or ATAD) versus low dose oral
misoprostol: all primiparae, Outcome 4 Serious neonatal morbidity/perinatal death.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Somirathne 2017 3/44 1/46 66.43% 3.14[0.34,29.03]
ten Eikelder 2016 3/596 0/610 33.57% 7.16[0.37,138.4]
   
Total (95% CI) 640 656 100% 4.49[0.77,26.14]
Total events: 6 (Balloon), 1 (Oral misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.2, df=1(P=0.66); I2=0%  
Test for overall effect: Z=1.67(P=0.09)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 10.5.   Comparison 10 Balloon (Foley or ATAD) versus low dose oral
misoprostol: all primiparae, Outcome 5 Serious maternal morbidity or death.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Somirathne 2017 0/44 0/46   Not estimable
ten Eikelder 2016 1/596 2/610 100% 0.51[0.05,5.63]
   
Total (95% CI) 640 656 100% 0.51[0.05,5.63]
Total events: 1 (Balloon), 2 (Oral misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.55(P=0.58)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Comparison 11.   Balloon (Foley or ATAD) versus low dose oral misoprostol: all multiparae
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Vaginal delivery not achieved in 24
hours
2 209 Risk Ratio (M-H, Fixed, 95% CI) 1.55 [1.17, 2.06]
2 Uterine hyperstimulation with
FHR changes
1 639 Risk Ratio (M-H, Fixed, 95% CI) 1.45 [0.24, 8.61]
3 Caesarean section 3 848 Risk Ratio (M-H, Fixed, 95% CI) 1.22 [0.79, 1.87]
4 Serious neonatal morbidity/peri-
natal death
2 729 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.14, 6.86]
5 Serious maternal morbidity or
death
2 729 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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Analysis 11.1.   Comparison 11 Balloon (Foley or ATAD) versus low dose oral
misoprostol: all multiparae, Outcome 1 Vaginal delivery not achieved in 24 hours.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Mundle 2017 17/53 13/66 31.66% 1.63[0.87,3.04]
Somirathne 2017 38/45 25/45 68.34% 1.52[1.14,2.03]
   
Total (95% CI) 98 111 100% 1.55[1.17,2.06]
Total events: 55 (Balloon), 38 (Oral misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.04, df=1(P=0.83); I2=0%  
Test for overall effect: Z=3.07(P=0)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 11.2.   Comparison 11 Balloon (Foley or ATAD) versus low dose oral
misoprostol: all multiparae, Outcome 2 Uterine hyperstimulation with FHR changes.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
ten Eikelder 2016 3/325 2/314 100% 1.45[0.24,8.61]
   
Total (95% CI) 325 314 100% 1.45[0.24,8.61]
Total events: 3 (Balloon), 2 (Oral misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.41(P=0.68)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 11.3.   Comparison 11 Balloon (Foley or ATAD) versus low
dose oral misoprostol: all multiparae, Outcome 3 Caesarean section.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Mundle 2017 13/53 12/66 32.43% 1.35[0.67,2.71]
Somirathne 2017 5/45 6/45 18.2% 0.83[0.27,2.54]
ten Eikelder 2016 21/325 16/314 49.37% 1.27[0.67,2.38]
   
Total (95% CI) 423 425 100% 1.22[0.79,1.87]
Total events: 39 (Balloon), 34 (Oral misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.55, df=2(P=0.76); I2=0%  
Test for overall effect: Z=0.89(P=0.38)  
Favours balloon 1000.01 100.1 1 Favours misoprostol
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Analysis 11.4.   Comparison 11 Balloon (Foley or ATAD) versus low dose oral
misoprostol: all multiparae, Outcome 4 Serious neonatal morbidity/perinatal death.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Somirathne 2017 1/45 0/45 24.68% 3[0.13,71.74]
ten Eikelder 2016 0/325 1/314 75.32% 0.32[0.01,7.88]
   
Total (95% CI) 370 359 100% 0.98[0.14,6.86]
Total events: 1 (Balloon), 1 (Oral misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.94, df=1(P=0.33); I2=0%  
Test for overall effect: Z=0.02(P=0.99)  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 11.5.   Comparison 11 Balloon (Foley or ATAD) versus low dose oral
misoprostol: all multiparae, Outcome 5 Serious maternal morbidity or death.
Study or subgroup Balloon Oral miso-
prostol
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Somirathne 2017 0/45 0/45   Not estimable
ten Eikelder 2016 0/325 0/314   Not estimable
   
Total (95% CI) 370 359 Not estimable
Total events: 0 (Balloon), 0 (Oral misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours balloon 100.1 50.2 20.5 1 Favours misoprostol
 
 
Comparison 12.   Balloon (Foley or ATAD) versus oxytocin: all women
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Uterine hyperstimulation with FHR
changes
1 200 Risk Ratio (M-H, Fixed, 95% CI) 0.2 [0.01, 4.11]
2 Caesarean section 8 781 Risk Ratio (M-H, Fixed, 95% CI) 0.68 [0.56, 0.83]
3 Serious neonatal morbidity/perina-
tal death
1 100 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Serious maternal morbidity or death 2 160 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Cervix unfavourable after 24 hours 1 100 Risk Ratio (M-H, Fixed, 95% CI) 0.56 [0.20, 1.54]
6 Uterine hyperstimulation without
FHR changes
3 192 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.23, 4.29]
7 Uterine rupture 1 100 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
Mechanical methods for induction of labour (Review)
Copyright © 2019 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane
Collaboration.
272
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
8 Instrumental vaginal delivery 3 220 Risk Ratio (M-H, Fixed, 95% CI) 1.19 [0.55, 2.57]
9 Meconium-stained liquor 2 272 Risk Ratio (M-H, Fixed, 95% CI) 0.53 [0.23, 1.21]
10 Apgar score < 7 at 5 minutes 2 300 Risk Ratio (M-H, Fixed, 95% CI) 0.71 [0.14, 3.53]
11 Neonatal intensive care unit admis-
sion
3 372 Risk Ratio (M-H, Fixed, 95% CI) 0.8 [0.32, 1.98]
12 Perinatal death 1 100 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 Hemorrhagia postpartum 4 396 Risk Ratio (M-H, Fixed, 95% CI) 1.26 [0.51, 3.11]
14 Maternal fever during labour 1 60 Risk Ratio (M-H, Fixed, 95% CI) 0.2 [0.01, 4.00]
15 Fetal distress 3 332 Risk Ratio (M-H, Fixed, 95% CI) 0.43 [0.19, 0.98]
 
 
Analysis 12.1.   Comparison 12 Balloon (Foley or ATAD) versus oxytocin:
all women, Outcome 1 Uterine hyperstimulation with FHR changes.
Study or subgroup Balloon oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Gelisen 2005 0/100 2/100 100% 0.2[0.01,4.11]
   
Total (95% CI) 100 100 100% 0.2[0.01,4.11]
Total events: 0 (Balloon), 2 (oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.04(P=0.3)  
Favours balloon 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 12.2.   Comparison 12 Balloon (Foley or ATAD) versus oxytocin: all women, Outcome 2 Caesarean section.
Study or subgroup Balloon oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Atad 1996 7/35 14/30 9.89% 0.43[0.2,0.92]
El Khouly 2017 6/36 15/36 9.84% 0.4[0.18,0.91]
Gelisen 2005 17/100 24/100 15.74% 0.71[0.41,1.24]
Jagani 1982 1/10 3/10 1.97% 0.33[0.04,2.69]
Joshi 2016 10/50 12/50 7.87% 0.83[0.4,1.75]
Meetei 2015 10/30 12/30 7.87% 0.83[0.43,1.63]
Orhue 1995 3/30 7/30 4.59% 0.43[0.12,1.5]
Sarreau 2016 50/101 65/103 42.22% 0.78[0.61,1]
   
Total (95% CI) 392 389 100% 0.68[0.56,0.83]
Total events: 104 (Balloon), 152 (oxytocin)  
Heterogeneity: Tau2=0; Chi2=5.88, df=7(P=0.55); I2=0%  
Favours balloon 100.1 50.2 20.5 1 Favours oxytocin
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Study or subgroup Balloon oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Test for overall effect: Z=3.83(P=0)  
Favours balloon 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 12.3.   Comparison 12 Balloon (Foley or ATAD) versus oxytocin:
all women, Outcome 3 Serious neonatal morbidity/perinatal death.
Study or subgroup Balloon oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Joshi 2016 0/50 0/50   Not estimable
   
Total (95% CI) 50 50 Not estimable
Total events: 0 (Balloon), 0 (oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours balloon 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 12.4.   Comparison 12 Balloon (Foley or ATAD) versus
oxytocin: all women, Outcome 4 Serious maternal morbidity or death.
Study or subgroup Balloon oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Joshi 2016 0/50 0/50   Not estimable
Orhue 1995 0/30 0/30   Not estimable
   
Total (95% CI) 80 80 Not estimable
Total events: 0 (Balloon), 0 (oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours balloon 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 12.5.   Comparison 12 Balloon (Foley or ATAD) versus
oxytocin: all women, Outcome 5 Cervix unfavourable aLer 24 hours.
Study or subgroup Balloon oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Joshi 2016 5/50 9/50 100% 0.56[0.2,1.54]
   
Total (95% CI) 50 50 100% 0.56[0.2,1.54]
Total events: 5 (Balloon), 9 (oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.13(P=0.26)  
Favours balloon 100.1 50.2 20.5 1 Favours oxytocin
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Analysis 12.6.   Comparison 12 Balloon (Foley or ATAD) versus oxytocin:
all women, Outcome 6 Uterine hyperstimulation without FHR changes.
Study or subgroup Balloon oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
El Khouly 2017 1/36 1/36 28.57% 1[0.07,15.38]
Meetei 2015 1/30 0/30 14.29% 3[0.13,70.83]
Orhue 1995 1/30 2/30 57.14% 0.5[0.05,5.22]
   
Total (95% CI) 96 96 100% 1[0.23,4.29]
Total events: 3 (Balloon), 3 (oxytocin)  
Heterogeneity: Tau2=0; Chi2=0.8, df=2(P=0.67); I2=0%  
Test for overall effect: Not applicable  
Favours balloon 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 12.7.   Comparison 12 Balloon (Foley or ATAD) versus oxytocin: all women, Outcome 7 Uterine rupture.
Study or subgroup Balloon oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Joshi 2016 0/50 0/50   Not estimable
   
Total (95% CI) 50 50 Not estimable
Total events: 0 (Balloon), 0 (oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours balloon 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 12.8.   Comparison 12 Balloon (Foley or ATAD) versus
oxytocin: all women, Outcome 8 Instrumental vaginal delivery.
Study or subgroup Balloon oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Joshi 2016 3/50 5/50 47.62% 0.6[0.15,2.38]
Meetei 2015 3/30 0/30 4.76% 7[0.38,129.93]
Orhue 1995 6/30 5/30 47.62% 1.2[0.41,3.51]
   
Total (95% CI) 110 110 100% 1.19[0.55,2.57]
Total events: 12 (Balloon), 10 (oxytocin)  
Heterogeneity: Tau2=0; Chi2=2.36, df=2(P=0.31); I2=15.43%  
Test for overall effect: Z=0.44(P=0.66)  
Favours balloon 100.1 50.2 20.5 1 Favours oxytocin
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Analysis 12.9.   Comparison 12 Balloon (Foley or ATAD) versus
oxytocin: all women, Outcome 9 Meconium-stained liquor.
Study or subgroup Balloon oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
El Khouly 2017 1/36 2/36 13.33% 0.5[0.05,5.27]
Gelisen 2005 7/100 13/100 86.67% 0.54[0.22,1.29]
   
Total (95% CI) 136 136 100% 0.53[0.23,1.21]
Total events: 8 (Balloon), 15 (oxytocin)  
Heterogeneity: Tau2=0; Chi2=0, df=1(P=0.95); I2=0%  
Test for overall effect: Z=1.5(P=0.13)  
Favours balloon 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 12.10.   Comparison 12 Balloon (Foley or ATAD) versus
oxytocin: all women, Outcome 10 Apgar score < 7 at 5 minutes.
Study or subgroup Balloon oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Gelisen 2005 0/100 1/100 42.86% 0.33[0.01,8.09]
Joshi 2016 2/50 2/50 57.14% 1[0.15,6.82]
   
Total (95% CI) 150 150 100% 0.71[0.14,3.53]
Total events: 2 (Balloon), 3 (oxytocin)  
Heterogeneity: Tau2=0; Chi2=0.34, df=1(P=0.56); I2=0%  
Test for overall effect: Z=0.41(P=0.68)  
Favours balloon 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 12.11.   Comparison 12 Balloon (Foley or ATAD) versus oxytocin:
all women, Outcome 11 Neonatal intensive care unit admission.
Study or subgroup Balloon oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
El Khouly 2017 1/36 2/36 20% 0.5[0.05,5.27]
Gelisen 2005 3/100 5/100 50% 0.6[0.15,2.44]
Joshi 2016 4/50 3/50 30% 1.33[0.31,5.65]
   
Total (95% CI) 186 186 100% 0.8[0.32,1.98]
Total events: 8 (Balloon), 10 (oxytocin)  
Heterogeneity: Tau2=0; Chi2=0.79, df=2(P=0.67); I2=0%  
Test for overall effect: Z=0.48(P=0.63)  
Favours balloon 100.1 50.2 20.5 1 Favours oxytocin
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Analysis 12.12.   Comparison 12 Balloon (Foley or ATAD) versus oxytocin: all women, Outcome 12 Perinatal death.
Study or subgroup Balloon oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Joshi 2016 0/50 0/50   Not estimable
   
Total (95% CI) 50 50 Not estimable
Total events: 0 (Balloon), 0 (oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours balloon 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 12.13.   Comparison 12 Balloon (Foley or ATAD) versus
oxytocin: all women, Outcome 13 Hemorrhagia postpartum.
Study or subgroup Balloon oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
El Khouly 2017 0/36 2/36 31.33% 0.2[0.01,4.03]
Meetei 2015 1/30 0/30 6.27% 3[0.13,70.83]
Orhue 1995 3/30 3/30 37.59% 1[0.22,4.56]
Sarreau 2016 5/101 2/103 24.82% 2.55[0.51,12.84]
   
Total (95% CI) 197 199 100% 1.26[0.51,3.11]
Total events: 9 (Balloon), 7 (oxytocin)  
Heterogeneity: Tau2=0; Chi2=2.55, df=3(P=0.47); I2=0%  
Test for overall effect: Z=0.5(P=0.62)  
Favours balloon 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 12.14.   Comparison 12 Balloon (Foley or ATAD) versus
oxytocin: all women, Outcome 14 Maternal fever during labour.
Study or subgroup Balloon oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Meetei 2015 0/30 2/30 100% 0.2[0.01,4]
   
Total (95% CI) 30 30 100% 0.2[0.01,4]
Total events: 0 (Balloon), 2 (oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.05(P=0.29)  
Favours balloon 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 12.15.   Comparison 12 Balloon (Foley or ATAD) versus oxytocin: all women, Outcome 15 Fetal distress.
Study or subgroup Balloon oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
El Khouly 2017 1/36 2/36 11.43% 0.5[0.05,5.27]
Gelisen 2005 6/100 13/100 74.29% 0.46[0.18,1.17]
Favours balloon 100.1 50.2 20.5 1 Favours oxytocin
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Study or subgroup Balloon oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Orhue 1995 0/30 2/30 14.29% 0.2[0.01,4]
   
Total (95% CI) 166 166 100% 0.43[0.19,0.98]
Total events: 7 (Balloon), 17 (oxytocin)  
Heterogeneity: Tau2=0; Chi2=0.29, df=2(P=0.87); I2=0%  
Test for overall effect: Z=2.01(P=0.04)  
Favours balloon 100.1 50.2 20.5 1 Favours oxytocin
 
 
Comparison 13.   Balloon (Foley or ATAD) versus oxytocin: previous caesarean section
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Caesarean section 3 364 Risk Ratio (M-H, Fixed, 95% CI) 0.80 [0.64, 1.00]
2 Serious neonatal morbidity/perina-
tal death
1 100 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Serious maternal morbidity or
death
1 100 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
 
 
Analysis 13.1.   Comparison 13 Balloon (Foley or ATAD) versus
oxytocin: previous caesarean section, Outcome 1 Caesarean section.
Study or subgroup Balloon oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Joshi 2016 10/50 12/50 13.58% 0.83[0.4,1.75]
Meetei 2015 10/30 12/30 13.58% 0.83[0.43,1.63]
Sarreau 2016 50/101 65/103 72.84% 0.78[0.61,1]
   
Total (95% CI) 181 183 100% 0.8[0.64,1]
Total events: 70 (Balloon), 89 (oxytocin)  
Heterogeneity: Tau2=0; Chi2=0.05, df=2(P=0.98); I2=0%  
Test for overall effect: Z=1.96(P=0.05)  
Favours balloon 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 13.2.   Comparison 13 Balloon (Foley or ATAD) versus oxytocin: previous
caesarean section, Outcome 2 Serious neonatal morbidity/perinatal death.
Study or subgroup Balloon oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Joshi 2016 0/50 0/50   Not estimable
   
Total (95% CI) 50 50 Not estimable
Favours balloon 100.1 50.2 20.5 1 Favours oxytocin
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Study or subgroup Balloon oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Total events: 0 (Balloon), 0 (oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours balloon 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 13.3.   Comparison 13 Balloon (Foley or ATAD) versus oxytocin:
previous caesarean section, Outcome 3 Serious maternal morbidity or death.
Study or subgroup Balloon oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Joshi 2016 0/50 0/50   Not estimable
   
Total (95% CI) 50 50 Not estimable
Total events: 0 (Balloon), 0 (oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours balloon 100.1 50.2 20.5 1 Favours oxytocin
 
 
Comparison 14.   Balloon (Foley or ATAD) versus oxytocin: all primiparae
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Caesarean section 1 60 Risk Ratio (M-H, Fixed, 95% CI) 0.43 [0.12, 1.50]
2 Serious maternal morbidity or
death
1 60 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
 
 
Analysis 14.1.   Comparison 14 Balloon (Foley or ATAD) versus
oxytocin: all primiparae, Outcome 1 Caesarean section.
Study or subgroup Balloon oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Orhue 1995 3/30 7/30 100% 0.43[0.12,1.5]
   
Total (95% CI) 30 30 100% 0.43[0.12,1.5]
Total events: 3 (Balloon), 7 (oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.32(P=0.19)  
Favours balloon 100.1 50.2 20.5 1 Favours oxytocin
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Analysis 14.2.   Comparison 14 Balloon (Foley or ATAD) versus oxytocin:
all primiparae, Outcome 2 Serious maternal morbidity or death.
Study or subgroup Balloon oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Orhue 1995 0/30 0/30   Not estimable
   
Total (95% CI) 30 30 Not estimable
Total events: 0 (Balloon), 0 (oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours balloon 100.1 50.2 20.5 1 Favours oxytocin
 
 
Comparison 15.   Balloon (foley or ATAD) versus amniotomy: all women
Outcome or subgroup title No. of
studies
No. of partici-
pants
Statistical method Effect size
1 Caesarean section 1 20 Risk Ratio (M-H, Fixed, 95% CI) 0.25 [0.03, 1.86]
 
 
Analysis 15.1.   Comparison 15 Balloon (foley or ATAD) versus amniotomy: all women, Outcome 1 Caesarean section.
Study or subgroup Balloon Amniotomy Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Jagani 1982 1/10 4/10 100% 0.25[0.03,1.86]
   
Total (95% CI) 10 10 100% 0.25[0.03,1.86]
Total events: 1 (Balloon), 4 (Amniotomy)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.35(P=0.18)  
Favours balloon 100.1 50.2 20.5 1 Favours amniotomy
 
 
Comparison 16.   Single balloon (Foley) versus double balloon (ATAD/Cook): all women
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Vaginal delivery not achieved in 24 hours 3 608 Risk Ratio (M-H, Random,
95% CI)
0.97 [0.75, 1.25]
2 Uterine hyperstimulation with FHR changes 1 217 Risk Ratio (M-H, Fixed, 95%
CI)
0.0 [0.0, 0.0]
3 Caesarean section 5 862 Risk Ratio (M-H, Random,
95% CI)
0.97 [0.71, 1.33]
4 Serious maternal morbidity or death 1 217 Risk Ratio (M-H, Fixed, 95%
CI)
0.0 [0.0, 0.0]
Mechanical methods for induction of labour (Review)
Copyright © 2019 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane
Collaboration.
280
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
5 Oxytcocin augmentation 2 278 Risk Ratio (M-H, Fixed, 95%
CI)
0.94 [0.82, 1.08]
6 Uterine hyperstimulation without FHR
changes
1 217 Risk Ratio (M-H, Fixed, 95%
CI)
0.0 [0.0, 0.0]
7 Uterine rupture 1 217 Risk Ratio (M-H, Fixed, 95%
CI)
0.0 [0.0, 0.0]
8 Epidural analgesia 3 608 Risk Ratio (M-H, Fixed, 95%
CI)
0.93 [0.83, 1.03]
9 Instrumental vaginal delivery 3 690 Risk Ratio (M-H, Fixed, 95%
CI)
0.86 [0.61, 1.20]
10 Meconium-stained liquor 1 98 Risk Ratio (M-H, Fixed, 95%
CI)
0.40 [0.15, 1.04]
11 Apgar score < 7 at 5 minutes 3 608 Risk Ratio (M-H, Fixed, 95%
CI)
0.84 [0.25, 2.79]
12 Neonatal intensive care unit admission 2 391 Risk Ratio (M-H, Fixed, 95%
CI)
1.67 [0.71, 3.93]
13 Other maternal side-effects: pain after in-
sertion
1 74 Risk Ratio (M-H, Fixed, 95%
CI)
0.67 [0.20, 2.17]
14 Postpartum haemorrhage 2 291 Risk Ratio (M-H, Fixed, 95%
CI)
0.83 [0.27, 2.52]
15 Maternal fever during labour 3 584 Risk Ratio (M-H, Random,
95% CI)
0.61 [0.16, 2.34]
16 Antibiotics during labour 1 217 Risk Ratio (M-H, Fixed, 95%
CI)
0.97 [0.61, 1.56]
17 Chorioamnionitis 1 98 Risk Ratio (M-H, Fixed, 95%
CI)
1.56 [0.47, 5.20]
18 Endometritis 1 217 Risk Ratio (M-H, Fixed, 95%
CI)
1.95 [0.18, 21.14]
19 Fetal distress 4 682 Risk Ratio (M-H, Fixed, 95%
CI)
0.98 [0.70, 1.36]
20 Umbilical artery pH < 7.10 1 217 Risk Ratio (M-H, Fixed, 95%
CI)
0.42 [0.11, 1.57]
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Analysis 16.1.   Comparison 16 Single balloon (Foley) versus double balloon
(ATAD/Cook): all women, Outcome 1 Vaginal delivery not achieved in 24 hours.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Hoppe 2016 40/48 35/50 37.64% 1.19[0.95,1.49]
Pennell 2009 57/110 67/107 36.59% 0.83[0.66,1.04]
Salim 2011 40/145 45/148 25.77% 0.91[0.63,1.3]
   
Total (95% CI) 303 305 100% 0.97[0.75,1.25]
Total events: 137 (Single balloon), 147 (Double balloon)  
Heterogeneity: Tau2=0.03; Chi2=5.64, df=2(P=0.06); I2=64.54%  
Test for overall effect: Z=0.22(P=0.83)  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
 
 
Analysis 16.2.   Comparison 16 Single balloon (Foley) versus double balloon (ATAD/
Cook): all women, Outcome 2 Uterine hyperstimulation with FHR changes.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Pennell 2009 0/110 0/107   Not estimable
   
Total (95% CI) 110 107 Not estimable
Total events: 0 (Single balloon), 0 (Double balloon)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
 
 
Analysis 16.3.   Comparison 16 Single balloon (Foley) versus double
balloon (ATAD/Cook): all women, Outcome 3 Caesarean section.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Ahmed 2016 11/37 8/37 12.11% 1.38[0.62,3.03]
Haugland 2012 18/90 19/90 18.64% 0.95[0.53,1.68]
Hoppe 2016 21/48 14/50 19.73% 1.56[0.9,2.7]
Pennell 2009 40/110 46/107 31.58% 0.85[0.61,1.18]
Salim 2011 15/145 26/148 17.94% 0.59[0.33,1.07]
   
Total (95% CI) 430 432 100% 0.97[0.71,1.33]
Total events: 105 (Single balloon), 113 (Double balloon)  
Heterogeneity: Tau2=0.05; Chi2=6.99, df=4(P=0.14); I2=42.81%  
Test for overall effect: Z=0.19(P=0.85)  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
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Analysis 16.4.   Comparison 16 Single balloon (Foley) versus double balloon
(ATAD/Cook): all women, Outcome 4 Serious maternal morbidity or death.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Pennell 2009 0/110 0/107   Not estimable
   
Total (95% CI) 110 107 Not estimable
Total events: 0 (Single balloon), 0 (Double balloon)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
 
 
Analysis 16.5.   Comparison 16 Single balloon (Foley) versus double
balloon (ATAD/Cook): all women, Outcome 5 Oxytcocin augmentation.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Haugland 2012 52/90 58/90 56.28% 0.9[0.71,1.13]
Hoppe 2016 44/48 46/50 43.72% 1[0.89,1.12]
   
Total (95% CI) 138 140 100% 0.94[0.82,1.08]
Total events: 96 (Single balloon), 104 (Double balloon)  
Heterogeneity: Tau2=0; Chi2=1.09, df=1(P=0.3); I2=7.89%  
Test for overall effect: Z=0.87(P=0.39)  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
 
 
Analysis 16.6.   Comparison 16 Single balloon (Foley) versus double balloon (ATAD/
Cook): all women, Outcome 6 Uterine hyperstimulation without FHR changes.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Pennell 2009 0/110 0/107   Not estimable
   
Total (95% CI) 110 107 Not estimable
Total events: 0 (Single balloon), 0 (Double balloon)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
 
 
Analysis 16.7.   Comparison 16 Single balloon (Foley) versus double
balloon (ATAD/Cook): all women, Outcome 7 Uterine rupture.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Pennell 2009 0/110 0/107   Not estimable
   
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
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Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Total (95% CI) 110 107 Not estimable
Total events: 0 (Single balloon), 0 (Double balloon)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
 
 
Analysis 16.8.   Comparison 16 Single balloon (Foley) versus double
balloon (ATAD/Cook): all women, Outcome 8 Epidural analgesia.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hoppe 2016 38/48 43/50 20.1% 0.92[0.77,1.11]
Pennell 2009 90/110 89/107 43.06% 0.98[0.87,1.11]
Salim 2011 66/145 78/148 36.84% 0.86[0.68,1.09]
   
Total (95% CI) 303 305 100% 0.93[0.83,1.03]
Total events: 194 (Single balloon), 210 (Double balloon)  
Heterogeneity: Tau2=0; Chi2=1.26, df=2(P=0.53); I2=0%  
Test for overall effect: Z=1.4(P=0.16)  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
 
 
Analysis 16.9.   Comparison 16 Single balloon (Foley) versus double
balloon (ATAD/Cook): all women, Outcome 9 Instrumental vaginal delivery.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Haugland 2012 20/90 24/90 40.54% 0.83[0.5,1.4]
Pennell 2009 25/110 23/107 39.39% 1.06[0.64,1.74]
Salim 2011 6/145 12/148 20.06% 0.51[0.2,1.32]
   
Total (95% CI) 345 345 100% 0.86[0.61,1.2]
Total events: 51 (Single balloon), 59 (Double balloon)  
Heterogeneity: Tau2=0; Chi2=1.83, df=2(P=0.4); I2=0%  
Test for overall effect: Z=0.9(P=0.37)  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
 
 
Analysis 16.10.   Comparison 16 Single balloon (Foley) versus double
balloon (ATAD/Cook): all women, Outcome 10 Meconium-stained liquor.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hoppe 2016 5/48 13/50 100% 0.4[0.15,1.04]
   
Total (95% CI) 48 50 100% 0.4[0.15,1.04]
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
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Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Total events: 5 (Single balloon), 13 (Double balloon)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.88(P=0.06)  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
 
 
Analysis 16.11.   Comparison 16 Single balloon (Foley) versus double
balloon (ATAD/Cook): all women, Outcome 11 Apgar score < 7 at 5 minutes.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hoppe 2016 4/48 3/50 53.7% 1.39[0.33,5.88]
Pennell 2009 0/110 2/107 46.3% 0.19[0.01,4.01]
Salim 2011 0/145 0/148   Not estimable
   
Total (95% CI) 303 305 100% 0.84[0.25,2.79]
Total events: 4 (Single balloon), 5 (Double balloon)  
Heterogeneity: Tau2=0; Chi2=1.37, df=1(P=0.24); I2=26.86%  
Test for overall effect: Z=0.29(P=0.77)  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
 
 
Analysis 16.12.   Comparison 16 Single balloon (Foley) versus double balloon
(ATAD/Cook): all women, Outcome 12 Neonatal intensive care unit admission.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hoppe 2016 6/48 4/50 49.74% 1.56[0.47,5.2]
Salim 2011 7/145 4/148 50.26% 1.79[0.53,5.97]
   
Total (95% CI) 193 198 100% 1.67[0.71,3.93]
Total events: 13 (Single balloon), 8 (Double balloon)  
Heterogeneity: Tau2=0; Chi2=0.02, df=1(P=0.88); I2=0%  
Test for overall effect: Z=1.19(P=0.24)  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
 
 
Analysis 16.13.   Comparison 16 Single balloon (Foley) versus double balloon (ATAD/
Cook): all women, Outcome 13 Other maternal side-e>ects: pain aLer insertion.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Ahmed 2016 4/37 6/37 100% 0.67[0.2,2.17]
   
Total (95% CI) 37 37 100% 0.67[0.2,2.17]
Total events: 4 (Single balloon), 6 (Double balloon)  
Heterogeneity: Not applicable  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
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Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Test for overall effect: Z=0.67(P=0.5)  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
 
 
Analysis 16.14.   Comparison 16 Single balloon (Foley) versus double
balloon (ATAD/Cook): all women, Outcome 14 Postpartum haemorrhage.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Ahmed 2016 0/37 1/37 22.83% 0.33[0.01,7.93]
Pennell 2009 5/110 5/107 77.17% 0.97[0.29,3.26]
   
Total (95% CI) 147 144 100% 0.83[0.27,2.52]
Total events: 5 (Single balloon), 6 (Double balloon)  
Heterogeneity: Tau2=0; Chi2=0.38, df=1(P=0.53); I2=0%  
Test for overall effect: Z=0.34(P=0.74)  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
 
 
Analysis 16.15.   Comparison 16 Single balloon (Foley) versus double
balloon (ATAD/Cook): all women, Outcome 15 Maternal fever during labour.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Ahmed 2016 0/37 0/37   Not estimable
Pennell 2009 19/110 18/107 63.07% 1.03[0.57,1.85]
Salim 2011 2/145 8/148 36.93% 0.26[0.06,1.18]
   
Total (95% CI) 292 292 100% 0.61[0.16,2.34]
Total events: 21 (Single balloon), 26 (Double balloon)  
Heterogeneity: Tau2=0.65; Chi2=2.85, df=1(P=0.09); I2=64.86%  
Test for overall effect: Z=0.72(P=0.47)  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
 
 
Analysis 16.16.   Comparison 16 Single balloon (Foley) versus double
balloon (ATAD/Cook): all women, Outcome 16 Antibiotics during labour.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Pennell 2009 26/110 26/107 100% 0.97[0.61,1.56]
   
Total (95% CI) 110 107 100% 0.97[0.61,1.56]
Total events: 26 (Single balloon), 26 (Double balloon)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.11(P=0.91)  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
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Analysis 16.17.   Comparison 16 Single balloon (Foley) versus double
balloon (ATAD/Cook): all women, Outcome 17 Chorioamnionitis.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hoppe 2016 6/48 4/50 100% 1.56[0.47,5.2]
   
Total (95% CI) 48 50 100% 1.56[0.47,5.2]
Total events: 6 (Single balloon), 4 (Double balloon)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.73(P=0.47)  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
 
 
Analysis 16.18.   Comparison 16 Single balloon (Foley) versus
double balloon (ATAD/Cook): all women, Outcome 18 Endometritis.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Pennell 2009 2/110 1/107 100% 1.95[0.18,21.14]
   
Total (95% CI) 110 107 100% 1.95[0.18,21.14]
Total events: 2 (Single balloon), 1 (Double balloon)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.55(P=0.58)  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
 
 
Analysis 16.19.   Comparison 16 Single balloon (Foley) versus
double balloon (ATAD/Cook): all women, Outcome 19 Fetal distress.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Ahmed 2016 7/37 4/37 6.7% 1.75[0.56,5.48]
Hoppe 2016 11/48 9/50 14.77% 1.27[0.58,2.8]
Pennell 2009 14/110 15/107 25.47% 0.91[0.46,1.79]
Salim 2011 26/145 32/148 53.06% 0.83[0.52,1.32]
   
Total (95% CI) 340 342 100% 0.98[0.7,1.36]
Total events: 58 (Single balloon), 60 (Double balloon)  
Heterogeneity: Tau2=0; Chi2=1.96, df=3(P=0.58); I2=0%  
Test for overall effect: Z=0.14(P=0.89)  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
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Analysis 16.20.   Comparison 16 Single balloon (Foley) versus double
balloon (ATAD/Cook): all women, Outcome 20 Umbilical artery pH < 7.10.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Pennell 2009 3/110 7/107 100% 0.42[0.11,1.57]
   
Total (95% CI) 110 107 100% 0.42[0.11,1.57]
Total events: 3 (Single balloon), 7 (Double balloon)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.29(P=0.2)  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
 
 
Comparison 17.   Single balloon (Foley) versus double balloon (ATAD): all primiparae
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Vaginal delivery not achieved in 24
hours
1 50 Risk Ratio (M-H, Fixed, 95% CI) 1.14 [0.95, 1.38]
2 Caesarean section 4 374 Risk Ratio (M-H, Random, 95% CI) 1.30 [0.76, 2.22]
 
 
Analysis 17.1.   Comparison 17 Single balloon (Foley) versus double balloon
(ATAD): all primiparae, Outcome 1 Vaginal delivery not achieved in 24 hours.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hoppe 2016 24/25 21/25 100% 1.14[0.95,1.38]
   
Total (95% CI) 25 25 100% 1.14[0.95,1.38]
Total events: 24 (Single balloon), 21 (Double balloon)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.39(P=0.17)  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
 
 
Analysis 17.2.   Comparison 17 Single balloon (Foley) versus double
balloon (ATAD): all primiparae, Outcome 2 Caesarean section.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Ahmed 2016 11/37 8/37 21.54% 1.38[0.62,3.03]
Hoppe 2016 17/25 10/25 28.33% 1.7[0.98,2.95]
Salim 2011 12/77 20/78 25.54% 0.61[0.32,1.16]
Solt 2009 20/50 9/45 24.59% 2[1.02,3.93]
   
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
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Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Total (95% CI) 189 185 100% 1.3[0.76,2.22]
Total events: 60 (Single balloon), 47 (Double balloon)  
Heterogeneity: Tau2=0.18; Chi2=7.96, df=3(P=0.05); I2=62.3%  
Test for overall effect: Z=0.96(P=0.34)  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
 
 
Comparison 18.   Single balloon (Foley) versus double balloon (ATAD): all multiparae
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Vaginal delivery not achieved in 24
hours
1 48 Risk Ratio (M-H, Fixed, 95% CI) 1.24 [0.80, 1.93]
2 Caesarean section 2 186 Risk Ratio (M-H, Fixed, 95% CI) 0.74 [0.30, 1.84]
 
 
Analysis 18.1.   Comparison 18 Single balloon (Foley) versus double balloon
(ATAD): all multiparae, Outcome 1 Vaginal delivery not achieved in 24 hours.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hoppe 2016 16/23 14/25 100% 1.24[0.8,1.93]
   
Total (95% CI) 23 25 100% 1.24[0.8,1.93]
Total events: 16 (Single balloon), 14 (Double balloon)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.97(P=0.33)  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
 
 
Analysis 18.2.   Comparison 18 Single balloon (Foley) versus double
balloon (ATAD): all multiparae, Outcome 2 Caesarean section.
Study or subgroup Single balloon Double balloon Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hoppe 2016 4/23 4/25 39.33% 1.09[0.31,3.85]
Salim 2011 3/68 6/70 60.67% 0.51[0.13,1.98]
   
Total (95% CI) 91 95 100% 0.74[0.3,1.84]
Total events: 7 (Single balloon), 10 (Double balloon)  
Heterogeneity: Tau2=0; Chi2=0.63, df=1(P=0.43); I2=0%  
Test for overall effect: Z=0.65(P=0.52)  
Favours single balloon 100.1 50.2 20.5 1 Favours double balloon
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Comparison 19.   Laminaria tent versus vaginal prostaglandin E2: all women
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Uterine hyperstimulation with FHR
changes
3 188 Risk Ratio (M-H, Fixed, 95% CI) 0.11 [0.02, 0.60]
2 Caesarean section 5 263 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.56, 1.48]
3 Serious perinatal morbidity/perina-
tal death
1 80 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Serious maternal morbidity or death 1 28 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Uterine hyperstimulation without fe-
tal heart rate changes
3 180 Risk Ratio (M-H, Fixed, 95% CI) 0.22 [0.09, 0.49]
6 Epidural analgesia 1 80 Risk Ratio (M-H, Fixed, 95% CI) 0.91 [0.74, 1.13]
7 Instrumental vaginal delivery 1 80 Risk Ratio (M-H, Fixed, 95% CI) 0.71 [0.43, 1.17]
8 Meconium-stained liquor 1 80 Risk Ratio (M-H, Fixed, 95% CI) 0.14 [0.01, 2.68]
9 Apgar score < 7 at 5 minutes 2 160 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
10 Perinatal death 1 80 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
11 Maternal side effects: all 1 28 Risk Ratio (M-H, Fixed, 95% CI) 0.29 [0.01, 6.60]
12 Maternal nausea 1 28 Risk Ratio (M-H, Fixed, 95% CI) 0.29 [0.01, 6.60]
13 Fetal distress 3 188 Risk Ratio (M-H, Fixed, 95% CI) 0.62 [0.34, 1.15]
 
 
Analysis 19.1.   Comparison 19 Laminaria tent versus vaginal prostaglandin
E2: all women, Outcome 1 Uterine hyperstimulation with FHR changes.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Bagratee 1990 0/40 5/40 42.75% 0.09[0.01,1.59]
Hay 1995 0/15 5/13 45.6% 0.08[0,1.31]
Johnson 1985 0/40 1/40 11.66% 0.33[0.01,7.95]
   
Total (95% CI) 95 93 100% 0.11[0.02,0.6]
Total events: 0 (Laminaria), 11 (PGE2)  
Heterogeneity: Tau2=0; Chi2=0.53, df=2(P=0.77); I2=0%  
Test for overall effect: Z=2.57(P=0.01)  
Favours laminaria 200.05 50.2 1 Favours PGE2
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Analysis 19.2.   Comparison 19 Laminaria tent versus vaginal
prostaglandin E2: all women, Outcome 2 Caesarean section.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Bagratee 1990 8/40 10/40 36.87% 0.8[0.35,1.82]
Hay 1995 2/15 1/13 3.95% 1.73[0.18,16.99]
Jeeva 1982 4/10 3/10 11.06% 1.33[0.4,4.49]
Johnson 1985 6/40 10/40 36.87% 0.6[0.24,1.49]
Roberts 1986 5/28 3/27 11.26% 1.61[0.42,6.08]
   
Total (95% CI) 133 130 100% 0.91[0.56,1.48]
Total events: 25 (Laminaria), 27 (PGE2)  
Heterogeneity: Tau2=0; Chi2=2.28, df=4(P=0.68); I2=0%  
Test for overall effect: Z=0.37(P=0.71)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 19.3.   Comparison 19 Laminaria tent versus vaginal prostaglandin
E2: all women, Outcome 3 Serious perinatal morbidity/perinatal death.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Bagratee 1990 0/40 0/40   Not estimable
   
Total (95% CI) 40 40 Not estimable
Total events: 0 (Laminaria), 0 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 19.4.   Comparison 19 Laminaria tent versus vaginal prostaglandin
E2: all women, Outcome 4 Serious maternal morbidity or death.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hay 1995 0/15 0/13   Not estimable
   
Total (95% CI) 15 13 Not estimable
Total events: 0 (Laminaria), 0 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
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Analysis 19.5.   Comparison 19 Laminaria tent versus vaginal prostaglandin E2: all
women, Outcome 5 Uterine hyperstimulation without fetal heart rate changes.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Bagratee 1990 5/40 24/40 94.12% 0.21[0.09,0.49]
Jeeva 1982 0/10 0/10   Not estimable
Johnson 1985 0/40 1/40 5.88% 0.33[0.01,7.95]
   
Total (95% CI) 90 90 100% 0.22[0.09,0.49]
Total events: 5 (Laminaria), 25 (PGE2)  
Heterogeneity: Tau2=0; Chi2=0.08, df=1(P=0.78); I2=0%  
Test for overall effect: Z=3.64(P=0)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 19.6.   Comparison 19 Laminaria tent versus vaginal
prostaglandin E2: all women, Outcome 6 Epidural analgesia.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Johnson 1985 31/40 34/40 100% 0.91[0.74,1.13]
   
Total (95% CI) 40 40 100% 0.91[0.74,1.13]
Total events: 31 (Laminaria), 34 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.86(P=0.39)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 19.7.   Comparison 19 Laminaria tent versus vaginal
prostaglandin E2: all women, Outcome 7 Instrumental vaginal delivery.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Johnson 1985 15/40 21/40 100% 0.71[0.43,1.17]
   
Total (95% CI) 40 40 100% 0.71[0.43,1.17]
Total events: 15 (Laminaria), 21 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.33(P=0.18)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 19.8.   Comparison 19 Laminaria tent versus vaginal
prostaglandin E2: all women, Outcome 8 Meconium-stained liquor.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Johnson 1985 0/40 3/40 100% 0.14[0.01,2.68]
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
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Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
   
Total (95% CI) 40 40 100% 0.14[0.01,2.68]
Total events: 0 (Laminaria), 3 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.3(P=0.19)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 19.9.   Comparison 19 Laminaria tent versus vaginal
prostaglandin E2: all women, Outcome 9 Apgar score < 7 at 5 minutes.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Bagratee 1990 0/40 0/40   Not estimable
Johnson 1985 0/40 0/40   Not estimable
   
Total (95% CI) 80 80 Not estimable
Total events: 0 (Laminaria), 0 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 19.10.   Comparison 19 Laminaria tent versus vaginal
prostaglandin E2: all women, Outcome 10 Perinatal death.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Bagratee 1990 0/40 0/40   Not estimable
   
Total (95% CI) 40 40 Not estimable
Total events: 0 (Laminaria), 0 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 19.11.   Comparison 19 Laminaria tent versus vaginal
prostaglandin E2: all women, Outcome 11 Maternal side e>ects: all.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hay 1995 0/15 1/13 100% 0.29[0.01,6.6]
   
Total (95% CI) 15 13 100% 0.29[0.01,6.6]
Total events: 0 (Laminaria), 1 (PGE2)  
Heterogeneity: Not applicable  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
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Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Test for overall effect: Z=0.77(P=0.44)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 19.12.   Comparison 19 Laminaria tent versus vaginal
prostaglandin E2: all women, Outcome 12 Maternal nausea.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hay 1995 0/15 1/13 100% 0.29[0.01,6.6]
   
Total (95% CI) 15 13 100% 0.29[0.01,6.6]
Total events: 0 (Laminaria), 1 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.77(P=0.44)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 19.13.   Comparison 19 Laminaria tent versus vaginal
prostaglandin E2: all women, Outcome 13 Fetal distress.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Bagratee 1990 8/40 10/40 46.3% 0.8[0.35,1.82]
Hay 1995 0/15 1/13 7.41% 0.29[0.01,6.6]
Johnson 1985 5/40 10/40 46.3% 0.5[0.19,1.33]
   
Total (95% CI) 95 93 100% 0.62[0.34,1.15]
Total events: 13 (Laminaria), 21 (PGE2)  
Heterogeneity: Tau2=0; Chi2=0.78, df=2(P=0.68); I2=0%  
Test for overall effect: Z=1.51(P=0.13)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Comparison 20.   Laminaria tent versus vaginal prostaglandin E2: all primiparae
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Uterine hyperstimulation with FHR
changes
1 80 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 7.95]
2 Caesarean section 2 90 Risk Ratio (M-H, Random, 95% CI) 1.07 [0.24, 4.89]
 
 
Mechanical methods for induction of labour (Review)
Copyright © 2019 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane
Collaboration.
294
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Analysis 20.1.   Comparison 20 Laminaria tent versus vaginal prostaglandin
E2: all primiparae, Outcome 1 Uterine hyperstimulation with FHR changes.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Johnson 1985 0/40 1/40 100% 0.33[0.01,7.95]
   
Total (95% CI) 40 40 100% 0.33[0.01,7.95]
Total events: 0 (Laminaria), 1 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.68(P=0.5)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 20.2.   Comparison 20 Laminaria tent versus vaginal
prostaglandin E2: all primiparae, Outcome 2 Caesarean section.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Jeeva 1982 3/5 1/5 36.17% 3[0.45,19.93]
Johnson 1985 6/40 10/40 63.83% 0.6[0.24,1.49]
   
Total (95% CI) 45 45 100% 1.07[0.24,4.89]
Total events: 9 (Laminaria), 11 (PGE2)  
Heterogeneity: Tau2=0.72; Chi2=2.25, df=1(P=0.13); I2=55.61%  
Test for overall effect: Z=0.09(P=0.93)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Comparison 21.   Laminaria tent versus vaginal prostaglandin E2: all multiparae
Outcome or subgroup title No. of
studies
No. of partici-
pants
Statistical method Effect size
1 Caesarean section 1 10 Risk Ratio (M-H, Fixed, 95% CI) 0.5 [0.06, 3.91]
 
 
Analysis 21.1.   Comparison 21 Laminaria tent versus vaginal
prostaglandin E2: all multiparae, Outcome 1 Caesarean section.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Jeeva 1982 1/5 2/5 100% 0.5[0.06,3.91]
   
Total (95% CI) 5 5 100% 0.5[0.06,3.91]
Total events: 1 (Laminaria), 2 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.66(P=0.51)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
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Comparison 22.   Laminaria tent versus intracervical prostaglandin E2: all women
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Uterine hyperstimulation with FHR changes 2 350 Risk Ratio (M-H, Fixed, 95%
CI)
0.17 [0.02, 1.42]
2 Caesarean section 5 920 Risk Ratio (M-H, Fixed, 95%
CI)
1.16 [0.93, 1.45]
3 Serious neonatal morbidity/perinatal death 1 185 Risk Ratio (M-H, Fixed, 95%
CI)
3.16 [0.13, 76.70]
4 Serious maternal morbidity or death 1 185 Risk Ratio (M-H, Fixed, 95%
CI)
0.35 [0.01, 8.52]
5 Cervix unfavourable/unchanged after 12-24
hours
2 218 Risk Ratio (M-H, Random,
95% CI)
0.46 [0.11, 1.96]
6 Oxytocin augmentation 1 185 Risk Ratio (M-H, Fixed, 95%
CI)
1.41 [1.21, 1.64]
7 Uterine hyperstimulation without FHR
changes
2 601 Risk Ratio (M-H, Fixed, 95%
CI)
0.17 [0.02, 1.36]
8 Uterine rupture 1 185 Risk Ratio (M-H, Fixed, 95%
CI)
0.35 [0.01, 8.52]
9 Instrumental vaginal delivery 3 424 Risk Ratio (M-H, Fixed, 95%
CI)
1.05 [0.65, 1.69]
10 Apgar score < 7 at 5 minutes 1 185 Risk Ratio (M-H, Fixed, 95%
CI)
5.28 [0.63, 44.30]
11 Neonatal intensive care unit admission 2 259 Risk Ratio (M-H, Fixed, 95%
CI)
1.58 [0.58, 4.33]
12 Perinatal death 1 185 Risk Ratio (M-H, Fixed, 95%
CI)
3.16 [0.13, 76.70]
13 Maternal side effects 1 165 Risk Ratio (M-H, Fixed, 95%
CI)
0.20 [0.01, 4.15]
14 Postpartum haemorrhage 2 239 Risk Ratio (M-H, Fixed, 95%
CI)
1.14 [0.46, 2.81]
15 Chorioamnionitis 1 74 Risk Ratio (M-H, Fixed, 95%
CI)
3.17 [0.35, 29.06]
16 Endometritis 2 490 Risk Ratio (M-H, Random,
95% CI)
0.30 [0.08, 1.09]
17 Fetal distress 2 128 Risk Ratio (M-H, Fixed, 95%
CI)
0.44 [0.07, 2.90]
Mechanical methods for induction of labour (Review)
Copyright © 2019 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane
Collaboration.
296
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
 
 
Analysis 22.1.   Comparison 22 Laminaria tent versus intracervical prostaglandin
E2: all women, Outcome 1 Uterine hyperstimulation with FHR changes.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Chua 1997 0/90 3/95 57.82% 0.15[0.01,2.88]
Roztocil 1998 0/82 2/83 42.18% 0.2[0.01,4.15]
   
Total (95% CI) 172 178 100% 0.17[0.02,1.42]
Total events: 0 (Laminaria), 5 (PGE2)  
Heterogeneity: Tau2=0; Chi2=0.02, df=1(P=0.89); I2=0%  
Test for overall effect: Z=1.63(P=0.1)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 22.2.   Comparison 22 Laminaria tent versus intracervical
prostaglandin E2: all women, Outcome 2 Caesarean section.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Chua 1997 22/90 20/95 18.22% 1.16[0.68,1.98]
Glagoleva 1999 7/27 5/26 4.77% 1.35[0.49,3.71]
Krammer 1995a 72/224 53/219 50.18% 1.33[0.98,1.8]
Roztocil 1998 16/82 21/83 19.54% 0.77[0.43,1.37]
Sanchez-Ramos 1992 7/36 8/38 7.29% 0.92[0.37,2.29]
   
Total (95% CI) 459 461 100% 1.16[0.93,1.45]
Total events: 124 (Laminaria), 107 (PGE2)  
Heterogeneity: Tau2=0; Chi2=3.04, df=4(P=0.55); I2=0%  
Test for overall effect: Z=1.3(P=0.19)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 22.3.   Comparison 22 Laminaria tent versus intracervical prostaglandin
E2: all women, Outcome 3 Serious neonatal morbidity/perinatal death.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Chua 1997 1/90 0/95 100% 3.16[0.13,76.7]
   
Total (95% CI) 90 95 100% 3.16[0.13,76.7]
Total events: 1 (Laminaria), 0 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.71(P=0.48)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
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Analysis 22.4.   Comparison 22 Laminaria tent versus intracervical
prostaglandin E2: all women, Outcome 4 Serious maternal morbidity or death.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Chua 1997 0/90 1/95 100% 0.35[0.01,8.52]
   
Total (95% CI) 90 95 100% 0.35[0.01,8.52]
Total events: 0 (Laminaria), 1 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.64(P=0.52)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 22.5.   Comparison 22 Laminaria tent versus intracervical prostaglandin
E2: all women, Outcome 5 Cervix unfavourable/unchanged aLer 12-24 hours.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Glagoleva 1999 1/27 6/26 31.6% 0.16[0.02,1.24]
Roztocil 1998 9/82 12/83 68.4% 0.76[0.34,1.7]
   
Total (95% CI) 109 109 100% 0.46[0.11,1.96]
Total events: 10 (Laminaria), 18 (PGE2)  
Heterogeneity: Tau2=0.62; Chi2=1.98, df=1(P=0.16); I2=49.6%  
Test for overall effect: Z=1.04(P=0.3)  
Favours laminaria 1000.01 100.1 1 Favours PGE2
 
 
Analysis 22.6.   Comparison 22 Laminaria tent versus intracervical
prostaglandin E2: all women, Outcome 6 Oxytocin augmentation.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Chua 1997 84/90 63/95 100% 1.41[1.21,1.64]
   
Total (95% CI) 90 95 100% 1.41[1.21,1.64]
Total events: 84 (Laminaria), 63 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=4.36(P<0.0001)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 22.7.   Comparison 22 Laminaria tent versus intracervical prostaglandin
E2: all women, Outcome 7 Uterine hyperstimulation without FHR changes.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Chua 1997 0/90 2/95 40.33% 0.21[0.01,4.34]
Krammer 1995a 0/214 3/202 59.67% 0.13[0.01,2.6]
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
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Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
   
Total (95% CI) 304 297 100% 0.17[0.02,1.36]
Total events: 0 (Laminaria), 5 (PGE2)  
Heterogeneity: Tau2=0; Chi2=0.04, df=1(P=0.84); I2=0%  
Test for overall effect: Z=1.67(P=0.09)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 22.8.   Comparison 22 Laminaria tent versus intracervical
prostaglandin E2: all women, Outcome 8 Uterine rupture.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Chua 1997 0/90 1/95 100% 0.35[0.01,8.52]
   
Total (95% CI) 90 95 100% 0.35[0.01,8.52]
Total events: 0 (Laminaria), 1 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.64(P=0.52)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 22.9.   Comparison 22 Laminaria tent versus intracervical
prostaglandin E2: all women, Outcome 9 Instrumental vaginal delivery.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Chua 1997 14/90 13/95 46.25% 1.14[0.57,2.28]
Roztocil 1998 5/82 5/83 18.17% 1.01[0.3,3.37]
Sanchez-Ramos 1992 9/36 10/38 35.58% 0.95[0.44,2.07]
   
Total (95% CI) 208 216 100% 1.05[0.65,1.69]
Total events: 28 (Laminaria), 28 (PGE2)  
Heterogeneity: Tau2=0; Chi2=0.12, df=2(P=0.94); I2=0%  
Test for overall effect: Z=0.19(P=0.85)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 22.10.   Comparison 22 Laminaria tent versus intracervical
prostaglandin E2: all women, Outcome 10 Apgar score < 7 at 5 minutes.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Chua 1997 5/90 1/95 100% 5.28[0.63,44.3]
   
Total (95% CI) 90 95 100% 5.28[0.63,44.3]
Total events: 5 (Laminaria), 1 (PGE2)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
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Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Heterogeneity: Not applicable  
Test for overall effect: Z=1.53(P=0.13)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 22.11.   Comparison 22 Laminaria tent versus intracervical prostaglandin
E2: all women, Outcome 11 Neonatal intensive care unit admission.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Chua 1997 7/90 3/95 50% 2.46[0.66,9.23]
Sanchez-Ramos 1992 2/36 3/38 50% 0.7[0.12,3.97]
   
Total (95% CI) 126 133 100% 1.58[0.58,4.33]
Total events: 9 (Laminaria), 6 (PGE2)  
Heterogeneity: Tau2=0; Chi2=1.27, df=1(P=0.26); I2=21.47%  
Test for overall effect: Z=0.9(P=0.37)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 22.12.   Comparison 22 Laminaria tent versus intracervical
prostaglandin E2: all women, Outcome 12 Perinatal death.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Chua 1997 1/90 0/95 100% 3.16[0.13,76.7]
   
Total (95% CI) 90 95 100% 3.16[0.13,76.7]
Total events: 1 (Laminaria), 0 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.71(P=0.48)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 22.13.   Comparison 22 Laminaria tent versus intracervical
prostaglandin E2: all women, Outcome 13 Maternal side e>ects.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Roztocil 1998 0/82 2/83 100% 0.2[0.01,4.15]
   
Total (95% CI) 82 83 100% 0.2[0.01,4.15]
Total events: 0 (Laminaria), 2 (PGE2)  
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=1.04(P=0.3)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
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Analysis 22.14.   Comparison 22 Laminaria tent versus intracervical
prostaglandin E2: all women, Outcome 14 Postpartum haemorrhage.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Roztocil 1998 9/82 8/83 100% 1.14[0.46,2.81]
Sanchez-Ramos 1992 0/36 0/38   Not estimable
   
Total (95% CI) 118 121 100% 1.14[0.46,2.81]
Total events: 9 (Laminaria), 8 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.28(P=0.78)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 22.15.   Comparison 22 Laminaria tent versus intracervical
prostaglandin E2: all women, Outcome 15 Chorioamnionitis.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Sanchez-Ramos 1992 3/36 1/38 100% 3.17[0.35,29.06]
   
Total (95% CI) 36 38 100% 3.17[0.35,29.06]
Total events: 3 (Laminaria), 1 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.02(P=0.31)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 22.16.   Comparison 22 Laminaria tent versus intracervical
prostaglandin E2: all women, Outcome 16 Endometritis.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Krammer 1995a 5/214 28/202 57.08% 0.17[0.07,0.43]
Sanchez-Ramos 1992 3/36 5/38 42.92% 0.63[0.16,2.46]
   
Total (95% CI) 250 240 100% 0.3[0.08,1.09]
Total events: 8 (Laminaria), 33 (PGE2)  
Heterogeneity: Tau2=0.54; Chi2=2.54, df=1(P=0.11); I2=60.57%  
Test for overall effect: Z=1.83(P=0.07)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
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Analysis 22.17.   Comparison 22 Laminaria tent versus intracervical
prostaglandin E2: all women, Outcome 17 Fetal distress.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Glagoleva 1999 0/27 1/27 43.53% 0.33[0.01,7.84]
Sanchez-Ramos 1992 1/36 2/38 56.47% 0.53[0.05,5.57]
   
Total (95% CI) 63 65 100% 0.44[0.07,2.9]
Total events: 1 (Laminaria), 3 (PGE2)  
Heterogeneity: Tau2=0; Chi2=0.05, df=1(P=0.82); I2=0%  
Test for overall effect: Z=0.85(P=0.4)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Comparison 23.   Laminaria tent versus intracervical prostaglandin E2: all primiparae
Outcome or subgroup title No. of
studies
No. of partici-
pants
Statistical method Effect size
1 Caesarean section 1 116 Risk Ratio (M-H, Fixed, 95% CI) 1.15 [0.62, 2.13]
 
 
Analysis 23.1.   Comparison 23 Laminaria tent versus intracervical
prostaglandin E2: all primiparae, Outcome 1 Caesarean section.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Chua 1997 15/54 15/62 100% 1.15[0.62,2.13]
   
Total (95% CI) 54 62 100% 1.15[0.62,2.13]
Total events: 15 (Laminaria), 15 (PGE2)  
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=0.44(P=0.66)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Comparison 24.   Laminaria tent versus intracervical: prostaglandin E2 all multiparae
Outcome or subgroup title No. of
studies
No. of partici-
pants
Statistical method Effect size
1 Caesarean section 1 69 Risk Ratio (M-H, Fixed, 95% CI) 1.28 [0.45, 3.65]
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Analysis 24.1.   Comparison 24 Laminaria tent versus intracervical:
prostaglandin E2 all multiparae, Outcome 1 Caesarean section.
Study or subgroup Laminaria PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Chua 1997 7/36 5/33 100% 1.28[0.45,3.65]
   
Total (95% CI) 36 33 100% 1.28[0.45,3.65]
Total events: 7 (Laminaria), 5 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.47(P=0.64)  
Favours laminaria 100.1 50.2 20.5 1 Favours PGE2
 
 
Comparison 25.   Laminaria tent versus oxytocin: all women
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Caesarean section 2 73 Risk Ratio (M-H, Fixed, 95% CI) 0.83 [0.36, 1.89]
2 Fetal distress 1 53 Risk Ratio (M-H, Fixed, 95% CI) 2.69 [0.11, 63.18]
 
 
Analysis 25.1.   Comparison 25 Laminaria tent versus oxytocin: all women, Outcome 1 Caesarean section.
Study or subgroup Laminaria Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Jagani 1982 3/10 3/10 32.12% 1[0.26,3.81]
Roberts 1986 5/28 6/25 67.88% 0.74[0.26,2.14]
   
Total (95% CI) 38 35 100% 0.83[0.36,1.89]
Total events: 8 (Laminaria), 9 (Oxytocin)  
Heterogeneity: Tau2=0; Chi2=0.12, df=1(P=0.73); I2=0%  
Test for overall effect: Z=0.45(P=0.65)  
Favours laminaria 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 25.2.   Comparison 25 Laminaria tent versus oxytocin: all women, Outcome 2 Fetal distress.
Study or subgroup Laminaria Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Roberts 1986 1/28 0/25 100% 2.69[0.11,63.18]
   
Total (95% CI) 28 25 100% 2.69[0.11,63.18]
Total events: 1 (Laminaria), 0 (Oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.61(P=0.54)  
Favours laminaria 100.1 50.2 20.5 1 Favours oxytocin
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Comparison 26.   Laminaria tent versus amniotomy: all women
Outcome or subgroup title No. of
studies
No. of partici-
pants
Statistical method Effect size
1 Caesarean section 1 20 Risk Ratio (M-H, Fixed, 95% CI) 0.75 [0.22, 2.52]
 
 
Analysis 26.1.   Comparison 26 Laminaria tent versus amniotomy: all women, Outcome 1 Caesarean section.
Study or subgroup Laminaria Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Jagani 1982 3/10 4/10 100% 0.75[0.22,2.52]
   
Total (95% CI) 10 10 100% 0.75[0.22,2.52]
Total events: 3 (Laminaria), 4 (Oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.46(P=0.64)  
Favours laminaria 100.1 50.2 20.5 1 Favours oxytocin
 
 
Comparison 27.   Laminaria tent versus other hygroscopic dilator: all women
Outcome or subgroup title No. of
studies
No. of partici-
pants
Statistical method Effect size
1 Caesarean section 1 41 Risk Ratio (M-H, Fixed, 95% CI) 1.70 [0.44, 6.66]
 
 
Analysis 27.1.   Comparison 27 Laminaria tent versus other
hygroscopic dilator: all women, Outcome 1 Caesarean section.
Study or subgroup Laminaria Other di-
latators
Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Blumenthal 1990 4/18 3/23 100% 1.7[0.44,6.66]
   
Total (95% CI) 18 23 100% 1.7[0.44,6.66]
Total events: 4 (Laminaria), 3 (Other dilatators)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.77(P=0.44)  
Favours laminaria 100.1 50.2 20.5 1 Favours other dilatators
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Comparison 28.   EASI versus vaginal prostaglandin E2: all women
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Vaginal delivery not
achieved in 24 hours
1 109 Risk Ratio (M-H, Fixed, 95% CI) 1.74 [1.21, 2.49]
2 Uterine hyperstimulation
with FHR changes
2 221 Risk Ratio (M-H, Fixed, 95% CI) 0.23 [0.03, 2.07]
3 Caesarean section 2 221 Risk Ratio (M-H, Fixed, 95% CI) 1.35 [0.94, 1.96]
4 Oxytocin augmentation 1 109 Risk Ratio (M-H, Fixed, 95% CI) 12.71 [3.20, 50.57]
5 Uterine hyperstimula-
tion without fetal heart rate
changes
2 221 Risk Ratio (M-H, Fixed, 95% CI) 0.23 [0.03, 2.07]
6 Epidural analgesia 1 112 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.97, 1.04]
7 Instrumental vaginal deliv-
ery
1 109 Risk Ratio (M-H, Fixed, 95% CI) 0.58 [0.30, 1.14]
8 Meconium-stained liquor 1 112 Risk Ratio (M-H, Fixed, 95% CI) 3.0 [0.12, 72.10]
9 Apgar score < 7 at 5 minutes 1 109 Risk Ratio (M-H, Fixed, 95% CI) 4.25 [0.21, 86.51]
10 Neonatal intensive care
unit admission
1 112 Risk Ratio (M-H, Fixed, 95% CI) 1.5 [0.45, 5.03]
11 Woman not satisfied 1 109 Risk Ratio (M-H, Fixed, 95% CI) 0.56 [0.10, 3.25]
12 Fetal distress 1 112 Risk Ratio (M-H, Fixed, 95% CI) 1.2 [0.39, 3.71]
 
 
Analysis 28.1.   Comparison 28 EASI versus vaginal prostaglandin
E2: all women, Outcome 1 Vaginal delivery not achieved in 24 hours.
Study or subgroup EASI PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Lyndrup 1994 43/59 21/50 100% 1.74[1.21,2.49]
   
Total (95% CI) 59 50 100% 1.74[1.21,2.49]
Total events: 43 (EASI), 21 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.99(P=0)  
Favours EASI 100.1 50.2 20.5 1 Favours PGE2
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Analysis 28.2.   Comparison 28 EASI versus vaginal prostaglandin E2:
all women, Outcome 2 Uterine hyperstimulation with FHR changes.
Study or subgroup EASI PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Lyndrup 1994 0/59 1/50 39.34% 0.28[0.01,6.8]
Rouben 1993 0/56 2/56 60.66% 0.2[0.01,4.07]
   
Total (95% CI) 115 106 100% 0.23[0.03,2.07]
Total events: 0 (EASI), 3 (PGE2)  
Heterogeneity: Tau2=0; Chi2=0.02, df=1(P=0.88); I2=0%  
Test for overall effect: Z=1.31(P=0.19)  
Favours EASI 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 28.3.   Comparison 28 EASI versus vaginal prostaglandin E2: all women, Outcome 3 Caesarean section.
Study or subgroup EASI PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Lyndrup 1994 18/59 5/50 17.23% 3.05[1.22,7.63]
Rouben 1993 26/56 26/56 82.77% 1[0.67,1.49]
   
Total (95% CI) 115 106 100% 1.35[0.94,1.96]
Total events: 44 (EASI), 31 (PGE2)  
Heterogeneity: Tau2=0; Chi2=5.24, df=1(P=0.02); I2=80.93%  
Test for overall effect: Z=1.61(P=0.11)  
Favours EASI 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 28.4.   Comparison 28 EASI versus vaginal prostaglandin E2: all women, Outcome 4 Oxytocin augmentation.
Study or subgroup EASI PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Lyndrup 1994 30/59 2/50 100% 12.71[3.2,50.57]
   
Total (95% CI) 59 50 100% 12.71[3.2,50.57]
Total events: 30 (EASI), 2 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=3.61(P=0)  
Favours EASI 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 28.5.   Comparison 28 EASI versus vaginal prostaglandin E2: all
women, Outcome 5 Uterine hyperstimulation without fetal heart rate changes.
Study or subgroup EASI PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Lyndrup 1994 0/59 1/50 39.34% 0.28[0.01,6.8]
Rouben 1993 0/56 2/56 60.66% 0.2[0.01,4.07]
   
Favours EASI 100.1 50.2 20.5 1 Favours PGE2
Mechanical methods for induction of labour (Review)
Copyright © 2019 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane
Collaboration.
306
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Study or subgroup EASI PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Total (95% CI) 115 106 100% 0.23[0.03,2.07]
Total events: 0 (EASI), 3 (PGE2)  
Heterogeneity: Tau2=0; Chi2=0.02, df=1(P=0.88); I2=0%  
Test for overall effect: Z=1.31(P=0.19)  
Favours EASI 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 28.6.   Comparison 28 EASI versus vaginal prostaglandin E2: all women, Outcome 6 Epidural analgesia.
Study or subgroup EASI PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Rouben 1993 56/56 56/56 100% 1[0.97,1.04]
   
Total (95% CI) 56 56 100% 1[0.97,1.04]
Total events: 56 (EASI), 56 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours EASI 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 28.7.   Comparison 28 EASI versus vaginal prostaglandin
E2: all women, Outcome 7 Instrumental vaginal delivery.
Study or subgroup EASI PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Lyndrup 1994 11/59 16/50 100% 0.58[0.3,1.14]
   
Total (95% CI) 59 50 100% 0.58[0.3,1.14]
Total events: 11 (EASI), 16 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.58(P=0.11)  
Favours EASI 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 28.8.   Comparison 28 EASI versus vaginal prostaglandin
E2: all women, Outcome 8 Meconium-stained liquor.
Study or subgroup EASI PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Rouben 1993 1/56 0/56 100% 3[0.12,72.1]
   
Total (95% CI) 56 56 100% 3[0.12,72.1]
Total events: 1 (EASI), 0 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.68(P=0.5)  
Favours EASI 100.1 50.2 20.5 1 Favours PGE2
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Analysis 28.9.   Comparison 28 EASI versus vaginal prostaglandin
E2: all women, Outcome 9 Apgar score < 7 at 5 minutes.
Study or subgroup EASI PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Lyndrup 1994 2/59 0/50 100% 4.25[0.21,86.51]
   
Total (95% CI) 59 50 100% 4.25[0.21,86.51]
Total events: 2 (EASI), 0 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.94(P=0.35)  
Favours EASI 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 28.10.   Comparison 28 EASI versus vaginal prostaglandin
E2: all women, Outcome 10 Neonatal intensive care unit admission.
Study or subgroup EASI PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Rouben 1993 6/56 4/56 100% 1.5[0.45,5.03]
   
Total (95% CI) 56 56 100% 1.5[0.45,5.03]
Total events: 6 (EASI), 4 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.66(P=0.51)  
Favours EASI 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 28.11.   Comparison 28 EASI versus vaginal prostaglandin E2: all women, Outcome 11 Woman not satisfied.
Study or subgroup EASI PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Lyndrup 1994 2/59 3/50 100% 0.56[0.1,3.25]
   
Total (95% CI) 59 50 100% 0.56[0.1,3.25]
Total events: 2 (EASI), 3 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.64(P=0.52)  
Favours EASI 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 28.12.   Comparison 28 EASI versus vaginal prostaglandin E2: all women, Outcome 12 Fetal distress.
Study or subgroup EASI PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Rouben 1993 6/56 5/56 100% 1.2[0.39,3.71]
   
Total (95% CI) 56 56 100% 1.2[0.39,3.71]
Total events: 6 (EASI), 5 (PGE2)  
Favours EASI 100.1 50.2 20.5 1 Favours PGE2
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Study or subgroup EASI PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Heterogeneity: Not applicable  
Test for overall effect: Z=0.32(P=0.75)  
Favours EASI 100.1 50.2 20.5 1 Favours PGE2
 
 
Comparison 29.   EASI versus intracervical prostaglandin E2: all women
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Caesarean section 2 155 Risk Ratio (M-H, Random, 95% CI) 0.73 [0.10, 5.12]
2 Cervix unfavourable/unchanged after
12-24 hours
1 85 Risk Ratio (M-H, Fixed, 95% CI) 0.06 [0.00, 0.97]
3 Oxytocin augmentation 1 70 Risk Ratio (M-H, Fixed, 95% CI) 1.1 [0.54, 2.25]
4 Instrumental vaginal delivery 1 85 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.04, 3.01]
5 Apgar score < 7 at 5 minutes 1 85 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Endometritis 1 85 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Fetal distress 1 70 Risk Ratio (M-H, Fixed, 95% CI) 0.29 [0.06, 1.28]
 
 
Analysis 29.1.   Comparison 29 EASI versus intracervical prostaglandin E2: all women, Outcome 1 Caesarean section.
Study or subgroup EASI PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Hemlin 1998 11/43 6/42 54.5% 1.79[0.73,4.4]
Moini 2003 2/35 8/35 45.5% 0.25[0.06,1.09]
   
Total (95% CI) 78 77 100% 0.73[0.1,5.12]
Total events: 13 (EASI), 14 (PGE2)  
Heterogeneity: Tau2=1.6; Chi2=5.11, df=1(P=0.02); I2=80.42%  
Test for overall effect: Z=0.32(P=0.75)  
Favours EASI 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 29.2.   Comparison 29 EASI versus intracervical prostaglandin E2:
all women, Outcome 2 Cervix unfavourable/unchanged aLer 12-24 hours.
Study or subgroup EASI PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hemlin 1998 0/43 8/42 100% 0.06[0,0.97]
   
Favours EASI 100.1 50.2 20.5 1 Favours PGE2
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Study or subgroup EASI PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Total (95% CI) 43 42 100% 0.06[0,0.97]
Total events: 0 (EASI), 8 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.98(P=0.05)  
Favours EASI 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 29.3.   Comparison 29 EASI versus intracervical
prostaglandin E2: all women, Outcome 3 Oxytocin augmentation.
Study or subgroup EASI PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Moini 2003 11/35 10/35 100% 1.1[0.54,2.25]
   
Total (95% CI) 35 35 100% 1.1[0.54,2.25]
Total events: 11 (EASI), 10 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.26(P=0.79)  
Favours EASI 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 29.4.   Comparison 29 EASI versus intracervical prostaglandin
E2: all women, Outcome 4 Instrumental vaginal delivery.
Study or subgroup EASI PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hemlin 1998 1/43 3/42 100% 0.33[0.04,3.01]
   
Total (95% CI) 43 42 100% 0.33[0.04,3.01]
Total events: 1 (EASI), 3 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.99(P=0.32)  
Favours EASI 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 29.5.   Comparison 29 EASI versus intracervical
prostaglandin E2: all women, Outcome 5 Apgar score < 7 at 5 minutes.
Study or subgroup EASI PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hemlin 1998 0/43 0/42   Not estimable
   
Total (95% CI) 43 42 Not estimable
Total events: 0 (EASI), 0 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours EASI 100.1 50.2 20.5 1 Favours PGE2
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Analysis 29.6.   Comparison 29 EASI versus intracervical prostaglandin E2: all women, Outcome 6 Endometritis.
Study or subgroup EASI PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hemlin 1998 0/43 0/42   Not estimable
   
Total (95% CI) 43 42 Not estimable
Total events: 0 (EASI), 0 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours EASI 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 29.7.   Comparison 29 EASI versus intracervical prostaglandin E2: all women, Outcome 7 Fetal distress.
Study or subgroup EASI PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Moini 2003 2/35 7/35 100% 0.29[0.06,1.28]
   
Total (95% CI) 35 35 100% 0.29[0.06,1.28]
Total events: 2 (EASI), 7 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.64(P=0.1)  
Favours EASI 100.1 50.2 20.5 1 Favours PGE2
 
 
Comparison 30.   EASI versus intracervical prostaglandin E2: all primiparae
Outcome or subgroup title No. of
studies
No. of partici-
pants
Statistical method Effect size
1 Caesarean section 1 70 Risk Ratio (M-H, Fixed, 95% CI) 0.25 [0.06, 1.09]
 
 
Analysis 30.1.   Comparison 30 EASI versus intracervical
prostaglandin E2: all primiparae, Outcome 1 Caesarean section.
Study or subgroup EASI PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Moini 2003 2/35 8/35 100% 0.25[0.06,1.09]
   
Total (95% CI) 35 35 100% 0.25[0.06,1.09]
Total events: 2 (EASI), 8 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.84(P=0.07)  
Favours EASI 100.1 50.2 20.5 1 Favours PGE2
 
 
Mechanical methods for induction of labour (Review)
Copyright © 2019 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane
Collaboration.
311
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Comparison 31.   Any mechanical method and prostaglandin E2 versus prostaglandin E2 alone: all women
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Vaginal delivery not achieved in 24 hours 1 39 Risk Ratio (M-H, Fixed, 95%
CI)
0.84 [0.53, 1.33]
2 Uterine hyperstimulation with FHR changes 2 122 Risk Ratio (M-H, Fixed, 95%
CI)
0.26 [0.01, 5.12]
3 Caesarean section 7 517 Risk Ratio (M-H, Random,
95% CI)
0.96 [0.66, 1.40]
4 Cervix unfavourable/unchanged after 24
hours
1 122 Risk Ratio (M-H, Fixed, 95%
CI)
0.52 [0.31, 0.85]
5 Oxytocin augmentation 1 44 Risk Ratio (M-H, Fixed, 95%
CI)
0.95 [0.64, 1.41]
6 Uterine hyperstimulation without FHR
changes
3 239 Risk Ratio (M-H, Fixed, 95%
CI)
0.0 [0.0, 0.0]
7 Epidural analgesia 1 39 Risk Ratio (M-H, Fixed, 95%
CI)
0.98 [0.77, 1.24]
8 Instrumental vaginal delivery 2 78 Risk Ratio (M-H, Fixed, 95%
CI)
0.56 [0.22, 1.45]
9 Meconium-stained liquor 1 120 Risk Ratio (M-H, Fixed, 95%
CI)
0.97 [0.33, 2.83]
10 Neonatal intensive care unit admission 1 44 Risk Ratio (M-H, Fixed, 95%
CI)
0.26 [0.01, 5.12]
11 Postpartum haemorrhage 1 39 Risk Ratio (M-H, Fixed, 95%
CI)
0.0 [0.0, 0.0]
12 Chorioamnionitis 2 122 Risk Ratio (M-H, Fixed, 95%
CI)
1.56 [0.45, 5.45]
13 Endometritis 3 237 Risk Ratio (M-H, Fixed, 95%
CI)
1.07 [0.41, 2.78]
14 Fetal distress 2 140 Risk Ratio (M-H, Fixed, 95%
CI)
2.28 [0.54, 9.69]
 
 
Analysis 31.1.   Comparison 31 Any mechanical method and prostaglandin E2 versus
prostaglandin E2 alone: all women, Outcome 1 Vaginal delivery not achieved in 24 hours.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hibbard 1998 13/22 12/17 100% 0.84[0.53,1.33]
Favours mechanical method 100.1 50.2 20.5 1 PGE2
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Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
   
Total (95% CI) 22 17 100% 0.84[0.53,1.33]
Total events: 13 (Mechanical method), 12 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.75(P=0.45)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
 
 
Analysis 31.2.   Comparison 31 Any mechanical method and prostaglandin E2 versus
prostaglandin E2 alone: all women, Outcome 2 Uterine hyperstimulation with FHR changes.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Sullivan 1996 0/37 0/41   Not estimable
Turnquest 1997 0/19 2/25 100% 0.26[0.01,5.12]
   
Total (95% CI) 56 66 100% 0.26[0.01,5.12]
Total events: 0 (Mechanical method), 2 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.89(P=0.38)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
 
 
Analysis 31.3.   Comparison 31 Any mechanical method and prostaglandin
E2 versus prostaglandin E2 alone: all women, Outcome 3 Caesarean section.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Browne 2011 16/36 14/34 20.1% 1.08[0.63,1.86]
Casey 1995 17/78 27/68 21.05% 0.55[0.33,0.92]
Hibbard 1998 8/22 2/17 5.91% 3.09[0.75,12.72]
Lyndrup 1989 1/20 3/19 2.78% 0.32[0.04,2.79]
Ridgway 1991 21/52 13/49 19.25% 1.52[0.86,2.69]
Sullivan 1996 14/37 19/41 20.55% 0.82[0.48,1.38]
Turnquest 1997 5/19 7/25 10.37% 0.94[0.35,2.51]
   
Total (95% CI) 264 253 100% 0.96[0.66,1.4]
Total events: 82 (Mechanical method), 85 (PGE2)  
Heterogeneity: Tau2=0.11; Chi2=11.16, df=6(P=0.08); I2=46.26%  
Test for overall effect: Z=0.23(P=0.82)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
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Analysis 31.4.   Comparison 31 Any mechanical method and prostaglandin E2 versus
prostaglandin E2 alone: all women, Outcome 4 Cervix unfavourable/unchanged aLer 24 hours.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Allouche 1993 16/63 29/59 100% 0.52[0.31,0.85]
   
Total (95% CI) 63 59 100% 0.52[0.31,0.85]
Total events: 16 (Mechanical method), 29 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.61(P=0.01)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
 
 
Analysis 31.5.   Comparison 31 Any mechanical method and prostaglandin E2
versus prostaglandin E2 alone: all women, Outcome 5 Oxytocin augmentation.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Turnquest 1997 13/19 18/25 100% 0.95[0.64,1.41]
   
Total (95% CI) 19 25 100% 0.95[0.64,1.41]
Total events: 13 (Mechanical method), 18 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.26(P=0.8)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
 
 
Analysis 31.6.   Comparison 31 Any mechanical method and prostaglandin E2 versus
prostaglandin E2 alone: all women, Outcome 6 Uterine hyperstimulation without FHR changes.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Allouche 1993 0/63 0/59   Not estimable
Hibbard 1998 0/22 0/17   Not estimable
Sullivan 1996 0/37 0/41   Not estimable
   
Total (95% CI) 122 117 Not estimable
Total events: 0 (Mechanical method), 0 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
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Analysis 31.7.   Comparison 31 Any mechanical method and prostaglandin
E2 versus prostaglandin E2 alone: all women, Outcome 7 Epidural analgesia.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hibbard 1998 19/22 15/17 100% 0.98[0.77,1.24]
   
Total (95% CI) 22 17 100% 0.98[0.77,1.24]
Total events: 19 (Mechanical method), 15 (PGE2)  
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=0.17(P=0.86)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
 
 
Analysis 31.8.   Comparison 31 Any mechanical method and prostaglandin E2 versus
prostaglandin E2 alone: all women, Outcome 8 Instrumental vaginal delivery.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hibbard 1998 4/22 4/17 46.81% 0.77[0.23,2.65]
Lyndrup 1989 2/20 5/19 53.19% 0.38[0.08,1.73]
   
Total (95% CI) 42 36 100% 0.56[0.22,1.45]
Total events: 6 (Mechanical method), 9 (PGE2)  
Heterogeneity: Tau2=0; Chi2=0.51, df=1(P=0.47); I2=0%  
Test for overall effect: Z=1.19(P=0.23)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
 
 
Analysis 31.9.   Comparison 31 Any mechanical method and prostaglandin E2
versus prostaglandin E2 alone: all women, Outcome 9 Meconium-stained liquor.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Allouche 1993 6/61 6/59 100% 0.97[0.33,2.83]
   
Total (95% CI) 61 59 100% 0.97[0.33,2.83]
Total events: 6 (Mechanical method), 6 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.06(P=0.95)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
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Analysis 31.10.   Comparison 31 Any mechanical method and prostaglandin E2 versus
prostaglandin E2 alone: all women, Outcome 10 Neonatal intensive care unit admission.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Turnquest 1997 0/19 2/25 100% 0.26[0.01,5.12]
   
Total (95% CI) 19 25 100% 0.26[0.01,5.12]
Total events: 0 (Mechanical method), 2 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.89(P=0.38)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
 
 
Analysis 31.11.   Comparison 31 Any mechanical method and prostaglandin E2
versus prostaglandin E2 alone: all women, Outcome 11 Postpartum haemorrhage.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hibbard 1998 0/22 0/17   Not estimable
   
Total (95% CI) 22 17 Not estimable
Total events: 0 (Mechanical method), 0 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
 
 
Analysis 31.12.   Comparison 31 Any mechanical method and prostaglandin
E2 versus prostaglandin E2 alone: all women, Outcome 12 Chorioamnionitis.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Sullivan 1996 2/37 1/41 26.8% 2.22[0.21,23.45]
Turnquest 1997 3/19 3/25 73.2% 1.32[0.3,5.81]
   
Total (95% CI) 56 66 100% 1.56[0.45,5.45]
Total events: 5 (Mechanical method), 4 (PGE2)  
Heterogeneity: Tau2=0; Chi2=0.14, df=1(P=0.71); I2=0%  
Test for overall effect: Z=0.69(P=0.49)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
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Analysis 31.13.   Comparison 31 Any mechanical method and prostaglandin
E2 versus prostaglandin E2 alone: all women, Outcome 13 Endometritis.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Allouche 1993 1/61 1/59 14.08% 0.97[0.06,15.11]
Lyndrup 1989 1/20 0/19 7.09% 2.86[0.12,66.11]
Sullivan 1996 5/37 6/41 78.83% 0.92[0.31,2.78]
   
Total (95% CI) 118 119 100% 1.07[0.41,2.78]
Total events: 7 (Mechanical method), 7 (PGE2)  
Heterogeneity: Tau2=0; Chi2=0.45, df=2(P=0.8); I2=0%  
Test for overall effect: Z=0.13(P=0.89)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
 
 
Analysis 31.14.   Comparison 31 Any mechanical method and prostaglandin
E2 versus prostaglandin E2 alone: all women, Outcome 14 Fetal distress.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Hibbard 1998 3/22 0/17 21.41% 5.48[0.3,99.39]
Ridgway 1991 3/52 2/49 78.59% 1.41[0.25,8.1]
   
Total (95% CI) 74 66 100% 2.28[0.54,9.69]
Total events: 6 (Mechanical method), 2 (PGE2)  
Heterogeneity: Tau2=0; Chi2=0.64, df=1(P=0.42); I2=0%  
Test for overall effect: Z=1.12(P=0.26)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
 
 
Comparison 32.   Any mechanical method and prostaglandin E2 versus low dose misoprostol alone: all women
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Vaginal delivery not
achieved in 24 hours
1 127 Risk Ratio (M-H, Fixed, 95% CI) 0.32 [0.12, 0.82]
2 Caesarean section 1 127 Risk Ratio (M-H, Fixed, 95% CI) 1.09 [0.58, 2.04]
3 Serious neonatal morbidi-
ty/perinatal death
1 127 Risk Ratio (M-H, Fixed, 95% CI) 0.19 [0.01, 3.90]
4 Cervix unfavourable/un-
changed after 12-24 hours
1 127 Risk Ratio (M-H, Fixed, 95% CI) 0.41 [0.25, 0.67]
5 Oxytocin augmentation 1 127 Risk Ratio (M-H, Fixed, 95% CI) 1.21 [1.01, 1.46]
6 Uterine hyperstimulation
without FHR changes
1 127 Risk Ratio (M-H, Fixed, 95% CI) 4.05 [1.44, 11.38]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
7 Instrumental vaginal deliv-
ery
1 127 Risk Ratio (M-H, Fixed, 95% CI) 1.26 [0.77, 2.04]
8 Meconium-stained liquor 1 127 Risk Ratio (M-H, Fixed, 95% CI) 0.56 [0.23, 1.32]
9 Apgar score < 7 at 5 minutes 1 127 Risk Ratio (M-H, Fixed, 95% CI) 1.91 [0.18, 20.51]
10 Neonatal intensive care
unit admission
1 127 Risk Ratio (M-H, Fixed, 95% CI) 0.64 [0.31, 1.31]
11 Perinatal death 1 127 Risk Ratio (M-H, Fixed, 95% CI) 0.19 [0.01, 3.90]
12 Chorioamnionitis 1 127 Risk Ratio (M-H, Fixed, 95% CI) 1.91 [0.18, 20.51]
13 Endometritis 1 127 Risk Ratio (M-H, Fixed, 95% CI) 1.91 [0.36, 10.05]
 
 
Analysis 32.1.   Comparison 32 Any mechanical method and prostaglandin E2 versus low
dose misoprostol alone: all women, Outcome 1 Vaginal delivery not achieved in 24 hours.
Study or subgroup Mechani-
cal method
misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Perry 1998 5/65 15/62 100% 0.32[0.12,0.82]
   
Total (95% CI) 65 62 100% 0.32[0.12,0.82]
Total events: 5 (Mechanical method), 15 (misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.36(P=0.02)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 32.2.   Comparison 32 Any mechanical method and prostaglandin E2
versus low dose misoprostol alone: all women, Outcome 2 Caesarean section.
Study or subgroup Mechani-
cal method
misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Perry 1998 16/65 14/62 100% 1.09[0.58,2.04]
   
Total (95% CI) 65 62 100% 1.09[0.58,2.04]
Total events: 16 (Mechanical method), 14 (misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.27(P=0.79)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 32.3.   Comparison 32 Any mechanical method and prostaglandin E2 versus low
dose misoprostol alone: all women, Outcome 3 Serious neonatal morbidity/perinatal death.
Study or subgroup Mechani-
cal method
misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Perry 1998 0/65 2/62 100% 0.19[0.01,3.9]
   
Total (95% CI) 65 62 100% 0.19[0.01,3.9]
Total events: 0 (Mechanical method), 2 (misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.08(P=0.28)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 32.4.   Comparison 32 Any mechanical method and prostaglandin E2 versus low dose
misoprostol alone: all women, Outcome 4 Cervix unfavourable/unchanged aLer 12-24 hours.
Study or subgroup Mechani-
cal method
misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Perry 1998 15/65 35/62 100% 0.41[0.25,0.67]
   
Total (95% CI) 65 62 100% 0.41[0.25,0.67]
Total events: 15 (Mechanical method), 35 (misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=3.54(P=0)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 32.5.   Comparison 32 Any mechanical method and prostaglandin E2
versus low dose misoprostol alone: all women, Outcome 5 Oxytocin augmentation.
Study or subgroup Mechani-
cal method
misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Perry 1998 56/65 44/62 100% 1.21[1.01,1.46]
   
Total (95% CI) 65 62 100% 1.21[1.01,1.46]
Total events: 56 (Mechanical method), 44 (misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.04(P=0.04)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 32.6.   Comparison 32 Any mechanical method and prostaglandin E2 versus low dose
misoprostol alone: all women, Outcome 6 Uterine hyperstimulation without FHR changes.
Study or subgroup Mechani-
cal method
misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Perry 1998 17/65 4/62 100% 4.05[1.44,11.38]
   
Total (95% CI) 65 62 100% 4.05[1.44,11.38]
Total events: 17 (Mechanical method), 4 (misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.66(P=0.01)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 32.7.   Comparison 32 Any mechanical method and prostaglandin E2 versus
low dose misoprostol alone: all women, Outcome 7 Instrumental vaginal delivery.
Study or subgroup Mechani-
cal method
misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Perry 1998 25/65 19/62 100% 1.26[0.77,2.04]
   
Total (95% CI) 65 62 100% 1.26[0.77,2.04]
Total events: 25 (Mechanical method), 19 (misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.92(P=0.36)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 32.8.   Comparison 32 Any mechanical method and prostaglandin E2 versus
low dose misoprostol alone: all women, Outcome 8 Meconium-stained liquor.
Study or subgroup Mechani-
cal method
misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Perry 1998 7/65 12/62 100% 0.56[0.23,1.32]
   
Total (95% CI) 65 62 100% 0.56[0.23,1.32]
Total events: 7 (Mechanical method), 12 (misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.33(P=0.18)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 32.9.   Comparison 32 Any mechanical method and prostaglandin E2 versus
low dose misoprostol alone: all women, Outcome 9 Apgar score < 7 at 5 minutes.
Study or subgroup Mechani-
cal method
misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Perry 1998 2/65 1/62 100% 1.91[0.18,20.51]
   
Total (95% CI) 65 62 100% 1.91[0.18,20.51]
Total events: 2 (Mechanical method), 1 (misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.53(P=0.59)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 32.10.   Comparison 32 Any mechanical method and prostaglandin E2 versus low
dose misoprostol alone: all women, Outcome 10 Neonatal intensive care unit admission.
Study or subgroup Mechani-
cal method
misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Perry 1998 10/65 15/62 100% 0.64[0.31,1.31]
   
Total (95% CI) 65 62 100% 0.64[0.31,1.31]
Total events: 10 (Mechanical method), 15 (misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.23(P=0.22)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 32.11.   Comparison 32 Any mechanical method and prostaglandin E2
versus low dose misoprostol alone: all women, Outcome 11 Perinatal death.
Study or subgroup Mechani-
cal method
misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Perry 1998 0/65 2/62 100% 0.19[0.01,3.9]
   
Total (95% CI) 65 62 100% 0.19[0.01,3.9]
Total events: 0 (Mechanical method), 2 (misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.08(P=0.28)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 32.12.   Comparison 32 Any mechanical method and prostaglandin E2
versus low dose misoprostol alone: all women, Outcome 12 Chorioamnionitis.
Study or subgroup Mechani-
cal method
misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Perry 1998 2/65 1/62 100% 1.91[0.18,20.51]
   
Total (95% CI) 65 62 100% 1.91[0.18,20.51]
Total events: 2 (Mechanical method), 1 (misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.53(P=0.59)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 32.13.   Comparison 32 Any mechanical method and prostaglandin
E2 versus low dose misoprostol alone: all women, Outcome 13 Endometritis.
Study or subgroup Mechani-
cal method
misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Perry 1998 4/65 2/62 100% 1.91[0.36,10.05]
   
Total (95% CI) 65 62 100% 1.91[0.36,10.05]
Total events: 4 (Mechanical method), 2 (misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.76(P=0.45)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Comparison 33.   Any mechanical method and prostaglandin E2 versus oxytocin alone: all women
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Caesarean section 1 44 Risk Ratio (M-H, Fixed, 95% CI) 0.3 [0.04, 2.47]
2 Instrumental vaginal delivery 1 44 Risk Ratio (M-H, Fixed, 95% CI) 0.6 [0.12, 2.94]
3 Endometritis 1 44 Risk Ratio (M-H, Fixed, 95% CI) 3.57 [0.15, 83.14]
 
 
Analysis 33.1.   Comparison 33 Any mechanical method and prostaglandin
E2 versus oxytocin alone: all women, Outcome 1 Caesarean section.
Study or subgroup Mechani-
cal method
Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Lyndrup 1989 1/20 4/24 100% 0.3[0.04,2.47]
   
Favours mechanical method 100.1 50.2 20.5 1 Favours oxytocin
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Study or subgroup Mechani-
cal method
Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Total (95% CI) 20 24 100% 0.3[0.04,2.47]
Total events: 1 (Mechanical method), 4 (Oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.12(P=0.26)  
Favours mechanical method 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 33.2.   Comparison 33 Any mechanical method and prostaglandin E2
versus oxytocin alone: all women, Outcome 2 Instrumental vaginal delivery.
Study or subgroup Mechani-
cal method
Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Lyndrup 1989 2/20 4/24 100% 0.6[0.12,2.94]
   
Total (95% CI) 20 24 100% 0.6[0.12,2.94]
Total events: 2 (Mechanical method), 4 (Oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.63(P=0.53)  
Favours mechanical method 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 33.3.   Comparison 33 Any mechanical method and prostaglandin
E2 versus oxytocin alone: all women, Outcome 3 Endometritis.
Study or subgroup Mechani-
cal method
Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Lyndrup 1989 1/20 0/24 100% 3.57[0.15,83.14]
   
Total (95% CI) 20 24 100% 3.57[0.15,83.14]
Total events: 1 (Mechanical method), 0 (Oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.79(P=0.43)  
Favours mechanical method 100.1 50.2 20.5 1 Favours oxytocin
 
 
Comparison 34.   Any mechanical method and low dose misoprostol versus prostaglandin E2 alone: all women
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Vaginal delivery not achieved in 24
hours
1 350 Risk Ratio (M-H, Fixed, 95% CI) 1.14 [0.89, 1.46]
2 Uterine hyperstimulation with FHR
changes
1 327 Risk Ratio (M-H, Fixed, 95% CI) 0.75 [0.27, 2.13]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
3 Caesarean section 1 350 Risk Ratio (M-H, Fixed, 95% CI) 0.85 [0.57, 1.25]
4 Serious neonatal morbidity/perina-
tal death
1 345 Risk Ratio (M-H, Fixed, 95% CI) 2.04 [0.19, 22.24]
5 Serious maternal morbidity or
death
1 350 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Oxytocin augmentation 1 350 Risk Ratio (M-H, Fixed, 95% CI) 0.54 [0.34, 0.86]
7 Uterine hyperstimulation without
fetal heart rate changes
1 327 Risk Ratio (M-H, Fixed, 95% CI) 0.54 [0.22, 1.32]
8 Uterine rupture 1 350 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 Instrumental vaginal delivery 1 350 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.26, 3.98]
10 Meconium-stained liquor 1 339 Risk Ratio (M-H, Fixed, 95% CI) 1.15 [0.60, 2.23]
11 Apgar score < 7 at 5 minutes 1 346 Risk Ratio (M-H, Fixed, 95% CI) 0.68 [0.25, 1.88]
12 Neonatal intensive care unit ad-
mission
1 346 Risk Ratio (M-H, Fixed, 95% CI) 0.68 [0.12, 4.03]
13 Perinatal death 1 345 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.06, 16.14]
14 Maternal side effects 1 314 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [0.95, 1.43]
15 Maternal nausea 1 300 Risk Ratio (M-H, Fixed, 95% CI) 1.65 [0.98, 2.79]
16 Maternal diarrhoea 1 313 Risk Ratio (M-H, Fixed, 95% CI) 3.72 [1.53, 9.00]
17 Postpartum haemorrhage 1 348 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.67, 1.41]
18 Serious maternal complications 1 350 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19 Maternal fever during labour 1 347 Risk Ratio (M-H, Fixed, 95% CI) 1.53 [0.26, 9.02]
 
 
Analysis 34.1.   Comparison 34 Any mechanical method and low dose misoprostol versus
prostaglandin E2 alone: all women, Outcome 1 Vaginal delivery not achieved in 24 hours.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 79/174 70/176 100% 1.14[0.89,1.46]
   
Total (95% CI) 174 176 100% 1.14[0.89,1.46]
Total events: 79 (Mechanical method), 70 (PGE2)  
Heterogeneity: Not applicable  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
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Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Test for overall effect: Z=1.06(P=0.29)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
 
 
Analysis 34.2.   Comparison 34 Any mechanical method and low dose misoprostol versus
prostaglandin E2 alone: all women, Outcome 2 Uterine hyperstimulation with FHR changes.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 6/163 8/164 100% 0.75[0.27,2.13]
   
Total (95% CI) 163 164 100% 0.75[0.27,2.13]
Total events: 6 (Mechanical method), 8 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.53(P=0.59)  
Favours mechanical method 200.05 50.2 1 PGE2
 
 
Analysis 34.3.   Comparison 34 Any mechanical method and low dose misoprostol
versus prostaglandin E2 alone: all women, Outcome 3 Caesarean section.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 36/174 43/176 100% 0.85[0.57,1.25]
   
Total (95% CI) 174 176 100% 0.85[0.57,1.25]
Total events: 36 (Mechanical method), 43 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.84(P=0.4)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
 
 
Analysis 34.4.   Comparison 34 Any mechanical method and low dose misoprostol versus
prostaglandin E2 alone: all women, Outcome 4 Serious neonatal morbidity/perinatal death.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 2/171 1/174 100% 2.04[0.19,22.24]
   
Total (95% CI) 171 174 100% 2.04[0.19,22.24]
Total events: 2 (Mechanical method), 1 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.58(P=0.56)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
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Analysis 34.5.   Comparison 34 Any mechanical method and low dose misoprostol versus
prostaglandin E2 alone: all women, Outcome 5 Serious maternal morbidity or death.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 0/174 0/176   Not estimable
   
Total (95% CI) 174 176 Not estimable
Total events: 0 (Mechanical method), 0 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
 
 
Analysis 34.6.   Comparison 34 Any mechanical method and low dose misoprostol
versus prostaglandin E2 alone: all women, Outcome 6 Oxytocin augmentation.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 23/174 43/176 100% 0.54[0.34,0.86]
   
Total (95% CI) 174 176 100% 0.54[0.34,0.86]
Total events: 23 (Mechanical method), 43 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.61(P=0.01)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
 
 
Analysis 34.7.   Comparison 34 Any mechanical method and low dose misoprostol versus prostaglandin
E2 alone: all women, Outcome 7 Uterine hyperstimulation without fetal heart rate changes.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 7/163 13/164 100% 0.54[0.22,1.32]
   
Total (95% CI) 163 164 100% 0.54[0.22,1.32]
Total events: 7 (Mechanical method), 13 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.35(P=0.18)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
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Analysis 34.8.   Comparison 34 Any mechanical method and low dose misoprostol
versus prostaglandin E2 alone: all women, Outcome 8 Uterine rupture.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 0/174 0/176   Not estimable
   
Total (95% CI) 174 176 Not estimable
Total events: 0 (Mechanical method), 0 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
 
 
Analysis 34.9.   Comparison 34 Any mechanical method and low dose misoprostol
versus prostaglandin E2 alone: all women, Outcome 9 Instrumental vaginal delivery.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 4/174 4/176 100% 1.01[0.26,3.98]
   
Total (95% CI) 174 176 100% 1.01[0.26,3.98]
Total events: 4 (Mechanical method), 4 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.02(P=0.99)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
 
 
Analysis 34.10.   Comparison 34 Any mechanical method and low dose misoprostol
versus prostaglandin E2 alone: all women, Outcome 10 Meconium-stained liquor.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 17/168 15/171 100% 1.15[0.6,2.23]
   
Total (95% CI) 168 171 100% 1.15[0.6,2.23]
Total events: 17 (Mechanical method), 15 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.42(P=0.67)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
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Analysis 34.11.   Comparison 34 Any mechanical method and low dose misoprostol
versus prostaglandin E2 alone: all women, Outcome 11 Apgar score < 7 at 5 minutes.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 6/171 9/175 100% 0.68[0.25,1.88]
   
Total (95% CI) 171 175 100% 0.68[0.25,1.88]
Total events: 6 (Mechanical method), 9 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.74(P=0.46)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
 
 
Analysis 34.12.   Comparison 34 Any mechanical method and low dose misoprostol versus
prostaglandin E2 alone: all women, Outcome 12 Neonatal intensive care unit admission.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 2/171 3/175 100% 0.68[0.12,4.03]
   
Total (95% CI) 171 175 100% 0.68[0.12,4.03]
Total events: 2 (Mechanical method), 3 (PGE2)  
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=0.42(P=0.67)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
 
 
Analysis 34.13.   Comparison 34 Any mechanical method and low dose misoprostol
versus prostaglandin E2 alone: all women, Outcome 13 Perinatal death.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 1/171 1/174 100% 1.02[0.06,16.14]
   
Total (95% CI) 171 174 100% 1.02[0.06,16.14]
Total events: 1 (Mechanical method), 1 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.01(P=0.99)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
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Analysis 34.14.   Comparison 34 Any mechanical method and low dose misoprostol
versus prostaglandin E2 alone: all women, Outcome 14 Maternal side e>ects.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 86/149 82/165 100% 1.16[0.95,1.43]
   
Total (95% CI) 149 165 100% 1.16[0.95,1.43]
Total events: 86 (Mechanical method), 82 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.42(P=0.15)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
 
 
Analysis 34.15.   Comparison 34 Any mechanical method and low dose misoprostol
versus prostaglandin E2 alone: all women, Outcome 15 Maternal nausea.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 31/149 19/151 100% 1.65[0.98,2.79]
   
Total (95% CI) 149 151 100% 1.65[0.98,2.79]
Total events: 31 (Mechanical method), 19 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.88(P=0.06)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
 
 
Analysis 34.16.   Comparison 34 Any mechanical method and low dose misoprostol
versus prostaglandin E2 alone: all women, Outcome 16 Maternal diarrhoea.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 20/148 6/165 100% 3.72[1.53,9]
   
Total (95% CI) 148 165 100% 3.72[1.53,9]
Total events: 20 (Mechanical method), 6 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.91(P=0)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
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Analysis 34.17.   Comparison 34 Any mechanical method and low dose misoprostol
versus prostaglandin E2 alone: all women, Outcome 17 Postpartum haemorrhage.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 42/174 43/174 100% 0.98[0.67,1.41]
   
Total (95% CI) 174 174 100% 0.98[0.67,1.41]
Total events: 42 (Mechanical method), 43 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.12(P=0.9)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
 
 
Analysis 34.18.   Comparison 34 Any mechanical method and low dose misoprostol
versus prostaglandin E2 alone: all women, Outcome 18 Serious maternal complications.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 0/174 0/176   Not estimable
   
Total (95% CI) 174 176 Not estimable
Total events: 0 (Mechanical method), 0 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
 
 
Analysis 34.19.   Comparison 34 Any mechanical method and low dose misoprostol
versus prostaglandin E2 alone: all women, Outcome 19 Maternal fever during labour.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 3/172 2/175 100% 1.53[0.26,9.02]
   
Total (95% CI) 172 175 100% 1.53[0.26,9.02]
Total events: 3 (Mechanical method), 2 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.47(P=0.64)  
Favours mechanical method 100.1 50.2 20.5 1 PGE2
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Comparison 35.   Any mechanical method and low dose misoprostol versus low dose misoprostol alone: all women
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Vaginal delivery not achieved in 24 hours 2 668 Risk Ratio (M-H, Random, 95%
CI)
0.70 [0.25, 1.95]
2 Uterine hyperstimulation with FHR
changes
4 707 Risk Ratio (M-H, Random, 95%
CI)
0.54 [0.20, 1.45]
3 Caesarean section 7 1422 Risk Ratio (M-H, Random, 95%
CI)
0.87 [0.66, 1.15]
4 Serious neonatal morbidity/perinatal
death
2 487 Risk Ratio (M-H, Fixed, 95% CI) 1.25 [0.34, 4.55]
5 Serious maternal morbidity or death 2 490 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Cervix unfavourable/unchanged after 12
hours
1 140 Risk Ratio (M-H, Fixed, 95% CI) 0.27 [0.08, 0.94]
7 Oxytocin augmentation 5 1051 Risk Ratio (M-H, Random, 95%
CI)
0.94 [0.70, 1.25]
8 Uterine hyperstimulation without FHR
changes
4 982 Risk Ratio (M-H, Fixed, 95% CI) 0.53 [0.32, 0.90]
9 Uterine rupture 2 490 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
10 Epidural analgesia 3 443 Risk Ratio (M-H, Random, 95%
CI)
1.00 [0.91, 1.10]
11 Instrumental vaginal delivery 3 676 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.58, 1.51]
12 Meconium-stained liquor 6 1243 Risk Ratio (M-H, Random, 95%
CI)
0.61 [0.35, 1.04]
13 Apgar score < 7 at 5 minutes 3 802 Risk Ratio (M-H, Random, 95%
CI)
0.71 [0.37, 1.36]
14 Neonatal intensive care unit admission 6 1246 Risk Ratio (M-H, Fixed, 95% CI) 0.57 [0.36, 0.91]
15 Perinatal death 1 347 Risk Ratio (M-H, Fixed, 95% CI) 3.09 [0.13, 75.26]
16 Maternal side effects 1 300 Risk Ratio (M-H, Fixed, 95% CI) 1.06 [0.87, 1.30]
17 Maternal nausea 1 300 Risk Ratio (M-H, Fixed, 95% CI) 1.37 [0.84, 2.23]
18 Maternal diarrhoea 1 298 Risk Ratio (M-H, Fixed, 95% CI) 3.38 [1.40, 8.17]
19 Postpartum haemorrhage 2 466 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.65, 1.33]
20 Serious maternal complications 1 350 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
21 Chorioamnionitis 3 443 Risk Ratio (M-H, Fixed, 95% CI) 0.63 [0.28, 1.38]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
22 Endometrits 2 435 Risk Ratio (M-H, Fixed, 95% CI) 0.41 [0.08, 2.08]
23 Fetal distress 4 784 Risk Ratio (M-H, Fixed, 95% CI) 0.78 [0.53, 1.14]
 
 
Analysis 35.1.   Comparison 35 Any mechanical method and low dose misoprostol versus low
dose misoprostol alone: all women, Outcome 1 Vaginal delivery not achieved in 24 hours.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Husain 2017 19/161 45/157 47.85% 0.41[0.25,0.67]
Matonhodze 2003 79/174 70/176 52.15% 1.14[0.89,1.46]
   
Total (95% CI) 335 333 100% 0.7[0.25,1.95]
Total events: 98 (Mechanical method), 115 (Misoprostol)  
Heterogeneity: Tau2=0.51; Chi2=14, df=1(P=0); I2=92.85%  
Test for overall effect: Z=0.68(P=0.5)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 35.2.   Comparison 35 Any mechanical method and low dose misoprostol versus low
dose misoprostol alone: all women, Outcome 2 Uterine hyperstimulation with FHR changes.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Aduloju 2016 0/70 0/70   Not estimable
Carbone 2013 10/56 12/61 36.34% 0.91[0.43,1.93]
Lanka 2014 5/63 25/63 33.56% 0.2[0.08,0.49]
Matonhodze 2003 6/163 7/161 30.1% 0.85[0.29,2.46]
   
Total (95% CI) 352 355 100% 0.54[0.2,1.45]
Total events: 21 (Mechanical method), 44 (Misoprostol)  
Heterogeneity: Tau2=0.57; Chi2=7.4, df=2(P=0.02); I2=72.98%  
Test for overall effect: Z=1.23(P=0.22)  
Favours mechanical method 1000.01 100.1 1 Favours misoprostol
 
 
Analysis 35.3.   Comparison 35 Any mechanical method and low dose misoprostol
versus low dose misoprostol alone: all women, Outcome 3 Caesarean section.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Aduloju 2016 15/70 19/70 11.98% 0.79[0.44,1.42]
Favours mechanical method 1000.01 100.1 1 Favours misoprostol
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Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Al-Ibraheemi 2018 30/100 38/100 17.35% 0.79[0.53,1.17]
Carbone 2013 15/56 16/61 11.69% 1.02[0.56,1.87]
Dionne 2011 30/84 35/87 17.52% 0.89[0.6,1.3]
Husain 2017 13/161 33/157 11.71% 0.38[0.21,0.7]
Lanka 2014 22/63 22/63 14.81% 1[0.62,1.61]
Matonhodze 2003 36/174 24/176 14.94% 1.52[0.95,2.43]
   
Total (95% CI) 708 714 100% 0.87[0.66,1.15]
Total events: 161 (Mechanical method), 187 (Misoprostol)  
Heterogeneity: Tau2=0.07; Chi2=13.33, df=6(P=0.04); I2=55%  
Test for overall effect: Z=0.98(P=0.33)  
Favours mechanical method 1000.01 100.1 1 Favours misoprostol
 
 
Analysis 35.4.   Comparison 35 Any mechanical method and low dose misoprostol versus low
dose misoprostol alone: all women, Outcome 4 Serious neonatal morbidity/perinatal death.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Aduloju 2016 3/70 3/70 74.95% 1[0.21,4.79]
Matonhodze 2003 2/174 1/173 25.05% 1.99[0.18,21.73]
   
Total (95% CI) 244 243 100% 1.25[0.34,4.55]
Total events: 5 (Mechanical method), 4 (Misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.22, df=1(P=0.64); I2=0%  
Test for overall effect: Z=0.34(P=0.74)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 35.5.   Comparison 35 Any mechanical method and low dose misoprostol versus
low dose misoprostol alone: all women, Outcome 5 Serious maternal morbidity or death.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Aduloju 2016 0/70 0/70   Not estimable
Matonhodze 2003 0/174 0/176   Not estimable
   
Total (95% CI) 244 246 Not estimable
Total events: 0 (Mechanical method), 0 (Misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 35.6.   Comparison 35 Any mechanical method and low dose misoprostol versus low
dose misoprostol alone: all women, Outcome 6 Cervix unfavourable/unchanged aLer 12 hours.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Aduloju 2016 3/70 11/70 100% 0.27[0.08,0.94]
   
Total (95% CI) 70 70 100% 0.27[0.08,0.94]
Total events: 3 (Mechanical method), 11 (Misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.07(P=0.04)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 35.7.   Comparison 35 Any mechanical method and low dose misoprostol
versus low dose misoprostol alone: all women, Outcome 7 Oxytocin augmentation.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Aduloju 2016 22/70 43/70 18.74% 0.51[0.35,0.76]
Carbone 2013 46/56 54/61 26.75% 0.93[0.8,1.08]
Husain 2017 62/161 71/157 23.35% 0.85[0.66,1.1]
Lanka 2014 35/63 29/63 20.31% 1.21[0.85,1.71]
Matonhodze 2003 23/174 11/176 10.85% 2.11[1.06,4.21]
   
Total (95% CI) 524 527 100% 0.94[0.7,1.25]
Total events: 188 (Mechanical method), 208 (Misoprostol)  
Heterogeneity: Tau2=0.07; Chi2=16.91, df=4(P=0); I2=76.34%  
Test for overall effect: Z=0.44(P=0.66)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 35.8.   Comparison 35 Any mechanical method and low dose misoprostol versus low
dose misoprostol alone: all women, Outcome 8 Uterine hyperstimulation without FHR changes.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Aduloju 2016 0/70 0/70   Not estimable
Al-Ibraheemi 2018 6/100 12/100 32.24% 0.5[0.2,1.28]
Husain 2017 7/161 11/157 29.92% 0.62[0.25,1.56]
Matonhodze 2003 7/163 14/161 37.84% 0.49[0.2,1.19]
   
Total (95% CI) 494 488 100% 0.53[0.32,0.9]
Total events: 20 (Mechanical method), 37 (Misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.15, df=2(P=0.93); I2=0%  
Test for overall effect: Z=2.34(P=0.02)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 35.9.   Comparison 35 Any mechanical method and low dose misoprostol
versus low dose misoprostol alone: all women, Outcome 9 Uterine rupture.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Aduloju 2016 0/70 0/70   Not estimable
Matonhodze 2003 0/174 0/176   Not estimable
   
Total (95% CI) 244 246 Not estimable
Total events: 0 (Mechanical method), 0 (Misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 35.10.   Comparison 35 Any mechanical method and low dose misoprostol
versus low dose misoprostol alone: all women, Outcome 10 Epidural analgesia.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Al-Ibraheemi 2018 91/100 96/100 51.62% 0.95[0.88,1.02]
Carbone 2013 50/56 52/61 29.09% 1.05[0.91,1.2]
Lanka 2014 51/63 47/63 19.29% 1.09[0.9,1.31]
   
Total (95% CI) 219 224 100% 1[0.91,1.1]
Total events: 192 (Mechanical method), 195 (Misoprostol)  
Heterogeneity: Tau2=0; Chi2=3.52, df=2(P=0.17); I2=43.26%  
Test for overall effect: Z=0.03(P=0.97)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 35.11.   Comparison 35 Any mechanical method and low dose misoprostol versus
low dose misoprostol alone: all women, Outcome 11 Instrumental vaginal delivery.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Al-Ibraheemi 2018 11/100 14/100 46.71% 0.79[0.38,1.65]
Lanka 2014 13/63 11/63 36.7% 1.18[0.57,2.44]
Matonhodze 2003 4/174 5/176 16.59% 0.81[0.22,2.96]
   
Total (95% CI) 337 339 100% 0.93[0.58,1.51]
Total events: 28 (Mechanical method), 30 (Misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.66, df=2(P=0.72); I2=0%  
Test for overall effect: Z=0.28(P=0.78)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 35.12.   Comparison 35 Any mechanical method and low dose misoprostol
versus low dose misoprostol alone: all women, Outcome 12 Meconium-stained liquor.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Aduloju 2016 2/70 2/70 6.32% 1[0.14,6.9]
Al-Ibraheemi 2018 4/100 15/100 14.25% 0.27[0.09,0.78]
Carbone 2013 8/56 15/61 19.24% 0.58[0.27,1.26]
Husain 2017 21/161 26/157 24.39% 0.79[0.46,1.34]
Lanka 2014 4/63 17/63 14.79% 0.24[0.08,0.66]
Matonhodze 2003 17/168 13/174 21.01% 1.35[0.68,2.7]
   
Total (95% CI) 618 625 100% 0.61[0.35,1.04]
Total events: 56 (Mechanical method), 88 (Misoprostol)  
Heterogeneity: Tau2=0.24; Chi2=11.55, df=5(P=0.04); I2=56.71%  
Test for overall effect: Z=1.81(P=0.07)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 35.13.   Comparison 35 Any mechanical method and low dose misoprostol
versus low dose misoprostol alone: all women, Outcome 13 Apgar score < 7 at 5 minutes.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Aduloju 2016 6/70 5/70 25.01% 1.2[0.38,3.75]
Husain 2017 11/161 24/157 49.02% 0.45[0.23,0.88]
Matonhodze 2003 6/171 6/173 25.97% 1.01[0.33,3.07]
   
Total (95% CI) 402 400 100% 0.71[0.37,1.36]
Total events: 23 (Mechanical method), 35 (Misoprostol)  
Heterogeneity: Tau2=0.11; Chi2=2.89, df=2(P=0.24); I2=30.78%  
Test for overall effect: Z=1.04(P=0.3)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 35.14.   Comparison 35 Any mechanical method and low dose misoprostol versus
low dose misoprostol alone: all women, Outcome 14 Neonatal intensive care unit admission.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Aduloju 2016 6/70 5/70 11.19% 1.2[0.38,3.75]
Al-Ibraheemi 2018 1/100 3/100 6.71% 0.33[0.04,3.15]
Carbone 2013 0/56 2/61 5.36% 0.22[0.01,4.44]
Husain 2017 11/161 26/157 58.9% 0.41[0.21,0.81]
Lanka 2014 5/63 5/63 11.19% 1[0.3,3.29]
Matonhodze 2003 2/171 3/174 6.65% 0.68[0.11,4.01]
   
Total (95% CI) 621 625 100% 0.57[0.36,0.91]
Total events: 25 (Mechanical method), 44 (Misoprostol)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
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Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Heterogeneity: Tau2=0; Chi2=4.04, df=5(P=0.54); I2=0%  
Test for overall effect: Z=2.37(P=0.02)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 35.15.   Comparison 35 Any mechanical method and low dose misoprostol
versus low dose misoprostol alone: all women, Outcome 15 Perinatal death.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 1/171 0/176 100% 3.09[0.13,75.26]
   
Total (95% CI) 171 176 100% 3.09[0.13,75.26]
Total events: 1 (Mechanical method), 0 (Misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.69(P=0.49)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 35.16.   Comparison 35 Any mechanical method and low dose misoprostol
versus low dose misoprostol alone: all women, Outcome 16 Maternal side e>ects.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 86/149 82/151 100% 1.06[0.87,1.3]
   
Total (95% CI) 149 151 100% 1.06[0.87,1.3]
Total events: 86 (Mechanical method), 82 (Misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.6(P=0.55)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 35.17.   Comparison 35 Any mechanical method and low dose misoprostol
versus low dose misoprostol alone: all women, Outcome 17 Maternal nausea.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 31/149 23/151 100% 1.37[0.84,2.23]
   
Total (95% CI) 149 151 100% 1.37[0.84,2.23]
Total events: 31 (Mechanical method), 23 (Misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.25(P=0.21)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 35.18.   Comparison 35 Any mechanical method and low dose misoprostol
versus low dose misoprostol alone: all women, Outcome 18 Maternal diarrhoea.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 20/148 6/150 100% 3.38[1.4,8.17]
   
Total (95% CI) 148 150 100% 3.38[1.4,8.17]
Total events: 20 (Mechanical method), 6 (Misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=2.7(P=0.01)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 35.19.   Comparison 35 Any mechanical method and low dose misoprostol
versus low dose misoprostol alone: all women, Outcome 19 Postpartum haemorrhage.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Carbone 2013 2/56 5/61 10.04% 0.44[0.09,2.16]
Matonhodze 2003 42/174 43/175 89.96% 0.98[0.68,1.42]
   
Total (95% CI) 230 236 100% 0.93[0.65,1.33]
Total events: 44 (Mechanical method), 48 (Misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.95, df=1(P=0.33); I2=0%  
Test for overall effect: Z=0.41(P=0.68)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 35.20.   Comparison 35 Any mechanical method and low dose misoprostol versus
low dose misoprostol alone: all women, Outcome 20 Serious maternal complications.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Matonhodze 2003 0/174 0/176   Not estimable
   
Total (95% CI) 174 176 Not estimable
Total events: 0 (Mechanical method), 0 (Misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 35.21.   Comparison 35 Any mechanical method and low dose misoprostol
versus low dose misoprostol alone: all women, Outcome 21 Chorioamnionitis.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Al-Ibraheemi 2018 4/100 8/100 54.42% 0.5[0.16,1.61]
Carbone 2013 5/56 7/61 45.58% 0.78[0.26,2.31]
Lanka 2014 0/63 0/63   Not estimable
   
Total (95% CI) 219 224 100% 0.63[0.28,1.38]
Total events: 9 (Mechanical method), 15 (Misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.3, df=1(P=0.59); I2=0%  
Test for overall effect: Z=1.16(P=0.25)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 35.22.   Comparison 35 Any mechanical method and low dose misoprostol
versus low dose misoprostol alone: all women, Outcome 22 Endometrits.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Carbone 2013 1/56 2/61 38.66% 0.54[0.05,5.84]
Husain 2017 1/161 3/157 61.34% 0.33[0.03,3.09]
   
Total (95% CI) 217 218 100% 0.41[0.08,2.08]
Total events: 2 (Mechanical method), 5 (Misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.1, df=1(P=0.76); I2=0%  
Test for overall effect: Z=1.08(P=0.28)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 35.23.   Comparison 35 Any mechanical method and low dose misoprostol
versus low dose misoprostol alone: all women, Outcome 23 Fetal distress.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Aduloju 2016 6/70 7/70 13.95% 0.86[0.3,2.42]
Al-Ibraheemi 2018 19/100 20/100 39.85% 0.95[0.54,1.67]
Husain 2017 6/161 15/157 30.26% 0.39[0.16,0.98]
Lanka 2014 8/63 8/63 15.94% 1[0.4,2.5]
   
Total (95% CI) 394 390 100% 0.78[0.53,1.14]
Total events: 39 (Mechanical method), 50 (Misoprostol)  
Heterogeneity: Tau2=0; Chi2=2.97, df=3(P=0.4); I2=0%  
Test for overall effect: Z=1.28(P=0.2)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
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Comparison 36.   Any mechanical method and low dose misoprostol versus low dose misoprostol alone: all
primiparae
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Vaginal delivery not achieved in 24
hours
1 53 Risk Ratio (M-H, Fixed, 95% CI) 0.83 [0.23, 2.96]
2 Caesarean section 1 53 Risk Ratio (M-H, Fixed, 95% CI) 0.62 [0.15, 2.51]
 
 
Analysis 36.1.   Comparison 36 Any mechanical method and low dose misoprostol versus low
dose misoprostol alone: all primiparae, Outcome 1 Vaginal delivery not achieved in 24 hours.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Husain 2017 4/29 4/24 100% 0.83[0.23,2.96]
   
Total (95% CI) 29 24 100% 0.83[0.23,2.96]
Total events: 4 (Mechanical method), 4 (Misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.29(P=0.77)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 36.2.   Comparison 36 Any mechanical method and low dose misoprostol
versus low dose misoprostol alone: all primiparae, Outcome 2 Caesarean section.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Husain 2017 3/29 4/24 100% 0.62[0.15,2.51]
   
Total (95% CI) 29 24 100% 0.62[0.15,2.51]
Total events: 3 (Mechanical method), 4 (Misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.67(P=0.5)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Comparison 37.   Any mechanical method and low dose misoprostol versus low dose misoprostol alone: all
multiparae
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Vaginal delivery not achieved in 24
hours
1 265 Risk Ratio (M-H, Fixed, 95% CI) 0.37 [0.21, 0.63]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
2 Caesarean section 1 265 Risk Ratio (M-H, Fixed, 95% CI) 0.35 [0.18, 0.68]
 
 
Analysis 37.1.   Comparison 37 Any mechanical method and low dose misoprostol versus low
dose misoprostol alone: all multiparae, Outcome 1 Vaginal delivery not achieved in 24 hours.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Husain 2017 15/132 41/133 100% 0.37[0.21,0.63]
   
Total (95% CI) 132 133 100% 0.37[0.21,0.63]
Total events: 15 (Mechanical method), 41 (Misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=3.62(P=0)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 37.2.   Comparison 37 Any mechanical method and low dose misoprostol
versus low dose misoprostol alone: all multiparae, Outcome 2 Caesarean section.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Husain 2017 10/132 29/133 100% 0.35[0.18,0.68]
   
Total (95% CI) 132 133 100% 0.35[0.18,0.68]
Total events: 10 (Mechanical method), 29 (Misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=3.06(P=0)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Comparison 38.   Any mechanical method and oxytocin versus prostaglandin E2 alone: all women (not pre-specified)
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Uterine hyperstimulation with FHR changes 1 151 Risk Ratio (M-H, Fixed, 95%
CI)
1.48 [0.55, 3.95]
2 Caesarean section 4 713 Risk Ratio (M-H, Fixed, 95%
CI)
0.93 [0.72, 1.20]
3 Serious maternal morbidity or death 1 200 Risk Ratio (M-H, Fixed, 95%
CI)
0.0 [0.0, 0.0]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
4 Oxytocin augmentation 1 200 Risk Ratio (M-H, Fixed, 95%
CI)
2.48 [1.95, 3.15]
5 Uterine hyperstimulation without FHR
changes
1 151 Risk Ratio (M-H, Fixed, 95%
CI)
2.19 [1.39, 3.46]
6 Instrumental vaginal delivery 1 41 Risk Ratio (M-H, Fixed, 95%
CI)
0.35 [0.08, 1.58]
7 Meconium-stained liquor 1 151 Risk Ratio (M-H, Fixed, 95%
CI)
1.13 [0.43, 2.95]
8 Apgar score < 7 at 5 minutes 1 151 Risk Ratio (M-H, Fixed, 95%
CI)
2.96 [0.12, 71.55]
9 Neonatal intensive care unit admission 1 151 Risk Ratio (M-H, Fixed, 95%
CI)
0.85 [0.30, 2.40]
10 Postpartum haemorrhage 1 151 Risk Ratio (M-H, Fixed, 95%
CI)
0.14 [0.01, 2.68]
11 Endometritis 1 41 Risk Ratio (M-H, Fixed, 95%
CI)
0.0 [0.0, 0.0]
12 Fetal distress 3 498 Risk Ratio (M-H, Random,
95% CI)
0.97 [0.61, 1.56]
 
 
Analysis 38.1.   Comparison 38 Any mechanical method and oxytocin versus prostaglandin E2
alone: all women (not pre-specified), Outcome 1 Uterine hyperstimulation with FHR changes.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Sharami 2005 9/76 6/75 100% 1.48[0.55,3.95]
   
Total (95% CI) 76 75 100% 1.48[0.55,3.95]
Total events: 9 (Mechanical method), 6 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.78(P=0.43)  
Favours mechanical method 100.1 50.2 20.5 1 Favours PGE2
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Analysis 38.2.   Comparison 38 Any mechanical method and oxytocin versus
prostaglandin E2 alone: all women (not pre-specified), Outcome 2 Caesarean section.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Guinn 2000 68/211 36/110 53.95% 0.98[0.71,1.37]
Lyndrup 1989 1/22 3/19 3.67% 0.29[0.03,2.54]
Mazhar 2003 15/100 11/100 12.54% 1.36[0.66,2.82]
Sharami 2005 19/76 26/75 29.84% 0.72[0.44,1.19]
   
Total (95% CI) 409 304 100% 0.93[0.72,1.2]
Total events: 103 (Mechanical method), 76 (PGE2)  
Heterogeneity: Tau2=0; Chi2=3.29, df=3(P=0.35); I2=8.9%  
Test for overall effect: Z=0.57(P=0.57)  
Favours mechanical method 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 38.3.   Comparison 38 Any mechanical method and oxytocin versus prostaglandin
E2 alone: all women (not pre-specified), Outcome 3 Serious maternal morbidity or death.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Mazhar 2003 0/100 0/100   Not estimable
   
Total (95% CI) 100 100 Not estimable
Total events: 0 (Mechanical method), 0 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours mechanical method 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 38.4.   Comparison 38 Any mechanical method and oxytocin versus prostaglandin
E2 alone: all women (not pre-specified), Outcome 4 Oxytocin augmentation.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Mazhar 2003 100/100 40/100 100% 2.48[1.95,3.15]
   
Total (95% CI) 100 100 100% 2.48[1.95,3.15]
Total events: 100 (Mechanical method), 40 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=7.46(P<0.0001)  
Favours mechanical method 100.1 50.2 20.5 1 Favours PGE2
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Analysis 38.5.   Comparison 38 Any mechanical method and oxytocin versus prostaglandin E2
alone: all women (not pre-specified), Outcome 5 Uterine hyperstimulation without FHR changes.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Sharami 2005 40/76 18/75 100% 2.19[1.39,3.46]
   
Total (95% CI) 76 75 100% 2.19[1.39,3.46]
Total events: 40 (Mechanical method), 18 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=3.38(P=0)  
Favours mechanical method 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 38.6.   Comparison 38 Any mechanical method and oxytocin versus prostaglandin
E2 alone: all women (not pre-specified), Outcome 6 Instrumental vaginal delivery.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Lyndrup 1989 2/22 5/19 100% 0.35[0.08,1.58]
   
Total (95% CI) 22 19 100% 0.35[0.08,1.58]
Total events: 2 (Mechanical method), 5 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.37(P=0.17)  
Favours mechanical method 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 38.7.   Comparison 38 Any mechanical method and oxytocin versus prostaglandin
E2 alone: all women (not pre-specified), Outcome 7 Meconium-stained liquor.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Sharami 2005 8/76 7/75 100% 1.13[0.43,2.95]
   
Total (95% CI) 76 75 100% 1.13[0.43,2.95]
Total events: 8 (Mechanical method), 7 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.24(P=0.81)  
Favours mechanical method 100.1 50.2 20.5 1 Favours PGE2
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Analysis 38.8.   Comparison 38 Any mechanical method and oxytocin versus prostaglandin
E2 alone: all women (not pre-specified), Outcome 8 Apgar score < 7 at 5 minutes.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Sharami 2005 1/76 0/75 100% 2.96[0.12,71.55]
   
Total (95% CI) 76 75 100% 2.96[0.12,71.55]
Total events: 1 (Mechanical method), 0 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.67(P=0.5)  
Favours mechanical method 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 38.9.   Comparison 38 Any mechanical method and oxytocin versus prostaglandin
E2 alone: all women (not pre-specified), Outcome 9 Neonatal intensive care unit admission.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Sharami 2005 6/76 7/75 100% 0.85[0.3,2.4]
   
Total (95% CI) 76 75 100% 0.85[0.3,2.4]
Total events: 6 (Mechanical method), 7 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.31(P=0.75)  
Favours mechanical method 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 38.10.   Comparison 38 Any mechanical method and oxytocin versus prostaglandin
E2 alone: all women (not pre-specified), Outcome 10 Postpartum haemorrhage.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Sharami 2005 0/76 3/75 100% 0.14[0.01,2.68]
   
Total (95% CI) 76 75 100% 0.14[0.01,2.68]
Total events: 0 (Mechanical method), 3 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.3(P=0.19)  
Favours mechanical method 100.1 50.2 20.5 1 Favours PGE2
 
 
Mechanical methods for induction of labour (Review)
Copyright © 2019 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane
Collaboration.
345
Cochrane
Library
Trusted evidence.
Informed decisions.
Better health.
 
 
Cochrane Database of Systematic Reviews
Analysis 38.11.   Comparison 38 Any mechanical method and oxytocin versus
prostaglandin E2 alone: all women (not pre-specified), Outcome 11 Endometritis.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Lyndrup 1989 0/22 0/19   Not estimable
   
Total (95% CI) 22 19 Not estimable
Total events: 0 (Mechanical method), 0 (PGE2)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours mechanical method 100.1 50.2 20.5 1 Favours PGE2
 
 
Analysis 38.12.   Comparison 38 Any mechanical method and oxytocin versus
prostaglandin E2 alone: all women (not pre-specified), Outcome 12 Fetal distress.
Study or subgroup Mechani-
cal method
PGE2 Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Guinn 2000 26/211 15/110 39.26% 0.9[0.5,1.63]
Mazhar 2003 3/15 5/11 13.43% 0.44[0.13,1.46]
Sharami 2005 25/76 19/75 47.31% 1.3[0.78,2.15]
   
Total (95% CI) 302 196 100% 0.97[0.61,1.56]
Total events: 54 (Mechanical method), 39 (PGE2)  
Heterogeneity: Tau2=0.06; Chi2=2.93, df=2(P=0.23); I2=31.64%  
Test for overall effect: Z=0.11(P=0.91)  
Favours mechanical method 100.1 50.2 20.5 1 Favours PGE2
 
 
Comparison 39.   Any mechanical method and oxytocin versus low dose misoprostol alone: all women (not pre-
specified)
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Vaginal delivery not achieved in 24 hours 2 362 Risk Ratio (M-H, Fixed, 95%
CI)
0.48 [0.37, 0.63]
2 Uterine hyperstimulation with FHR
changes
3 1463 Risk Ratio (M-H, Fixed, 95%
CI)
0.43 [0.17, 1.11]
3 Caesarean section 5 1779 Risk Ratio (M-H, Fixed, 95%
CI)
0.95 [0.80, 1.12]
4 Serious neonatal morbidity/perinatal
death
2 1263 Risk Ratio (M-H, Fixed, 95%
CI)
0.82 [0.18, 3.65]
5 Oxytocin augmentation 2 336 Risk Ratio (M-H, Random,
95% CI)
3.89 [0.70, 21.72]
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Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
6 Uterine hyperstimulation without FHR
changes
3 498 Risk Ratio (M-H, Fixed, 95%
CI)
0.52 [0.30, 0.92]
7 Epidural analgesia 1 162 Risk Ratio (M-H, Fixed, 95%
CI)
1.07 [0.90, 1.27]
8 Meconium-stained liquor 2 362 Risk Ratio (M-H, Fixed, 95%
CI)
0.72 [0.43, 1.19]
9 Apgar score < 7 at 5 minutes 1 162 Risk Ratio (M-H, Fixed, 95%
CI)
0.95 [0.20, 4.58]
10 Neonatal intensive care unit admission 4 1599 Risk Ratio (M-H, Fixed, 95%
CI)
0.66 [0.49, 0.90]
11 Perinatal death 2 1263 Risk Ratio (M-H, Fixed, 95%
CI)
0.82 [0.18, 3.65]
12 Women not satisfied 1 866 Risk Ratio (M-H, Fixed, 95%
CI)
1.68 [1.47, 1.93]
13 Maternal fever 2 298 Risk Ratio (M-H, Fixed, 95%
CI)
0.13 [0.04, 0.50]
14 Chorioamnionitis 1 200 Risk Ratio (M-H, Fixed, 95%
CI)
0.65 [0.32, 1.31]
15 Fetal distress 2 362 Risk Ratio (M-H, Fixed, 95%
CI)
0.55 [0.25, 1.21]
 
 
Analysis 39.1.   Comparison 39 Any mechanical method and oxytocin versus low dose misoprostol
alone: all women (not pre-specified), Outcome 1 Vaginal delivery not achieved in 24 hours.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Culver 2004 28/83 51/79 52.12% 0.52[0.37,0.74]
Mullin 2002 21/100 48/100 47.88% 0.44[0.28,0.67]
   
Total (95% CI) 183 179 100% 0.48[0.37,0.63]
Total events: 49 (Mechanical method), 99 (Misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.41, df=1(P=0.52); I2=0%  
Test for overall effect: Z=5.28(P<0.0001)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 39.2.   Comparison 39 Any mechanical method and oxytocin versus low dose misoprostol
alone: all women (not pre-specified), Outcome 2 Uterine hyperstimulation with FHR changes.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Culver 2004 2/83 7/79 51.25% 0.27[0.06,1.27]
Gilson 2017 3/526 4/575 27.31% 0.82[0.18,3.65]
Mullin 2002 1/100 3/100 21.44% 0.33[0.04,3.15]
   
Total (95% CI) 709 754 100% 0.43[0.17,1.11]
Total events: 6 (Mechanical method), 14 (Misoprostol)  
Heterogeneity: Tau2=0; Chi2=1.1, df=2(P=0.58); I2=0%  
Test for overall effect: Z=1.74(P=0.08)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 39.3.   Comparison 39 Any mechanical method and oxytocin versus low dose
misoprostol alone: all women (not pre-specified), Outcome 3 Caesarean section.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Culver 2004 24/83 28/79 13.65% 0.82[0.52,1.28]
Dionne 2011 40/93 35/87 17.2% 1.07[0.76,1.51]
Garba 2016 6/66 14/70 6.46% 0.45[0.19,1.11]
Gilson 2017 101/526 117/575 53.17% 0.94[0.74,1.2]
Mullin 2002 25/100 20/100 9.51% 1.25[0.74,2.1]
   
Total (95% CI) 868 911 100% 0.95[0.8,1.12]
Total events: 196 (Mechanical method), 214 (Misoprostol)  
Heterogeneity: Tau2=0; Chi2=4.58, df=4(P=0.33); I2=12.67%  
Test for overall effect: Z=0.66(P=0.51)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 39.4.   Comparison 39 Any mechanical method and oxytocin versus low dose misoprostol
alone: all women (not pre-specified), Outcome 4 Serious neonatal morbidity/perinatal death.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Culver 2004 0/83 0/79   Not estimable
Gilson 2017 3/526 4/575 100% 0.82[0.18,3.65]
   
Total (95% CI) 609 654 100% 0.82[0.18,3.65]
Total events: 3 (Mechanical method), 4 (Misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.26(P=0.79)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 39.5.   Comparison 39 Any mechanical method and oxytocin versus low dose
misoprostol alone: all women (not pre-specified), Outcome 5 Oxytocin augmentation.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Garba 2016 48/66 6/70 47.59% 8.48[3.89,18.5]
Mullin 2002 100/100 52/100 52.41% 1.91[1.59,2.31]
   
Total (95% CI) 166 170 100% 3.89[0.7,21.72]
Total events: 148 (Mechanical method), 58 (Misoprostol)  
Heterogeneity: Tau2=1.46; Chi2=18.47, df=1(P<0.0001); I2=94.58%  
Test for overall effect: Z=1.55(P=0.12)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 39.6.   Comparison 39 Any mechanical method and oxytocin versus low dose misoprostol
alone: all women (not pre-specified), Outcome 6 Uterine hyperstimulation without FHR changes.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Culver 2004 13/83 17/79 56.47% 0.73[0.38,1.4]
Garba 2016 0/66 2/70 7.87% 0.21[0.01,4.33]
Mullin 2002 3/100 11/100 35.66% 0.27[0.08,0.95]
   
Total (95% CI) 249 249 100% 0.52[0.3,0.92]
Total events: 16 (Mechanical method), 30 (Misoprostol)  
Heterogeneity: Tau2=0; Chi2=2.37, df=2(P=0.31); I2=15.59%  
Test for overall effect: Z=2.25(P=0.02)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 39.7.   Comparison 39 Any mechanical method and oxytocin versus low dose
misoprostol alone: all women (not pre-specified), Outcome 7 Epidural analgesia.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Culver 2004 65/83 58/79 100% 1.07[0.9,1.27]
   
Total (95% CI) 83 79 100% 1.07[0.9,1.27]
Total events: 65 (Mechanical method), 58 (Misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.73(P=0.47)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 39.8.   Comparison 39 Any mechanical method and oxytocin versus low dose
misoprostol alone: all women (not pre-specified), Outcome 8 Meconium-stained liquor.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Culver 2004 11/83 15/79 50.61% 0.7[0.34,1.43]
Mullin 2002 11/100 15/100 49.39% 0.73[0.35,1.52]
   
Total (95% CI) 183 179 100% 0.72[0.43,1.19]
Total events: 22 (Mechanical method), 30 (Misoprostol)  
Heterogeneity: Tau2=0; Chi2=0.01, df=1(P=0.92); I2=0%  
Test for overall effect: Z=1.29(P=0.2)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 39.9.   Comparison 39 Any mechanical method and oxytocin versus low dose
misoprostol alone: all women (not pre-specified), Outcome 9 Apgar score < 7 at 5 minutes.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Culver 2004 3/83 3/79 100% 0.95[0.2,4.58]
   
Total (95% CI) 83 79 100% 0.95[0.2,4.58]
Total events: 3 (Mechanical method), 3 (Misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.06(P=0.95)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 39.10.   Comparison 39 Any mechanical method and oxytocin versus low dose misoprostol
alone: all women (not pre-specified), Outcome 10 Neonatal intensive care unit admission.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Culver 2004 16/83 19/79 21.33% 0.8[0.44,1.45]
Garba 2016 0/66 2/70 2.66% 0.21[0.01,4.33]
Gilson 2017 33/526 59/575 61.77% 0.61[0.41,0.92]
Mullin 2002 10/100 13/100 14.24% 0.77[0.35,1.67]
   
Total (95% CI) 775 824 100% 0.66[0.49,0.9]
Total events: 59 (Mechanical method), 93 (Misoprostol)  
Heterogeneity: Tau2=0; Chi2=1.24, df=3(P=0.74); I2=0%  
Test for overall effect: Z=2.62(P=0.01)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 39.11.   Comparison 39 Any mechanical method and oxytocin versus low
dose misoprostol alone: all women (not pre-specified), Outcome 11 Perinatal death.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Culver 2004 0/83 0/79   Not estimable
Gilson 2017 3/526 4/575 100% 0.82[0.18,3.65]
   
Total (95% CI) 609 654 100% 0.82[0.18,3.65]
Total events: 3 (Mechanical method), 4 (Misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=0.26(P=0.79)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 39.12.   Comparison 39 Any mechanical method and oxytocin versus low dose
misoprostol alone: all women (not pre-specified), Outcome 12 Women not satisfied.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Gilson 2017 256/400 177/466 100% 1.68[1.47,1.93]
   
Total (95% CI) 400 466 100% 1.68[1.47,1.93]
Total events: 256 (Mechanical method), 177 (Misoprostol)  
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=7.45(P<0.0001)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 39.13.   Comparison 39 Any mechanical method and oxytocin versus low
dose misoprostol alone: all women (not pre-specified), Outcome 13 Maternal fever.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Culver 2004 2/83 8/79 44.57% 0.24[0.05,1.09]
Garba 2016 0/66 10/70 55.43% 0.05[0,0.84]
   
Total (95% CI) 149 149 100% 0.13[0.04,0.5]
Total events: 2 (Mechanical method), 18 (Misoprostol)  
Heterogeneity: Tau2=0; Chi2=1.01, df=1(P=0.31); I2=1.06%  
Test for overall effect: Z=2.99(P=0)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
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Analysis 39.14.   Comparison 39 Any mechanical method and oxytocin versus low dose
misoprostol alone: all women (not pre-specified), Outcome 14 Chorioamnionitis.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Mullin 2002 11/100 17/100 100% 0.65[0.32,1.31]
   
Total (95% CI) 100 100 100% 0.65[0.32,1.31]
Total events: 11 (Mechanical method), 17 (Misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.21(P=0.23)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Analysis 39.15.   Comparison 39 Any mechanical method and oxytocin versus low
dose misoprostol alone: all women (not pre-specified), Outcome 15 Fetal distress.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Culver 2004 3/83 12/79 75.45% 0.24[0.07,0.81]
Mullin 2002 6/100 4/100 24.55% 1.5[0.44,5.15]
   
Total (95% CI) 183 179 100% 0.55[0.25,1.21]
Total events: 9 (Mechanical method), 16 (Misoprostol)  
Heterogeneity: Tau2=0; Chi2=4.33, df=1(P=0.04); I2=76.92%  
Test for overall effect: Z=1.49(P=0.14)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
 
 
Comparison 40.   Any mechanical method and oxytocin versus low dose misoprostol alone: all multiparae
Outcome or subgroup title No. of
studies
No. of partici-
pants
Statistical method Effect size
1 Caesarean section 1 136 Risk Ratio (M-H, Fixed, 95% CI) 0.45 [0.19, 1.11]
 
 
Analysis 40.1.   Comparison 40 Any mechanical method and oxytocin versus
low dose misoprostol alone: all multiparae, Outcome 1 Caesarean section.
Study or subgroup Mechani-
cal method
Misoprostol Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Garba 2016 6/66 14/70 100% 0.45[0.19,1.11]
   
Total (95% CI) 66 70 100% 0.45[0.19,1.11]
Total events: 6 (Mechanical method), 14 (Misoprostol)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.73(P=0.08)  
Favours mechanical method 100.1 50.2 20.5 1 Favours misoprostol
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Comparison 41.   Any mechanical method and oxytocin versus oxytocin alone: all women (not pre-specified)
Outcome or subgroup title No. of
studies
No. of
partici-
pants
Statistical method Effect size
1 Vaginal delivery not achieved in 24 hours 2 321 Risk Ratio (M-H, Random, 95%
CI)
0.71 [0.21, 2.40]
2 Caesarean section 6 718 Risk Ratio (M-H, Random, 95%
CI)
0.68 [0.39, 1.20]
3 Serious neonatal morbidity/perinatal
death
2 321 Risk Ratio (M-H, Fixed, 95% CI) 0.71 [0.12, 4.13]
4 Serious maternal morbidity or death 2 321 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Uterine hyperstimulation without FHR
changes
2 199 Risk Ratio (M-H, Fixed, 95% CI) 0.85 [0.34, 2.09]
6 Uterine rupture 1 120 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
7 Epidural analgesia 1 127 Risk Ratio (M-H, Fixed, 95% CI) 1.03 [0.98, 1.09]
8 Instrumental vaginal delivery 3 293 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.48, 2.02]
9 Meconium-stained liquor 3 319 Risk Ratio (M-H, Fixed, 95% CI) 0.72 [0.32, 1.63]
10 Neonatal intensive care unit admission 3 400 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.61, 1.58]
11 Postpartum haemorrhage 3 319 Risk Ratio (M-H, Fixed, 95% CI) 1.18 [0.44, 3.18]
12 Serious maternal complications 1 201 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 Antibiotics during labour 1 201 Risk Ratio (M-H, Fixed, 95% CI) 2.32 [0.82, 6.55]
14 Chorionamnionitis 2 328 Risk Ratio (M-H, Random, 95%
CI)
4.34 [0.55, 34.01]
15 Endometritis 3 374 Risk Ratio (M-H, Fixed, 95% CI) 1.08 [0.16, 7.45]
16 Fetal distress 3 400 Risk Ratio (M-H, Fixed, 95% CI) 1.37 [0.68, 2.77]
 
 
Analysis 41.1.   Comparison 41 Any mechanical method and oxytocin versus oxytocin
alone: all women (not pre-specified), Outcome 1 Vaginal delivery not achieved in 24 hours.
Study or subgroup Mechani-
cal method
Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Mackeen 2018 32/93 28/108 49.54% 1.33[0.87,2.03]
Wu 2017 21/60 54/60 50.46% 0.39[0.27,0.55]
   
Favours mechanical method 100.1 50.2 20.5 1 Favours oxytocin
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Study or subgroup Mechani-
cal method
Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Total (95% CI) 153 168 100% 0.71[0.21,2.4]
Total events: 53 (Mechanical method), 82 (Oxytocin)  
Heterogeneity: Tau2=0.72; Chi2=19.17, df=1(P<0.0001); I2=94.78%  
Test for overall effect: Z=0.54(P=0.59)  
Favours mechanical method 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 41.2.   Comparison 41 Any mechanical method and oxytocin versus
oxytocin alone: all women (not pre-specified), Outcome 2 Caesarean section.
Study or subgroup Mechani-
cal method
Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Amorosa 2017 18/61 16/66 20.46% 1.22[0.68,2.17]
El Khouly 2017 10/36 15/36 19.31% 0.67[0.35,1.28]
Lyndrup 1989 1/22 4/24 5.66% 0.27[0.03,2.26]
Mackeen 2018 25/93 21/108 21.45% 1.38[0.83,2.3]
Tita 2006 11/79 17/73 18.78% 0.6[0.3,1.19]
Wu 2017 4/60 22/60 14.34% 0.18[0.07,0.5]
   
Total (95% CI) 351 367 100% 0.68[0.39,1.2]
Total events: 69 (Mechanical method), 95 (Oxytocin)  
Heterogeneity: Tau2=0.32; Chi2=17.15, df=5(P=0); I2=70.85%  
Test for overall effect: Z=1.32(P=0.19)  
Favours mechanical method 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 41.3.   Comparison 41 Any mechanical method and oxytocin versus oxytocin alone:
all women (not pre-specified), Outcome 3 Serious neonatal morbidity/perinatal death.
Study or subgroup Mechani-
cal method
Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Mackeen 2018 1/93 1/108 31.63% 1.16[0.07,18.31]
Wu 2017 1/60 2/60 68.37% 0.5[0.05,5.37]
   
Total (95% CI) 153 168 100% 0.71[0.12,4.13]
Total events: 2 (Mechanical method), 3 (Oxytocin)  
Heterogeneity: Tau2=0; Chi2=0.21, df=1(P=0.65); I2=0%  
Test for overall effect: Z=0.38(P=0.7)  
Favours mechanical method 100.1 50.2 20.5 1 Favours oxytocin
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Analysis 41.4.   Comparison 41 Any mechanical method and oxytocin versus oxytocin
alone: all women (not pre-specified), Outcome 4 Serious maternal morbidity or death.
Study or subgroup Mechani-
cal method
Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Mackeen 2018 0/93 0/108   Not estimable
Wu 2017 0/60 0/60   Not estimable
   
Total (95% CI) 153 168 Not estimable
Total events: 0 (Mechanical method), 0 (Oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours mechanical method 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 41.5.   Comparison 41 Any mechanical method and oxytocin versus oxytocin alone:
all women (not pre-specified), Outcome 5 Uterine hyperstimulation without FHR changes.
Study or subgroup Mechani-
cal method
Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Amorosa 2017 7/61 8/66 83.67% 0.95[0.37,2.45]
El Khouly 2017 0/36 1/36 16.33% 0.33[0.01,7.92]
   
Total (95% CI) 97 102 100% 0.85[0.34,2.09]
Total events: 7 (Mechanical method), 9 (Oxytocin)  
Heterogeneity: Tau2=0; Chi2=0.39, df=1(P=0.53); I2=0%  
Test for overall effect: Z=0.36(P=0.72)  
Favours mechanical method 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 41.6.   Comparison 41 Any mechanical method and oxytocin versus
oxytocin alone: all women (not pre-specified), Outcome 6 Uterine rupture.
Study or subgroup Mechani-
cal method
Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Wu 2017 0/60 0/60   Not estimable
   
Total (95% CI) 60 60 Not estimable
Total events: 0 (Mechanical method), 0 (Oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours mechanical method 100.1 50.2 20.5 1 Favours oxytocin
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Analysis 41.7.   Comparison 41 Any mechanical method and oxytocin versus
oxytocin alone: all women (not pre-specified), Outcome 7 Epidural analgesia.
Study or subgroup Mechani-
cal method
Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Amorosa 2017 61/61 64/66 100% 1.03[0.98,1.09]
   
Total (95% CI) 61 66 100% 1.03[0.98,1.09]
Total events: 61 (Mechanical method), 64 (Oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.12(P=0.26)  
Favours mechanical method 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 41.8.   Comparison 41 Any mechanical method and oxytocin versus oxytocin
alone: all women (not pre-specified), Outcome 8 Instrumental vaginal delivery.
Study or subgroup Mechani-
cal method
Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Amorosa 2017 7/61 7/66 49.62% 1.08[0.4,2.91]
Lyndrup 1989 2/22 4/24 28.24% 0.55[0.11,2.69]
Wu 2017 4/60 3/60 22.14% 1.33[0.31,5.7]
   
Total (95% CI) 143 150 100% 0.99[0.48,2.02]
Total events: 13 (Mechanical method), 14 (Oxytocin)  
Heterogeneity: Tau2=0; Chi2=0.73, df=2(P=0.69); I2=0%  
Test for overall effect: Z=0.04(P=0.97)  
Favours mechanical method 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 41.9.   Comparison 41 Any mechanical method and oxytocin versus
oxytocin alone: all women (not pre-specified), Outcome 9 Meconium-stained liquor.
Study or subgroup Mechani-
cal method
Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Amorosa 2017 4/61 6/66 45.16% 0.72[0.21,2.43]
El Khouly 2017 1/36 2/36 15.67% 0.5[0.05,5.27]
Wu 2017 4/60 5/60 39.17% 0.8[0.23,2.83]
   
Total (95% CI) 157 162 100% 0.72[0.32,1.63]
Total events: 9 (Mechanical method), 13 (Oxytocin)  
Heterogeneity: Tau2=0; Chi2=0.12, df=2(P=0.94); I2=0%  
Test for overall effect: Z=0.79(P=0.43)  
Favours mechanical method 100.1 50.2 20.5 1 Favours oxytocin
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Analysis 41.10.   Comparison 41 Any mechanical method and oxytocin versus oxytocin
alone: all women (not pre-specified), Outcome 10 Neonatal intensive care unit admission.
Study or subgroup Mechani-
cal method
Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Amorosa 2017 4/61 8/66 27.26% 0.54[0.17,1.71]
El Khouly 2017 1/36 2/36 7.09% 0.5[0.05,5.27]
Mackeen 2018 21/93 20/108 65.65% 1.22[0.71,2.11]
   
Total (95% CI) 190 210 100% 0.98[0.61,1.58]
Total events: 26 (Mechanical method), 30 (Oxytocin)  
Heterogeneity: Tau2=0; Chi2=1.95, df=2(P=0.38); I2=0%  
Test for overall effect: Z=0.07(P=0.95)  
Favours mechanical method 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 41.11.   Comparison 41 Any mechanical method and oxytocin versus oxytocin
alone: all women (not pre-specified), Outcome 11 Postpartum haemorrhage.
Study or subgroup Mechani-
cal method
Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Amorosa 2017 5/61 2/66 27.76% 2.7[0.54,13.43]
El Khouly 2017 1/36 2/36 28.9% 0.5[0.05,5.27]
Wu 2017 2/60 3/60 43.34% 0.67[0.12,3.85]
   
Total (95% CI) 157 162 100% 1.18[0.44,3.18]
Total events: 8 (Mechanical method), 7 (Oxytocin)  
Heterogeneity: Tau2=0; Chi2=1.95, df=2(P=0.38); I2=0%  
Test for overall effect: Z=0.34(P=0.74)  
Favours mechanical method 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 41.12.   Comparison 41 Any mechanical method and oxytocin versus oxytocin
alone: all women (not pre-specified), Outcome 12 Serious maternal complications.
Study or subgroup Mechani-
cal method
Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Mackeen 2018 0/93 0/108   Not estimable
   
Total (95% CI) 93 108 Not estimable
Total events: 0 (Mechanical method), 0 (Oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Not applicable  
Favours mechanical method 100.1 50.2 20.5 1 Favours oxytocin
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Analysis 41.13.   Comparison 41 Any mechanical method and oxytocin versus
oxytocin alone: all women (not pre-specified), Outcome 13 Antibiotics during labour.
Study or subgroup Mechani-
cal method
Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Mackeen 2018 10/93 5/108 100% 2.32[0.82,6.55]
   
Total (95% CI) 93 108 100% 2.32[0.82,6.55]
Total events: 10 (Mechanical method), 5 (Oxytocin)  
Heterogeneity: Not applicable  
Test for overall effect: Z=1.59(P=0.11)  
Favours mechanical method 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 41.14.   Comparison 41 Any mechanical method and oxytocin versus
oxytocin alone: all women (not pre-specified), Outcome 14 Chorionamnionitis.
Study or subgroup Mechani-
cal method
Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Random, 95% CI   M-H, Random, 95% CI
Amorosa 2017 6/61 3/66 66.59% 2.16[0.57,8.28]
Mackeen 2018 7/93 0/108 33.41% 17.39[1.01,300.51]
   
Total (95% CI) 154 174 100% 4.34[0.55,34.01]
Total events: 13 (Mechanical method), 3 (Oxytocin)  
Heterogeneity: Tau2=1.19; Chi2=1.92, df=1(P=0.17); I2=47.93%  
Test for overall effect: Z=1.4(P=0.16)  
Favours mechanical method 100.1 50.2 20.5 1 Favours oxytocin
 
 
Analysis 41.15.   Comparison 41 Any mechanical method and oxytocin versus
oxytocin alone: all women (not pre-specified), Outcome 15 Endometritis.
Study or subgroup Mechani-
cal method
Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Amorosa 2017 2/61 2/66 100% 1.08[0.16,7.45]
Lyndrup 1989 0/22 0/24   Not estimable
Mackeen 2018 0/93 0/108   Not estimable
   
Total (95% CI) 176 198 100% 1.08[0.16,7.45]
Total events: 2 (Mechanical method), 2 (Oxytocin)  
Heterogeneity: Tau2=0; Chi2=0, df=0(P<0.0001); I2=100%  
Test for overall effect: Z=0.08(P=0.94)  
Favours mechanical method 100.1 50.2 20.5 1 Favours oxytocin
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Analysis 41.16.   Comparison 41 Any mechanical method and oxytocin versus
oxytocin alone: all women (not pre-specified), Outcome 16 Fetal distress.
Study or subgroup Mechani-
cal method
Oxytocin Risk Ratio Weight Risk Ratio
  n/N n/N M-H, Fixed, 95% CI   M-H, Fixed, 95% CI
Amorosa 2017 4/61 5/66 38.87% 0.87[0.24,3.08]
El Khouly 2017 1/36 2/36 16.19% 0.5[0.05,5.27]
Mackeen 2018 11/93 6/108 44.94% 2.13[0.82,5.53]
   
Total (95% CI) 190 210 100% 1.37[0.68,2.77]
Total events: 16 (Mechanical method), 13 (Oxytocin)  
Heterogeneity: Tau2=0; Chi2=2.03, df=2(P=0.36); I2=1.24%  
Test for overall effect: Z=0.89(P=0.37)  
Favours mechanical method 100.1 50.2 20.5 1 Favours oxytocin
 
 
A P P E N D I C E S
Appendix 1. ICTRP and ClinicalTrials.gov - search methods
ICTRP
Each line was run separately
foley AND induction
foley AND ripening
catheter AND induction
catheter AND ripening
balloon AND induction
balloon AND ripening
laminaria AND induction
laminaria AND ripening
lamicel AND induction
lamicel AND ripening
extraamniotic AND induction
extraamniotic AND ripening
dilapan AND induction
dilapan AND ripening
ClinicalTrials.gov
Advanced search
Interventional studies | cervical ripening | catheter
Interventional studies | induction of labor | catheter
Interventional studies | cervical ripening | balloon
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Interventional studies | induction of labor | balloon
Interventional studies | cervical ripening | foley
Interventional studies | induction of labor | foley
Interventional studies | cervical ripening | mechanical
Interventional studies | induction of labor | mechanical
Interventional studies | cervical ripening | laminaria
Interventional studies | induction of labor | laminaria
Interventional studies | cervical ripening | lamicel
Interventional studies | induction of labor | lamicel
Interventional studies | cervical ripening | dilapan
Interventional studies | induction of labor | dilapan
Interventional studies | cervical ripening | extraamniotic
Interventional studies | induction of labor | extraamniotic
W H A T ' S   N E W
 
Date Event Description
9 January 2018 New citation required and conclusions
have changed
In this updated review, there is now evidence that mechanical in-
duction of labour with a balloon probably is as effective as vagi-
nal prostaglandin E2 (PGE2), but safer for the neonate. A balloon
catheter may be slightly less effective as oral misoprostol, but
It remains unclear if there is a difference in safety outcomes for
the neonate. When compared to low-dose vaginal misoprostol, a
balloon catheter may be less effective, but probably has a better
safety profile.
9 January 2018 New search has been performed Search updated. We included 60 new studies and excluded 74
new studies. Eighteen studies (previous included) are now ex-
cluded as they are no longer eligible. Also, 21 ongoing studies
were identified (Ongoing studies) and two studies are awaiting
further classification (Agboghoroma 2015; Mallah 2011).
We updated the search on 19 March 2019 and added a further
38 trial reports to Studies awaiting classification for the next up-
date. The references have been assessed but not incorporated
into the review. Only seven of these trials are likely to contribute
data for this review and are mainly small trials (Khatib 2019; Lim
2018; Osoti 2018; Souizi 2018; ten Eikelder 2017; Tulek 2018; Vi-
teri 2019). We imputed the data for these trials and there is no
change in results (not in direction or strength of the evidence).
We will incorporate these trials fully at the next update.
For this review, studies with high-dose misoprostol were exclud-
ed. Balloons, laminaria tents and extra-amniotic space infusion
(EASI) were compared separately with other pharmacological
methods and new comparisons were included. Comparisons
with no intervention or placebo were excluded.
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H I S T O R Y
Protocol first published: Issue 2, 2000
Review first published: Issue 4, 2001
 
Date Event Description
30 September 2011 New citation required and conclusions
have changed
New trials were added and the review was edited accordingly:
the conclusion on primary outcome delivery before 24 hours has
changed, partly due to change in statistical method (random-ef-
fects model, due to substantial heterogeneity). Also, some con-
clusions on secondary outcome measures have changed.
We updated the search on 16 January 2012 and added the results
to Studies awaiting classification for consideration in the next
update.
30 April 2011 New search has been performed Search updated. We have included 27 new studies and excluded
28 new studies. One trial (previously included) has now been re-
classified as excluded (Abramovici 1999). Four new ongoing stud-
ies have also been identified (Hallak 2008a; Jozwiak 2009a; Lin
2006a; Manyonda 2007a).
18 September 2008 Amended Converted to new review format.
 
C O N T R I B U T I O N S   O F   A U T H O R S
For this update, M de Vaan, M ten Eikelder, KR Palmer and BW Mol performed data extraction. Risk of bias was assessed by M de Vaan, M ten
Eikelder, KR Palmer and M Jozwiak. Marieke de Vaan and Marta Jozwiak entered the data and the review was drafted M de Vaan, which was
finalised after feedback from M. ten Eikelder, M Jozwiak, KR Palmer, M Davies, K Bloemenkamp, BW Mol and M Boulvain. M. ten Eikelder,
M. Jozwiak and BW Mol were not involved in data extraction nor in the 'Risk of bias' assessment of Jozwiak 2012; Jozwiak 2013; Jozwiak
2014; ten Eikelder 2016, due to their authorship.
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Marta Jozwiak is co-author of four included trials (Jozwiak 2012; Jozwiak 2013; Jozwiak 2014; ten Eikelder 2016). She has not been involved
in 'Risk of bias' assessment and data extraction of these studies.
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Miranda Davies-Tuck: none known.
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External sources• Marieke de Vaan received a grant from The Netherlands Organisation for Scientific Research (NWO), Netherlands.
grant number: 023.011.051
D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
Comparisons of a balloon catheter with concurrent oxytocin or prostaglandins versus prostaglandins or oxytocin alone were added. Also,
comparisons of a single versus a double balloon and different forms of laminaria tents were added. The comparisons with placebo/no
treatment were excluded. Regarding studies where a comparison was made with misoprostol, we chose only to include studies in which
low-dose misoprostol was used. A number of non pre-specified outcomes relevant to the comparisons made in this review were added
(maternal fever, antibiotics during labour, endometritis, chorioamnionitis. fetal distress, umbilical artery pH < 7.10).
For this update, we have also searched ClinicalTrials.gov, the WHO International Clinical Trials Registry Platform (ICTRP).
I N D E X   T E R M S
Medical Subject Headings (MeSH)
*Cervical Ripening;   *Laminaria;   *Oxytocics;   Catheterization   [*methods];   Cervix Uteri;   Dinoprostone;   Labor, Induced   [*methods];
  Misoprostol;  Oxytocin;  Pessaries;  Polymers;  Randomized Controlled Trials as Topic
MeSH check words
Female; Humans; Pregnancy
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